{"actualizat":"2026-10-31","studii":[{"id":"NCT04613596","t":"Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7","dn":"KRYSTAL-7","sp":"Mirati Therapeutics Inc.","c":["Advanced Non-Small Cell Lung Cancer","Metastatic Non-Small Cell Lung Cancer"],"iv":["Adagrasib","Pembrolizumab"],"ivro":["adagrasib","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["kras","pdl1"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Adagrasib cu pembrolizumab față de pembrolizumab singur, ca prim tratament în cancerul pulmonar avansat cu mutație KRAS G12C"},"loc":[[62,"RECRUITING",[]],[76,"RECRUITING",[]],[45,"RECRUITING",[]],[63,"RECRUITING",[]],[135,"RECRUITING",[]]]},{"id":"NCT06299839","t":"PAS-004 in Patients With Advanced Solid Tumors","sp":"Pasithea Therapeutics Corp.","c":["RAS Mutation","NF1 Mutation","RAF Mutation","Advanced Solid Tumors"],"iv":["PAS-004 Capsules","PAS-004 Tablets"],"ivro":["PAS-004"],"d":["onco"],"tu":["solide"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"PAS-004, un inhibitor MEK, în tumorile solide avansate cu mutații RAS, NF1 sau RAF (studiu de fază 1)"},"loc":[[62,"RECRUITING",[[372,"c"],[142,"pi"]]],[8,"RECRUITING",[[373,"c"],[64,"pi"]]]]},{"id":"NCT06237452","t":"VE303 for Prevention of Recurrent Clostridioides Difficile Infection","dn":"RESTORATiVE303","sp":"Vedanta Biosciences, Inc.","c":["Clostridium Difficile","Clostridium Difficile Infections","Clostridium Difficile Infection Recurrence","Clostridioides Difficile Infection","Clostridioides Difficile Infection Recurrence","CDI","C. Diff Infection","Recurrent Clostridium Difficile Infection"],"iv":["VE303"],"ivro":["VE303"],"d":["gastro","inf"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"VE303 față de placebo pentru prevenirea revenirii infecției cu Clostridioides difficile (RESTORATiVE303)"},"loc":[[162,"RECRUITING",[[529,"c"]]],[161,"RECRUITING",[[530,"c"]]],[417,"ACTIVE_NOT_RECRUITING",[]],[60,"WITHDRAWN",[]],[418,"RECRUITING",[[531,"c"]]],[140,"WITHDRAWN",[]]]},{"id":"NCT06920004","t":"A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP","dn":"emvigorate","sp":"argenx","c":["Chronic Inflammatory Demyelinating Polyneuropathy","CIDP","CIDP - Chronic Inflammatory Demyelinating Polyneuropathy"],"iv":["empasiprubart","IVIg","empasiprubart-placebo","IVIg-placebo"],"ivro":["empasiprubart","IVIg","imunoglobulină intravenoasă"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Empasiprubart față de imunoglobulina intravenoasă la adulții cu polineuropatie demielinizantă inflamatorie cronică (CIDP)"},"loc":[[425,"RECRUITING",[[544,"pi"]]],[425,"RECRUITING",[[544,"c"]]],[354,"RECRUITING",[[526,"pi"]]],[92,"RECRUITING",[[545,"pi"]]]]},{"id":"NCT06623422","t":"A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)","dn":"INTerpath-009 (V940-009)","sp":"Merck Sharp & Dohme LLC","c":["Carcinoma, Non-Small-Cell Lung"],"iv":["Pembrolizumab","Cisplatin","Carboplatin","Pemetrexed","Gemcitabine","Paclitaxel","Intismeran autogene"],"ivro":["pembrolizumab","cisplatină","carboplatină","pemetrexed","gemcitabină","paclitaxel"],"d":["onco"],"tu":["nsclc"],"bm":["egfr"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pembrolizumab cu sau fără intismeran autogene (V940) după operație, în cancerul pulmonar fără celule mici operabil, stadiile II–IIIB (N2)"},"loc":[[149,"RECRUITING",[[136,"pi"]],null,{"can_enroll":true,"own_centre":true}],[9,"RECRUITING",[[163,"pi"]]],[32,"RECRUITING",[]],[25,"RECRUITING",[[503,"pi"]]],[139,"UNKNOWN",[[127,"pi"]]]]},{"id":"NCT06619990","t":"Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis","sp":"Xencor, Inc.","c":["Ulcerative Colitis (UC)"],"iv":["XmAb942"],"ivro":["XmAb942"],"d":["gastro"],"f":"1/2","tip":"I","vmin":18,"vmax":75,"vs":1,"content_status":"complete","ro":{"titlu":"XmAb942 la voluntari sănătoși și la pacienții cu colită ulcerativă activă moderată sau severă"},"loc":[[5,"RECRUITING",[]],[179,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[186,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07504458","t":"Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia","dn":"QUATRO-APL","sp":"Quetzal Therapeutics","c":["Acute Promyelocytic Leukemia (APL)","Acute Promyelocytic Leukaemia","Acute Promyelocytic Leukemia With PML-RARA","Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA","Acute Promyelocytic Leukemia"],"iv":["QTX-2101 + ATRA","IV arsenic trioxide (ATO) + ATRA"],"ivro":["trioxid de arsen","ATRA","QTX-2101","trioxid de arsen","ATRA","Trioxid de arsen"],"d":["onco"],"tu":["lam"],"bm":["pmlrara"],"f":"3","tip":"I","vmin":18,"vmax":71,"content_status":"complete","ro":{"titlu":"Trioxid de arsen oral (QTX-2101) cu ATRA în leucemia acută promielocitară nou diagnosticată, cu risc scăzut"},"loc":[[8,"RECRUITING",[[37,"pi"]]],[30,"UNKNOWN",[[34,"pi"]]],[31,"UNKNOWN",[[27,"pi"]]],[28,"UNKNOWN",[[22,"pi"]]],[29,"UNKNOWN",[[23,"pi"]]],[27,"UNKNOWN",[[48,"pi"]]],[25,"UNKNOWN",[[686,"pi"]]]]},{"id":"NCT07907224","t":"Characterization of Small Intestinal Bacterial Overgrowth and Intestinal Barrier-Related Biomarkers in Patients With Severe Periodontitis: A Pilot Prospective Longitudinal Observational Cohort Study","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Periodontitis (Stage 3)","Periodontitis Stage IV","SIBO"],"iv":[],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic — medicină","gen":1},"loc":[[529,"RECRUITING",[]]]},{"id":"NCT07562152","t":"Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma","sp":"Immuneering Corporation","c":["Pancreatic Cancer","Pancreatic Cancer Metastatic","PDAC","PDAC - Pancreatic Ductal Adenocarcinoma","Pancreatic Ductal Adenocarcinoma","Pancreatic Adenocarcinoma Metastatic","Pancreatic Ductal Adenocarcinoma (PDAC)","Pancreatic Adenocarcinoma"],"iv":["Atebimetinib","GnP","mGnP"],"d":["onco"],"tu":["pancreas"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — Cancer pancreatic","gen":1},"loc":[[210,"RECRUITING",[]],[139,"RECRUITING",[]]]},{"id":"NCT07037459","t":"Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity","dn":"MARITIME-HF","sp":"Amgen","c":["Heart Failure With Preserved Ejection Fraction","Heart Failure With Mildly Reduced Ejection Fraction","Obesity"],"iv":["Maridebart cafraglutide"],"ivro":["maridebart cafraglutidă"],"d":["cardio","metab"],"f":"3","tip":"I","vmin":18,"vmax":99,"content_status":"complete","ro":{"titlu":"Maridebart cafraglutidă în insuficiența cardiacă cu fracție de ejecție păstrată sau ușor redusă, la persoane cu obezitate"},"loc":[[229,"RECRUITING",[]],[262,"RECRUITING",[]],[103,"RECRUITING",[]],[12,"RECRUITING",[]],[31,"RECRUITING",[]],[252,"RECRUITING",[]],[232,"RECRUITING",[]],[95,"RECRUITING",[]],[92,"RECRUITING",[]],[88,"RECRUITING",[]],[28,"RECRUITING",[]]]},{"id":"NCT05696626","t":"Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation","dn":"ELAINE-3","sp":"LeonaBio","c":["Metastatic Breast Cancer"],"iv":["Lasofoxifene in combination with abemaciclib","Fulvestrant in combination with abemaciclib"],"ivro":["Lasofoxifen","abemaciclib","Fulvestrant"],"d":["onco"],"tu":["san_hr","san"],"bm":["esr1","hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Lasofoxifen cu abemaciclib, comparat cu fulvestrant cu abemaciclib, în cancerul de sân ER+/HER2-negativ avansat cu mutație ESR1"},"loc":[[389,"WITHDRAWN",[]],[71,"RECRUITING",[[61,"c"]]],[45,"RECRUITING",[[62,"c"]]],[74,"COMPLETED",[]],[10,"RECRUITING",[[5,"c"]]],[150,"RECRUITING",[[137,"c"]]],[9,"RECRUITING",[[163,"c"]]]]},{"id":"NCT06422143","t":"Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]","dn":"TroFuse-023 (MK-2870-023)","sp":"Merck Sharp & Dohme LLC","c":["Non-small Cell Lung Cancer","NSCLC"],"iv":["Pembrolizumab","sac-TMT","Carboplatin","Paclitaxel","Nab-paclitaxel"],"ivro":["pembrolizumab","carboplatină","paclitaxel","nab-paclitaxel","sacituzumab tirumotecan"],"d":["onco"],"tu":["nsclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pembrolizumab cu sau fără sacituzumab tirumotecan ca tratament de întreținere în cancerul pulmonar scuamos metastatic"},"loc":[[149,"ACTIVE_NOT_RECRUITING",[[136,"pi"]],null,{"can_enroll":false,"own_centre":true}],[44,"RECRUITING",[[63,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[9,"RECRUITING",[[163,"pi"]]],[32,"RECRUITING",[[409,"pi"]]],[99,"RECRUITING",[[403,"pi"]]],[2,"RECRUITING",[[132,"pi"]]]]},{"id":"NCT04928846","t":"A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","sp":"AbbVie","c":["Non Small Cell Lung Cancer","c-MET"],"iv":["Telisotuzumab Vedotin","Docetaxel"],"ivro":["telisotuzumab vedotin","docetaxel"],"d":["onco"],"tu":["nsclc"],"bm":["met","egfr"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Telisotuzumab vedotin comparat cu docetaxel în cancerul pulmonar nonscuamos tratat anterior, cu supraexpresie c-Met"},"loc":[[151,"RECRUITING",[[498,"pi"]]],[44,"RECRUITING",[[63,"pi"]]],[11,"RECRUITING",[[6,"pi"]]],[148,"RECRUITING",[[133,"pi"]]],[135,"RECRUITING",[[164,"pi"]]],[12,"RECRUITING",[[499,"pi"]]],[25,"RECRUITING",[[234,"pi"]]],[139,"RECRUITING",[[127,"pi"]]]]},{"id":"NCT07221734","t":"Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma","sp":"mAbxience Research S.L.","c":["Advanced (Unresectable or Metastatic) Melanoma"],"iv":["MB11 (Proposed Nivolumab Biosimilar)","EU-Opdivo®","US- sourced Opdivo®"],"d":["onco"],"tu":["melanom"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — Melanom","gen":1},"loc":[[4,"RECRUITING",[]]]},{"id":"NCT05814237","t":"POS-ARI-ER Observational Study of Acute Respiratory Infections","sp":"European Clinical Research Alliance for Infectious Diseases (ECRAID)","c":["Acute Respiratory Infection","Acute Respiratory Tract Infection"],"iv":["Data collection"],"d":["inf"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic — boli infecțioase","gen":1},"loc":[[47,"COMPLETED",[]],[341,"RECRUITING",[]],[161,"COMPLETED",[]],[513,"COMPLETED",[]]]},{"id":"NCT06615479","t":"A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)","dn":"QUINTESSENTIAL-2","sp":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","c":["Relapsed or Refractory Multiple Myeloma (RRMM)"],"iv":["BMS-986393","Cyclophosphamide","Fludarabine","Daratumumab","Pomalidomide","Dexamethasone","Carfilzomib"],"ivro":["Arlocabtagene autoleucel","ciclofosfamidă","fludarabină","daratumumab","pomalidomidă","carfilzomib"],"d":["onco"],"tu":["mielom"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Terapia CAR-T arlocabtagene autoleucel față de tratamentele standard în mielomul multiplu recidivat, expus la lenalidomidă"},"loc":[[30,"RECRUITING",[]],[31,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT07355296","t":"PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease","dn":"PODOMOUNT-Basket","sp":"Boehringer Ingelheim","c":["Proteinuric Kidney Diseases"],"iv":["BI 764198"],"ivro":["BI 764198"],"d":["alte"],"f":"2","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"BI 764198 comparat cu placebo în patru boli de rinichi cu pierdere de proteine în urină (PODOMOUNT-Basket)"},"loc":[[30,"RECRUITING",[]],[140,"RECRUITING",[]]]},{"id":"NCT00231400","t":"Pompe Disease Registry Protocol","sp":"Genzyme, a Sanofi Company","c":["Glycogen Storage Disease Type II","Pompe Disease"],"iv":[],"d":["metab","neuro"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul internațional al bolii Pompe"},"loc":[[5,"RECRUITING",[]]]},{"id":"NCT06281899","t":"Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus","sp":"Anemia Working Group Romania","c":["Chronic Kidney Diseases","Type 2 Diabetes Mellitus"],"iv":["Dapagliflozin 10 mg Tab","Low protein diet"],"d":["metab","nefro","gin"],"f":"4","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 4 — diabet și endocrinologie, nefrologie și urologie, obstetrică-ginecologie","gen":1},"loc":[[341,"RECRUITING",[]]],"ofi":[]},{"id":"NCT06424288","t":"A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure","dn":"EASi-HF Preserved","sp":"Boehringer Ingelheim","c":["Heart Failure"],"iv":["vicadrostat","empagliflozin"],"ivro":["vicadrostat","empagliflozin"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Vicadrostat adăugat la empagliflozin în insuficiența cardiacă cu fracție de ejecție de cel puțin 40%"},"loc":[[380,"RECRUITING",[[267,"pi"]]],[49,"RECRUITING",[[240,"pi"]]],[251,"RECRUITING",[[254,"pi"]]],[96,"RECRUITING",[[83,"pi"]]],[31,"RECRUITING",[[89,"pi"]]],[381,"RECRUITING",[[444,"pi"]]],[43,"RECRUITING",[[447,"pi"]]],[382,"RECRUITING",[]],[14,"RECRUITING",[[95,"pi"]]],[42,"RECRUITING",[[446,"pi"]]],[105,"RECRUITING",[[448,"pi"]]],[95,"RECRUITING",[[82,"pi"]]],[92,"RECRUITING",[[77,"pi"]]],[92,"RECRUITING",[]],[88,"RECRUITING",[[72,"pi"]]],[104,"RECRUITING",[[94,"pi"]]],[90,"UNKNOWN",[[74,"pi"]]],[383,"UNKNOWN",[[445,"pi"]]]]},{"id":"NCT07064473","t":"EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease","dn":"EASi-PROTKT","sp":"Boehringer Ingelheim","c":["Diabetes Mellitus, Type 2","Hypertension","Cardiovascular Diseases"],"iv":["Vicadrostat","Empagliflozin"],"ivro":["vicadrostat","empagliflozin"],"d":["cardio","metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Vicadrostat împreună cu empagliflozin, comparat cu placebo împreună cu empagliflozin, la persoanele cu diabet de tip 2, hipertensiune și boală cardiovasculară (EASi-PROTKT)"},"loc":[[384,"RECRUITING",[[450,"pi"]]],[205,"RECRUITING",[[202,"pi"]]],[262,"RECRUITING",[[267,"pi"]]],[381,"RECRUITING",[[444,"pi"]]],[240,"RECRUITING",[[242,"pi"]]],[231,"RECRUITING",[[255,"pi"]]],[50,"RECRUITING",[[452,"pi"]]],[138,"RECRUITING",[[220,"pi"]]],[31,"RECRUITING",[[89,"pi"]]],[385,"RECRUITING",[[449,"pi"]]],[252,"COMPLETED",[[259,"pi"]]],[225,"RECRUITING",[[207,"pi"]]],[253,"RECRUITING",[[260,"pi"]]],[232,"RECRUITING",[]],[243,"RECRUITING",[[246,"pi"]]],[233,"RECRUITING",[[247,"pi"]]],[95,"RECRUITING",[[82,"pi"]]],[92,"RECRUITING",[[77,"pi"]]],[234,"RECRUITING",[[262,"pi"],[251,"pi"]]],[88,"RECRUITING",[[72,"pi"]]],[386,"RECRUITING",[[451,"pi"]]],[247,"RECRUITING",[[252,"pi"]]],[104,"RECRUITING",[[94,"pi"]]]]},{"id":"NCT07902141","t":"A Web-based Intervention Program for Postpartum Depression","sp":"Babes-Bolyai University","c":["Postpartum Depression (PPD)","Web-based Intervention"],"iv":["Web-based program for postpartum depression"],"d":["psih","nefro","gin"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 1 — psihiatrie, nefrologie și urologie, obstetrică-ginecologie","gen":1},"loc":[[78,"RECRUITING",[]]]},{"id":"NCT07409181","t":"A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)","sp":"Boehringer Ingelheim","c":["Systemic Lupus Erythematosus"],"iv":["BI 3000202"],"ivro":["BI 3000202"],"d":["reum","derm"],"f":"2","tip":"I","vmin":18,"vmax":74,"content_status":"complete","ro":{"titlu":"BI 3000202 în patru doze față de placebo, adăugat la tratamentul de fond, în lupusul eritematos sistemic moderat–sever"},"loc":[[13,"RECRUITING",[[10,"pi"]]],[176,"RECRUITING",[[175,"pi"]]],[373,"RECRUITING",[[508,"pi"]]],[30,"NOT_YET_RECRUITING",[[75,"pi"]]]]},{"id":"NCT07116967","t":"Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)","dn":"PRAGMATYK","sp":"Bristol-Myers Squibb","c":["Plaque Psoriasis"],"iv":["Deucravacitinib","Ustekinumab"],"ivro":["deucravacitinib","ustekinumab"],"d":["alte"],"f":"3","tip":"I","vmin":40,"vmax":null,"content_status":"complete","ro":{"titlu":"Siguranța pe termen lung a deucravacitinib comparativ cu ustekinumab în psoriazisul în plăci moderat–sever"},"loc":[[447,"RECRUITING",[]],[12,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[55,"RECRUITING",[]],[23,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[457,"RECRUITING",[]],[458,"RECRUITING",[]],[459,"RECRUITING",[]]]},{"id":"NCT06858579","t":"A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)","dn":"CAPTIVATE","sp":"Dianthus Therapeutics","c":["Chronic Inflammatory Demyelinating Polyneuropathy"],"iv":["Claseprubart"],"ivro":["claseprubart"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Claseprubart (DNTH103) față de placebo la adulții cu polineuropatie demielinizantă inflamatorie cronică (CIDP)"},"loc":[[5,"RECRUITING",[]],[18,"RECRUITING",[]]]},{"id":"NCT06935370","t":"A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart","dn":"EASi-HF Reduced","sp":"Boehringer Ingelheim","c":["Heart Failure"],"iv":["vicadrostat","empagliflozin"],"ivro":["vicadrostat","empagliflozin"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Vicadrostat asociat cu empagliflozin, comparat cu placebo și empagliflozin, în insuficiența cardiacă cronică cu fracție de ejecție sub 40%"},"loc":[[380,"RECRUITING",[[267,"pi"]]],[49,"RECRUITING",[[240,"pi"]]],[251,"RECRUITING",[[254,"pi"]]],[141,"RECRUITING",[[647,"pi"]]],[31,"RECRUITING",[[89,"pi"]]],[381,"RECRUITING",[[444,"pi"]]],[382,"RECRUITING",[]],[14,"RECRUITING",[[95,"pi"]]],[105,"RECRUITING",[[448,"pi"]]],[95,"RECRUITING",[[82,"pi"]]],[500,"RECRUITING",[[648,"pi"]]],[92,"RECRUITING",[[77,"pi"]]],[88,"RECRUITING",[[72,"pi"]]],[92,"RECRUITING",[]],[104,"RECRUITING",[[94,"pi"]]],[28,"RECRUITING",[[79,"pi"]]],[383,"UNKNOWN",[[445,"pi"]]],[42,"UNKNOWN",[[446,"pi"]]],[96,"UNKNOWN",[[83,"pi"]]],[90,"UNKNOWN",[[74,"pi"]]]]},{"id":"NCT07220083","t":"A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)","sp":"Boehringer Ingelheim","c":["Focal Segmental Glomerulosclerosis"],"iv":["BI 764198"],"ivro":["BI 764198"],"d":["nefro","gin"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"BI 764198 (apecotrep) față de placebo în glomeruloscleroza segmentară focală primară sau genetică legată de TRPC6"},"loc":[[30,"RECRUITING",[[75,"pi"]]],[59,"RECRUITING",[[419,"pi"]]],[105,"NOT_YET_RECRUITING",[]],[140,"NOT_YET_RECRUITING",[]]]},{"id":"NCT06819007","t":"Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)","dn":"DESTINY-Ovarian01","sp":"Daiichi Sankyo","c":["Ovarian Cancer"],"iv":["Trastuzumab Deruxtecan","Bevacizumab"],"ivro":["Trastuzumab deruxtecan","bevacizumab","Bevacizumab"],"d":["onco"],"tu":["ovar"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trastuzumab deruxtecan cu bevacizumab comparat cu bevacizumab singur ca întreținere de primă linie în cancerul ovarian cu expresie HER2"},"loc":[[173,"RECRUITING",[[403,"pi"]]],[474,"RECRUITING",[]],[71,"RECRUITING",[[61,"pi"]]],[514,"RECRUITING",[]]]},{"id":"NCT07472517","t":"DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy","dn":"DAREON-Lung-1","sp":"Boehringer Ingelheim","c":["Small Cell Lung Cancer (SCLC)","Extensive-stage Small Cell Lung Cancer (ES-SCLC)"],"iv":["obrixtamig","atezolizumab","carboplatin","etoposide"],"ivro":["obrixtamig","atezolizumab","carboplatină","etopozid"],"d":["onco"],"tu":["sclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Obrixtamig adăugat la atezolizumab, carboplatină și etopozid, ca prim tratament în cancerul pulmonar cu celule mici în stadiu extins"},"loc":[[62,"RECRUITING",[[142,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[10,"NOT_YET_RECRUITING",[[5,"pi"]]]]},{"id":"NCT06632444","t":"LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis","dn":"LIVERAGE","sp":"Boehringer Ingelheim","c":["Metabolic Dysfunction Associated Steatohepatitis (MASH)","Liver Fibrosis"],"iv":["Survodutide"],"ivro":["survodutide"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Survodutide în steatohepatita asociată disfuncției metabolice (MASH/NASH) cu fibroză hepatică moderată sau avansată, fără ciroză"},"loc":[[16,"NOT_YET_RECRUITING",[[715,"pi"]]],[552,"RECRUITING",[]],[155,"RECRUITING",[[681,"pi"]]],[14,"RECRUITING",[[714,"pi"]]],[219,"RECRUITING",[[477,"pi"]]],[101,"RECRUITING",[[479,"pi"]]],[30,"UNKNOWN",[[153,"pi"]]],[59,"UNKNOWN",[[344,"pi"]]]]},{"id":"NCT06632457","t":"LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis","dn":"LIVERAGE-Cirrhosis","sp":"Boehringer Ingelheim","c":["Metabolic Dysfunction Associated Steatohepatitis"],"iv":["Survodutide"],"ivro":["survodutidă"],"d":["alte"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Survodutidă în ciroza compensată din steatohepatita asociată disfuncției metabolice (MASH)"},"loc":[[155,"RECRUITING",[[681,"pi"]]],[101,"NOT_YET_RECRUITING",[]],[59,"UNKNOWN",[[344,"pi"]]],[30,"UNKNOWN",[[153,"pi"]]],[219,"UNKNOWN",[[477,"pi"]]]]},{"id":"NCT06252753","t":"Observational Study Protocol: LIVER-R","dn":"LIVER-R","sp":"AstraZeneca","c":["Hepatobiliary Cancers"],"iv":["Durvalumab-based combination therapies in observational study setting","Non Durvalumab-based therapies in observational study setting","Durvalumab-based combination therapies in observational study settings"],"ivro":["durvalumab","tremelimumab","durvalumab","gemcitabină","cisplatină"],"d":["onco"],"tu":["hcc","biliar"],"f":"","tip":"O","vmin":18,"vmax":130,"content_status":"complete","ro":{"titlu":"Rezultatele în practica reală ale tratamentelor cu sau fără durvalumab în cancerele hepatobiliare (studiu observațional LIVER-R)"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]]]},{"id":"NCT07361302","t":"A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well","dn":"TENACITY","sp":"Boehringer Ingelheim","c":["Acute Ischemic Stroke"],"iv":["Tenecteplase","Standard of care treatment"],"ivro":["tenecteplază"],"d":["cardio","neuro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Tenecteplază intravenoasă față de tratamentul standard în accidentul vascular cerebral ischemic acut la peste 4,5 ore de la ultima stare bună (TENACITY)"},"loc":[[190,"RECRUITING",[[213,"pi"]]],[141,"RECRUITING",[[212,"pi"]]],[120,"NOT_YET_RECRUITING",[]],[215,"RECRUITING",[]],[216,"RECRUITING",[[215,"pi"]]],[92,"RECRUITING",[]],[217,"UNKNOWN",[[211,"pi"]]]]},{"id":"NCT06713837","t":"IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.","dn":"IMPACT-AML","sp":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","c":["Acute Myeloid Leukemia","Relapse/Recurrence"],"iv":["High intensity therapies","Low intensity therapies"],"ivro":["venetoclax","decitabină","azacitidină","citarabină","gilteritinib","ivosidenib"],"d":["onco"],"tu":["lam"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Tratament de intensitate redusă comparat cu chimioterapia intensivă în leucemia acută mieloidă recidivată sau refractară"},"loc":[[30,"RECRUITING",[[34,"pi"]]]]},{"id":"NCT06979453","t":"A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis","dn":"POETYK-PsO-Ped","sp":"Bristol-Myers Squibb","c":["Plaque Psoriasis"],"iv":["Deucravacitinib"],"ivro":["deucravacitinib"],"d":["derm"],"f":"3","tip":"I","vmin":12,"vmax":17,"content_status":"complete","ro":{"titlu":"Deucravacitinib la adolescenți cu psoriazis în plăci moderat sau sever"},"loc":[[5,"WITHDRAWN",[]],[99,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"WITHDRAWN",[]],[3,"NOT_YET_RECRUITING",[]],[236,"RECRUITING",[]],[237,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07067463","t":"A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis","sp":"Zenas BioPharma (USA), LLC","c":["Multiple Sclerosis (MS) Primary Progressive"],"iv":["Orelabrutinib"],"ivro":["orelabrutinib"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":60,"content_status":"complete","ro":{"titlu":"Orelabrutinib în scleroza multiplă primar progresivă"},"loc":[[278,"RECRUITING",[]],[21,"RECRUITING",[]]]},{"id":"NCT06459024","t":"Master Framework For Relapse or Refractory Acute Myeloid Leukemia","dn":"IMPACT STREAM","sp":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","c":["Acute Myeloid Leukemia, in Relapse","Acute Myeloid Leukemia Refractory"],"iv":["Registration into the STREAM platform"],"d":["onco"],"tu":["lam"],"f":"","tip":"O","vmin":6,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul european IMPACT STREAM pentru leucemia acută mieloidă recidivată sau refractară — studiu observațional"},"loc":[[30,"RECRUITING",[[34,"c"]]]]},{"id":"NCT06875310","t":"A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)","dn":"KRYSTAL-4","sp":"Mirati Therapeutics Inc.","c":["Carcinoma, Non-Small-Cell Lung"],"iv":["Adagrasib","Pembrolizumab","Carboplatin","Pemetrexed","Cisplatin"],"ivro":["adagrasib","pembrolizumab","pemetrexed","carboplatină","cisplatină"],"d":["onco"],"tu":["nsclc"],"bm":["kras"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Adagrasib adăugat la pembrolizumab și chimioterapie în cancerul pulmonar nonscuamos avansat cu mutație KRAS G12C"},"loc":[[71,"RECRUITING",[]],[62,"RECRUITING",[]],[3,"COMPLETED",[]],[45,"RECRUITING",[]],[171,"COMPLETED",[]],[10,"RECRUITING",[]],[64,"RECRUITING",[]],[8,"RECRUITING",[]],[8,"RECRUITING",[]],[23,"COMPLETED",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[283,"RECRUITING",[]]]},{"id":"NCT06585787","t":"A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)","dn":"ADEPT-4","sp":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","c":["Alzheimer Disease"],"iv":["KarXT"],"ivro":["KarXT"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":55,"vmax":90,"content_status":"complete","ro":{"titlu":"KarXT pentru psihoza asociată bolii Alzheimer (ADEPT-4)"},"loc":[[168,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[19,"RECRUITING",[]],[360,"RECRUITING",[]],[200,"RECRUITING",[]],[24,"WITHDRAWN",[]],[169,"RECRUITING",[]]]},{"id":"NCT07473700","t":"Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease","sp":"Tectonic Operating Company, Inc.","c":["Hypertension, Pulmonary","Lung Diseases, Interstitial"],"iv":["TX000045"],"ivro":["TX000045"],"d":["cardio","resp"],"f":"2","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"TX000045 în hipertensiunea pulmonară cauzată de boala pulmonară interstițială"},"loc":[[431,"RECRUITING",[]]]},{"id":"NCT06976216","t":"A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease","dn":"MINDSET 1","sp":"Bristol-Myers Squibb","c":["Alzheimer's Disease"],"iv":["KarXT","KarX-EC"],"ivro":["KarXT","KarX-EC","memantină"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":60,"vmax":85,"content_status":"complete","ro":{"titlu":"KarXT + KarX-EC, comparat cu placebo, pentru tulburările cognitive din boala Alzheimer ușoară până la moderată (MINDSET 1)"},"loc":[[19,"RECRUITING",[]],[19,"RECRUITING",[]],[454,"RECRUITING",[]],[455,"RECRUITING",[]],[20,"RECRUITING",[]]]},{"id":"NCT06772623","t":"Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations","sp":"AbbVie","c":["Non Small Cell Lung Carcinoma","c-MET"],"iv":["Telisotuzumab Adizutecan","Budigalimab","Pembrolizumab","Carboplatin","Pemetrexed","Cisplatin"],"ivro":["telisotuzumab adizutecan","budigalimab","pembrolizumab","pemetrexed","carboplatină","cisplatină"],"d":["onco"],"tu":["nsclc"],"bm":["egfr"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Telisotuzumab adizutecan cu imunoterapie anti-PD-1 în cancerul pulmonar nonscuamos avansat, fără alterații genetice țintibile"},"loc":[[8,"RECRUITING",[[64,"pi"],[410,"pi"]]],[8,"RECRUITING",[]],[45,"RECRUITING",[[62,"pi"]]],[293,"RECRUITING",[[315,"pi"]]],[27,"RECRUITING",[[70,"pi"]]],[2,"RECRUITING",[[132,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]]]},{"id":"NCT07091630","t":"A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP","dn":"emnergize","sp":"argenx","c":["Chronic Inflammatory Demyelinating Polyneuropathy","CIDP","Chronic Inflammatory Demyelinating Polyradiculoneuropathy"],"iv":["Empasiprubart IV"],"ivro":["empasiprubart"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Empasiprubart intravenos în polineuropatia demielinizantă inflamatorie cronică (CIDP)"},"loc":[[515,"RECRUITING",[[679,"c"]]],[257,"RECRUITING",[[654,"pi"]]],[414,"RECRUITING",[[524,"pi"]]],[115,"RECRUITING",[[680,"pi"]]],[251,"UNKNOWN",[[679,"pi"]]]]},{"id":"NCT07454837","t":"Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide","dn":"AZURE-3","sp":"Mirum Pharmaceuticals, Inc.","c":["Chronic Hepatitis D"],"iv":["Brelovitug (BJT-778)","Bulevirtide"],"ivro":["brelovitug","bulevirtidă"],"d":["gastro","inf"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trecerea de la bulevirtidă la brelovitug în hepatita cronică D (AZURE-3)"},"loc":[[42,"RECRUITING",[]],[162,"RECRUITING",[]],[30,"RECRUITING",[]],[161,"RECRUITING",[]],[162,"RECRUITING",[]],[163,"RECRUITING",[]]]},{"id":"NCT07596849","t":"A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.","dn":"VitaliThy","sp":"argenx","c":["Graves Disease"],"iv":["efgartigimod PH20 SC"],"ivro":["efgartigimod PH20"],"d":["metab","reum","oft"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Efgartigimod PH20 subcutanat față de placebo în boala Graves insuficient controlată cu medicamente antitiroidiene (VitaliThy)"},"loc":[[544,"RECRUITING",[[703,"c"]]],[178,"UNKNOWN",[[176,"pi"]]],[140,"UNKNOWN",[[704,"pi"]]],[59,"UNKNOWN",[[178,"pi"]]],[36,"UNKNOWN",[[550,"pi"]]],[69,"UNKNOWN",[[705,"pi"]]],[405,"UNKNOWN",[[706,"pi"]]]]},{"id":"NCT04728893","t":"Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)","dn":"MK-1026-003","sp":"Merck Sharp & Dohme LLC","c":["Hematologic Malignancies","Waldenstroms Macroglobulinaemia","Non-Hodgkins Lymphoma","Chronic Lymphocytic Leukaemia"],"iv":["Nemtabrutinib"],"ivro":["Nemtabrutinib"],"d":["onco"],"tu":["llc","lnh"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nemtabrutinib în leucemia limfocitară cronică și în limfoame cu celule B recidivate sau refractare"},"loc":[[27,"RECRUITING",[]],[26,"COMPLETED",[]],[351,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT07012395","t":"A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis","dn":"SKYLINE-UC","sp":"Spyre Therapeutics, Inc.","c":["Ulcerative Colitis","Inflammatory Bowel Diseases","Colitis","Colitis, Ulcerative"],"iv":["SPY001","SPY002","SPY003"],"ivro":["SPY001","SPY002","SPY003"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Anticorpi cu acțiune prelungită, singuri sau în combinații, în colita ulcerativă moderată până la severă"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[23,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT06842186","t":"A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity","dn":"INLIGHT","sp":"Wave Life Sciences USA, Inc.","c":["Overweight and Obesity"],"iv":["WVE-007"],"ivro":["WVE-007"],"d":["metab"],"f":"1/2","tip":"I","vmin":18,"vmax":75,"vs":1,"content_status":"complete","ro":{"titlu":"WVE-007 în doze crescătoare la adulții cu suprapondere sau obezitate (INLIGHT, faza 1/2a)"},"loc":[[16,"RECRUITING",[[131,"c"]]],[59,"RECRUITING",[[14,"c"]]]]},{"id":"NCT04772079","t":"A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis","sp":"Bristol-Myers Squibb","c":["Plaque Psoriasis"],"iv":["Deucravacitinib"],"ivro":["deucravacitinib"],"d":["derm"],"f":"3","tip":"I","vmin":4,"vmax":18,"content_status":"complete","ro":{"titlu":"Deucravacitinib la copiii și adolescenții cu psoriazis în plăci moderat sau sever"},"loc":[[5,"WITHDRAWN",[]],[5,"WITHDRAWN",[]],[5,"WITHDRAWN",[]],[5,"RECRUITING",[]],[99,"RECRUITING",[]],[172,"RECRUITING",[]],[21,"RECRUITING",[]]]},{"id":"NCT07179380","t":"Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","dn":"PALM-ILD","sp":"Insmed Incorporated","c":["Pulmonary Hypertension","Interstitial Lung Disease"],"iv":["Treprostinil Palmitil Inhalation Powder"],"ivro":["treprostinil palmitil"],"d":["cardio","resp"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Treprostinil palmitil inhalator (TPIP) în hipertensiunea pulmonară asociată bolii pulmonare interstițiale"},"loc":[[195,"RECRUITING",[]],[196,"RECRUITING",[]],[197,"RECRUITING",[]],[198,"RECRUITING",[]],[199,"UNKNOWN",[[191,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]],[142,"UNKNOWN",[[192,"pi"]]],[154,"UNKNOWN",[[193,"pi"]]]]},{"id":"NCT07246863","t":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","dn":"GDFATHER-NSCLC-02","sp":"CatalYm GmbH","c":["Metastatic Non-Squamous Non-Small Cell Lung Cancer","Adult Solid Tumor"],"iv":["Visugromab RDE (recommended dose for expansion)","Visugromab 6mg/kg","Nivolumab","Docetaxel"],"ivro":["Visugromab","nivolumab","docetaxel"],"d":["onco"],"tu":["nsclc"],"bm":["egfr","alk"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Visugromab cu nivolumab, cu sau fără docetaxel, în linia a doua a cancerului pulmonar nonscuamos metastatic după imunoterapie"},"loc":[[10,"RECRUITING",[[5,"pi"],[354,"c"]]],[2,"RECRUITING",[[132,"pi"],[355,"c"]]],[9,"RECRUITING",[[163,"c"],[356,"c"]]],[64,"UNKNOWN",[[163,"pi"]]]]},{"id":"NCT07190248","t":"A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)","dn":"KANDLELIT-007 (MK-1084-007)","sp":"Merck Sharp & Dohme LLC","c":["Non-small Cell Lung Cancer"],"iv":["Calderasib","Pembrolizumab (+) Berahyaluronidase alfa","Pemetrexed","Cisplatin","Carboplatin"],"ivro":["calderasib","pembrolizumab","berahialuronidază alfa","pemetrexed","carboplatină","cisplatină"],"d":["onco"],"tu":["nsclc"],"bm":["kras"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Calderasib cu pembrolizumab subcutanat față de pembrolizumab cu chimioterapie, în cancerul pulmonar avansat cu mutație KRAS G12C"},"loc":[[27,"RECRUITING",[[70,"pi"]]],[8,"RECRUITING",[[410,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[283,"RECRUITING",[]],[32,"RECRUITING",[[409,"pi"]]],[293,"RECRUITING",[[315,"pi"]]],[13,"RECRUITING",[[408,"pi"]]],[184,"UNKNOWN",[[180,"pi"]]]]},{"id":"NCT07011719","t":"Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma","dn":"PEAK-1","sp":"Arcus Biosciences, Inc.","c":["Metastatic Clear Cell Renal Cell Carcinoma","Advanced Clear Cell Renal Cell Carcinoma"],"iv":["Casdatifan","Cabozantinib"],"ivro":["casdatifan","cabozantinib"],"d":["onco"],"tu":["rinichi"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Casdatifan plus cabozantinib față de placebo plus cabozantinib în cancerul renal cu celule clare avansat, după imunoterapie"},"loc":[[5,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]],[167,"RECRUITING",[]],[6,"RECRUITING",[]],[139,"UNKNOWN",[[127,"pi"]]],[71,"UNKNOWN",[[61,"pi"]]],[25,"UNKNOWN",[[234,"pi"]]],[9,"UNKNOWN",[[4,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]]]},{"id":"NCT06929273","t":"A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)","dn":"BALSAM-3","sp":"Bristol-Myers Squibb","c":["Bipolar Disorder Type I With Mania"],"iv":["KarXT","Lithium","Valproate","Lamotrigine"],"ivro":["xanomelină/clorură de trospiu","litiu","valproat","lamotrigină"],"d":["neuro"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Siguranța pe termen lung a xanomelină/trospiu (KarXT) în mania din tulburarea bipolară de tip I (BALSAM-3)"},"loc":[[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[454,"RECRUITING",[]],[188,"RECRUITING",[]],[36,"RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[189,"RECRUITING",[]]]},{"id":"NCT06644781","t":"A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)","dn":"IDeate-Esophageal01","sp":"Daiichi Sankyo","c":["Esophageal Squamous Cell Carcinoma"],"iv":["Ifinatamab deruxtecan","Docetaxel","Paclitaxel","Irinotecan hydrochloride (HCl)"],"ivro":["ifinatamab deruxtecan","docetaxel","paclitaxel","irinotecan"],"d":["onco"],"tu":["esofag"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Ifinatamab deruxtecan comparat cu chimioterapia în cancerul esofagian scuamos avansat, tratat anterior"},"loc":[[71,"RECRUITING",[[61,"pi"]]],[30,"RECRUITING",[[128,"pi"]]],[8,"RECRUITING",[[219,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[63,"RECRUITING",[[290,"pi"]]],[139,"RECRUITING",[[127,"pi"]]]]},{"id":"NCT06345729","t":"A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)","dn":"KANDLELIT-004 (MK-1084-004)","sp":"Merck Sharp & Dohme LLC","c":["Non-small Cell Lung Cancer"],"iv":["Calderasib","Pembrolizumab"],"ivro":["calderasib","pembrolizumab"],"d":["onco"],"tu":["nsclc","sarcom"],"bm":["kras","pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Calderasib adăugat la pembrolizumab în cancerul pulmonar fără celule mici cu mutație KRAS G12C și PD-L1 ≥ 50%"},"loc":[[413,"RECRUITING",[[678,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[9,"RECRUITING",[[163,"pi"]]],[32,"RECRUITING",[[409,"pi"]]],[293,"RECRUITING",[[315,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[139,"RECRUITING",[[127,"pi"]]]]},{"id":"NCT06819891","t":"A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease","dn":"SIBERITE-2","sp":"Hoffmann-La Roche","c":["Moderately to Severely Active Crohns Disease"],"iv":["Afimkibart"],"ivro":["afimkibart","afimkibart"],"d":["alte"],"f":"3","tip":"I","vmin":16,"vmax":80,"content_status":"complete","ro":{"titlu":"Afimkibart ca tratament de inducție în boala Crohn activă moderată până la severă"},"loc":[[549,"RECRUITING",[]],[364,"UNKNOWN",[[424,"pi"]]]]},{"id":"NCT06613360","t":"A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus","sp":"Cullinan Therapeutics Inc.","c":["SLE","SLE (Systemic Lupus)"],"iv":["CLN-978"],"ivro":["CLN-978"],"d":["reum","derm"],"f":"1","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"CLN-978, administrat sub piele, în lupusul eritematos sistemic moderat sau sever"},"loc":[[16,"RECRUITING",[[761,"c"]]],[17,"RECRUITING",[[14,"c"]]]]},{"id":"NCT07680764","t":"A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","sp":"Bristol-Myers Squibb","c":["Locally Advanced Non-Small Cell Lung Cancer (NSCLC)","Metastatic Non-Small Cell Lung Cancer (NSCLC)"],"iv":["Pumitamig","Imzokitug","Pemetrexed","Cisplatin","Carboplatin","Paclitaxel"],"ivro":["pumitamig","imzokitug","pemetrexed","cisplatină","carboplatină","paclitaxel"],"d":["onco"],"tu":["nsclc"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Imzokitug adăugat la pumitamig și chimioterapie, ca prim tratament în cancerul pulmonar fără celule mici avansat"},"loc":[[45,"RECRUITING",[]],[62,"RECRUITING",[]],[8,"RECRUITING",[]],[10,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[64,"RECRUITING",[]]]},{"id":"NCT06430801","t":"A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)","dn":"MK-7240-008","sp":"Merck Sharp & Dohme LLC","c":["Crohn's Disease"],"iv":["IV Tulisokibart","SC Tulisokibart","IV Placebo","SC Placebo"],"ivro":["tulisokibart","tulisokibart"],"d":["gastro"],"f":"3","tip":"I","vmin":16,"vmax":80,"content_status":"complete","ro":{"titlu":"Tulisokibart față de placebo în boala Crohn moderat până la sever activă"},"loc":[[71,"RECRUITING",[]],[30,"RECRUITING",[[117,"pi"]]],[132,"RECRUITING",[[121,"pi"]]],[21,"RECRUITING",[[120,"pi"]]],[64,"RECRUITING",[[118,"pi"]]],[133,"RECRUITING",[[122,"pi"]]],[134,"UNKNOWN",[[119,"pi"]]]]},{"id":"NCT06899126","t":"Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer","dn":"DESTINY-Lung06","sp":"Daiichi Sankyo","c":["Non-small Cell Lung Cancer"],"iv":["Trastuzumab Deruxtecan","pembrolizumab","Pemetrexed","Platinum Chemotherapy"],"ivro":["trastuzumab deruxtecan","pembrolizumab","pemetrexed","cisplatină","carboplatină"],"d":["onco"],"tu":["nsclc"],"bm":["her2","pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trastuzumab deruxtecan cu pembrolizumab, comparat cu chimioterapie cu platină și pembrolizumab, în prima linie, în cancerul pulmonar nonscuamos cu supraexpresie HER2"},"loc":[[13,"RECRUITING",[[42,"pi"]]],[29,"RECRUITING",[[69,"pi"]]],[71,"RECRUITING",[[61,"pi"]]],[8,"RECRUITING",[[219,"pi"]]],[235,"RECRUITING",[[233,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[25,"RECRUITING",[[234,"pi"]]],[148,"RECRUITING",[[133,"pi"]]],[184,"RECRUITING",[[180,"pi"]]]]},{"id":"NCT07293351","t":"A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)","dn":"ROSETTA RCC-208","sp":"Bristol-Myers Squibb","c":["Advanced Renal Cell Carcinoma (RCC)"],"iv":["Pumitamig","Ipilimumab","Cabozantinib","Casdatifan"],"ivro":["pumitamig","ipilimumab","cabozantinib","casdatifan (AB521)","casdatifan"],"d":["onco"],"tu":["rinichi"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig singur sau în combinație cu ipilimumab, cabozantinib sau casdatifan în carcinomul renal avansat"},"loc":[[3,"NOT_YET_RECRUITING",[]],[10,"RECRUITING",[[5,"pi"]]],[24,"NOT_YET_RECRUITING",[]],[147,"NOT_YET_RECRUITING",[]],[9,"UNKNOWN",[[4,"pi"]]],[2,"UNKNOWN",[[132,"pi"]]],[25,"UNKNOWN",[[162,"pi"]]],[8,"UNKNOWN",[[64,"pi"]]]]},{"id":"NCT07533955","t":"A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis","sp":"Jade Biosciences, Inc.","c":["Rhematoid Arthritis"],"iv":["JADE201"],"d":["alte"],"f":"1","tip":"I","vmin":18,"vmax":70,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 1 — medicină","gen":1},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]]]},{"id":"NCT07387549","t":"A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis","dn":"ELASCOPE","sp":"Ipsen","c":["Primary Sclerosing Cholangitis"],"iv":["Elafibranor"],"ivro":["elafibranor"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Elafibranor, comparat cu placebo, în colangita sclerozantă primitivă (ELASCOPE)"},"loc":[[101,"RECRUITING",[[479,"pi"]]],[155,"RECRUITING",[[145,"pi"]]],[176,"RECRUITING",[[478,"pi"]]],[30,"NOT_YET_RECRUITING",[[117,"pi"]]],[219,"RECRUITING",[[477,"pi"]]]]},{"id":"NCT05920356","t":"A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)","dn":"CodeBreaK 202","sp":"Amgen","c":["Non-Small Cell Lung Cancer (NSCLC)"],"iv":["Sotorasib","Pembrolizumab"],"ivro":["sotorasib","carboplatină","pemetrexed","pembrolizumabului","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["kras","pdl1"],"f":"3","tip":"I","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"Sotorasib cu chimioterapie față de pembrolizumab cu chimioterapie în cancerul pulmonar nonscuamos avansat KRAS G12C, PD-L1 negativ"},"loc":[[62,"RECRUITING",[[138,"pi"]]],[31,"RECRUITING",[[511,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[76,"RECRUITING",[[126,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[25,"RECRUITING",[[234,"pi"]]],[184,"RECRUITING",[[180,"pi"]]],[9,"RECRUITING",[[134,"pi"]]]]},{"id":"NCT06016842","t":"A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis","dn":"ELFIDENCE","sp":"Ipsen","c":["Primary Biliary Cholangitis (PBC)"],"iv":["Elafibranor","Matched 80 mg placebo"],"ivro":["elafibranor"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elafibranor pe termen lung la adulții cu colangită biliară primitivă și ciroză"},"loc":[[408,"RECRUITING",[]],[55,"RECRUITING",[[512,"pi"]]],[176,"RECRUITING",[[478,"pi"]]],[409,"RECRUITING",[]],[155,"RECRUITING",[[145,"pi"]]],[219,"RECRUITING",[[477,"pi"]]],[231,"UNKNOWN",[[255,"pi"]]],[59,"UNKNOWN",[[344,"pi"]]],[92,"UNKNOWN",[[513,"pi"]]]]},{"id":"NCT06930625","t":"A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs","dn":"OXTEND-03","sp":"Debiopharm International SA","c":["Acromegaly"],"iv":["Debio 4126"],"ivro":["Debio 4126","Debio 4126"],"d":["metab","neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Debio 4126 (octreotidă cu administrare la 12 săptămâni) în acromegalia tratată anterior cu analogi de somatostatină"},"loc":[[178,"RECRUITING",[]],[13,"RECRUITING",[]],[59,"RECRUITING",[]]]},{"id":"NCT07063745","t":"A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion","dn":"MountainTAP-29","sp":"Bristol-Myers Squibb","c":["Metastatic Non-small Cell Lung Cancer With MTAP Deletion"],"iv":["BMS-986504","Pembrolizumab","Cisplatin","Carboplatin","Pemetrexed","Paclitaxel","Nab-paclitaxel"],"ivro":["navlimetostat","pembrolizumab","cisplatină","carboplatină","pemetrexed","paclitaxel"],"d":["onco"],"tu":["nsclc"],"bm":["mtap"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Navlimetostat adăugat la pembrolizumab și chimioterapie, ca prim tratament în cancerul pulmonar fără celule mici metastatic cu deleție MTAP"},"loc":[[85,"NOT_YET_RECRUITING",[]],[62,"RECRUITING",[]],[3,"NOT_YET_RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[148,"RECRUITING",[]],[413,"RECRUITING",[]],[8,"RECRUITING",[]],[8,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[283,"RECRUITING",[]]]},{"id":"NCT07190222","t":"Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype","dn":"THESEUS","sp":"Sanofi","c":["Chronic Obstructive Pulmonary Disease"],"iv":["Lunsekimig"],"ivro":["lunsekimig"],"d":["resp"],"f":"3","tip":"I","vmin":40,"vmax":80,"content_status":"complete","ro":{"titlu":"Lunsekimig comparat cu placebo în BPOC necontrolată, cu eozinofile crescute în sânge"},"loc":[[22,"RECRUITING",[]],[3,"RECRUITING",[]],[85,"RECRUITING",[]],[480,"UNKNOWN",[[547,"pi"]]],[309,"UNKNOWN",[[283,"pi"]]],[183,"UNKNOWN",[[327,"pi"]]]]},{"id":"NCT07221357","t":"A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer","dn":"ROSETTA CRC-203","sp":"Bristol-Myers Squibb","c":["Untreated, Unresectable, or Metastatic Colorectal Cancer"],"iv":["Pumitamig","FOLFOX","FOLFIRI","Bevacizumab","CAPOX"],"ivro":["pumitamig","FOLFOX","FOLFIRI","bevacizumab","CAPOX"],"d":["onco"],"tu":["colorectal"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig cu chimioterapie față de bevacizumab cu chimioterapie în cancerul colorectal metastatic netratat"},"loc":[[30,"RECRUITING",[]],[155,"RECRUITING",[]],[10,"RECRUITING",[]],[8,"RECRUITING",[]],[45,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT07361510","t":"A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)","dn":"ROSETTA Lung-202","sp":"Bristol-Myers Squibb","c":["Non-Small Cell Lung Cancer (NSCLC)"],"iv":["Pumitamig","Pembrolizumab"],"ivro":["pumitamig","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig comparat cu pembrolizumab în prima linie, în cancerul pulmonar avansat cu PD-L1 ≥ 50%"},"loc":[[413,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[64,"RECRUITING",[]],[49,"RECRUITING",[]],[27,"RECRUITING",[]],[31,"RECRUITING",[]],[8,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT06561386","t":"A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%","dn":"RELATIVITY-1093","sp":"Bristol-Myers Squibb","c":["Non-small Cell Lung Cancer"],"iv":["Nivolumab","Relatlimab","Pembrolizumab","Carboplatin","Pemetrexed","Cisplatin"],"ivro":["nivolumab","relatlimab","pemetrexed","carboplatină","cisplatină","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nivolumab + relatlimab cu chimioterapie față de pembrolizumab cu chimioterapie în cancerul pulmonar nonscuamos PD-L1 pozitiv"},"loc":[[71,"RECRUITING",[]],[62,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[8,"RECRUITING",[]],[25,"RECRUITING",[]],[283,"RECRUITING",[]]]},{"id":"NCT07059000","t":"A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)","sp":"Kedrion S.p.A.","c":["Chronic Primary Immune Thrombocytopenia (ITP)"],"iv":["Kedrion IVIG 10%"],"ivro":["imunoglobulină intravenoasă 10% Kedrion"],"d":["hem","reum"],"f":"3","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"Imunoglobulină umană normală intravenoasă 10% (Kedrion) la adulții cu trombocitopenie imună cronică"},"loc":[[27,"RECRUITING",[[48,"pi"]]],[8,"RECRUITING",[[49,"pi"]]],[37,"RECRUITING",[[33,"pi"]]]]},{"id":"NCT07276724","t":"A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)","dn":"SOLAIRIA-1","sp":"Generate Biomedicines","c":["Severe Asthma"],"iv":["GB-0895"],"ivro":["GB-0895"],"d":["resp","reum"],"f":"3","tip":"I","vmin":12,"vmax":80,"content_status":"complete","ro":{"titlu":"GB-0895 adăugat la tratamentul de fond în astmul sever necontrolat, la adulți și adolescenți"},"loc":[[85,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[3,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07213700","t":"InRAD Observational Study","dn":"InRAD","sp":"Stichting International Registry for Alzheimer's Disease and other Dementias Foundation","c":["Alzheimer's Disease(AD)","Mild Cognitive Impairment (MCI)","Subjective Cognitive Decline (SCD)","Non-Alzheimer Degenerative Dementia"],"iv":["None, this is a non-interventional observational study"],"d":["neuro","psih"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul internațional InRAD pentru boala Alzheimer și alte demențe (studiu observațional)"},"loc":[[141,"RECRUITING",[[212,"pi"]]],[439,"RECRUITING",[[589,"pi"]]],[440,"RECRUITING",[[589,"pi"]]]]},{"id":"NCT07441876","t":"Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia","dn":"ASPEN","sp":"BioMarin Pharmaceutical","c":["Achondroplasia"],"iv":["BMN 333","Vosoritide Injection [Voxzogo]"],"ivro":["BMN 333","vosoritidă"],"d":["reum"],"f":"2/3","tip":"I","vmin":2,"vmax":17,"content_status":"complete","ro":{"titlu":"BMN 333 comparat cu vosoritidă la copiii cu acondroplazie netratați anterior (ASPEN)"},"loc":[[178,"RECRUITING",[[280,"c"]]],[453,"RECRUITING",[[601,"c"]]]]},{"id":"NCT05890677","t":"The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema","dn":"LYMPH","sp":"University Hospital, Basel, Switzerland","c":["Lymphedema, Breast Cancer"],"iv":["Surgical Intervention","Conservative Complex Physical Decongestion Therapy"],"d":["onco"],"tu":["san"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Chirurgia limfatică față de tratamentul conservator în limfedemul cronic al brațului după cancerul de sân"},"loc":[[8,"RECRUITING",[[642,"c"]]]]},{"id":"NCT07211958","t":"Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation","dn":"REVEAL-ND NPM1","sp":"Syndax Pharmaceuticals","c":["Acute Myeloid Leukemias"],"iv":["Revumenib","Intensive Chemotherapy Regimen"],"ivro":["revumenib","citarabină","daunorubicină"],"d":["onco"],"tu":["lam"],"bm":["npm1"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"Revumenib adăugat la chimioterapia intensivă în leucemia acută mieloidă nou diagnosticată cu mutație NPM1"},"loc":[[18,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[24,"RECRUITING",[]],[28,"UNKNOWN",[[22,"pi"]]],[25,"UNKNOWN",[[19,"pi"]]],[8,"UNKNOWN",[[37,"pi"]]],[92,"UNKNOWN",[[159,"pi"]]],[29,"UNKNOWN",[]],[27,"UNKNOWN",[[21,"pi"]]]]},{"id":"NCT06677060","t":"Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin","dn":"Prevent-HF","sp":"AstraZeneca","c":["Heart Failure"],"iv":["Baxdrostat and dapagliflozin"],"ivro":["baxdrostat","dapagliflozin"],"d":["cardio"],"f":"3","tip":"I","vmin":40,"vmax":null,"content_status":"complete","ro":{"titlu":"Baxdrostat adăugat la dapagliflozin pentru prevenirea insuficienței cardiace la persoanele cu diabet de tip 2, boală cardiovasculară și hipertensiune"},"loc":[[279,"RECRUITING",[]],[170,"RECRUITING",[]],[170,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]],[186,"RECRUITING",[]],[87,"RECRUITING",[]],[18,"RECRUITING",[]],[280,"UNKNOWN",[[293,"pi"]]],[268,"UNKNOWN",[[294,"pi"]]],[50,"UNKNOWN",[[295,"pi"]]],[281,"UNKNOWN",[[239,"pi"]]],[31,"UNKNOWN",[[89,"pi"]]],[36,"UNKNOWN",[[296,"pi"]]],[99,"UNKNOWN",[[87,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]],[212,"UNKNOWN",[[209,"pi"]]],[103,"UNKNOWN",[[93,"pi"]]],[282,"UNKNOWN",[[297,"pi"]]],[14,"UNKNOWN",[[95,"pi"]]],[240,"UNKNOWN",[[242,"pi"]]],[101,"UNKNOWN",[[91,"pi"]]],[232,"UNKNOWN",[]],[205,"UNKNOWN",[[202,"pi"]]]]},{"id":"NCT06717347","t":"A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)","dn":"waveLINE-010 (MK-2140-010)","sp":"Merck Sharp & Dohme LLC","c":["Diffuse Large B-Cell Lymphoma"],"iv":["Zilovertamab vedotin","Rituximab","Cyclophosphamide","Doxorubicin","Rituximab Biosimilar","Prednisone","Prednisolone","Vincristine","Rescue medication","Methylprednisolone"],"ivro":["zilovertamab vedotin","R-CHP","rituximab","ciclofosfamidă","doxorubicină","prednison"],"d":["onco"],"tu":["lnh"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zilovertamab vedotin cu R-CHP față de R-CHOP în limfomul difuz cu celule B mari netratat"},"loc":[[27,"COMPLETED",[]],[8,"RECRUITING",[[25,"pi"]]],[351,"RECRUITING",[]],[352,"RECRUITING",[]],[69,"UNKNOWN",[[407,"pi"]]],[32,"UNKNOWN",[[28,"pi"]]],[29,"UNKNOWN",[[23,"pi"]]]]},{"id":"NCT07493304","t":"Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers","dn":"ROXI-CAT-II","sp":"Regeneron Pharmaceuticals","c":["Venous Thromboembolism (VTE)"],"iv":["REGN7508","Apixaban"],"ivro":["REGN7508 (cenvacibart)","apixaban"],"d":["cardio","hem"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"REGN7508 comparat cu apixaban pentru tratamentul și prevenirea recidivei trombozei venoase la pacienții cu cancer"},"loc":[[62,"RECRUITING",[[142,"pi"]]],[8,"RECRUITING",[[64,"pi"]]]]},{"id":"NCT06463587","t":"Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)","dn":"MyClad","sp":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","c":["Generalized Myasthenia Gravis"],"iv":["Cladribine Low Dose","Cladribine High Dose"],"ivro":["cladribină","cladribină"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Cladribină orală (formulare nouă) comparată cu placebo în miastenia gravis generalizată"},"loc":[[30,"WITHDRAWN",[[657,"pi"]]],[257,"RECRUITING",[[654,"pi"]]],[354,"RECRUITING",[[526,"pi"]]],[506,"RECRUITING",[]],[507,"UNKNOWN",[[656,"pi"]]],[92,"UNKNOWN",[]]]},{"id":"NCT06136650","t":"A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)","dn":"OMAHA-004 (MK-5684-004)","sp":"Merck Sharp & Dohme LLC","c":["Metastatic Castration-resistant Prostate Cancer (mCRPC)","Prostatic Neoplasms"],"iv":["Opevesostat","Dexamethasone","Fludrocortisone acetate","Hydrocortisone","Abiraterone acetate","Prednisone acetate","Enzalutamide"],"ivro":["opevesostat","dexametazonă","fludrocortizon","hidrocortizon","abirateronă","prednison"],"d":["onco"],"tu":["prostata"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Opevesostat comparat cu abirateronă sau enzalutamidă în cancerul de prostată metastatic rezistent la castrare, după un tratament hormonal de nouă generație"},"loc":[[44,"COMPLETED",[]],[45,"COMPLETED",[]],[10,"RECRUITING",[[45,"pi"]]],[13,"RECRUITING",[[42,"pi"]]],[46,"RECRUITING",[[43,"pi"]]],[47,"RECRUITING",[]],[48,"UNKNOWN",[[44,"pi"]]],[49,"UNKNOWN",[[46,"pi"]]]]},{"id":"NCT07099898","t":"A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]","dn":"EMBOLD SCLC-301","sp":"GlaxoSmithKline","c":["Neoplasms, Lung"],"iv":["Risvutatug rezetecan (Ris-Rez)","Topotecan"],"ivro":["risvutatug rezetecan","topotecan"],"d":["onco"],"tu":["sclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Risvutatug rezetecan (GSK5764227) comparat cu topotecan în cancerul pulmonar cu celule mici recidivat"},"loc":[[4,"RECRUITING",[[135,"pi"]]],[3,"RECRUITING",[[161,"pi"]]],[4,"RECRUITING",[[5,"pi"]]],[137,"RECRUITING",[[62,"pi"]]],[24,"RECRUITING",[[162,"pi"]]],[6,"RECRUITING",[[163,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]],[9,"UNKNOWN",[[163,"pi"]]],[11,"UNKNOWN",[[135,"pi"]]],[45,"UNKNOWN",[[62,"pi"]]],[8,"UNKNOWN",[[161,"pi"]]],[25,"UNKNOWN",[[162,"pi"]]]]},{"id":"NCT07335497","t":"CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors","dn":"ASCEND","sp":"Crescent Biopharma, Inc.","c":["Locally Advanced / Metastatic Solid Tumors"],"iv":["CR-001","Paclitaxel","trifluridine and tipiracil","Pemetrexed","Carboplatin","Oxaliplatin","Gemcitabin","Cisplatin","Capecitabine","FOLFOX"],"ivro":["CR-001"],"d":["onco"],"tu":["nsclc","hcc","biliar","endometru","col","ovar","esofag","gastric","colorectal","solide"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"CR-001 în tumori solide avansate local sau metastatice — primul studiu la om, stabilirea dozei"},"loc":[[3,"RECRUITING",[]],[5,"RECRUITING",[]],[8,"UNKNOWN",[[64,"pi"]]],[62,"UNKNOWN",[[142,"pi"]]]]},{"id":"NCT06901531","t":"A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer","dn":"LUCERNA","sp":"Astellas Pharma Global Development, Inc.","c":["Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer","Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer","Metastatic Gastric Adenocarcinoma or Cancer","Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma"],"iv":["zolbetuximab","Pembrolizumab","Capecitabine","Oxaliplatin","Folinic acid (leucovorin or local equivalent)","5-fluorouracil (5-FU)"],"ivro":["zolbetuximab","pembrolizumab","CAPOX","mFOLFOX6"],"d":["onco"],"tu":["esofag","gastric"],"bm":["cldn","pdl1","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zolbetuximab cu pembrolizumab și chimioterapie în cancerul gastric avansat Claudin 18.2 și PD-L1 pozitiv"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[3,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[137,"RECRUITING",[]],[24,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT06951711","t":"A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)","dn":"BALSAM-2","sp":"Bristol-Myers Squibb","c":["Bipolar Disorder Type I With Mania or Mania With Mixed Features"],"iv":["KarXT"],"ivro":["KarXT","xanomelină și clorură de trospiu"],"d":["neuro"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"KarXT (xanomelină și clorură de trospiu) comparat cu placebo în episoadele maniacale din tulburarea bipolară de tip I"},"loc":[[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[331,"RECRUITING",[]],[188,"RECRUITING",[]],[36,"RECRUITING",[]],[24,"WITHDRAWN",[]],[189,"RECRUITING",[]]]},{"id":"NCT06865417","t":"A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis","dn":"Galapeduca","sp":"Alfasigma S.p.A.","c":["Ulcerative Colitis"],"iv":["Filgotinib"],"ivro":["filgotinib"],"d":["gastro"],"f":"3","tip":"I","vmin":8,"vmax":18,"content_status":"complete","ro":{"titlu":"Filgotinib la copiii și adolescenții de 8 până la sub 18 ani cu rectocolită ulcerativă moderat până la sever activă (Galapeduca)"},"loc":[[288,"RECRUITING",[[429,"c"]]],[267,"RECRUITING",[[430,"c"]]]]},{"id":"NCT04804553","t":"Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis","dn":"PEAPOD","sp":"Amgen","c":["Active Juvenile Psoriatic Arthritis"],"iv":["Apremilast"],"ivro":["apremilast"],"d":["reum","derm"],"f":"3","tip":"I","vmin":5,"vmax":17,"content_status":"complete","ro":{"titlu":"Apremilast față de placebo la copiii și adolescenții cu artrită psoriazică juvenilă activă (PEAPOD)"},"loc":[[136,"TERMINATED",[]],[267,"RECRUITING",[]]]},{"id":"NCT06801834","t":"Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer","dn":"EVOKE-SCLC-04","sp":"Gilead Sciences","c":["Extensive Stage Small Cell Lung Cancer (ES-SCLC)"],"iv":["Sacituzumab Govitecan (SG)","Topotecan","Amrubicin (Japan only)","Lurbinectedin (regions/countries where approved and available)"],"ivro":["sacituzumab govitecan","topotecan","lurbinectedin"],"d":["onco"],"tu":["sclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sacituzumab govitecan față de tratamentul standard în cancerul pulmonar cu celule mici în stadiu extins, după chimioterapie cu platină"},"loc":[[62,"RECRUITING",[]],[27,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[430,"RECRUITING",[]],[26,"RECRUITING",[]],[184,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT06667700","t":"A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)","dn":"MOVe-NOW (MK-4482-023)","sp":"Merck Sharp & Dohme LLC","c":["Coronavirus Disease (COVID-19)"],"iv":["Molnupiravir"],"ivro":["molnupiravir"],"d":["resp","inf"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Molnupiravir pentru prevenirea formelor severe de COVID-19 la adulții cu risc mare, care nu pot sau nu doresc să primească nirmatrelvir/ritonavir"},"loc":[[161,"RECRUITING",[[672,"pi"]]],[49,"COMPLETED",[]],[55,"RECRUITING",[[485,"pi"]]],[162,"RECRUITING",[[155,"pi"],[11,"pi"]]],[162,"RECRUITING",[]],[417,"RECRUITING",[[671,"pi"]]],[163,"RECRUITING",[[156,"pi"]]]]},{"id":"NCT05947955","t":"Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)","sp":"BioAegis Therapeutics Inc.","c":["Acute Respiratory Distress Syndrome","Infections"],"iv":["Rhu-pGSN","normal saline"],"ivro":["rhu-pGSN"],"d":["resp","inf"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Gelsolină plasmatică umană recombinantă (rhu-pGSN) adăugată la tratamentul standard în sindromul de detresă respiratorie acută (ARDS) moderat sau sever produs de infecții"},"loc":[[563,"RECRUITING",[[725,"pi"]]],[564,"RECRUITING",[[167,"pi"]]],[565,"RECRUITING",[]]]},{"id":"NCT07052903","t":"TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy","dn":"TRITON-CM","sp":"Alnylam Pharmaceuticals","c":["Transthyretin Amyloidosis With Cardiomyopathy"],"iv":["Nucresiran","Sterile Normal Saline (0.9% NaCl)"],"ivro":["nucresiran"],"d":["cardio","metab"],"f":"3","tip":"I","vmin":18,"vmax":85,"content_status":"complete","ro":{"titlu":"Nucresiran comparat cu placebo în amiloidoza cu transtiretină cu afectare a inimii (TRITON-CM)"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[138,"UNKNOWN",[[578,"pi"]]],[66,"UNKNOWN",[[265,"pi"]]]]},{"id":"NCT07881133","t":"Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery","sp":"Bucharest Emergency Hospital","c":["Colorectal (Colon or Rectal) Cancer","STOMACH NEOPLASM"],"iv":["Perioperative Biomarker-Guided Monitoring"],"d":["onco"],"tu":["gastric","colorectal"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic — Cancer gastric (stomac), Cancer colorectal (colon, rect)","gen":1},"loc":[[61,"RECRUITING",[[47,"pi"]]]]},{"id":"NCT07422480","t":"A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions","dn":"ELRiSE MDS","sp":"Takeda","c":["Myelodysplastic Syndrome","Anemia"],"iv":["Elritercept","Epoetin Alfa"],"ivro":["Elritercept","Epoetină alfa"],"d":["onco"],"tu":["smd"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elritercept comparat cu epoetină alfa pentru anemia din sindroamele mielodisplazice cu risc scăzut, la pacienții care au nevoie de transfuzii"},"loc":[[8,"RECRUITING",[[25,"pi"]]],[37,"RECRUITING",[[33,"pi"]]]]},{"id":"NCT07098988","t":"Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC","dn":"GDFATHER-NSCLC-01","sp":"CatalYm GmbH","c":["Metastatic Non-Squamous Non-Small Cell Lung Cancer","Adult Solid Tumor"],"iv":["Visugromab","Matching placebo for visugromab","Pembrolizumab 200 mg Q3W","Pemetrexed 500 mg/m^2","Carboplatin AUC 5"],"ivro":["visugromab","pembrolizumab","pemetrexed","carboplatină"],"d":["onco"],"tu":["nsclc"],"bm":["egfr","alk"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Visugromab față de placebo, adăugat la pembrolizumab, pemetrexed și carboplatină, în cancerul pulmonar nonscuamos metastatic"},"loc":[[10,"RECRUITING",[[5,"c"]]],[150,"RECRUITING",[[137,"c"]]],[2,"RECRUITING",[[132,"c"]]],[9,"RECRUITING",[[163,"c"]]]]},{"id":"NCT07875582","t":"Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma","sp":"Grigore T. Popa University of Medicine and Pharmacy","c":["Pancreatic Cancer","Chronic Pancreatitis","Intraductal Papillary Mucinous Neoplasm","Mucinous Cystic Neoplasm"],"iv":["Blood-Based Protein Biomarker Assessment"],"d":["onco"],"tu":["pancreas"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic — Cancer pancreatic","gen":1},"loc":[[327,"RECRUITING",[[762,"c"]]]],"ofi":[[762,"pi"]]},{"id":"NCT05980949","t":"Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)","dn":"ADEPT-3","sp":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","c":["Psychosis Associated With Alzheimer's Disease"],"iv":["KarXT"],"ivro":["xanomelină–trospiu"],"d":["alte"],"f":"3","tip":"I","vmin":55,"vmax":90,"content_status":"complete","ro":{"titlu":"Xanomelină–trospiu (KarXT) pe termen lung în psihoza asociată bolii Alzheimer: studiu de extensie deschis (ADEPT-3)"},"loc":[[168,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[19,"RECRUITING",[]],[23,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[169,"RECRUITING",[]]]},{"id":"NCT07878767","t":"Pilot Study: Evaluation of the Safety of the Application of Non-thermal HIFU for Varicose Veins Treatment of the Lower Limbs","sp":"VeinSound","c":["Superficial Venous Insufficiency, Varicose Veins"],"iv":["Non-thermal HIFU application along the saphenous vein of one leg / 3-month follow-up"],"d":["cardio"],"f":"","tip":"I","vmin":35,"vmax":80,"content_status":"preparing","ro":{"titlu":"Studiu clinic — cardiologie","gen":1},"loc":[[295,"RECRUITING",[]]]},{"id":"NCT06819878","t":"A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease","dn":"SIBERITE-1","sp":"Hoffmann-La Roche","c":["Moderately to Severely Active Crohns Disease"],"iv":["Afimkibart"],"ivro":["afimkibart"],"d":["alte"],"f":"3","tip":"I","vmin":16,"vmax":80,"content_status":"complete","ro":{"titlu":"Afimkibart (RO7790121), comparat cu placebo, ca tratament de inducție și întreținere în boala Crohn moderată până la severă (SIBERITE-1)"},"loc":[[29,"RECRUITING",[[224,"pi"]]],[176,"RECRUITING",[[478,"pi"]]],[14,"UNKNOWN",[[442,"pi"]]]]},{"id":"NCT07194850","t":"A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)","dn":"Advance Jr","sp":"argenx","c":["Immune Thrombocytopenia (ITP)","ITP - Immune Thrombocytopenia","ITP","Immune Thrombocytopenic Purpura","Immune Thrombocytopenic Purpura ( ITP )","Idiopathic Thrombocytopenic Purpura","Idiopathic Thrombocytopenic Purpura (ITP)"],"iv":["Efgartigimod IV"],"ivro":["efgartigimod"],"d":["hem","reum"],"f":"2/3","tip":"I","vmin":12,"vmax":17,"content_status":"complete","ro":{"titlu":"Efgartigimod intravenos la adolescenții de 12 până la sub 18 ani cu trombocitopenie imună cronică"},"loc":[[30,"RECRUITING",[[65,"pi"]]]]},{"id":"NCT05776927","t":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","sp":"Novartis Pharmaceuticals","c":["Asthma"],"iv":["QVM149","Salmeterol Xinafoate / Fluticasone Propionate"],"ivro":["indacaterol/glicopironiu/mometazonă","salmeterol/fluticazonă","salmeterol/fluticazonă","indacaterol/glicopironiu/mometazonă"],"d":["resp","reum"],"f":"3","tip":"I","vmin":12,"vmax":17,"content_status":"complete","ro":{"titlu":"Indacaterol/glicopironiu/mometazonă (QVM149) comparat cu salmeterol/fluticazonă la adolescenții cu astm"},"loc":[[5,"RECRUITING",[]]]},{"id":"NCT07181109","t":"Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease","dn":"ZENITH","sp":"Alnylam Pharmaceuticals","c":["High Risk Cardiovascular Disease","Hypertension","High Cardiovascular Risk"],"iv":["Zilebesiran"],"ivro":["zilebesiran"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zilebesiran adăugat la tratamentul hipertensiunii arteriale insuficient controlate, la pacienții cu boală cardiovasculară sau cu risc cardiovascular mare"},"loc":[[170,"RECRUITING",[]],[170,"RECRUITING",[]],[22,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[261,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]],[24,"RECRUITING",[]],[85,"RECRUITING",[]],[85,"RECRUITING",[]],[186,"RECRUITING",[]],[87,"RECRUITING",[]],[147,"RECRUITING",[]],[18,"RECRUITING",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[66,"UNKNOWN",[[265,"pi"]]],[245,"UNKNOWN",[[249,"pi"]]],[104,"UNKNOWN",[[94,"pi"]]],[120,"UNKNOWN",[[266,"pi"]]],[262,"UNKNOWN",[[267,"pi"]]],[251,"UNKNOWN",[[254,"pi"]]],[105,"UNKNOWN",[[96,"pi"],[271,"pi"],[277,"pi"]]],[252,"UNKNOWN",[[259,"pi"]]],[232,"UNKNOWN",[]],[12,"UNKNOWN",[[269,"pi"]]],[263,"UNKNOWN",[[270,"pi"]]],[30,"UNKNOWN",[[153,"pi"]]],[101,"UNKNOWN",[[91,"pi"]]],[100,"UNKNOWN",[[88,"pi"]]],[205,"UNKNOWN",[[202,"pi"]]],[234,"UNKNOWN",[[272,"pi"]]],[241,"UNKNOWN",[[87,"pi"]]],[93,"UNKNOWN",[[273,"pi"]]],[28,"UNKNOWN",[[253,"pi"],[79,"pi"]]],[14,"UNKNOWN",[[274,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]],[264,"UNKNOWN",[[275,"pi"]]],[265,"UNKNOWN",[[276,"pi"]]],[31,"UNKNOWN",[[89,"pi"]]],[97,"UNKNOWN",[[90,"pi"]]]]},{"id":"NCT05562466","t":"A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma","sp":"Novartis Pharmaceuticals","c":["Asthma"],"iv":["QMF149","Budesonide"],"ivro":["indacaterol/mometazonă","budesonidă"],"d":["resp","reum"],"f":"3","tip":"I","vmin":6,"vmax":11,"content_status":"complete","ro":{"titlu":"Indacaterol/mometazonă (QMF149) față de budesonidă la copiii de 6–11 ani cu astm"},"loc":[[6,"WITHDRAWN",[]],[5,"RECRUITING",[]],[324,"UNKNOWN",[[361,"pi"]]]]},{"id":"NCT07424404","t":"A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents","sp":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","c":["Schizophrenia","Autism-Related Irritability"],"iv":["KarXT","KarX-EC"],"ivro":["KarXT","xanomelină","clorură de trospiu","KarX-EC"],"d":["psih"],"f":"3","tip":"I","vmin":5,"vmax":17,"content_status":"complete","ro":{"titlu":"Siguranța pe termen lung a KarXT (xanomelină și clorură de trospiu) la copiii și adolescenții cu schizofrenie sau cu iritabilitate asociată autismului"},"loc":[[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[332,"RECRUITING",[[378,"pi"]]],[333,"RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[267,"RECRUITING",[[380,"pi"]]],[19,"UNKNOWN",[[377,"pi"]]],[20,"UNKNOWN",[[379,"pi"]]],[334,"UNKNOWN",[[381,"pi"]]],[136,"UNKNOWN",[[382,"pi"]]]]},{"id":"NCT07195695","t":"Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations","dn":"Beamion LUNG-3","sp":"Boehringer Ingelheim","c":["Non-small Cell Lung Cancer"],"iv":["Zongertinib","Pembrolizumab","Atezolizumab","Durvalumab","Nivolumab"],"ivro":["zongertinib","pembrolizumab","atezolizumab","durvalumab","nivolumab"],"d":["onco"],"tu":["nsclc"],"bm":["her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zongertinib după operație comparat cu tratamentul standard în cancerul pulmonar fără celule mici cu mutații HER2, stadiile II–IIIB"},"loc":[[99,"RECRUITING",[[427,"pi"]]],[71,"RECRUITING",[[61,"pi"]]],[26,"RECRUITING",[[20,"pi"]]],[367,"NOT_YET_RECRUITING",[[63,"pi"]]]]},{"id":"NCT06312137","t":"A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)","dn":"TroFuse-019 (MK-2870-019)","sp":"Merck Sharp & Dohme LLC","c":["Non Small Cell Lung Cancer"],"iv":["Sacituzumab tirumotecan","Pembrolizumab","Cisplatin","Pemetrexed","Gemcitabine","Carboplatin","Paclitaxel","Rescue medication"],"ivro":["Pembrolizumab","cisplatină","carboplatină","pemetrexed","gemcitabină","paclitaxel"],"d":["onco"],"tu":["nsclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pembrolizumab cu sau fără sacituzumab tirumotecan după operație, în cancerul pulmonar operabil fără răspuns patologic complet"},"loc":[[71,"RECRUITING",[]],[62,"RECRUITING",[[222,"pi"]]],[44,"COMPLETED",[]],[45,"RECRUITING",[[62,"pi"]]],[10,"COMPLETED",[]],[28,"RECRUITING",[[528,"pi"]]],[32,"RECRUITING",[[409,"pi"]]],[293,"RECRUITING",[[315,"pi"]]],[13,"RECRUITING",[[42,"pi"]]],[47,"RECRUITING",[]],[25,"RECRUITING",[[162,"pi"]]],[49,"UNKNOWN",[[46,"pi"]]],[58,"UNKNOWN",[[61,"pi"]]]]},{"id":"NCT06712316","t":"Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)","sp":"BioNTech SE","c":["Non-small Cell Lung Cancer"],"iv":["Pumitamig","Pembrolizumab","Carboplatin","Pemetrexed","Paclitaxel"],"ivro":["pumitamig","carboplatină","pemetrexed","paclitaxel","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig (BNT327) cu chimioterapie comparat cu pembrolizumab cu chimioterapie, ca prim tratament în cancerul pulmonar fără celule mici avansat"},"loc":[[27,"RECRUITING",[[70,"pi"]]],[173,"RECRUITING",[[575,"pi"]]],[62,"RECRUITING",[[138,"pi"]]],[44,"RECRUITING",[[63,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[76,"RECRUITING",[[126,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[74,"RECRUITING",[[143,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[63,"RECRUITING",[[290,"pi"]]],[25,"RECRUITING",[[503,"pi"]]],[26,"WITHDRAWN",[[20,"pi"]]],[184,"RECRUITING",[[180,"pi"]]],[9,"RECRUITING",[[163,"pi"]]]]},{"id":"NCT07011732","t":"A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)","dn":"ADAGIO-1","sp":"Bristol-Myers Squibb","c":["Alzheimer Disease"],"iv":["Xanomeline/Trospium Chloride Capsule","Xanomeline Enteric Capsule"],"ivro":["xanomelină/clorură de trospiu","xanomelină enterică"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":55,"vmax":90,"content_status":"complete","ro":{"titlu":"Xanomelină/trospiu (KarXT) plus xanomelină enterică (KarX-EC) față de placebo în agitația din boala Alzheimer (ADAGIO-1)"},"loc":[[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[5,"WITHDRAWN",[]],[5,"NOT_YET_RECRUITING",[]],[5,"WITHDRAWN",[]],[19,"RECRUITING",[]],[360,"RECRUITING",[]],[20,"RECRUITING",[]],[189,"RECRUITING",[]],[147,"NOT_YET_RECRUITING",[]],[202,"RECRUITING",[]]]},{"id":"NCT07288489","t":"Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.","sp":"VarmX B.V.","c":["Blood Loss, Surgical","Coagulation Disorder"],"iv":["Reltodecacog alfa","Usual Pharmacological Care"],"d":["hem","cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — hematologie, cardiologie","gen":1},"loc":[[238,"RECRUITING",[]],[98,"RECRUITING",[]],[142,"RECRUITING",[]],[140,"RECRUITING",[]]]},{"id":"NCT00196742","t":"Fabry Disease Registry & Pregnancy Sub-registry","sp":"Genzyme, a Sanofi Company","c":["Fabry Disease"],"iv":[],"ivro":["agalsidază beta"],"d":["cardio","metab","neuro"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul bolii Fabry și subregistrul de sarcină (studiu observațional)"},"loc":[[22,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"COMPLETED",[]]]},{"id":"NCT07577843","t":"A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease","sp":"Janssen Research & Development, LLC","c":["Crohn Disease"],"iv":["JNJ-78934804","Guselkumab"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — gastroenterologie","gen":1},"loc":[[379,"RECRUITING",[]],[29,"RECRUITING",[[224,"pi"]]],[30,"RECRUITING",[[507,"pi"]]],[132,"RECRUITING",[[121,"pi"]]],[64,"RECRUITING",[[118,"pi"]]],[405,"UNKNOWN",[[506,"pi"]]],[134,"UNKNOWN",[[119,"pi"]]]]},{"id":"NCT00358943","t":"International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry","dn":"ICGG Gaucher Registry","sp":"Genzyme, a Sanofi Company","c":["Gaucher Disease","Cerebroside Lipidosis Syndrome","Glucocerebrosidase Deficiency Disease","Glucosylceramide Beta-Glucosidase Deficiency Disease"],"iv":[],"ivro":["imiglucerază"],"d":["metab","neuro"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul internațional al bolii Gaucher (ICGG) și subregistrul de sarcină (studiu observațional)"},"loc":[[3,"COMPLETED",[]],[3,"COMPLETED",[]],[3,"RECRUITING",[]]]},{"id":"NCT06712355","t":"Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer","sp":"BioNTech SE","c":["Extensive-stage Small-cell Lung Cancer"],"iv":["Pumitamig","Atezolizumab","Etoposide","Carboplatin (or cisplatin if carboplatin is not tolerated)"],"ivro":["atezolizumab","etopozid","carboplatină","cisplatină","carboplatină","pumitamig"],"d":["onco"],"tu":["sclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig (BNT327) cu chimioterapie comparat cu atezolizumab cu chimioterapie, în cancerul pulmonar cu celule mici în stadiu extins, netratat anterior"},"loc":[[73,"RECRUITING",[[438,"pi"]]],[62,"RECRUITING",[[138,"pi"]]],[27,"RECRUITING",[[70,"pi"]]],[44,"RECRUITING",[[63,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[63,"RECRUITING",[[290,"pi"]]],[527,"RECRUITING",[]],[135,"RECRUITING",[[164,"pi"]]],[9,"RECRUITING",[[404,"pi"]]],[528,"UNKNOWN",[[696,"pi"]]]]},{"id":"NCT07225504","t":"A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis","dn":"REMASTER","sp":"Novartis Pharmaceuticals","c":["Secondary Progressive Multiple Sclerosis (SPMS)"],"iv":["Remibrutinib (blinded)","Remibrutinib (Open label)"],"ivro":["remibrutinib","remibrutinib"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Remibrutinib în scleroza multiplă secundar progresivă"},"loc":[[23,"RECRUITING",[]],[5,"RECRUITING",[]],[276,"RECRUITING",[]]]},{"id":"NCT06023589","t":"A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma","dn":"HORIZON","sp":"AstraZeneca","c":["Asthma"],"iv":["Tezepelumab"],"ivro":["tezepelumab"],"d":["resp","reum"],"f":"3","tip":"I","vmin":5,"vmax":11,"content_status":"complete","ro":{"titlu":"Tezepelumab față de placebo la copiii de 5–11 ani cu astm sever necontrolat"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]]]},{"id":"NCT06841354","t":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","dn":"TroFuse-011 (MK-2870-011)","sp":"Merck Sharp & Dohme LLC","c":["Triple Negative Breast Neoplasms"],"iv":["Sacituzumab tirumotecan","Pembrolizumab","Rescue Medication","Paclitaxel","Nab-paclitaxel","Gemcitabine","Carboplatin"],"ivro":["Sacituzumab tirumotecan","pembrolizumab","paclitaxel","nab-paclitaxel","gemcitabină","carboplatină"],"d":["onco"],"tu":["san_tn","san"],"bm":["pdl1","hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sacituzumab tirumotecan singur sau cu pembrolizumab față de chimioterapie, în cancerul de sân triplu-negativ metastatic cu PD-L1 CPS sub 10"},"loc":[[8,"RECRUITING",[[140,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[283,"RECRUITING",[]],[9,"RECRUITING",[[4,"pi"]]],[7,"RECRUITING",[[2,"pi"]]],[325,"RECRUITING",[]],[293,"UNKNOWN",[[362,"pi"]]],[184,"UNKNOWN",[[298,"pi"]]]]},{"id":"NCT07088068","t":"A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes","dn":"βETA PRESERVE","sp":"Sanofi","c":["Type 1 Diabetes Mellitus"],"iv":["Teplizumab"],"ivro":["teplizumab","insulină"],"d":["metab","reum"],"f":"3","tip":"I","vmin":1,"vmax":25,"content_status":"complete","ro":{"titlu":"Teplizumab față de placebo la copiii, adolescenții și tinerii între 1 și 25 de ani cu diabet zaharat de tip 1 stadiul 3 recent diagnosticat (βETA PRESERVE)"},"loc":[[279,"RECRUITING",[]],[24,"RECRUITING",[]]]},{"id":"NCT07441642","t":"A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration","sp":"Novartis Pharmaceuticals","c":["Geographic Atrophy Secondary to Age-related Macular Degeneration"],"iv":["FWY003"],"ivro":["FWY003"],"d":["alte"],"f":"2","tip":"I","vmin":50,"vmax":null,"content_status":"complete","ro":{"titlu":"FWY003 în trei doze, comparat cu placebo, în atrofia geografică din degenerescența maculară legată de vârstă"},"loc":[[3,"RECRUITING",[]],[5,"RECRUITING",[]]]},{"id":"NCT07577856","t":"A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis","sp":"Janssen Research & Development, LLC","c":["Colitis, Ulcerative"],"iv":["JNJ-78934804","Guselkumab"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — gastroenterologie","gen":1},"loc":[[379,"RECRUITING",[]],[29,"RECRUITING",[[224,"pi"]]],[30,"RECRUITING",[[507,"pi"]]],[132,"RECRUITING",[[121,"pi"]]],[64,"RECRUITING",[[118,"pi"]]],[134,"UNKNOWN",[[119,"pi"]]],[405,"UNKNOWN",[[506,"pi"]]]]},{"id":"NCT06824467","t":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","dn":"TroFuse-022 (MK-2870-022)","sp":"Merck Sharp & Dohme LLC","c":["Ovarian Cancer","Fallopian Tube Cancer","Primary Peritoneal Cancer"],"iv":["Sacituzumab tirumotecan","Bevacizumab","H1 receptor antagonist","H2 receptor antagonist","Acetaminophen (or equivalent)","Dexamethasone (or equivalent)","Steroid mouthwash (dexamethasone or equivalent)"],"ivro":["sacituzumab tirumotecan","bevacizumab"],"d":["onco"],"tu":["ovar"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sacituzumab tirumotecan ca tratament de întreținere în cancerul ovarian recidivat sensibil la platină"},"loc":[[8,"RECRUITING",[[410,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[9,"RECRUITING",[[163,"pi"]]],[7,"RECRUITING",[[2,"pi"]]],[293,"RECRUITING",[[362,"pi"]]]]},{"id":"NCT06307652","t":"Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function","dn":"BalanceD-HF","sp":"AstraZeneca","c":["Heart Failure and Impaired Kidney Function"],"iv":["balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg","balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg","dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozin"],"ivro":["balcinrenonă","dapagliflozin"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":130,"content_status":"complete","ro":{"titlu":"Balcinrenonă/dapagliflozin comparat cu dapagliflozin în insuficiența cardiacă cu funcție renală scăzută (BalanceD-HF)"},"loc":[[465,"RECRUITING",[]],[466,"RECRUITING",[]],[170,"RECRUITING",[]],[22,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"WITHDRAWN",[]],[5,"TERMINATED",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"WITHDRAWN",[]],[3,"TERMINATED",[]],[24,"WITHDRAWN",[]],[24,"RECRUITING",[]],[87,"RECRUITING",[]],[18,"RECRUITING",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"TERMINATED",[]],[380,"UNKNOWN",[[267,"pi"]]],[467,"UNKNOWN",[[615,"pi"]]],[190,"UNKNOWN",[[616,"pi"]]],[28,"UNKNOWN",[[79,"pi"]]],[206,"UNKNOWN",[[617,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]],[138,"UNKNOWN",[[618,"pi"]]],[468,"UNKNOWN",[[446,"pi"]]],[101,"UNKNOWN",[[91,"pi"]]],[103,"UNKNOWN",[[93,"pi"]]],[88,"UNKNOWN",[[72,"pi"]]],[36,"UNKNOWN",[[296,"pi"]]],[264,"UNKNOWN",[[85,"pi"]]]]},{"id":"NCT06980480","t":"A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma","sp":"Takeda","c":["Multiple Myeloma","Secondary Immunodeficiency"],"iv":["IGI, 10%"],"ivro":["imunoglobulină umană 10%"],"d":["onco"],"tu":["mielom"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Imunoglobuline intravenoase pentru prevenirea infecțiilor la adulții cu mielom multiplu tratați cu teclistamab"},"loc":[[29,"RECRUITING",[[313,"pi"]]],[30,"RECRUITING",[[26,"pi"]]],[27,"RECRUITING",[[21,"pi"]]],[8,"RECRUITING",[[25,"pi"],[643,"pi"]]],[37,"RECRUITING",[[33,"pi"]]]]},{"id":"NCT07351058","t":"A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes","sp":"Hoffmann-La Roche","c":["Obesity or Overweight","Type 2 Diabetes Mellitus"],"iv":["Enicepatide"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — diabet și endocrinologie","gen":1},"loc":[[140,"RECRUITING",[[749,"pi"]]],[240,"UNKNOWN",[[242,"pi"]]],[222,"UNKNOWN",[[206,"pi"]]],[12,"UNKNOWN",[[748,"pi"]]],[59,"UNKNOWN",[[658,"pi"]]],[268,"UNKNOWN",[[294,"pi"]]],[232,"UNKNOWN",[]]]},{"id":"NCT06966700","t":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","dn":"MK-2870-032","sp":"Merck Sharp & Dohme LLC","c":["Breast Neoplasms","Triple Negative Breast Neoplasms","HR Low-Positive/HER2-Negative Breast Neoplasms"],"iv":["Sacituzumab tirumotecan","Pembrolizumab","Rescue Medication","Carboplatin","Paclitaxel","Doxorubicin","Epirubicin","Cyclophosphamide","Capecitabine","Olaparib"],"ivro":["sacituzumab tirumotecan","pembrolizumab","carboplatină","paclitaxel","pembrolizumab","pembrolizumab"],"d":["onco"],"tu":["san_tn","san"],"bm":["hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sacituzumab tirumotecan cu pembrolizumab și chimioterapie înainte de operație în cancerul de sân triplu-negativ sau HR-low/HER2-negativ, stadiu incipient cu risc crescut"},"loc":[[45,"RECRUITING",[[62,"pi"]]],[9,"RECRUITING",[[4,"pi"]]],[7,"RECRUITING",[[2,"pi"]]],[8,"RECRUITING",[[140,"pi"]]],[25,"RECRUITING",[[141,"pi"]]]]},{"id":"NCT07540221","t":"A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","dn":"XPERT","sp":"Grifols Therapeutics LLC","c":["CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)"],"iv":["Gamunex-C","Xembify"],"ivro":["Gamunex-C","Xembify"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Imunoglobulină subcutanată Xembify față de imunoglobulina intravenoasă Gamunex-C în polineuropatia demielinizantă inflamatorie cronică (CIDP)"},"loc":[[18,"RECRUITING",[[181,"c"]]]]},{"id":"NCT07284121","t":"A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice","sp":"Hoffmann-La Roche","c":["Lung Cancer, Hepatocellular Carcinoma"],"iv":["Atezolizumab"],"ivro":["atezolizumab"],"d":["onco"],"tu":["plaman","hcc"],"bm":["pdl1","egfr","alk"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Satisfacția pacienților și rezultatele tratamentului cu atezolizumab subcutanat în practica obișnuită (cancer pulmonar, cancer hepatic)"},"loc":[[47,"RECRUITING",[]],[62,"RECRUITING",[]],[30,"RECRUITING",[]],[155,"RECRUITING",[]],[317,"RECRUITING",[]],[25,"RECRUITING",[]],[184,"RECRUITING",[]],[101,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT05066217","t":"An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome","sp":"Epygenix","c":["Lennox Gastaut Syndrome"],"iv":["Clemizole HCl"],"ivro":["clemizol clorhidrat"],"d":["neuro"],"f":"3","tip":"I","vmin":2,"vmax":55,"content_status":"complete","ro":{"titlu":"Clemizol adăugat la tratamentul antiepileptic la copiii și adulții cu sindrom Lennox-Gastaut"},"loc":[[266,"RECRUITING",[[281,"pi"]]],[31,"RECRUITING",[[301,"pi"]]],[395,"RECRUITING",[[476,"pi"]]]]},{"id":"NCT06878261","t":"A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)","dn":"JOURNEY","sp":"AstraZeneca","c":["Chronic Obstructive Pulmonary Disease (COPD)"],"iv":["Tezepelumab"],"ivro":["tezepelumab"],"d":["resp"],"f":"3","tip":"I","vmin":40,"vmax":80,"content_status":"complete","ro":{"titlu":"Tezepelumab în bronhopneumopatia obstructivă cronică (BPOC) moderată până la foarte severă, cu exacerbări frecvente"},"loc":[[5,"WITHDRAWN",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"SUSPENDED",[]],[3,"RECRUITING",[]],[85,"RECRUITING",[]],[6,"SUSPENDED",[]],[6,"RECRUITING",[]]]},{"id":"NCT07169851","t":"A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer","sp":"Eli Lilly and Company","c":["Nausea","Vomiting","Drug-Related Side Effects and Adverse Reactions","Neoplasms"],"iv":["LY3537021","Standard of Care Antiemetic Therapies","Background Chemotherapy"],"ivro":["LY3537021","dexametazonă"],"d":["onco"],"tu":["suport"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"LY3537021 față de placebo pentru greața și vărsăturile produse de chimioterapie"},"loc":[[71,"RECRUITING",[[61,"pi"]]],[29,"RECRUITING",[[69,"pi"]]],[27,"RECRUITING",[[70,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[26,"RECRUITING",[[20,"pi"]]]]},{"id":"NCT07200908","t":"A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)","dn":"AZURE-2","sp":"Mirum Pharmaceuticals, Inc.","c":["Chronic Hepatitis D Infection"],"iv":["Brelovitug 300 mg","Bulevirtide 2 mg and Brelovitug - 300 mg"],"ivro":["brelovitug","bulevirtidă"],"d":["gastro","inf"],"f":"3","tip":"I","vmin":18,"vmax":99,"content_status":"complete","ro":{"titlu":"Brelovitug comparat cu bulevirtidă în hepatita cronică D (delta)"},"loc":[[160,"RECRUITING",[]],[161,"RECRUITING",[[154,"pi"]]],[42,"RECRUITING",[[158,"pi"]]],[162,"RECRUITING",[[155,"pi"],[157,"pi"]]],[30,"RECRUITING",[[153,"pi"]]],[163,"RECRUITING",[[156,"pi"]]]]},{"id":"NCT06226883","t":"A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease","dn":"GARNET","sp":"Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)","c":["Inflammatory Bowel Diseases","Crohn's Disease"],"iv":["MORF-057"],"ivro":["MORF-057","MORF-057"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":85,"content_status":"complete","ro":{"titlu":"MORF-057 față de placebo la adulții cu boală Crohn moderat până la sever activă (GARNET)"},"loc":[[221,"RECRUITING",[[223,"pi"]]],[58,"RECRUITING",[[119,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[64,"RECRUITING",[[118,"pi"]]]]},{"id":"NCT07241390","t":"A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)","dn":"ATTAIN-Outcomes","sp":"Eli Lilly and Company","c":["Atherosclerosis Cardiovascular Disease","Chronic Kidney Disease"],"iv":["Orforglipron"],"ivro":["orforglipron"],"d":["cardio","neuro","nefro","gin"],"f":"3","tip":"I","vmin":50,"vmax":null,"content_status":"complete","ro":{"titlu":"Orforglipron și evenimentele cardiovasculare majore la adulții cu boală cardiovasculară aterosclerotică și/sau boală cronică de rinichi"},"loc":[[205,"RECRUITING",[[202,"pi"]]],[239,"RECRUITING",[[239,"pi"]]],[49,"RECRUITING",[[240,"pi"]]],[12,"RECRUITING",[[241,"pi"]]],[240,"RECRUITING",[[242,"pi"]]],[207,"RECRUITING",[[204,"pi"]]],[224,"RECRUITING",[[243,"pi"]]],[99,"RECRUITING",[[244,"pi"]]],[241,"RECRUITING",[[87,"pi"]]],[242,"RECRUITING",[[245,"pi"]]],[243,"RECRUITING",[[246,"pi"]]],[233,"RECRUITING",[[247,"pi"]]],[244,"RECRUITING",[[248,"pi"]]],[212,"RECRUITING",[[209,"pi"]]],[245,"RECRUITING",[[249,"pi"]]],[246,"RECRUITING",[[250,"pi"]]],[234,"RECRUITING",[[251,"pi"]]],[88,"RECRUITING",[[72,"pi"]]],[247,"RECRUITING",[[252,"pi"]]],[248,"RECRUITING",[[253,"pi"]]],[214,"UNKNOWN",[[204,"pi"]]],[249,"UNKNOWN",[[239,"pi"]]],[104,"UNKNOWN",[[253,"pi"]]],[250,"UNKNOWN",[[250,"pi"]]]]},{"id":"NCT07213804","t":"A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer","dn":"FRAmework-01","sp":"Eli Lilly and Company","c":["Ovarian Neoplasms","Fallopian Tube Neoplasms","Peritoneal Neoplasms","Neoplasm Metastasis"],"iv":["Sofetabart Mipitecan","Paclitaxel","Topotecan","Gemcitabine","Pegylated liposomal doxorubicin (PLD)","MIRV","Bevacizumab","Carboplatin"],"ivro":["sofetabart mipitecan","paclitaxel","topotecan","gemcitabină","doxorubicină lipozomală pegilată","mirvetuximab soravtansine"],"d":["onco"],"tu":["ovar"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sofetabart mipitecan față de tratamentul standard în cancerul ovarian recidivat, rezistent sau sensibil la platină"},"loc":[[71,"RECRUITING",[[61,"pi"]]],[293,"RECRUITING",[[315,"pi"]]],[25,"RECRUITING",[[316,"pi"]]],[135,"RECRUITING",[[164,"pi"]]]]},{"id":"NCT07759245","t":"A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)","dn":"RENEW-COPD","sp":"Eli Lilly and Company","c":["Pulmonary Disease, Chronic Obstructive"],"iv":["Brenipatide","Standard of Care"],"ivro":["brenipatide"],"d":["resp","inf"],"f":"2","tip":"I","vmin":40,"vmax":75,"content_status":"complete","ro":{"titlu":"Brenipatide comparat cu placebo în bronhopneumopatia obstructivă cronică (BPOC) moderată sau severă"},"loc":[[16,"NOT_YET_RECRUITING",[[39,"pi"]]],[13,"NOT_YET_RECRUITING",[[323,"pi"]]],[301,"NOT_YET_RECRUITING",[[324,"pi"]]],[59,"NOT_YET_RECRUITING",[[325,"pi"]]],[154,"NOT_YET_RECRUITING",[[326,"pi"]]],[227,"RECRUITING",[[228,"pi"]]],[183,"NOT_YET_RECRUITING",[[327,"pi"]]],[199,"NOT_YET_RECRUITING",[[328,"pi"]]]]},{"id":"NCT07015905","t":"REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults","dn":"ROXI-APEX","sp":"Regeneron Pharmaceuticals","c":["Venous Thromboembolism (VTE)"],"iv":["REGN7508","Apixaban","Enoxaparin"],"ivro":["cenvacibart","apixaban","enoxaparină"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Cenvacibart (REGN7508) comparat cu apixaban și enoxaparină pentru prevenirea cheagurilor de sânge după protezarea totală a genunchiului"},"loc":[[16,"RECRUITING",[[375,"pi"]]],[17,"RECRUITING",[]],[59,"UNKNOWN",[[374,"pi"]]]]},{"id":"NCT06976203","t":"A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)","dn":"MINDSET 2","sp":"Bristol-Myers Squibb","c":["Alzheimer's Disease"],"iv":["KarXT","KarX-EC"],"ivro":["KarXT","KarX-EC"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":60,"vmax":85,"content_status":"complete","ro":{"titlu":"KarXT + KarX-EC comparat cu placebo pentru tulburările de memorie și gândire din boala Alzheimer ușoară sau moderată"},"loc":[[19,"RECRUITING",[]],[19,"RECRUITING",[]],[354,"RECRUITING",[]],[5,"WITHDRAWN",[]],[189,"RECRUITING",[]]]},{"id":"NCT07165028","t":"A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)","dn":"SYNERGY-Outcomes","sp":"Eli Lilly and Company","c":["Metabolic Dysfunction-Associated Steatotic Liver Disease"],"iv":["Tirzepatide","Retatrutide"],"ivro":["tirzepatidă","retatrutidă"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Retatrutidă sau tirzepatidă față de placebo pentru prevenirea complicațiilor hepatice grave în boala ficatului gras metabolic (MASLD) cu risc crescut"},"loc":[[13,"RECRUITING",[[139,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[155,"RECRUITING",[[681,"pi"]]],[113,"RECRUITING",[[574,"pi"]]],[101,"RECRUITING",[[479,"pi"]]],[120,"UNKNOWN",[[574,"pi"]]]]},{"id":"NCT07186101","t":"LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:","dn":"TOPAZ-UC","sp":"Eli Lilly and Company","c":["Ulcerative Colitis"],"iv":["LY4268989","Mirikizumab","LY4268989 Placebo"],"ivro":["zotemtegrast","mirikizumab"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"Zotemtegrast (LY4268989, MORF-057) adăugat la mirikizumab, comparat cu mirikizumab și placebo, în colita ulcerativă moderată până la severă (TOPAZ-UC)"},"loc":[[13,"RECRUITING",[[139,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[113,"RECRUITING",[[574,"pi"]]],[101,"RECRUITING",[[479,"pi"]]],[274,"RECRUITING",[[152,"pi"]]]]},{"id":"NCT07202884","t":"A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight","dn":"RESTRAIN-SUI","sp":"Eli Lilly and Company","c":["Urinary Incontinence,Stress"],"iv":["Orforglipron"],"ivro":["orforglipron"],"d":["nefro","gin"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Orforglipron față de placebo la femeile cu incontinență urinară de efort și obezitate sau suprapondere"},"loc":[[251,"RECRUITING",[[538,"pi"]]],[141,"RECRUITING",[[632,"pi"]]],[358,"RECRUITING",[[726,"pi"]]],[13,"RECRUITING",[[727,"pi"]]],[29,"RECRUITING",[[728,"pi"]]],[566,"RECRUITING",[[729,"pi"]]],[567,"RECRUITING",[[730,"pi"]]],[30,"RECRUITING",[[171,"pi"]]],[568,"RECRUITING",[[731,"pi"]]],[46,"RECRUITING",[[43,"pi"]]],[14,"RECRUITING",[[732,"pi"]]],[105,"RECRUITING",[[629,"pi"]]],[2,"RECRUITING",[[733,"pi"]]],[367,"RECRUITING",[[734,"pi"]]],[569,"RECRUITING",[[735,"pi"]]],[140,"RECRUITING",[[631,"pi"]]],[36,"UNKNOWN",[[736,"pi"]]]]},{"id":"NCT07668388","t":"A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes","sp":"Novo Nordisk A/S","c":["Diabetes Mellitus, Type 2"],"iv":["UBT251","UBT251 Placebo","Semaglutide","Semaglutide Placebo"],"ivro":["UBT251","semaglutidă"],"d":["metab"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Diferite doze de UBT251, o dată pe săptămână, la adulții cu diabet zaharat de tip 2"},"loc":[[222,"RECRUITING",[]],[223,"RECRUITING",[]],[224,"RECRUITING",[]],[225,"RECRUITING",[]],[212,"RECRUITING",[]],[140,"RECRUITING",[]]]},{"id":"NCT06338995","t":"A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)","dn":"CONTRAST-NP","sp":"Eli Lilly and Company","c":["Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)"],"iv":["LY3650150","Standard therapy for INCS"],"ivro":["lebrikizumab"],"d":["alte"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"Lebrikizumab în rinosinuzita cronică cu polipi nazali, la pacienți care folosesc corticosteroizi intranazali"},"loc":[[251,"RECRUITING",[[306,"pi"]]],[12,"RECRUITING",[[307,"pi"],[308,"pi"]]],[12,"RECRUITING",[[308,"pi"]]],[13,"RECRUITING",[[309,"pi"],[310,"pi"]]],[13,"RECRUITING",[[310,"pi"]]],[44,"RECRUITING",[[311,"pi"]]],[292,"RECRUITING",[[312,"pi"]]]]},{"id":"NCT06119581","t":"A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer","dn":"SUNRAY-01","sp":"Eli Lilly and Company","c":["Carcinoma, Non-Small-Cell Lung","Neoplasm Metastasis"],"iv":["LY3537982","Pembrolizumab","Cisplatin","Carboplatin","Pemetrexed"],"ivro":["olomorasib","pembrolizumab","pemetrexed","cisplatină","carboplatină"],"d":["onco"],"tu":["nsclc"],"bm":["kras","pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Olomorasib cu pembrolizumab, cu sau fără chimioterapie, în cancerul pulmonar avansat cu mutația KRAS G12C, prima linie"},"loc":[[99,"RECRUITING",[[403,"pi"]]],[71,"RECRUITING",[[61,"pi"]]],[173,"RECRUITING",[[170,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[26,"RECRUITING",[[20,"pi"]]],[135,"RECRUITING",[[164,"pi"]]],[9,"RECRUITING",[[404,"pi"]]]]},{"id":"NCT06997497","t":"A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)","dn":"KANDLELIT-012 (MK-1084-012)","sp":"Merck Sharp & Dohme LLC","c":["Colon Adenocarcinoma","Rectal Adenocarcinoma"],"iv":["Calderasib","Oxaliplatin","Leucovorin/levofolinate calcium","5-Fluorouracil","Cetuximab","Bevacizumab","Bevacizumab biosimilar"],"ivro":["calderasib","cetuximab","mFOLFOX6","oxaliplatină","leucovorin","levofolinat de calciu"],"d":["onco"],"tu":["colorectal"],"bm":["kras"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Calderasib cu cetuximab și chimioterapie mFOLFOX6 în cancerul colorectal avansat cu mutația KRAS G12C, prima linie"},"loc":[[8,"RECRUITING",[[64,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[30,"RECRUITING",[[128,"pi"]]],[25,"RECRUITING",[]]]},{"id":"NCT06937099","t":"Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight","dn":"COMMIT-CD","sp":"Eli Lilly and Company","c":["Crohn's Disease","Obesity or Overweight"],"iv":["Mirikizumab","Tirzepatide"],"ivro":["mirikizumab","tirzepatidă"],"d":["metab","gastro"],"f":"3","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"Mirikizumab cu tirzepatidă sau cu placebo la adulții cu boala Crohn moderată până la severă și obezitate sau suprapondere (COMMIT-CD)"},"loc":[[434,"RECRUITING",[[572,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[31,"RECRUITING",[[573,"pi"]]],[113,"RECRUITING",[[574,"pi"]]],[14,"RECRUITING",[[442,"pi"]]],[274,"RECRUITING",[[152,"pi"]]]]},{"id":"NCT04910685","t":"(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis","dn":"HARBOR","sp":"Blueprint Medicines Corporation","c":["Indolent Systemic Mastocytosis","Smoldering Systemic Mastocytosis"],"iv":["Elenestinib"],"ivro":["elenestinib"],"d":["onco"],"tu":["nmp"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elenestinib față de placebo în mastocitoza sistemică indolentă cu simptome necontrolate"},"loc":[[29,"RECRUITING",[]],[31,"RECRUITING",[]]]},{"id":"NCT06937086","t":"Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study","dn":"COMMIT-UC","sp":"Eli Lilly and Company","c":["Ulcerative Colitis","Obesity or Overweight"],"iv":["Mirikizumab","Tirzepatide"],"ivro":["mirikizumab","tirzepatidă"],"d":["metab","gastro"],"f":"3","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"Mirikizumab împreună cu tirzepatidă sau cu placebo la adulții cu colită ulcerativă activă și obezitate sau suprapondere"},"loc":[[434,"RECRUITING",[[572,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[31,"RECRUITING",[[573,"pi"]]],[113,"RECRUITING",[[574,"pi"]]],[14,"RECRUITING",[[442,"pi"]]],[274,"RECRUITING",[[152,"pi"]]]]},{"id":"NCT06890598","t":"Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer","dn":"SUNRAY-02","sp":"Eli Lilly and Company","c":["Carcinoma, Non-Small-Cell Lung"],"iv":["Olomorasib","Pembrolizumab","Durvalumab"],"ivro":["Olomorasib","pembrolizumab","olomorasib","durvalumab"],"d":["onco"],"tu":["nsclc"],"bm":["kras"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Olomorasib adăugat la imunoterapie în cancerul pulmonar fără celule mici cu mutație KRAS G12C, operat sau stadiul III inoperabil"},"loc":[[99,"RECRUITING",[[750,"pi"]]],[71,"RECRUITING",[[61,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[26,"RECRUITING",[[20,"pi"]]]]},{"id":"NCT07355218","t":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)","dn":"ELOWEN-2","sp":"EMD Serono Research & Development Institute, Inc.","c":["Systematic Lupus Erythematosus","Cutaneous Lupus Erythematosus"],"iv":["Enpatoran","Standard of care (SoC)"],"ivro":["enpatoran"],"d":["reum","derm"],"f":"3","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Enpatoran adăugat la tratamentul standard în lupusul cutanat activ, cu sau fără lupus eritematos sistemic (ELOWEN-2)"},"loc":[[257,"RECRUITING",[[264,"pi"]]],[13,"UNKNOWN",[[10,"pi"]]],[43,"UNKNOWN",[[40,"pi"]]]]},{"id":"NCT06869551","t":"A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis","sp":"Bristol-Myers Squibb","c":["Juvenile Psoriatic Arthritis"],"iv":["Deucravacitinib"],"ivro":["deucravacitinib"],"d":["reum","derm"],"f":"3","tip":"I","vmin":5,"vmax":17,"content_status":"complete","ro":{"titlu":"Deucravacitinib la copiii și adolescenții cu artrită psoriazică juvenilă activă"},"loc":[[136,"RECRUITING",[]],[24,"WITHDRAWN",[]],[15,"RECRUITING",[]]]},{"id":"NCT06051617","t":"Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis","dn":"AFFIRM","sp":"Gilead Sciences","c":["Primary Biliary Cholangitis"],"iv":["Seladelpar"],"ivro":["seladelpar"],"d":["gastro"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Seladelpar comparat cu placebo în colangita biliară primitivă cu ciroză compensată"},"loc":[[30,"RECRUITING",[]]]},{"id":"NCT07323654","t":"A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma","dn":"BREADTH","sp":"Kymera Therapeutics, Inc.","c":["Eosinophilic Asthma"],"iv":["KT-621"],"ivro":["KT-621"],"d":["hem","resp"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"KT-621 pe cale orală în astmul eozinofilic moderat–sever necontrolat"},"loc":[[22,"RECRUITING",[]],[4,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07288567","t":"A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)","dn":"EMERGENT TEEN","sp":"Bristol-Myers Squibb","c":["Schizophrenia"],"iv":["KarXT","KarXT Matching Placebo"],"ivro":["KarXT","xanomelină","clorură de trospiu"],"d":["psih"],"f":"3","tip":"I","vmin":13,"vmax":17,"content_status":"complete","ro":{"titlu":"KarXT (xanomelină și clorură de trospiu) față de placebo la adolescenții cu schizofrenie (EMERGENT TEEN)"},"loc":[[5,"NOT_YET_RECRUITING",[]],[334,"RECRUITING",[[381,"pi"]]],[332,"RECRUITING",[[378,"pi"]]],[333,"RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[147,"NOT_YET_RECRUITING",[]],[267,"RECRUITING",[[380,"pi"]]],[136,"UNKNOWN",[[382,"pi"]]],[19,"UNKNOWN",[[377,"pi"]]],[20,"UNKNOWN",[[379,"pi"]]]]},{"id":"NCT07332481","t":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease","dn":"ELOWEN-1","sp":"EMD Serono Research & Development Institute, Inc.","c":["Systemic Lupus Erythematosus (SLE)","Cutaneous Lupus Erythematosus (CLE)"],"iv":["Enpatoran","Standard of care (SoC)"],"ivro":["enpatoran"],"d":["reum","derm"],"f":"3","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Enpatoran în manifestările cutanate active ale lupusului eritematos, cu sau fără boală sistemică"},"loc":[[206,"RECRUITING",[[670,"pi"]]],[176,"UNKNOWN",[[175,"pi"]]]]},{"id":"NCT06982521","t":"Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer","dn":"ReDiscover-2","sp":"Relay Therapeutics, Inc.","c":["PIK3CA Mutation","HER2- Negative Breast Cancer","Hormone Receptor Positive Tumor","Breast Cancer","Metastatic Breast Cancer","Advanced Breast Cancer"],"iv":["Zovegalisib","Capivasertib","Fulvestrant"],"ivro":["zovegalisib","fulvestrant","capivasertib"],"d":["onco"],"tu":["san_hr","san"],"bm":["pik3ca","hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zovegalisib (RLY-2608) cu fulvestrant comparat cu capivasertib cu fulvestrant în cancerul mamar avansat HR+/HER2- cu mutație PIK3CA, după inhibitor CDK4/6"},"loc":[[11,"RECRUITING",[]],[65,"RECRUITING",[]],[64,"RECRUITING",[]]]},{"id":"NCT06961214","t":"Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)","dn":"ENDURA-2","sp":"GlaxoSmithKline","c":["Pulmonary Disease, Chronic Obstructive"],"iv":["Depemokimab"],"ivro":["depemokimab"],"d":["resp"],"f":"3","tip":"I","vmin":40,"vmax":80,"content_status":"complete","ro":{"titlu":"Depemokimab comparat cu placebo în BPOC cu inflamație de tip 2 și exacerbări frecvente"},"loc":[[85,"RECRUITING",[[327,"pi"]]],[85,"RECRUITING",[[546,"pi"]]],[6,"RECRUITING",[[331,"pi"]]],[5,"RECRUITING",[[324,"pi"]]],[3,"RECRUITING",[[547,"pi"]]],[3,"RECRUITING",[[326,"pi"]]],[23,"RECRUITING",[[548,"pi"]]]]},{"id":"NCT07218926","t":"A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy","dn":"StrateGIST 3","sp":"GlaxoSmithKline","c":["Gastrointestinal Neoplasms"],"iv":["IDRX-42","Sunitinib"],"ivro":["IDRX-42","sunitinib"],"d":["onco"],"tu":["gist"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"IDRX-42 față de sunitinib în tumorile stromale gastrointestinale (GIST) metastatice sau inoperabile, după imatinib"},"loc":[[5,"RECRUITING",[[61,"pi"]]],[5,"RECRUITING",[[128,"pi"]]],[4,"RECRUITING",[[5,"pi"]]],[6,"RECRUITING",[[164,"pi"]]],[135,"UNKNOWN",[[164,"pi"]]],[71,"UNKNOWN",[[61,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]],[30,"UNKNOWN",[[128,"pi"]]]]},{"id":"NCT06472245","t":"Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor","dn":"ARTEMIA","sp":"OSE Immunotherapeutics","c":["Patients With Non-Small Cell Lung Cancer"],"iv":["OSE2101","Docetaxel","NGS HLAA2 assay"],"ivro":["OSE2101","docetaxel"],"d":["onco"],"tu":["nsclc"],"bm":["hla"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Vaccinul terapeutic OSE2101 comparat cu docetaxel în cancerul pulmonar metastatic HLA-A2 pozitiv, după rezistență secundară la imunoterapie"},"loc":[[8,"RECRUITING",[]],[10,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT06283966","t":"A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease","dn":"THARROS","sp":"AstraZeneca","c":["COPD (Chronic Obstructive Pulmonary Disease)"],"iv":["BGF MDI 320/14.4/9.6 μg","GFF MDI 14.4/9.6 μg"],"ivro":["budesonidă/glicopironiu/formoterol","glicopironiu/formoterol"],"d":["resp"],"f":"3","tip":"I","vmin":40,"vmax":80,"content_status":"complete","ro":{"titlu":"Terapie triplă inhalatorie budesonidă/glicopironiu/formoterol față de glicopironiu/formoterol asupra evenimentelor cardiace și pulmonare în BPOC (THARROS)"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[574,"RECRUITING",[]],[575,"RECRUITING",[]],[85,"RECRUITING",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[154,"UNKNOWN",[[753,"pi"],[193,"pi"]]],[105,"UNKNOWN",[[546,"pi"]]],[21,"UNKNOWN",[[754,"pi"],[759,"pi"]]],[576,"UNKNOWN",[[755,"pi"]]],[577,"UNKNOWN",[[756,"pi"]]],[199,"UNKNOWN",[[637,"pi"]]],[578,"UNKNOWN",[[757,"pi"]]],[142,"UNKNOWN",[[192,"pi"]]],[579,"UNKNOWN",[[758,"pi"]]],[314,"UNKNOWN",[[331,"pi"]]],[324,"UNKNOWN",[[361,"pi"]]]]},{"id":"NCT06160635","t":"D-SOLVE Cohorts (Cohort A and B)","dn":"D-SOLVE","sp":"Hannover Medical School","c":["HDV","HDV Infection","Chronic Liver Disease"],"iv":[],"d":["gastro","inf"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Cohortele D-SOLVE: studiu observațional al pacienților cu hepatită D cronică"},"loc":[[162,"RECRUITING",[[368,"c"]]]]},{"id":"NCT07286032","t":"A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)","dn":"ExCIT","sp":"Jiangsu HengRui Medicine Co., Ltd.","c":["Patients With Chemotherapy-Induced Thrombocytopenia"],"iv":["Hetrombopag Olamine","Hetrombopag Olamine; Hetrombopag Olamine Placebo"],"ivro":["hetrombopag olamină"],"d":["onco"],"tu":["suport"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Hetrombopag olamină față de placebo în scăderea trombocitelor produsă de chimioterapie (ExCIT)"},"loc":[[62,"RECRUITING",[[142,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[10,"NOT_YET_RECRUITING",[[5,"pi"]]]]},{"id":"NCT05645107","t":"A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","dn":"EXCELL","sp":"Grifols Therapeutics LLC","c":["Hypogammaglobulinemia","Bacterial Infections","B-cell Chronic Lymphocytic Leukemia","Multiple Myleoma","Non-Hodgkin Lymphoma"],"iv":["Xembify"],"ivro":["XEMBIFY","imunoglobulină umană subcutanată 20%"],"d":["onco"],"tu":["llc","lnh","mielom"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Imunoglobulină subcutanată (XEMBIFY) pentru prevenirea infecțiilor în leucemia limfocitară cronică, mielomul multiplu și limfomul non-Hodgkin cu imunoglobuline scăzute"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[6,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[23,"RECRUITING",[]],[24,"RECRUITING",[]],[25,"UNKNOWN",[[19,"pi"]]],[26,"UNKNOWN",[[20,"pi"]]],[27,"UNKNOWN",[[21,"pi"]]],[28,"UNKNOWN",[[22,"pi"]]],[29,"UNKNOWN",[[23,"pi"]]],[30,"UNKNOWN",[[24,"pi"],[26,"pi"]]],[8,"UNKNOWN",[[25,"pi"]]],[31,"UNKNOWN",[[27,"pi"]]],[32,"UNKNOWN",[[28,"pi"]]]]},{"id":"NCT07221851","t":"Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders","sp":"Ascendis Pharma A/S","c":["Turner Syndrome","Short Stature Homeobox Gene Mutation","Idiopathic Short Stature","Small for Gestational Age at Delivery"],"iv":["Lonapegsomatropin [SKYTROFA®]","Somatropin Pen Injector"],"ivro":["lonapegsomatropină","somatropină"],"d":["cardio","metab","reum","derm","nefro","gin"],"f":"3","tip":"I","vmin":2,"vmax":17,"content_status":"complete","ro":{"titlu":"Lonapegsomatropină săptămânal față de somatropină zilnic la copiii cu statură mică în sindromul Turner, deficitul SHOX, născuți mici pentru vârsta gestațională sau cu statură mică idiopatică"},"loc":[[24,"RECRUITING",[]],[18,"RECRUITING",[]]]},{"id":"NCT06072482","t":"A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis","dn":"AVASET","sp":"Amgen","c":["Antineutrophil Cytoplasmic Antibody-associated Vasculitis"],"iv":["Avacopan","Standard of Care"],"ivro":["avacopan"],"d":["cardio","reum","derm"],"f":"4","tip":"I","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"Siguranța pe termen lung a avacopanului la pacienții cu vasculită asociată ANCA"},"loc":[[67,"RECRUITING",[]],[176,"RECRUITING",[]],[59,"RECRUITING",[]]]},{"id":"NCT07533175","t":"AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight","dn":"AMAZE 2","sp":"Novo Nordisk A/S","c":["Diabetes Mellitus","Overweight","Obesity"],"iv":["NNC0487-0111"],"ivro":["NNC0487-0111"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"NNC0487-0111 injectabil o dată pe săptămână, față de placebo, la adulții cu exces de greutate sau obezitate și diabet zaharat de tip 2 (AMAZE 2)"},"loc":[[222,"RECRUITING",[]],[298,"RECRUITING",[]],[204,"RECRUITING",[]],[224,"RECRUITING",[]],[56,"RECRUITING",[]],[242,"RECRUITING",[]],[299,"RECRUITING",[]],[300,"NOT_YET_RECRUITING",[]],[101,"RECRUITING",[]]]},{"id":"NCT06887192","t":"A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis","sp":"MapLight Therapeutics","c":["Psychosis Associated With Alzheimer's Disease"],"iv":["ML-007C-MA"],"ivro":["ML-007C-MA"],"d":["neuro","psih"],"f":"2","tip":"I","vmin":55,"vmax":90,"content_status":"complete","ro":{"titlu":"ML-007C-MA comparat cu placebo pentru halucinațiile și ideile delirante din psihoza asociată bolii Alzheimer"},"loc":[[5,"RECRUITING",[]],[20,"UNKNOWN",[[398,"pi"]]],[363,"UNKNOWN",[[423,"pi"]]],[19,"UNKNOWN",[[324,"pi"]]]]},{"id":"NCT07032662","t":"Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","sp":"Immunovant Sciences GmbH","c":["Chronic Inflammatory Demyelinating Polyneuropathy"],"iv":["Imeroprubart"],"ivro":["imeroprubart"],"d":["neuro","reum"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Imeroprubart la adulții cu polineuropatie demielinizantă inflamatorie cronică (CIDP)"},"loc":[[5,"NOT_YET_RECRUITING",[]],[23,"RECRUITING",[]]]},{"id":"NCT07253285","t":"A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight","sp":"Novo Nordisk A/S","c":["Overweight","Obesity"],"iv":["Cagrilintide","Semaglutide"],"ivro":["CagriSema","cagrilintidă","semaglutidă"],"d":["metab"],"f":"3","tip":"I","vmin":8,"vmax":18,"content_status":"complete","ro":{"titlu":"Cagrilintidă și CagriSema (cagrilintidă + semaglutidă) pentru scăderea în greutate la copii și adolescenți cu supraponderalitate sau obezitate"},"loc":[[380,"NOT_YET_RECRUITING",[]],[451,"RECRUITING",[]],[452,"RECRUITING",[]],[140,"RECRUITING",[]]]},{"id":"NCT07361497","t":"A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)","dn":"ROSETTA Lung-201","sp":"Bristol-Myers Squibb","c":["Non-small Cell Lung Cancer (NSCLC)"],"iv":["Pumitamig","Durvalumab"],"ivro":["pumitamig","durvalumab"],"d":["onco"],"tu":["nsclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig față de durvalumab după radiochimioterapie în cancerul pulmonar fără celule mici stadiul III inoperabil"},"loc":[[413,"RECRUITING",[]],[45,"RECRUITING",[]],[31,"RECRUITING",[]],[8,"RECRUITING",[]],[10,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT07221149","t":"A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)","dn":"ROSETTA Gastric-204","sp":"Bristol-Myers Squibb","c":["Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma"],"iv":["Pumitamig","Folfox","Capox","Nivolumab"],"ivro":["pumitamig","FOLFOX","CAPOX","nivolumab"],"d":["onco"],"tu":["esofag","gastric"],"bm":["pdl1","her2"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pumitamig sau nivolumab, ambele cu chimioterapie, în adenocarcinomul gastric sau esofagian avansat"},"loc":[[155,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[8,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT06651567","t":"A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia","sp":"Intra-Cellular Therapies, Inc.","c":["Agitation Associated With Alzheimer's Dementia"],"iv":["ITI-1284"],"ivro":["ITI-1284"],"d":["alte"],"f":"2","tip":"I","vmin":55,"vmax":null,"content_status":"complete","ro":{"titlu":"ITI-1284 comparat cu placebo pentru agitația asociată demenței din boala Alzheimer"},"loc":[[36,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[188,"RECRUITING",[]],[189,"RECRUITING",[]],[169,"RECRUITING",[]]]},{"id":"NCT04701684","t":"WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)","dn":"WE-TRUST","sp":"Philips Clinical & Medical Affairs Global","c":["Stroke, Acute"],"iv":["Direct to Angio Suite (DTAS) Philips' CBCT triage","Conventional CT/MR triage"],"d":["cardio","neuro"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Transferul direct în sala de angiografie față de evaluarea obișnuită prin CT/RMN în accidentul vascular cerebral ischemic acut"},"loc":[[143,"RECRUITING",[[220,"c"],[221,"c"]]]]},{"id":"NCT06904235","t":"Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)","sp":"Helsinn Healthcare SA","c":["Nausea and Vomiting Chemotherapy-Induced","Nausea Post Chemotherapy"],"iv":["IV NEPA (fosnetupitant/palonosetron)","Reference Treatment: IV ondansetron infusion","Reference Treatment: IV fosaprepitant infusion"],"ivro":["NEPA","fosaprepitant","ondansetron"],"d":["onco"],"tu":["suport"],"f":"2","tip":"I","vmin":0,"vmax":18,"content_status":"complete","ro":{"titlu":"NEPA intravenos (fosnetupitant/palonosetron) pentru prevenirea greței și vărsăturilor la copiii cu cancer care primesc chimioterapie puternic emetogenă"},"loc":[[30,"RECRUITING",[]],[62,"RECRUITING",[]],[267,"RECRUITING",[]]]},{"id":"NCT06540833","t":"A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease","sp":"Intra-Cellular Therapies, Inc.","c":["Psychotic Disorders","Alzheimer Disease"],"iv":["ITI-1284"],"ivro":["ITI-1284"],"d":["neuro","psih"],"f":"2","tip":"I","vmin":55,"vmax":null,"content_status":"complete","ro":{"titlu":"ITI-1284 față de placebo în psihoza asociată bolii Alzheimer"},"loc":[[36,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[188,"SUSPENDED",[]],[426,"RECRUITING",[]],[169,"RECRUITING",[]]]},{"id":"NCT05744921","t":"A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works","dn":"ACCESS-EXT","sp":"Regeneron Pharmaceuticals","c":["Paroxysmal Nocturnal Hemoglobinuria"],"iv":["Pozelimab","Cemdisiran"],"ivro":["pozelimab","cemdisiran"],"d":["hem"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Tratamentul pe termen lung cu pozelimab + cemdisiran în hemoglobinuria paroxistică nocturnă (studiu de extensie ACCESS-EXT)"},"loc":[[8,"RECRUITING",[[49,"pi"]]],[37,"UNKNOWN",[[33,"pi"]]],[92,"UNKNOWN",[[159,"pi"]]]]},{"id":"NCT06096116","t":"Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass","sp":"Octapharma","c":["Acquired Antithrombin Deficiency"],"iv":["Human plasma derived antithrombin"],"ivro":["Atenativ"],"d":["hem"],"f":"3","tip":"I","vmin":18,"vmax":85,"content_status":"complete","ro":{"titlu":"Antitrombină umană derivată din plasmă (Atenativ) în două doze, față de placebo, la pacienții cu rezistență la heparină operați pe cord cu circulație extracorporeală"},"loc":[[138,"RECRUITING",[]]]},{"id":"NCT07277231","t":"A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia","sp":"BeOne Medicines","c":["Chronic Lymphocytic Leukemia"],"iv":["Sonrotoclax","Zanubrutinib","Acalabrutinib","Venetoclax"],"ivro":["Sonrotoclax","zanubrutinib","Venetoclax","acalabrutinib"],"d":["onco"],"tu":["llc","lnh"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sonrotoclax cu zanubrutinib față de venetoclax cu acalabrutinib în leucemia limfocitară cronică netratată"},"loc":[[27,"RECRUITING",[[48,"pi"]]],[30,"RECRUITING",[[34,"pi"]]],[8,"RECRUITING",[[25,"pi"]]]]},{"id":"NCT06973187","t":"A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","sp":"BeOne Medicines","c":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"iv":["Tacabrutideg","Pirtobrutinib"],"ivro":["tacabrutideg","pirtobrutinib"],"d":["onco"],"tu":["llc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Tacabrutideg față de pirtobrutinib în leucemia limfocitară cronică recidivată sau refractară după un inhibitor BTK"},"loc":[[27,"RECRUITING",[[48,"pi"]]],[8,"RECRUITING",[[25,"pi"]]],[25,"RECRUITING",[[19,"pi"]]]]},{"id":"NCT04918173","t":"Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery","sp":"Octapharma","c":["Congenital Antithrombin Deficiency"],"iv":["Atenativ"],"ivro":["Atenativ"],"d":["alte"],"f":"3","tip":"I","vmin":12,"vmax":80,"content_status":"complete","ro":{"titlu":"Atenativ (concentrat de antitrombină) la pacienții cu deficit congenital de antitrombină care urmează o operație sau o naștere"},"loc":[[14,"RECRUITING",[]]]},{"id":"NCT06807424","t":"A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis","dn":"ICONIC-PsA 2","sp":"Janssen Research & Development, LLC","c":["Arthritis, Psoriatic"],"iv":["Icotrokinra"],"ivro":["icotrokinra"],"d":["reum","derm"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Icotrokinra în artrita psoriazică activă, la pacienți tratați sau netratați anterior cu medicamente biologice"},"loc":[[40,"RECRUITING",[[38,"pi"]]],[13,"RECRUITING",[[10,"pi"]]],[5,"RECRUITING",[]],[41,"RECRUITING",[[41,"pi"]]],[4,"RECRUITING",[]],[42,"RECRUITING",[[39,"pi"]]],[15,"RECRUITING",[]],[43,"UNKNOWN",[[40,"pi"]]]]},{"id":"NCT07048600","t":"Brief Trial of ACT-i for Adults With Chronic Insomnia","sp":"Babes-Bolyai University","c":["Chronic Insomnia"],"iv":["Acceptance and Commitment Therapy for Insomnia","Attentional Control Group"],"d":["neuro","psih"],"f":"","tip":"I","vmin":18,"vmax":59,"content_status":"complete","ro":{"titlu":"Terapie scurtă de acceptare și angajament, în grup și online, pentru insomnia cronică la adulți"},"loc":[[78,"RECRUITING",[[67,"c"],[68,"c"]]]]},{"id":"NCT06868277","t":"A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer","dn":"ARTEMIDE-Lung04","sp":"AstraZeneca","c":["Carcinoma, Non-Small Cell Lung"],"iv":["Rilvegostomig","Pembrolizumab"],"ivro":["rilvegostomig","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["pdl1","egfr","alk","ros1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Rilvegostomig comparat cu pembrolizumab în cancerul pulmonar fără celule mici metastatic, cu PD-L1 ridicat"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[4,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[72,"RECRUITING",[]],[86,"RECRUITING",[]],[147,"RECRUITING",[]],[6,"RECRUITING",[]],[2,"UNKNOWN",[[132,"pi"]]],[148,"UNKNOWN",[[133,"pi"]]],[9,"UNKNOWN",[[134,"pi"]]],[11,"UNKNOWN",[[135,"pi"]]],[149,"UNKNOWN",[[136,"pi"]],null,{"can_enroll":true,"own_centre":true}],[27,"UNKNOWN",[[70,"pi"]]],[150,"UNKNOWN",[[137,"pi"]]],[62,"UNKNOWN",[[138,"pi"]]],[71,"UNKNOWN",[[61,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]]]},{"id":"NCT06559306","t":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","sp":"Janssen Research & Development, LLC","c":["Depressive Disorder, Major"],"iv":["Seltorexant","Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)"],"ivro":["seltorexant"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":74,"content_status":"complete","ro":{"titlu":"Seltorexant adăugat la antidepresiv în tulburarea depresivă majoră cu simptome de insomnie"},"loc":[[19,"COMPLETED",[[15,"pi"]]],[19,"RECRUITING",[]],[59,"COMPLETED",[]],[59,"COMPLETED",[]],[200,"RECRUITING",[[194,"pi"]]],[201,"COMPLETED",[]],[20,"COMPLETED",[]],[20,"COMPLETED",[]],[20,"COMPLETED",[]],[105,"RECRUITING",[[196,"pi"]]],[189,"RECRUITING",[]],[202,"COMPLETED",[]],[202,"COMPLETED",[]],[203,"UNKNOWN",[[195,"pi"]]]]},{"id":"NCT07114874","t":"NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia","dn":"NBI-1117568-SCZ3032","sp":"Neurocrine Biosciences","c":["Schizophrenia"],"iv":["NBI-1117568"],"ivro":["NBI-1117568"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Siguranța pe termen lung a NBI-1117568 la adulții cu schizofrenie"},"loc":[[22,"RECRUITING",[]],[5,"COMPLETED",[]],[343,"RECRUITING",[]],[19,"UNKNOWN",[[324,"pi"],[384,"pi"]]],[20,"UNKNOWN",[[398,"pi"]]],[203,"UNKNOWN",[[195,"pi"]]]]},{"id":"NCT05766839","t":"Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels","dn":"EMERALD2","sp":"Vifor Pharma, Inc.","c":["Hyperkalemia"],"iv":["Patiromer"],"ivro":["patiromer"],"d":["metab"],"f":"2","tip":"I","vmin":0,"vmax":11,"content_status":"complete","ro":{"titlu":"Patiromer la copii sub 12 ani cu potasiu crescut în sânge (hiperkaliemie)"},"loc":[[267,"RECRUITING",[[402,"pi"]]]]},{"id":"NCT07438496","t":"A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus","dn":"GARDENIA-SLE","sp":"Janssen Research & Development, LLC","c":["Lupus Erythematosus, Systemic"],"iv":["Nipocalimab","Standard of care treatment"],"ivro":["nipocalimab","nipocalimab"],"d":["reum","derm"],"f":"3","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Nipocalimab, comparat cu placebo, adăugat la tratamentul standard în lupusul eritematos sistemic moderat până la sever (GARDENIA-SLE)"},"loc":[[12,"RECRUITING",[[9,"pi"]]],[67,"RECRUITING",[[53,"pi"]]],[5,"RECRUITING",[]],[41,"RECRUITING",[[41,"pi"]]],[59,"RECRUITING",[[54,"pi"]]],[355,"RECRUITING",[[415,"pi"]]],[105,"RECRUITING",[[271,"pi"]]],[356,"RECRUITING",[]],[357,"UNKNOWN",[[416,"pi"]]],[43,"UNKNOWN",[[40,"pi"]]]]},{"id":"NCT06750094","t":"A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy","dn":"OrigAMI-3","sp":"Janssen Research & Development, LLC","c":["Colorectal Neoplasms"],"iv":["Amivantamab","Cetuximab","Bevacizumab","5-fluorouracil","Leucovorin calcium/Levoleucovorin","Irinotecan"],"ivro":["amivantamab","FOLFIRI","5-fluorouracil","acid folinic","levoleucovorin","irinotecan"],"d":["onco"],"tu":["colorectal"],"bm":["kras","nras","braf"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Amivantamab cu FOLFIRI comparat cu cetuximab sau bevacizumab cu FOLFIRI în cancerul colorectal metastatic fără mutații KRAS/NRAS/BRAF, linia a doua"},"loc":[[251,"RECRUITING",[[434,"pi"]]],[374,"RECRUITING",[]],[375,"RECRUITING",[]],[376,"COMPLETED",[]],[8,"RECRUITING",[[219,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[25,"RECRUITING",[[141,"pi"]]],[151,"RECRUITING",[[435,"pi"]]],[293,"UNKNOWN",[[362,"pi"]]],[71,"UNKNOWN",[[61,"pi"]]],[13,"UNKNOWN",[[436,"pi"]]]]},{"id":"NCT07196748","t":"A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis","dn":"ICONIC-UC","sp":"Janssen Research & Development, LLC","c":["Colitis, Ulcerative"],"iv":["Icotrokinra"],"ivro":["icotrokinra"],"d":["gastro"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"Icotrokinra oral în colita ulcerativă moderat până la sever activă, la adulți și adolescenți"},"loc":[[13,"RECRUITING",[[139,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[155,"RECRUITING",[[443,"pi"]]],[273,"COMPLETED",[[440,"pi"]]],[14,"COMPLETED",[[442,"pi"]]],[378,"COMPLETED",[]],[69,"UNKNOWN",[[439,"pi"]]],[71,"UNKNOWN",[[441,"pi"]]],[379,"UNKNOWN",[[119,"pi"]]]]},{"id":"NCT06742723","t":"A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure","dn":"BaxDuo-Pacific","sp":"AstraZeneca","c":["Chronic Kidney Disease and Hypertension"],"iv":["Baxdrostat/dapagliflozin"],"ivro":["baxdrostat","dapagliflozină"],"d":["cardio","nefro","gin"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Baxdrostat adăugat la dapagliflozină în boala cronică de rinichi cu tensiune arterială mare"},"loc":[[22,"WITHDRAWN",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"WITHDRAWN",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[4,"RECRUITING",[]],[85,"RECRUITING",[]],[167,"TERMINATED",[]],[6,"RECRUITING",[]],[403,"UNKNOWN",[[116,"pi"]]],[404,"UNKNOWN",[[100,"pi"]]],[30,"UNKNOWN",[[75,"pi"]]],[107,"UNKNOWN",[[500,"pi"]]],[140,"UNKNOWN",[[418,"pi"]]],[14,"UNKNOWN",[[501,"pi"]]],[216,"UNKNOWN",[[502,"pi"]]],[59,"UNKNOWN",[[419,"pi"]]],[105,"UNKNOWN",[[271,"pi"]]]]},{"id":"NCT07602088","t":"A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia","dn":"REALITY-RO","sp":"Janssen Research & Development, LLC","c":["Leukemia, Lymphocytic, Chronic, B-Cell"],"iv":[],"ivro":["ibrutinib + venetoclax"],"d":["onco"],"tu":["llc"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Studiu observațional în România: ibrutinib cu venetoclax, durată fixă, în prima linie în leucemia limfocitară cronică"},"loc":[[31,"RECRUITING",[]]]},{"id":"NCT07105098","t":"NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia","dn":"NBI-1117568-SCZ3030","sp":"Neurocrine Biosciences","c":["Schizophrenia"],"iv":["NBI-1117568"],"ivro":["NBI-1117568"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"NBI-1117568 față de placebo la adulții cu schizofrenie aflați într-o agravare acută care necesită internare"},"loc":[[22,"RECRUITING",[]],[22,"RECRUITING",[]],[5,"COMPLETED",[]],[19,"UNKNOWN",[[324,"pi"],[384,"pi"],[515,"pi"]]],[203,"UNKNOWN",[[195,"pi"]]],[412,"UNKNOWN",[[516,"pi"]]],[20,"UNKNOWN",[[398,"pi"]]]]},{"id":"NCT07276399","t":"A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer","dn":"OrigAMI-5","sp":"Janssen Research & Development, LLC","c":["Squamous Cell Carcinoma of Head and Neck"],"iv":["Amivantamab","Pembrolizumab","Carboplatin","5-Flurouracil","Cisplatin"],"ivro":["amivantamab","pembrolizumab","carboplatină","5-fluorouracil","cisplatină"],"d":["onco"],"tu":["capgat"],"bm":["hpv"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Amivantamab cu pembrolizumab și carboplatină, comparat cu tratamentul standard, în cancerul scuamos al capului și gâtului recidivat sau metastatic"},"loc":[[27,"RECRUITING",[[70,"pi"]]],[44,"RECRUITING",[[63,"pi"]]],[8,"RECRUITING",[[64,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[25,"RECRUITING",[]],[135,"RECRUITING",[[164,"pi"]]]]},{"id":"NCT05160584","t":"A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma","dn":"MoMMent","sp":"Janssen Pharmaceutica N.V., Belgium","c":["Relapsed/Refractory Multiple Myeloma"],"iv":["No intervention"],"ivro":["talquetamab"],"d":["onco"],"tu":["mielom"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Observarea tratamentelor standard în practica obișnuită la pacienții cu mielom multiplu recidivat sau refractar"},"loc":[[30,"RECRUITING",[]],[27,"RECRUITING",[]],[8,"RECRUITING",[]]]},{"id":"NCT06548542","t":"Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease","dn":"Target CD","sp":"AbbVie","c":["Crohn's Disease"],"iv":["Risankizumab","Lutikizumab","Trosunilimab","ABBV-8736"],"ivro":["risankizumab","trosunilimab","lutikizumab","ABBV-8736"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Studiu-platformă cu terapii țintite (risankizumab, trosunilimab, lutikizumab, ABBV-8736), singure sau în combinație, în boala Crohn moderată sau severă"},"loc":[[71,"RECRUITING",[[119,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[132,"RECRUITING",[[121,"pi"]]],[64,"RECRUITING",[[118,"pi"]]]]},{"id":"NCT04892173","t":"JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC","dn":"NANORAY-312","sp":"Johnson & Johnson Enterprise Innovation Inc.","c":["Carcinoma, Squamous Cell"],"iv":["JNJ-90301900 (NBTXR3)","Cetuximab","Radiation Therapy"],"ivro":["NBTXR3","cetuximab"],"d":["onco"],"tu":["capgat"],"f":"3","tip":"I","vmin":60,"vmax":null,"content_status":"complete","ro":{"titlu":"Nanoparticule NBTXR3 activate prin radioterapie, cu sau fără cetuximab, la vârstnici cu cancer ORL avansat local care nu pot primi platină"},"loc":[[62,"RECRUITING",[[571,"pi"]]]]},{"id":"NCT07227454","t":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","dn":"AVENUE","sp":"Janssen Research & Development, LLC","c":["Depressive Disorder, Major"],"iv":["Esketamine","Midazolam","Oral Placebo","Intranasal Placebo"],"ivro":["esketamină","midazolam"],"d":["psih"],"f":"3","tip":"I","vmin":12,"vmax":17,"content_status":"complete","ro":{"titlu":"Esketamină intranazală adăugată la tratamentul standard la adolescenții cu depresie majoră și idei sau comportament suicidar acut"},"loc":[[19,"RECRUITING",[[377,"pi"]]],[136,"RECRUITING",[[382,"pi"]]],[202,"RECRUITING",[[644,"pi"]]],[267,"RECRUITING",[[380,"pi"]]]]},{"id":"NCT06233461","t":"A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease","sp":"Takeda","c":["Crohn's Disease"],"iv":["TAK-279"],"ivro":["zasocitinib"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Zasocitinib (TAK-279) în trei doze, comparat cu placebo, în boala Crohn moderată până la severă"},"loc":[[274,"RECRUITING",[[152,"pi"]]],[488,"RECRUITING",[[641,"pi"]]],[498,"RECRUITING",[[139,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[176,"RECRUITING",[[478,"pi"]]],[499,"RECRUITING",[[122,"pi"]]],[30,"RECRUITING",[[507,"pi"]]],[133,"UNKNOWN",[[122,"pi"]]],[13,"UNKNOWN",[[139,"pi"]]],[82,"UNKNOWN",[[152,"pi"]]]]},{"id":"NCT07582783","t":"A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania","dn":"PROGRESS-RO","sp":"Janssen Research & Development, LLC","c":["Psoriasis"],"iv":[],"ivro":["guselkumab"],"d":["derm"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Continuarea tratamentului cu guselkumab la pacienții fără tratament biologic anterior, cu psoriazis în plăci moderat–sever, în România (PROGRESS-RO)"},"loc":[[531,"RECRUITING",[]],[532,"RECRUITING",[]],[142,"RECRUITING",[]],[29,"RECRUITING",[]],[29,"RECRUITING",[]],[533,"RECRUITING",[]],[534,"RECRUITING",[]],[59,"RECRUITING",[]],[235,"RECRUITING",[]],[535,"RECRUITING",[]],[536,"RECRUITING",[]],[537,"RECRUITING",[]],[538,"RECRUITING",[]],[539,"RECRUITING",[]],[105,"RECRUITING",[]],[540,"RECRUITING",[]],[541,"RECRUITING",[]],[216,"RECRUITING",[]],[542,"RECRUITING",[]],[34,"RECRUITING",[]]]},{"id":"NCT07196722","t":"A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease","dn":"ICONIC-CD","sp":"Janssen Research & Development, LLC","c":["Crohn Disease"],"iv":["Icotrokinra"],"ivro":["icotrokinra"],"d":["gastro"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Icotrokinra, tabletă zilnică, în boala Crohn activă moderată până la severă"},"loc":[[13,"RECRUITING",[[139,"pi"]]],[29,"RECRUITING",[[224,"pi"]]],[559,"RECRUITING",[]],[155,"RECRUITING",[[443,"pi"]]],[273,"RECRUITING",[[440,"pi"]]],[69,"RECRUITING",[[439,"pi"]]],[364,"UNKNOWN",[[474,"pi"]]],[71,"UNKNOWN",[[441,"pi"]]],[379,"UNKNOWN",[[119,"pi"]]]]},{"id":"NCT06758401","t":"This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.","sp":"Pfizer","c":["Non-Small Cell Lung Cancer","Carcinoma, Non-Small-Cell Lung","Carcinoma, Non-Small-Cell Lung (NSCLC)"],"iv":["Sigvotatug Vedotin","Pembrolizumab"],"ivro":["sigvotatug vedotin","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["pdl1","egfr","alk","ros1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sigvotatug vedotin cu pembrolizumab comparat cu pembrolizumab singur în cancerul pulmonar avansat cu PD-L1 ≥ 50%, prima linie"},"loc":[[71,"RECRUITING",[[61,"pi"]]],[62,"RECRUITING",[[138,"pi"]]],[293,"NOT_YET_RECRUITING",[[315,"pi"]]],[76,"RECRUITING",[[553,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[26,"RECRUITING",[[20,"pi"]]],[11,"RECRUITING",[[135,"pi"]]],[10,"NOT_YET_RECRUITING",[[5,"pi"]]],[135,"NOT_YET_RECRUITING",[[164,"pi"]]],[9,"UNKNOWN",[[163,"pi"]]],[25,"UNKNOWN",[[503,"pi"]]],[8,"UNKNOWN",[[219,"pi"]]]]},{"id":"NCT07085767","t":"Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer","dn":"OPERA-02","sp":"Olema Pharmaceuticals, Inc.","c":["Breast Cancer","Locally Advanced Breast Cancer","Metastatic Breast Cancer","ER Positive Breast Cancer","HER2 Negative Breast Carcinoma"],"iv":["Palazestrant","Letrozole-matching placebo","Ribociclib","Letrozole","Palazestrant matching-placebo"],"ivro":["palazestrant","ribociclib","letrozolului","letrozol","palazestrantului"],"d":["onco"],"tu":["san_hr","san"],"bm":["hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Palazestrant cu ribociclib comparat cu letrozol cu ribociclib, ca prim tratament în cancerul mamar avansat ER+/HER2-"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[171,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07326709","t":"A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease","dn":"INVEST-HD","sp":"Novartis Pharmaceuticals","c":["Huntington Disease"],"iv":["Votoplam (blinded)"],"ivro":["votoplam"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":21,"vmax":70,"content_status":"complete","ro":{"titlu":"Votoplam, comparat cu placebo, în boala Huntington simptomatică precoce (INVEST-HD)"},"loc":[[5,"RECRUITING",[]],[18,"RECRUITING",[]]]},{"id":"NCT07392190","t":"A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin","dn":"ENLIGHTEN-6","sp":"Eli Lilly and Company","c":["Overweight","Obesity"],"iv":["Eloralintide"],"ivro":["eloralintide"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Eloralintide săptămânal, adăugat la tratamentul cu incretină, în obezitatea sau supraponderea persistentă"},"loc":[[223,"RECRUITING",[[552,"pi"]]],[12,"RECRUITING",[[241,"pi"]]],[207,"RECRUITING",[[204,"pi"]]],[224,"RECRUITING",[[243,"pi"]]],[211,"RECRUITING",[]],[233,"RECRUITING",[[247,"pi"]]],[212,"RECRUITING",[[209,"pi"]]],[213,"RECRUITING",[[210,"pi"]]],[246,"RECRUITING",[[250,"pi"]]],[247,"RECRUITING",[[252,"pi"]]],[250,"UNKNOWN",[[250,"pi"]]],[214,"UNKNOWN",[[204,"pi"]]]]},{"id":"NCT07112196","t":"Visugromab in Cachexia International Trial","dn":"VINCIT","sp":"CatalYm GmbH","c":["Cancer-associated Cachexia"],"iv":["Visugromab (CTL-002)"],"ivro":["visugromab"],"d":["onco"],"tu":["suport"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Visugromab față de placebo în cașexia asociată cancerului (scădere în greutate nedorită)"},"loc":[[206,"RECRUITING",[]],[11,"RECRUITING",[]],[10,"RECRUITING",[]],[210,"RECRUITING",[]],[151,"RECRUITING",[]],[26,"RECRUITING",[]],[150,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT05485961","t":"Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)","dn":"POSIBIL6ESKD","sp":"CSL Behring","c":["End Stage Kidney Disease"],"iv":["CSL300"],"ivro":["clazakizumab"],"d":["cardio","metab","nefro","gin"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Clazakizumab (CSL300) la adulții dializați cu boală renală în stadiu terminal și inflamație sistemică: stabilirea dozei și efectul asupra evenimentelor cardiovasculare"},"loc":[[106,"RECRUITING",[]],[50,"WITHDRAWN",[[108,"pi"]]],[107,"RECRUITING",[[110,"pi"]]],[108,"RECRUITING",[]],[109,"RECRUITING",[]],[30,"RECRUITING",[[101,"pi"],[106,"pi"]]],[110,"RECRUITING",[]],[30,"RECRUITING",[]],[111,"RECRUITING",[]],[112,"RECRUITING",[]],[113,"RECRUITING",[]],[114,"RECRUITING",[]],[115,"RECRUITING",[[103,"pi"]]],[116,"RECRUITING",[[97,"pi"]]],[117,"RECRUITING",[]],[118,"RECRUITING",[]],[101,"RECRUITING",[[115,"pi"]]],[119,"RECRUITING",[[104,"pi"]]],[120,"UNKNOWN",[[98,"pi"]]],[121,"UNKNOWN",[[99,"pi"]]],[122,"UNKNOWN",[[100,"pi"]]],[123,"UNKNOWN",[[102,"pi"]]],[124,"UNKNOWN",[[105,"pi"]]],[125,"UNKNOWN",[[107,"pi"]]],[126,"UNKNOWN",[[109,"pi"]]],[127,"UNKNOWN",[[111,"pi"]]],[128,"UNKNOWN",[[112,"pi"]]],[129,"UNKNOWN",[[113,"pi"]]],[130,"UNKNOWN",[[114,"pi"]]],[131,"UNKNOWN",[[116,"pi"]]]]},{"id":"NCT06767514","t":"Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1","dn":"HARMONi-7","sp":"Summit Therapeutics","c":["Non-Small Cell Lung Cancer"],"iv":["Ivonescimab Injection","Pembrolizumab Injection"],"ivro":["ivonescimab","pembrolizumab"],"d":["onco"],"tu":["nsclc"],"bm":["pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Ivonescimab față de pembrolizumab în prima linie a cancerului pulmonar fără celule mici metastatic cu PD-L1 crescut"},"loc":[[3,"RECRUITING",[]],[3,"RECRUITING",[]],[3,"RECRUITING",[]],[320,"RECRUITING",[]],[171,"RECRUITING",[]],[4,"RECRUITING",[]],[24,"RECRUITING",[]],[170,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"RECRUITING",[]],[5,"RECRUITING",[]]]},{"id":"NCT06855771","t":"A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)","dn":"MountainTAP-9","sp":"Bristol-Myers Squibb","c":["Carcinoma, Non-Small-Cell Lung"],"iv":["BMS-986504","Izalontamab Brengitecan"],"ivro":["navlimetostat","izalontamab brengitecan"],"d":["onco"],"tu":["nsclc"],"bm":["mtap"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Navlimetostat singur sau cu izalontamab brengitecan în cancerul pulmonar fără celule mici avansat cu deleție MTAP, după tratamente anterioare"},"loc":[[62,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[413,"RECRUITING",[]],[8,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT07407933","t":"A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors","sp":"MediLink Therapeutics (Suzhou) Co., Ltd.","c":["Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma"],"iv":["YL201","Atezolizumab"],"ivro":["YL201","atezolizumab"],"d":["onco"],"tu":["sclc"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"YL201 plus atezolizumab în cancerul pulmonar cu celule mici în stadiu extins, netratat anterior"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]]]},{"id":"NCT04879043","t":"Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma","sp":"Heidelberg Pharma AG","c":["Multiple Myeloma","Plasma Cell Disorder"],"iv":["HDP-101"],"ivro":["HDP-101"],"d":["onco"],"tu":["mielom"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"HDP-101 în mielomul multiplu recidivat sau refractar — studiu de fază 1/2a"},"loc":[[16,"RECRUITING",[]],[8,"RECRUITING",[]]]},{"id":"NCT06492616","t":"A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence","dn":"ELEGANT","sp":"Stemline Therapeutics, Inc.","c":["Breast Cancer"],"iv":["Elacestrant","Anastrozole","Letrozole","Exemestane","Tamoxifen"],"ivro":["elacestrant","anastrozol","letrozol","exemestan","tamoxifen"],"d":["onco"],"tu":["san_hr","san_her2low","san"],"bm":["hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elacestrant comparat cu hormonoterapia standard după operație, în cancerul mamar incipient ER+/HER2-negativ cu risc mare de recidivă"},"loc":[[8,"RECRUITING",[[140,"pi"]]],[11,"RECRUITING",[[6,"pi"]]],[74,"RECRUITING",[[143,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[9,"RECRUITING",[[134,"pi"]]],[7,"RECRUITING",[[2,"pi"]]],[342,"RECRUITING",[[393,"pi"]]],[29,"RECRUITING",[[69,"pi"]]],[71,"RECRUITING",[[61,"pi"]]],[45,"RECRUITING",[[62,"pi"]]],[25,"RECRUITING",[[394,"pi"]]]]},{"id":"NCT07363590","t":"A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)","dn":"MK-1045-004","sp":"Merck Sharp & Dohme LLC","c":["Systemic Lupus Erythematosus","Rheumatoid Arthritis"],"iv":["MK-1045"],"ivro":["MK-1045"],"d":["reum","derm"],"f":"1","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"MK-1045 în doze crescătoare la pacienți cu lupus eritematos sistemic sau poliartrită reumatoidă (studiu de fază 1)"},"loc":[[16,"RECRUITING",[[371,"pi"]]],[17,"RECRUITING",[]],[59,"UNKNOWN",[[370,"pi"]]]]},{"id":"NCT07325136","t":"A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer","sp":"Bristol-Myers Squibb","c":["Relapsed/Refractory Small Cell Lung Cancer"],"iv":["BMS-986525","Pumitamig"],"ivro":["BMS-986525","pumitamig"],"d":["onco"],"tu":["sclc"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"BMS-986525 singur sau cu pumitamig în cancerul pulmonar cu celule mici recidivat sau refractar"},"loc":[[64,"RECRUITING",[]],[10,"RECRUITING",[]]]},{"id":"NCT05722938","t":"Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)","dn":"ESsCAPE","sp":"Biotest","c":["Community-acquired Pneumonia"],"iv":["Trimodulin"],"ivro":["trimodulină"],"d":["resp","inf"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trimodulină adăugată la tratamentul standard în pneumonia severă dobândită în comunitate, la pacienții ventilați mecanic"},"loc":[[30,"WITHDRAWN",[]],[31,"RECRUITING",[]],[140,"WITHDRAWN",[]]]},{"id":"NCT06303505","t":"FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC","dn":"NAPISTAR 1-01","sp":"Gilead Sciences","c":["Ovarian Cancer","Non-small Cell Lung Cancer"],"iv":["TUB-040"],"ivro":["TUB-040","bevacizumab"],"d":["onco"],"tu":["nsclc","ovar"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"TUB-040 în cancerul ovarian rezistent la platină și în adenocarcinomul pulmonar recidivat sau refractar"},"loc":[[17,"RECRUITING",[]]]},{"id":"NCT05065216","t":"Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","dn":"ReMEDy2","sp":"DiaMedica Therapeutics Inc","c":["Acute Stroke","Ischemic Stroke","Stroke"],"iv":["Recombinant human tissue kallikrein"],"ivro":["rinvecalinază alfa"],"d":["cardio","neuro"],"f":"2/3","tip":"I","vmin":18,"vmax":90,"content_status":"complete","ro":{"titlu":"DM199 (rinvecalinază alfa) în accidentul vascular cerebral ischemic acut de severitate moderată (ReMEDy2)"},"loc":[[30,"RECRUITING",[[602,"c"],[521,"pi"]]],[142,"RECRUITING",[[603,"pi"]]]]},{"id":"NCT05306041","t":"Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer","dn":"GeparPiPPa","sp":"GBG Forschungs GmbH","c":["HER2-positive Breast Cancer"],"iv":["Inavolisib","PHESGO","Endocrine therapy"],"ivro":["Inavolisib","pertuzumab","trastuzumab","tamoxifen","Pertuzumab","inavolisib"],"d":["onco"],"tu":["san_hr","san_her2","san"],"bm":["her2","pik3ca","hr"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Hormonoterapie cu pertuzumab și trastuzumab, cu sau fără inavolisib, înainte de operație, în cancerul mamar incipient HER2+/HR+ cu mutație PIK3CA"},"loc":[[7,"RECRUITING",[[2,"c"]]],[8,"RECRUITING",[[140,"c"]]],[25,"RECRUITING",[[455,"c"]]],[9,"RECRUITING",[[4,"c"]]]]},{"id":"NCT05817175","t":"International Prospective REgistry on Pre-pectorAl Breast REconstruction","dn":"I-PREPARE","sp":"European Breast Cancer Research Association of Surgical Trialists","c":["Breast Cancer"],"iv":["pre-pectoral breast reconstruction"],"d":["onco"],"tu":["san"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Registru internațional despre reconstrucția mamară prepectorală cu implant după mastectomie pentru cancer (I-PREPARE)"},"loc":[[8,"RECRUITING",[[642,"c"]]]]},{"id":"NCT06657222","t":"First in Human Study of TUB-030 in Patients With Advanced Solid Tumors","dn":"5-STAR 1-01","sp":"Gilead Sciences","c":["Advanced Solid Tumors","HNSCC","SCLC","NSCLC","TNBC - Triple-Negative Breast Cancer","CRC"],"iv":["TUB-030"],"ivro":["TUB-030"],"d":["onco"],"tu":["nsclc","sclc","san_tn","san","colorectal","capgat","solide"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"TUB-030, conjugat anticorp-medicament anti-5T4, primul studiu la om în tumori solide avansate"},"loc":[[16,"RECRUITING",[]],[17,"RECRUITING",[]]]},{"id":"NCT05719259","t":"Perpetual Observational Study - Ventilator Associated Pneumonia","dn":"POS-VAP","sp":"European Clinical Research Alliance for Infectious Diseases (ECRAID)","c":["Ventilator Associated Pneumonia"],"iv":[],"d":["resp","inf"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Studiu observațional permanent al pneumoniei asociate ventilației mecanice la pacienții din terapie intensivă (POS-VAP)"},"loc":[[36,"RECRUITING",[[341,"c"],[342,"pi"]]],[142,"RECRUITING",[[343,"c"]]]]},{"id":"NCT07638306","t":"Internal Jugular Vein Ultrasound and Acute Kidney Injury After Abdominal Surgery","dn":"PRO-JUGULAR","sp":"Tîrgu Mureș Emergency Clinical County Hospital, Romania","c":["Intraoperative Hypotension","Jugular Veins","Hypotension on Induction","General Anesthesia With Propofol"],"iv":["Internal Jugular Vein Ultrasound Assesment"],"ivro":["propofol"],"d":["nefro","gin"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Ecografia venei jugulare interne la inducția anesteziei și riscul de tensiune scăzută și afectare a rinichilor după chirurgia abdominală"},"loc":[[92,"RECRUITING",[[396,"c"],[397,"c"]]]]},{"id":"NCT06408259","t":"Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis","sp":"Bristol-Myers Squibb","c":["Multiple Sclerosis, Relapsing-Remitting"],"iv":["Ozanimod","Fingolimod"],"ivro":["ozanimod","fingolimod"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":10,"vmax":17,"content_status":"complete","ro":{"titlu":"Ozanimod comparat cu fingolimod la copiii și adolescenții cu scleroză multiplă recurent-remisivă"},"loc":[[288,"RECRUITING",[]],[19,"RECRUITING",[]]]},{"id":"NCT06008197","t":"A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients","dn":"REDEFINE-HF","sp":"Colorado Prevention Center","c":["Heart Failure","Acute Heart Failure"],"iv":["Finerenone"],"ivro":["finerenonă"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Finerenonă la pacienții internați pentru insuficiență cardiacă decompensată, cu fracția de ejecție de cel puțin 40%"},"loc":[[86,"RECRUITING",[[763,"c"]]],[6,"RECRUITING",[[763,"c"]]],[22,"RECRUITING",[[763,"c"]]],[5,"RECRUITING",[[763,"c"]]]]},{"id":"NCT06970977","t":"CRS Questionnaire Validation Project","sp":"The European Forum for Research and Education in Allergy and Airway Diseases","c":["Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps"],"iv":[],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Validarea a două chestionare noi pentru rinosinuzita cronică, cu sau fără polipi nazali"},"loc":[[275,"RECRUITING",[[289,"c"]]]]},{"id":"NCT06774131","t":"A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer","sp":"UroGen Pharma Ltd.","c":["Upper Urinary Tract Urothelial Carcinoma","Urothelial Carcinoma"],"iv":["UGN-104"],"ivro":["UGN-104","mitomicină"],"d":["onco"],"tu":["urotelial"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"UGN-104 (mitomicină în gel) instilat în rinichi pentru cancerul urotelial de grad scăzut al căilor urinare superioare"},"loc":[[477,"RECRUITING",[[624,"pi"]]],[13,"RECRUITING",[[625,"c"],[626,"pi"]]],[48,"RECRUITING",[[627,"c"],[44,"pi"]]],[25,"RECRUITING",[[234,"c"],[162,"pi"]]],[105,"RECRUITING",[[628,"c"],[629,"pi"]]],[140,"RECRUITING",[[630,"c"],[631,"pi"]]],[141,"UNKNOWN",[[632,"pi"]]],[358,"UNKNOWN",[[624,"pi"]]]]},{"id":"NCT06252649","t":"Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation","dn":"CodeBreaK 301","sp":"Amgen","c":["Metastatic Colorectal Cancer"],"iv":["FOLFIRI Regimen","Sotorasib","Panitumumab","Bevacizumab-awwb"],"ivro":["sotorasib","panitumumab","FOLFIRI","bevacizumab","bevacizumab-awwb"],"d":["onco"],"tu":["colorectal"],"bm":["kras"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sotorasib cu panitumumab și FOLFIRI față de FOLFIRI ± bevacizumab, ca prim tratament în cancerul colorectal metastatic cu mutație KRAS G12C"},"loc":[[30,"RECRUITING",[]],[62,"RECRUITING",[]],[8,"RECRUITING",[]],[10,"RECRUITING",[]],[25,"RECRUITING",[]],[184,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT07227896","t":"Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease","dn":"PUCCIN (P25-758)","sp":"AbbVie","c":["Parkinson's Disease"],"iv":[],"ivro":["foslevodopa/foscarbidopa"],"d":["neuro"],"f":"","tip":"O","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"Foslevodopa/foscarbidopa în practica obișnuită, la pacienții cu boală Parkinson aflați la începutul stadiului avansat (studiu observațional PUCCIN)"},"loc":[[30,"RECRUITING",[]],[493,"RECRUITING",[]],[494,"RECRUITING",[]],[141,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07096193","t":"Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus","sp":"Gilead Sciences","c":["Chronic Hepatitis Delta"],"iv":["GS-4321","GS-4321 Placebo"],"ivro":["GS-4321"],"d":["gastro","inf"],"f":"1/2","tip":"I","vmin":18,"vmax":69,"vs":1,"content_status":"complete","ro":{"titlu":"GS-4321 la voluntari sănătoși și la pacienții cu hepatită cronică D (studiu de fază 1/2)"},"loc":[[162,"RECRUITING",[]],[218,"RECRUITING",[]],[162,"RECRUITING",[]],[219,"RECRUITING",[]]]},{"id":"NCT07786220","t":"Cognitive Load and Inhaler Technique in COPD","dn":"DUAL-INH","sp":"Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara","c":["COPD"],"iv":["Working-Memory Cognitive Load During Inhaler Use","Single-Task Inhaler Use"],"d":["resp"],"f":"","tip":"I","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"Efortul mental și tehnica de folosire a inhalatorului în bronhopneumopatia obstructivă cronică (BPOC)"},"loc":[[199,"RECRUITING",[[390,"c"]]]]},{"id":"NCT06366464","t":"A Study of Pitolisant in Patients With Prader-Willi Syndrome","sp":"Harmony Biosciences Management, Inc.","c":["Prader-Willi Syndrome"],"iv":["Pitolisant tablet"],"ivro":["pitolisant"],"d":["metab","neuro","psih"],"f":"3","tip":"I","vmin":6,"vmax":null,"content_status":"complete","ro":{"titlu":"Pitolisant comparat cu placebo pentru somnolența excesivă din timpul zilei în sindromul Prader-Willi"},"loc":[[178,"RECRUITING",[[176,"pi"]]],[178,"RECRUITING",[[280,"pi"]]],[266,"RECRUITING",[[281,"pi"]]],[267,"RECRUITING",[[282,"pi"]]]]},{"id":"NCT07444931","t":"Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD","dn":"SCAR","sp":"Tampere Heart Hospital","c":["Coronary Arterial Disease (CAD)","Sudden Cardiac Arrest","Sudden Cardiac Death"],"iv":[],"d":["cardio"],"f":"","tip":"O","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Factorii de risc pentru stopul cardiac subit la pacienții cu boală coronariană (studiu observațional)"},"loc":[[387,"RECRUITING",[[673,"c"],[674,"si"]]]]},{"id":"NCT06680232","t":"Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B","dn":"ELIMINATE-B","sp":"Precision BioSciences, Inc.","c":["HEPATITIS B CHRONIC"],"iv":["PBGENE-HBV"],"ivro":["PBGENE-HBV"],"d":["gastro","inf"],"f":"1","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"PBGENE-HBV, editare genetică în ficat, la adulții cu hepatită B cronică (ELIMINATE-B)"},"loc":[[16,"RECRUITING",[[11,"pi"],[12,"c"]]],[17,"RECRUITING",[[13,"pi"],[14,"c"]]]]},{"id":"NCT07000357","t":"A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event","dn":"AZURE-Outcomes","sp":"AstraZeneca","c":["Cardiovascular Disease"],"iv":["AZD0780"],"ivro":["AZD0780"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"AZD0780, un inhibitor PCSK9 oral, comparat cu placebo, pentru prevenirea evenimentelor cardiovasculare majore la pacienții cu boală aterosclerotică sau cu risc crescut (AZURE-Outcomes)"},"loc":[[466,"RECRUITING",[]],[279,"RECRUITING",[]],[22,"NOT_YET_RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[4,"RECRUITING",[]],[259,"NOT_YET_RECRUITING",[]],[24,"WITHDRAWN",[]],[85,"RECRUITING",[]],[85,"RECRUITING",[]],[87,"RECRUITING",[]],[18,"TERMINATED",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT03813407","t":"An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia","dn":"PEDZ-K","sp":"AstraZeneca","c":["Hyperkalaemia"],"iv":["Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level","Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1)","Sodium Zirconium Cyclosilicate (SZC) Dose Level 2 (DL2)","Sodium Zirconium Cyclosilicate (SZC) Dose Level 3 (DL3)","Sodium Zirconium Cyclosilicate (SZC) Dose During 28 Day Maintenance Phase"],"ivro":["ciclosilicat de zirconiu sodic"],"d":["metab"],"f":"3","tip":"I","vmin":0,"vmax":18,"content_status":"complete","ro":{"titlu":"Ciclosilicat de zirconiu sodic (SZC) pentru potasiul crescut în sânge la copii și adolescenți (PEDZ-K)"},"loc":[[5,"RECRUITING",[]],[5,"WITHDRAWN",[]],[3,"RECRUITING",[]],[18,"WITHDRAWN",[]],[6,"RECRUITING",[]],[267,"UNKNOWN",[[402,"pi"]]],[30,"UNKNOWN",[[697,"pi"]]],[136,"UNKNOWN",[[504,"pi"]]],[92,"UNKNOWN",[[698,"pi"]]]]},{"id":"NCT06911112","t":"NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)","dn":"NBI-1065845-MDD3025","sp":"Neurocrine Biosciences","c":["Major Depressive Disorder"],"iv":["NBI-1065845"],"ivro":["NBI-1065845"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"NBI-1065845 adăugat la antidepresiv în tulburarea depresivă majoră cu răspuns insuficient la tratament"},"loc":[[5,"RECRUITING",[]],[5,"RECRUITING",[]],[4,"RECRUITING",[]],[85,"RECRUITING",[]],[200,"UNKNOWN",[[194,"pi"]]],[105,"UNKNOWN",[[383,"pi"]]],[19,"UNKNOWN",[[384,"pi"]]],[188,"UNKNOWN",[[385,"pi"]]]]},{"id":"NCT06731478","t":"Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer","dn":"DESTINY-Gastric05","sp":"Daiichi Sankyo","c":["Gastric Cancer","Gastroesophageal Junction Cancer"],"iv":["Trastuzumab Deruxtecan","pembrolizumab","Trastuzumab","Chemotherapy"],"ivro":["trastuzumab deruxtecan","5-FU","capecitabină","pembrolizumab","trastuzumab","cisplatină"],"d":["onco"],"tu":["esofag","gastric"],"bm":["her2","pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trastuzumab deruxtecan cu chimioterapie, cu sau fără pembrolizumab, în cancerul gastric HER2-pozitiv metastatic, prima linie"},"loc":[[30,"RECRUITING",[]],[8,"RECRUITING",[]],[76,"RECRUITING",[]],[10,"RECRUITING",[]],[25,"RECRUITING",[]],[26,"RECRUITING",[]],[139,"RECRUITING",[]]]},{"id":"NCT06926868","t":"A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)","dn":"IZABRIGHT-Breast01","sp":"Bristol-Myers Squibb","c":["Breast Neoplasms"],"iv":["Iza-bren","Nab-paclitaxel","Paclitaxel","Capecitabine","Carboplatin","Gemcitabine"],"ivro":["izalontamab brengitecan","paclitaxel","nab-paclitaxel","carboplatină + gemcitabină","capecitabină"],"d":["onco"],"tu":["san_tn","san"],"bm":["hr","her2"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Izalontamab brengitecan comparat cu chimioterapia în cancerul mamar triplu-negativ avansat, prima linie, la pacienții care nu pot primi imunoterapie"},"loc":[[550,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[64,"RECRUITING",[]],[7,"RECRUITING",[]],[8,"RECRUITING",[]],[45,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[283,"RECRUITING",[]]]},{"id":"NCT06203210","t":"A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer","dn":"IDeate-Lung02","sp":"Daiichi Sankyo","c":["Small Cell Lung Cancer"],"iv":["Ifinatamab deruxtecan","Topotecan","Amrubicin","Lurbinectedin"],"ivro":["Ifinatamab deruxtecan","topotecan","lurbinectedin","amrubicină"],"d":["onco"],"tu":["sclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Ifinatamab deruxtecan față de chimioterapia aleasă de medic în cancerul pulmonar cu celule mici recidivat"},"loc":[[45,"RECRUITING",[[62,"pi"]]],[8,"NOT_YET_RECRUITING",[[219,"pi"]]],[10,"RECRUITING",[[5,"pi"]]],[139,"NOT_YET_RECRUITING",[[127,"pi"]]]]},{"id":"NCT05232916","t":"Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects","dn":"FLAMINGO-01","sp":"Greenwich LifeSciences, Inc.","c":["Breast Cancer"],"iv":["GLSI-100"],"ivro":["GLSI-100"],"d":["onco"],"tu":["san"],"bm":["her2"],"f":"3","tip":"I","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"Imunoterapia GLSI-100 (GP2 + GM-CSF) după tratamentul standard în cancerul mamar HER2-pozitiv cu risc crescut de recidivă"},"loc":[[508,"RECRUITING",[]],[7,"RECRUITING",[]],[8,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT06056297","t":"A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections","sp":"X4 Pharmaceuticals","c":["Neutropenia"],"iv":["Mavorixafor"],"ivro":["mavorixafor"],"d":["hem","cardio","metab","gastro","reum"],"f":"3","tip":"I","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"Mavorixafor în neutropeniile cronice congenitale, autoimune primare și idiopatice cu infecții repetate sau grave"},"loc":[[29,"RECRUITING",[[23,"pi"],[600,"pi"]]],[29,"RECRUITING",[]],[30,"RECRUITING",[[36,"pi"],[65,"pi"]]],[30,"RECRUITING",[]],[92,"RECRUITING",[[159,"pi"]]]]},{"id":"NCT06788756","t":"L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML","sp":"Moleculin Biotech, Inc.","c":["Acute Myeloid Leukaemia (AML)"],"iv":["Liposomal Annamycin Injection in combination with Cytarabine Injection","Liposomal Annamycin for Injection in combination with Cytarabine Injection."],"ivro":["citarabină","L-Annamycin"],"d":["onco"],"tu":["lam"],"f":"2/3","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"L-Annamycin cu citarabină, comparat cu placebo cu citarabină, în leucemia acută mieloidă recidivată sau refractară după o singură linie de tratament"},"loc":[[8,"RECRUITING",[[25,"pi"]]],[27,"UNKNOWN",[[21,"pi"]]],[28,"UNKNOWN",[[22,"pi"]]],[37,"UNKNOWN",[[33,"pi"]]]]},{"id":"NCT07230834","t":"Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants","dn":"VIENNA","sp":"Regeneron Pharmaceuticals","c":["Geographic Atrophy (GA)"],"iv":["Pozelimab"],"ivro":["pozelimab"],"d":["oft"],"f":"1","tip":"I","vmin":50,"vmax":null,"content_status":"complete","ro":{"titlu":"Pozelimab injectat în ochi (intravitreal) în atrofia geografică – studiu de fază 1"},"loc":[[16,"RECRUITING",[[509,"pi"]]],[17,"RECRUITING",[]],[59,"UNKNOWN",[[510,"pi"]]]]},{"id":"NCT06100289","t":"A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease","sp":"Takeda","c":["Ulcerative Colitis","Crohn's Disease"],"iv":["Vedolizumab IV","Vedolizumab SC"],"ivro":["vedolizumab"],"d":["gastro"],"f":"3","tip":"I","vmin":2,"vmax":17,"content_status":"complete","ro":{"titlu":"Vedolizumab subcutanat la copiii și adolescenții cu colită ulcerativă sau boală Crohn moderat până la sever activă"},"loc":[[140,"ACTIVE_NOT_RECRUITING",[[542,"pi"]]],[288,"RECRUITING",[[429,"pi"]]],[330,"RECRUITING",[[543,"pi"]]]]},{"id":"NCT05169333","t":"The Oxford Risk Factors And Non-Invasive Imaging Study","dn":"ORFAN","sp":"University of Oxford","c":["Cardiovascular Diseases","Cardiovascular Risk Factors"],"iv":[],"d":["cardio"],"f":"","tip":"O","vmin":18,"vmax":99,"content_status":"complete","ro":{"titlu":"Studiul observațional ORFAN: factori de risc și imagistică prin tomografie computerizată pentru prezicerea bolilor cardiovasculare"},"loc":[[350,"RECRUITING",[]]]},{"id":"NCT06991114","t":"AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.","sp":"Artiva Biotherapeutics, Inc.","c":["Refractory Rheumatoid Arthritis (RA)","Idiopathic Inflammatory Myopathies (IIMs)","Systemic Sclerosis (SSc)","Rheumatoid Arthritis (RA","IIM","Myositis","Scleroderma","Sjogren Syndrome"],"iv":["Allogeneic NK Cells"],"ivro":["AlloNK","rituximab"],"d":["neuro","reum","derm","oft"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"AlloNK (celule NK din sânge de cordon ombilical) împreună cu rituximab în bolile reumatologice dependente de limfocitele B, cu recăderi"},"loc":[[553,"RECRUITING",[]],[554,"RECRUITING",[]]]},{"id":"NCT07039916","t":"Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis","sp":"Immunovant Sciences GmbH","c":["Generalized Myasthenia Gravis"],"iv":["IMVT-1402"],"ivro":["IMVT-1402"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"IMVT-1402 la adulții cu miastenie gravis generalizată ușoară până la severă"},"loc":[[23,"RECRUITING",[]],[18,"RECRUITING",[]],[354,"UNKNOWN",[[526,"pi"]]],[12,"UNKNOWN",[[751,"pi"]]],[92,"UNKNOWN",[]]]},{"id":"NCT07106762","t":"Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy","dn":"IZABRIGHT-Bladder01","sp":"Bristol-Myers Squibb","c":["Urothelial Cancer"],"iv":["Iza-bren","Cisplatin","Gemcitabine","Carboplatin"],"ivro":["izalontamab brengitecan","gemcitabină","cisplatină","carboplatină"],"d":["onco"],"tu":["urotelial"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Izalontamab brengitecan comparat cu chimioterapia cu platină în cancerul urotelial metastatic după imunoterapie"},"loc":[[10,"RECRUITING",[]],[8,"RECRUITING",[]],[25,"RECRUITING",[]]]},{"id":"NCT07731126","t":"New Care Pathways for Supporting TRANSitional CARE From Hospital to Home Using AI and Personalized Digital Assistance","dn":"TRANSCARE","sp":"Istituto Nazionale di Ricovero e Cura per Anziani","c":["Transitional Care","Remote Patient Monitoring (RPM)","Geriatric Multimorbidity"],"iv":["TRANSCARE Digital Remote Monitoring Ecosystem"],"d":["alte"],"f":"","tip":"I","vmin":65,"vmax":null,"content_status":"complete","ro":{"titlu":"Monitorizare digitală la domiciliu după externare pentru vârstnicii cu mai multe boli cronice (TRANSCARE)"},"loc":[[66,"RECRUITING",[[51,"c"]]]],"ofi":[[52,"chair"]]},{"id":"NCT06966401","t":"Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)","sp":"Neurocrine Biosciences","c":["Major Depressive Disorder"],"iv":["NBI-1065845"],"ivro":["NBI-1065845"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"NBI-1065845 adăugat la antidepresiv pe termen lung în tulburarea depresivă majoră: studiu deschis de siguranță"},"loc":[[4,"RECRUITING",[]],[200,"UNKNOWN",[[194,"pi"]]],[105,"UNKNOWN",[[383,"pi"]]],[19,"UNKNOWN",[[384,"pi"]]],[188,"UNKNOWN",[[385,"pi"]]]]},{"id":"NCT07288333","t":"Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia","sp":"Neurocrine Biosciences","c":["Schizophrenia"],"iv":["NBI-1117570"],"ivro":["NBI-1117570"],"d":["psih"],"f":"2","tip":"I","vmin":18,"vmax":55,"content_status":"complete","ro":{"titlu":"NBI-1117570 în două doze, comparat cu placebo, la adulți internați pentru o exacerbare acută a schizofreniei"},"loc":[[18,"RECRUITING",[]],[19,"UNKNOWN",[[15,"pi"],[18,"pi"]]],[20,"UNKNOWN",[[16,"pi"]]],[21,"UNKNOWN",[[17,"pi"]]]]},{"id":"NCT06371417","t":"Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)","dn":"RAINBOW","sp":"Chugai Pharmaceutical","c":["Antiphospholipid Syndrome (APS)","Bullous Pemphigoid (BP)","Behçet's Syndrome (BS)","Dermatomyositis (DM)","Immune-mediated Necrotizing Myopathy (IMNM)","Immune Thrombocytopenia (ITP)"],"iv":["RAY121"],"ivro":["RAY121"],"d":["hem","cardio","neuro","reum","derm","oft"],"f":"1","tip":"I","vmin":18,"vmax":85,"content_status":"complete","ro":{"titlu":"RAY121, inhibitor al căii clasice a complementului, în mai multe boli imunologice (studiul RAINBOW)"},"loc":[[58,"RECRUITING",[]],[8,"RECRUITING",[]]]},{"id":"NCT07384975","t":"A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa","dn":"Mainsail","sp":"Navigator Medicines, Inc.","c":["Hidradenitis Suppurativa (HS)"],"iv":["NAV-240"],"ivro":["NAV-240"],"d":["derm","inf"],"f":"2","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"NAV-240 în hidradenita supurativă moderată până la severă"},"loc":[[206,"RECRUITING",[[590,"pi"]]],[29,"RECRUITING",[[31,"pi"]]],[210,"RECRUITING",[[591,"pi"]]]]},{"id":"NCT07657897","t":"The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma Ablation","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Hepato Cellular Carcinoma (HCC)","Sedation and Analgesia","Ablation Techniques"],"iv":["Sedation using combination of Propofol and Fentanyl.","Sedation using combination of Propofol and Fentanyl and lidocaine"],"ivro":["propofol","fentanil","lidocaină"],"d":["onco"],"tu":["hcc"],"f":"","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"Lidocaină intravenoasă adăugată sedării în ablația cu radiofrecvență a carcinomului hepatocelular și efectul asupra inflamației"},"loc":[[155,"RECRUITING",[[174,"c"]]]]},{"id":"NCT06649110","t":"A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)","sp":"Novartis Pharmaceuticals","c":["Healthy Volunteers, Pulmonary Arterial Hypertension"],"iv":["LTP"],"ivro":["LTP001"],"d":["resp"],"f":"1/2","tip":"I","vmin":18,"vmax":100,"vs":1,"content_status":"complete","ro":{"titlu":"LTP001 la voluntari sănătoși (partea A) și la pacienții cu hipertensiune arterială pulmonară (partea B)"},"loc":[[6,"RECRUITING",[]],[5,"RECRUITING",[]]]},{"id":"NCT07115745","t":"A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases","sp":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","c":["Refractory Autoimmune Diseases"],"iv":["BMS-986515","Fludarabine","Cyclophosphamide","Tocilizumab"],"ivro":["BMS-986515","fludarabină","ciclofosfamidă","tocilizumab"],"d":["neuro","reum","derm","nefro","gin"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Celule CAR-T anti-CD19 de la donatori sănătoși (BMS-986515) în boli autoimune severe, refractare"},"loc":[[17,"RECRUITING",[]],[30,"RECRUITING",[]]]},{"id":"NCT05712200","t":"Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)","dn":"LILAC-TIMI 76","sp":"Anthos Therapeutics, Inc.","c":["Atrial Fibrillation (AF)"],"iv":["Abelacimab"],"ivro":["abelacimab"],"d":["cardio"],"f":"3","tip":"I","vmin":65,"vmax":null,"content_status":"complete","ro":{"titlu":"Abelacimab la pacienți cu fibrilație atrială și risc crescut, care nu pot lua anticoagulante orale"},"loc":[[83,"WITHDRAWN",[]],[22,"RECRUITING",[]],[84,"WITHDRAWN",[]],[5,"RECRUITING",[]],[5,"WITHDRAWN",[]],[5,"RECRUITING",[]],[5,"RECRUITING",[]],[3,"RECRUITING",[]],[4,"RECRUITING",[]],[4,"RECRUITING",[]],[85,"RECRUITING",[]],[86,"RECRUITING",[]],[86,"RECRUITING",[]],[87,"WITHDRAWN",[]],[18,"WITHDRAWN",[]],[18,"RECRUITING",[]],[18,"RECRUITING",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]],[6,"WITHDRAWN",[]],[6,"WITHDRAWN",[]],[6,"RECRUITING",[]],[6,"WITHDRAWN",[]],[88,"UNKNOWN",[[72,"pi"]]],[89,"UNKNOWN",[[73,"pi"]]],[90,"UNKNOWN",[[74,"pi"]]],[30,"UNKNOWN",[[75,"pi"]]],[91,"UNKNOWN",[[76,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]],[93,"UNKNOWN",[[78,"pi"]]],[28,"UNKNOWN",[[79,"pi"]]],[94,"UNKNOWN",[[80,"pi"]]],[48,"UNKNOWN",[[81,"pi"]]],[95,"UNKNOWN",[[82,"pi"]]],[96,"UNKNOWN",[[83,"pi"]]],[49,"UNKNOWN",[[84,"pi"]]],[97,"UNKNOWN",[[85,"pi"],[90,"pi"]]],[98,"UNKNOWN",[[86,"pi"]]],[99,"UNKNOWN",[[87,"pi"]]],[100,"UNKNOWN",[[88,"pi"]]],[31,"UNKNOWN",[[89,"pi"]]],[101,"UNKNOWN",[[91,"pi"]]],[102,"UNKNOWN",[[92,"pi"]]],[103,"UNKNOWN",[[93,"pi"]]],[104,"UNKNOWN",[[94,"pi"]]],[14,"UNKNOWN",[[95,"pi"]]],[105,"UNKNOWN",[[96,"pi"]]]]},{"id":"NCT06533813","t":"Clinical Epidemiology in Contemporary Patients With Myelofibrosis.","dn":"ERNEST-3","sp":"FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS","c":["Myelofibrosis"],"iv":[],"d":["onco"],"tu":["nmp"],"f":"","tip":"O","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"ERNEST-3: registru european observațional al pacienților cu mielofibroză"},"loc":[[30,"RECRUITING",[[34,"pi"]]]]},{"id":"NCT07575347","t":"Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)","dn":"PERIO-RA-RE","sp":"Stefan Lujinschi","c":["Periodontal Disease","Periodontitis","CKD","Chronic Kidney Disease","Alport Syndrome","Fabry Disease","Lupus or SLE","Tuberous Sclerosis Complex (TSC)"],"iv":["Observational assessment"],"d":["cardio","metab","neuro","reum","derm","nefro","gin"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Boala parodontală în bolile renale rare și în lupusul cu afectare renală (PERIO-RA-RE)"},"loc":[[30,"RECRUITING",[[125,"si"],[569,"pi"]]]],"ofi":[[75,"chair"],[569,"pi"]]},{"id":"NCT07301736","t":"Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma","dn":"TRECONY","sp":"Chiesi Farmaceutici S.p.A.","c":["Asthma"],"iv":["CHF5993 pMDI with HFA-152a","CHF5993 pMDI with HFA-134a","CHF718 pMDI with HFA-134a"],"ivro":["beclometazonă dipropionat/formoterol fumarat/glicopironiu bromură","beclometazonă dipropionat"],"d":["resp","reum"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Inhalatorul CHF5993 cu un propulsor nou, cu impact climatic redus, comparat cu varianta actuală, în astmul ușor până la moderat"},"loc":[[306,"RECRUITING",[[329,"pi"]]],[307,"RECRUITING",[[330,"pi"]]],[308,"RECRUITING",[[331,"pi"]]],[309,"RECRUITING",[[283,"pi"]]],[29,"RECRUITING",[[332,"pi"],[339,"pi"]]],[310,"RECRUITING",[[333,"pi"]]],[13,"RECRUITING",[[323,"pi"]]],[227,"RECRUITING",[[228,"pi"]]],[311,"RECRUITING",[[334,"pi"]]],[183,"RECRUITING",[[335,"pi"],[327,"pi"]]],[312,"RECRUITING",[[336,"pi"]]],[313,"RECRUITING",[[337,"pi"]]],[199,"RECRUITING",[[338,"pi"]]],[314,"UNKNOWN",[[331,"pi"]]],[315,"UNKNOWN",[[333,"pi"]]],[154,"UNKNOWN",[[340,"pi"]]]]},{"id":"NCT04219254","t":"A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors","sp":"BioInvent International AB","c":["Solid Tumor, Adult"],"iv":["BI1206"],"ivro":["BI-1206","pembrolizumab"],"d":["onco"],"tu":["nsclc","melanom","solide"],"bm":["pdl1","egfr","alk"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"BI-1206 (anticorp anti-CD32b) cu pembrolizumab în cancerul pulmonar avansat cu PD-L1 ≥ 50% și în melanomul uveal"},"loc":[[8,"RECRUITING",[]],[10,"TERMINATED",[]]]},{"id":"NCT02834884","t":"SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access","dn":"SPECTA","sp":"European Organisation for Research and Treatment of Cancer - EORTC","c":["All Tumor Types"],"iv":["RP-1828 IMMUcan","RP-1759 AYA/TYA","RP-1843 Arcagen","RP-1920 BioRadon","2148 MRD"],"d":["onco"],"tu":["suport"],"f":"","tip":"O","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"SPECTA: platforma EORTC de colectare de probe biologice și date pentru cercetarea în cancer"},"loc":[[76,"RECRUITING",[]]]},{"id":"NCT07140913","t":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","sp":"Bristol-Myers Squibb","c":["Mania","Bipolar Disorder"],"iv":["Xanomeline/Trospium Chloride"],"ivro":["KarXT","xanomelină și clorură de trospiu","litiu","valproat","lamotrigină"],"d":["neuro","psih"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"KarXT adăugat la litiu, valproat sau lamotrigină, comparat cu placebo, în mania din tulburarea bipolară de tip I"},"loc":[[5,"NOT_YET_RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[19,"RECRUITING",[]],[454,"RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[189,"RECRUITING",[]],[147,"NOT_YET_RECRUITING",[]]]},{"id":"NCT06104566","t":"Global Trial in APG2575 for Patients With CLL/SLL","dn":"GLORA","sp":"Ascentage Pharma Group Inc.","c":["CLL/SLL"],"iv":["lisaftoclax +BTK inhibitor","BTK inhibitor"],"ivro":["lisaftoclax"],"d":["onco"],"tu":["llc"],"f":"3","tip":"I","vmin":18,"vmax":99,"content_status":"complete","ro":{"titlu":"Lisaftoclax adăugat la un inhibitor BTK, comparat cu inhibitorul BTK singur, în leucemia limfocitară cronică și limfomul limfocitic cu celule mici tratate anterior (GLORA)"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT07653048","t":"Personality Traits and Biochemical Risk Phenotypes","dn":"PHEBiP","sp":"Medical Center TOPMED","c":["Prediabetes","Hyperglycemia","Metabolic Syndrome"],"iv":[],"d":["metab"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Trăsăturile de personalitate și anomaliile analizelor de rutină la adulții care fac un control medical (PHEBiP)"},"loc":[[397,"RECRUITING",[[486,"c"]]]],"ofi":[[486,"pi"]]},{"id":"NCT05491525","t":"Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC","dn":"KANGUROO","sp":"Urovant Sciences GmbH","c":["Neurogenic Detrusor Overactivity"],"iv":["Vibegron"],"ivro":["vibegron"],"d":["nefro"],"f":"2/3","tip":"I","vmin":2,"vmax":17,"content_status":"complete","ro":{"titlu":"Vibegron la copii și adolescenți cu vezică neurogenă hiperactivă care folosesc cateterizarea intermitentă"},"loc":[[30,"RECRUITING",[[171,"pi"]]],[174,"RECRUITING",[[172,"pi"]]]]},{"id":"NCT05430971","t":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry","sp":"Immune Oncology Research Institute","c":["Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)"],"iv":[],"d":["onco"],"tu":["alte_hem"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registru internațional pentru neoplasmul cu celule dendritice plasmocitoide blastice (BPDCN)"},"loc":[[30,"RECRUITING",[[533,"c"],[34,"c"]]]]},{"id":"NCT05656469","t":"Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders","dn":"PSY-PGx","sp":"Parnassia Groep","c":["Mood Disorders","Anxiety Disorders","Psychotic Disorders"],"iv":["Personalised medication advice based on pharmacogenetic testing"],"ivro":["sertralină","escitalopram","aripiprazol","risperidonă"],"d":["psih"],"f":"","tip":"I","vmin":16,"vmax":70,"content_status":"complete","ro":{"titlu":"Tratament psihiatric ghidat de testarea farmacogenetică, comparat cu dozarea obișnuită, în depresie, anxietate și tulburări psihotice"},"loc":[[297,"RECRUITING",[[320,"pi"]]]]},{"id":"NCT06855160","t":"A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age","sp":"GlaxoSmithKline","c":["Chickenpox"],"iv":["Candidate varicella vaccine","Marketed varicella vaccine","MMR vaccine","Hepatitis A vaccine","PCV (pneumococcal conjugate vaccine) 13","PCV 20","Vaxneuvance"],"ivro":["vaccin varicelos experimental","Priorix","vaccin hepatitic A","vaccin pneumococic conjugat","Vaxneuvance","Varivax"],"d":["inf"],"f":"3","tip":"I","vmin":1,"vmax":1.2,"vs":1,"content_status":"complete","ro":{"titlu":"Vaccin varicelos experimental și Priorix administrate intramuscular, față de Varivax și Priorix administrate subcutanat, la copiii sănătoși de 12–15 luni"},"loc":[[22,"RECRUITING",[[683,"pi"]]],[181,"RECRUITING",[[684,"pi"]]],[12,"UNKNOWN",[[683,"pi"]]],[520,"UNKNOWN",[[684,"pi"]]]]},{"id":"NCT04953910","t":"Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment","sp":"Taiho Oncology, Inc.","c":["Acute Myeloid Leukemia","Myelodysplastic Syndromes"],"iv":["ASTX727"],"ivro":["decitabină","cedazuridină"],"d":["onco"],"tu":["lam","smd"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Decitabină și cedazuridină orale la pacienți cu cancer și insuficiență hepatică moderată sau severă: studiu de farmacocinetică și siguranță"},"loc":[[62,"RECRUITING",[[142,"pi"]]],[8,"RECRUITING",[[64,"pi"]]]]},{"id":"NCT04953897","t":"Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment","sp":"Taiho Oncology, Inc.","c":["Acute Myeloid Leukemia","Myelodysplastic Syndromes"],"iv":["ASTX727"],"ivro":["decitabină 35 mg + cedazuridină 100 mg"],"d":["onco"],"tu":["lam","smd"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Decitabină și cedazuridină pe cale orală la pacienți oncologici cu insuficiență renală severă: studiu de farmacocinetică"},"loc":[[62,"RECRUITING",[[142,"pi"]]],[8,"RECRUITING",[[64,"pi"]]]]},{"id":"NCT06959992","t":"Developing Resilience in Transgender and Nonbinary Individuals - Exploring the Impact of Social Challenges in the Metaverse","dn":"RESILIDENT","sp":"University of Bucharest","c":["Resilience,Psychological","Well-Being, Psychological","Self-Compassion"],"iv":["Metaverse group","Online asynchronously"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":35,"vs":1,"content_status":"complete","ro":{"titlu":"Grupuri de sprijin în mediul virtual (Metavers) pentru reziliența persoanelor transgender și non-binare"},"loc":[[284,"RECRUITING",[[299,"c"]]]],"ofi":[[299,"pi"]]},{"id":"NCT06747429","t":"High Fat Diet for Cardiac Metabolic Reprogramming","dn":"HF4HF","sp":"Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III","c":["Non-ischemic Dilated Cardiomyopathy","Heart Failure With Reduced Ejection Fraction"],"iv":["High fat diet","Standard diet"],"d":["cardio"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Dieta bogată în grăsimi pentru „reprogramarea” metabolismului inimii în cardiomiopatia dilatativă neischemică cu fracție de ejecție redusă"},"loc":[[341,"RECRUITING",[[578,"c"]]]],"ofi":[[578,"pi"]]},{"id":"NCT06256588","t":"A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma","dn":"JADE","sp":"GlaxoSmithKline","c":["Neoplasms, Head and Neck"],"iv":["Dostarlimab"],"ivro":["dostarlimab"],"d":["onco"],"tu":["capgat"],"bm":["pdl1"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Dostarlimab comparat cu placebo după radiochimioterapie, în cancerul scuamos al capului și gâtului avansat local, neoperat"},"loc":[[5,"RECRUITING",[[61,"pi"]]],[5,"RECRUITING",[[575,"pi"]]],[4,"RECRUITING",[[143,"pi"]]],[4,"RECRUITING",[[5,"pi"]]],[137,"WITHDRAWN",[]],[24,"RECRUITING",[]],[85,"RECRUITING",[[541,"pi"]]],[86,"RECRUITING",[[137,"pi"]]],[167,"RECRUITING",[[127,"pi"]]],[6,"RECRUITING",[[662,"pi"]]]]},{"id":"NCT07604376","t":"Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration Ropivacaine 0,2%","sp":"Matild Keresztes","c":["Postoperative Pain","Postoperative Acute Pain"],"iv":["Postoperative analgesia using TAP block, Ropivacaine 0,2%, volume: 0,4 ml/kg per side","Postoperative pain management using \"traditional\" analgesia iv regime"],"ivro":["ropivacaină","ibuprofen","paracetamol","tramadol","metamizol","dexketoprofen"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Blocul nervos TAP cu ropivacaină 0,2% comparat cu schema obișnuită de calmare a durerii după operația cezariană"},"loc":[[92,"RECRUITING",[[396,"c"],[397,"c"]]]],"ofi":[[397,"director"],[396,"pi"]]},{"id":"NCT06588478","t":"A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","sp":"Loxo Oncology, Inc.","c":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"iv":["Pirtobrutinib"],"ivro":["Pirtobrutinib"],"d":["onco"],"tu":["llc"],"bm":["del17p"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Trei doze de pirtobrutinib în leucemia limfocitară cronică recidivată după un inhibitor BTK covalent și în LLC netratată cu deleție 17p"},"loc":[[30,"RECRUITING",[[36,"pi"]]],[27,"RECRUITING",[[21,"pi"]]],[8,"RECRUITING",[[25,"pi"]]],[37,"RECRUITING",[[33,"pi"]]],[25,"RECRUITING",[[19,"pi"]]],[26,"RECRUITING",[]]]},{"id":"NCT07589114","t":"REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift","dn":"RESTWELL","sp":"George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures","c":["Healthy Adult Participants"],"iv":["Mobile smartwatch application."],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Aplicație pe ceas inteligent pentru îmbunătățirea somnului REM la studenți sănătoși (RESTWELL)"},"loc":[[220,"RECRUITING",[[747,"c"]]],[220,"RECRUITING",[]]]},{"id":"NCT07027306","t":"The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures","sp":"AO Foundation, AO Spine","c":["Osteoporotic Fractures","Osteoporosis"],"iv":["Posterior stabilization (pedicle screws)"],"d":["metab","reum"],"f":"","tip":"O","vmin":50,"vmax":null,"content_status":"complete","ro":{"titlu":"Scorul bazat pe clasificarea OF pentru decizia de tratament în fracturile osteoporotice ale coloanei toracice și lombare"},"loc":[[319,"RECRUITING",[[353,"c"]]]]},{"id":"NCT07433335","t":"A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis","sp":"SciRhom GmbH","c":["Rheumatoid Arthritis"],"iv":["SR-878"],"ivro":["SR-878","metotrexat"],"d":["reum","derm"],"f":"1","tip":"I","vmin":18,"vmax":60,"content_status":"complete","ro":{"titlu":"SR-878 în poliartrita reumatoidă: studiu de fază 1b privind siguranța și alegerea dozei"},"loc":[[5,"RECRUITING",[]],[3,"RECRUITING",[]],[59,"UNKNOWN",[[370,"pi"]]],[16,"UNKNOWN",[[371,"pi"]]]]},{"id":"NCT06757543","t":"A Stepped Wedge Cluster Randomised Trial Of Video Versus Direct Laryngoscopy For Intubation Of Newborn Infants","dn":"NEU-VODE","sp":"University College Dublin","c":["Intubation","Intubation Complications","Infant, Newborn","Infant Respiratory Distress Syndrome","Video Laryngoscopy"],"iv":["Video laryngoscopy","Direct laryngoscopy with standard laryngoscope"],"d":["resp"],"f":"","tip":"I","vmin":0,"vmax":0.1,"content_status":"complete","ro":{"titlu":"Videolaringoscopie comparată cu laringoscopia directă pentru intubația nou-născuților (NEU-VODE)"},"loc":[[69,"RECRUITING",[[58,"c"]]],[368,"RECRUITING",[[428,"c"]]]]},{"id":"NCT06544499","t":"A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia","dn":"ADVANCE NEXT","sp":"argenx","c":["Primary Immune Thrombocytopenia (ITP)"],"iv":["Efgartigimod IV"],"ivro":["efgartigimod","efgartigimod"],"d":["hem","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Efgartigimod intravenos în trombocitopenia imună primară a adultului"},"loc":[[27,"RECRUITING",[[21,"pi"]]],[29,"RECRUITING",[[23,"pi"]]],[456,"RECRUITING",[[407,"c"]]],[92,"RECRUITING",[[159,"pi"]]],[69,"UNKNOWN",[[407,"pi"]]]]},{"id":"NCT04916613","t":"ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)","dn":"PEACE6-Vulnerable (GETUG-AFU 40)","sp":"UNICANCER","c":["Prostate Cancer Metastatic"],"iv":["Darolutamide 300 mg","Androgen deprivation therapy"],"ivro":["darolutamidă"],"d":["onco"],"tu":["prostata"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Darolutamidă adăugată la terapia hormonală în cancerul de prostată metastatic de la diagnostic, la pacienții vulnerabili"},"loc":[[62,"NOT_YET_RECRUITING",[[142,"pi"]]],[45,"NOT_YET_RECRUITING",[[161,"c"],[482,"pi"]]],[519,"RECRUITING",[[482,"c"]]],[64,"RECRUITING",[[134,"c"]]],[8,"UNKNOWN",[[161,"pi"]]],[9,"UNKNOWN",[[134,"pi"]]]]},{"id":"NCT06456593","t":"Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease","dn":"ENHANCE-CD","sp":"Abivax S.A.","c":["Moderately to Severely Active Crohn Disease"],"iv":["Obefazimod"],"ivro":["obefazimod"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Obefazimod comparat cu placebo în boala Crohn moderat până la sever activă (ENHANCE-CD)"},"loc":[[13,"RECRUITING",[[139,"c"]]],[57,"RECRUITING",[[122,"c"]]],[29,"NOT_YET_RECRUITING",[[224,"c"]]],[151,"NOT_YET_RECRUITING",[[640,"c"]]],[488,"RECRUITING",[[641,"c"]]]]},{"id":"NCT04381936","t":"Randomised Evaluation of COVID-19 Therapy","dn":"RECOVERY","sp":"University of Oxford","c":["Pneumonia"],"iv":["Lopinavir-Ritonavir","Corticosteroid","Hydroxychloroquine","Azithromycin","Convalescent plasma","Tocilizumab","Immunoglobulin","Synthetic neutralising antibodies","Aspirin","Colchicine","Baricitinib","Anakinra","Dimethyl fumarate","High Dose Corticosteroid","Empagliflozin","Sotrovimab","Molnupiravir","Paxlovid","Baloxavir Marboxil","Oseltamivir","Corticosteroids (dexamethasone)"],"ivro":["baloxavir marboxil","oseltamivir","dexametazonă"],"d":["resp","inf"],"f":"3","tip":"I","vmin":0,"vmax":null,"content_status":"complete","ro":{"titlu":"RECOVERY: tratamente pentru pacienții internați cu pneumonie produsă de gripă sau pneumonie comunitară"},"loc":[[580,"RECRUITING",[]]]},{"id":"NCT06064877","t":"A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma","dn":"FIERCE-HN","sp":"AVEO Pharmaceuticals, Inc.","c":["Metastatic Head-and-neck Squamous-cell Carcinoma","Recurrent Head and Neck Squamous Cell Carcinoma"],"iv":["Ficlatuzumab","Cetuximab"],"ivro":["ficlatuzumab","cetuximab"],"d":["onco"],"tu":["capgat"],"bm":["hpv","p16"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Ficlatuzumab cu cetuximab în cancerul scuamos al capului și gâtului recidivat sau metastatic, HPV-negativ"},"loc":[[76,"RECRUITING",[]],[45,"RECRUITING",[]]]},{"id":"NCT07011043","t":"A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)","sp":"Climb Bio, Inc.","c":["Systemic Lupus Erythematosus"],"iv":["Budoprutug"],"ivro":["budoprutug"],"d":["reum","derm"],"f":"1","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Budoprutug (TNT119) în doză unică crescătoare la adulți cu lupus eritematos sistemic activ (studiu de fază 1b)"},"loc":[[3,"RECRUITING",[]]]},{"id":"NCT07491848","t":"Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D","sp":"Research Center of Periodontal-Systemic Interactions","c":["HEPATITIS B CHRONIC","Hepatitis D","Periodontitis"],"iv":["Bulevirtide","No intervention"],"ivro":["bulevirtidă"],"d":["gastro","inf"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Sănătatea gingiilor și markerii de inflamație din salivă la pacienții cu hepatită B+D, tratați sau nu cu bulevirtidă"},"loc":[[14,"RECRUITING",[[535,"c"]]],[388,"RECRUITING",[[536,"c"]]]]},{"id":"NCT07423650","t":"Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Pancreatoduodenectomy","Pain Management","Opioid Analgesia","Multimodal Analgesia"],"iv":["Nefopam 120mg/day infusion","Lidocaine Infusion","Peridural","Multimodal IV analgesia"],"ivro":["paracetamol","nefopam","ketoprofen","morfină","lidocaină"],"d":["neuro"],"f":"4","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"Nefopam în perfuzie continuă, comparat cu lidocaina în perfuzie și cu analgezia peridurală, după duodenopancreatectomie"},"loc":[[155,"RECRUITING",[[517,"c"]]]]},{"id":"NCT07134270","t":"Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients","sp":"Valeriu Gheorghita","c":["Multi Drug Resistant Organisms"],"iv":["MDRO Rectal Screening","30-Day Telephone Follow-Up"],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Purtarea digestivă de bacterii multirezistente și riscul de infecții la pacienții internați"},"loc":[[47,"RECRUITING",[[456,"c"],[457,"si"],[458,"si"],[459,"si"],[460,"si"],[461,"si"],[462,"si"],[463,"si"],[464,"si"],[465,"si"],[466,"si"],[46,"si"],[467,"si"],[468,"si"],[469,"si"],[470,"si"],[471,"si"],[472,"si"]]]]},{"id":"NCT07348263","t":"EFESO: Study on Juvenile Onset Eosinophilic Fasciitis","dn":"EFESO","sp":"Meyer Children's Hospital IRCCS","c":["Eosinophilic Fasciitis"],"iv":[],"d":["alte"],"f":"","tip":"O","vmin":null,"vmax":18,"content_status":"complete","ro":{"titlu":"Fasciita eozinofilică cu debut în copilărie: manifestări și răspuns la tratament (studiu observațional EFESO)"},"loc":[[316,"RECRUITING",[]]]},{"id":"NCT05744596","t":"Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis","dn":"INCREASE","sp":"Clinical Hospital Colentina","c":["Chronic; Gastritis, Atrophic"],"iv":["Incisura biopsy analysis"],"d":["gastro"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Rolul biopsiei din incizura unghiulară în stadializarea gastritei cronice (INCREASE)"},"loc":[[29,"RECRUITING",[[682,"pi"]]]]},{"id":"NCT07442552","t":"Perioperative Sepsis. An Epigenetic Perspective","dn":"PESE","sp":"Carol Davila University of Medicine and Pharmacy","c":["Sepsis Abdominal"],"iv":["• Presepsin • C-reactive protein (CRP) • Fibrinogen • Aspartate aminotransferase (AST) • Alanine aminotransferase (ALT) • Creatinine • Urea • Creatine kinase (CK) • Creatine kinase-MB (CK-MB) • NT-pro"],"d":["inf"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Sepsisul perioperator la pacienții operați pe abdomen: inflamație, coagulare, funcția inimii și microARN"},"loc":[[30,"RECRUITING",[[197,"pi"],[216,"si"],[198,"si"]]]],"ofi":[[197,"director"],[198,"chair"]]},{"id":"NCT06532006","t":"A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer","sp":"Shanghai Henlius Biotech","c":["Gastroesophageal-junction Cancer","Monoclonal Antibody","Gastric Cancer","HER2-positive Gastric Cancer"],"iv":["HLX22","Pembrolizumab","Trastuzumab","Oxaliplatin","Capecitabine"],"ivro":["HLX22","trastuzumab","XELOX","oxaliplatină","capecitabină","pembrolizumab"],"d":["onco"],"tu":["esofag","gastric"],"bm":["her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"HLX22 adăugat la trastuzumab și chimioterapie în cancerul gastric HER2-pozitiv avansat, primă linie"},"loc":[[155,"RECRUITING",[]],[45,"RECRUITING",[]],[10,"RECRUITING",[]],[151,"RECRUITING",[]],[139,"RECRUITING",[]]]},{"id":"NCT07437755","t":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","dn":"PROTECT-CIRR","sp":"Grigore T. Popa University of Medicine and Pharmacy","c":["Liver Cirrhosis With Acute Decompensation"],"iv":["Blood Products transfusion"],"ivro":["plasmă proaspătă congelată","concentrat trombocitar","crioprecipitat"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Transfuzia ghidată prin tromboelastometrie (ROTEM) față de transfuzia ghidată prin analizele obișnuite de coagulare, înaintea procedurilor invazive în ciroza decompensată"},"loc":[[511,"RECRUITING",[[663,"si"],[664,"pi"],[366,"si"],[665,"si"],[666,"si"],[667,"si"]]]]},{"id":"NCT06112314","t":"IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)","dn":"PRISM-MEL-301","sp":"Immunocore Ltd","c":["Advanced Melanoma"],"iv":["Brenetafusp","Nivolumab","Nivolumab + Relatlimab"],"ivro":["Brenetafusp","nivolumab","Nivolumab","nivolumab + relatlimab"],"d":["onco"],"tu":["melanom"],"bm":["hla"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Brenetafusp (IMC-F106C) cu nivolumab față de nivolumab ± relatlimab în melanomul avansat netratat, la persoanele HLA-A*02:01 pozitive"},"loc":[[8,"RECRUITING",[[386,"c"]]],[10,"RECRUITING",[[387,"c"]]],[63,"RECRUITING",[[290,"c"]]]]},{"id":"NCT06771999","t":"Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Pharmacist","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Palliative Care","Cancer"],"iv":["Educational intervention by a clinical pharmacist"],"d":["onco"],"tu":["suport"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Atitudinea pacienților cu cancer în tratament paliativ față de renunțarea la medicamentele neoncologice și efectul unei intervenții educaționale a farmacistului clinician"},"loc":[[177,"RECRUITING",[]]]},{"id":"NCT07136467","t":"A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa","dn":"MEASUREAAVitHS","sp":"AbbVie","c":["Non-Segmental Vitiligo (NSV)","Alopecia Areata","Hidradenitis Suppurativa"],"iv":[],"d":["derm","inf"],"f":"","tip":"O","vmin":12,"vmax":null,"content_status":"complete","ro":{"titlu":"Povara reală a bolii la adolescenți și adulți cu alopecie areata, vitiligo sau hidradenită supurativă (studiu observațional, o singură vizită)"},"loc":[[302,"RECRUITING",[]],[36,"RECRUITING",[]],[142,"RECRUITING",[]],[29,"RECRUITING",[]],[29,"RECRUITING",[]],[59,"RECRUITING",[]],[81,"RECRUITING",[]]]},{"id":"NCT05544019","t":"Study of SGR-1505 in Mature B-Cell Neoplasms","sp":"Schrödinger, Inc.","c":["Mature B-Cell Neoplasm","Non Hodgkin Lymphoma","DLBCL","Waldenstrom Macroglobulinemia","MALT Lymphoma","Follicular Lymphoma","Pediatric-Type Follicular Lymphoma","IRF4 Gene Rearrangement"],"iv":["SGR-1505"],"ivro":["SGR-1505"],"d":["onco"],"tu":["llc","lnh","alte_hem"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"SGR-1505, inhibitor MALT1 pe cale orală, în limfoamele și alte neoplazii cu celule B mature"},"loc":[[62,"RECRUITING",[]],[8,"RECRUITING",[]]]},{"id":"NCT05980806","t":"A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia","dn":"SENTRY-2","sp":"Karyopharm Therapeutics Inc","c":["Myelofibrosis","Moderate Thrombocytopenia","Mild Thrombocytopenia"],"iv":["Selinexor 60 mg","Selinexor 40 mg","Ruxolitinib","Pacritinib","Momelotinib"],"ivro":["Selinexor","ruxolitinib","pacritinib","momelotinib"],"d":["onco"],"tu":["nmp"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Selinexor în mielofibroza netratată anterior cu inhibitori JAK, cu trombocite scăzute moderat"},"loc":[[27,"RECRUITING",[[21,"pi"]]],[37,"RECRUITING",[[33,"pi"]]],[25,"RECRUITING",[[19,"pi"]]]]},{"id":"NCT07399626","t":"Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian","sp":"Babes-Bolyai University","c":["Bipolar Disorder (BD)"],"iv":["Hypomanic Personality Scale - 6"],"d":["psih"],"f":"1/2","tip":"I","vmin":18,"vmax":50,"vs":1,"content_status":"complete","ro":{"titlu":"Adaptarea și validarea în limba română a Scalei personalității hipomaniacale (HPS-6)"},"loc":[[78,"RECRUITING",[[760,"c"]]]]},{"id":"NCT04895436","t":"Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)","dn":"ReVenG","sp":"AbbVie","c":["Chronic Lymphocytic Leukemia (CLL)"],"iv":["Venetoclax","Obinutuzumab"],"ivro":["venetoclax + obinutuzumab","venetoclax"],"d":["onco"],"tu":["llc"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Reluarea tratamentului cu venetoclax și obinutuzumab în leucemia limfocitară cronică revenită după venetoclax în prima linie"},"loc":[[30,"RECRUITING",[]],[572,"UNKNOWN",[[238,"pi"]]]]},{"id":"NCT06927739","t":"Focused Orticumab Research for Treating Inflammation in Coronary Arteries","dn":"FORTIFY","sp":"Abcentra","c":["Acute Coronary Syndromes","Coronary Arterial Disease (CAD)","Inflammation","Heart Disease","Myocardial Infarct","Atherosclerotic Coronary Vascular Disease"],"iv":["Orticumab"],"ivro":["orticumab"],"d":["cardio"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Orticumab, comparat cu placebo, la pacienții după infarct miocardic care au inflamație coronariană crescută la angio-CT (FORTIFY)"},"loc":[[170,"RECRUITING",[]],[18,"RECRUITING",[]],[6,"RECRUITING",[]]]},{"id":"NCT06389474","t":"Efficacy of INM004 in Children With STEC-HUS","sp":"Inmunova S.A.","c":["Hemolytic-Uremic Syndrome"],"iv":["INM004"],"ivro":["INM004"],"d":["hem","nefro","gin"],"f":"3","tip":"I","vmin":0.8,"vmax":17,"content_status":"complete","ro":{"titlu":"INM004 (antitoxină Shiga) adăugat la tratamentul standard la copiii cu sindrom hemolitic uremic produs de Escherichia coli secretoare de toxină Shiga"},"loc":[[551,"NOT_YET_RECRUITING",[]],[136,"RECRUITING",[]],[267,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07332234","t":"Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies","dn":"EICON","sp":"Spitalul Clinic de Boli Infecțioase și tropicale \"Dr. Victor Babeș\"","c":["Meningitis","Meningitis/Encephalitis","Stroke","Ultrasound","Intracranial Hypertension","Cerebral Tumors"],"iv":["Optic Nerve Sheath Diameter"],"d":["neuro"],"f":"","tip":"O","vmin":18,"vmax":60,"content_status":"complete","ro":{"titlu":"Ecografia nervului optic pentru evaluarea inflamației cerebrale și a hipertensiunii intracraniene la pacienții internați cu afectare cerebrală"},"loc":[[30,"RECRUITING",[[197,"pi"],[198,"pi"]]],[161,"RECRUITING",[[199,"pi"],[200,"si"]]]],"ofi":[[199,"pi"]]},{"id":"NCT06908304","t":"A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC","sp":"Maia Biotechnology","c":["Carcinoma, Non-Small -Cell Lung"],"iv":["6-Thio-2'-Deoxyguanosine","Cemiplimab","Docetaxel","Vinorelbine","Gemcitabine alone"],"ivro":["THIO","cemiplimab","vinorelbină","gemcitabină","docetaxel"],"d":["onco"],"tu":["nsclc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"THIO urmat de cemiplimab comparat cu chimioterapia în cancerul pulmonar avansat, linia a treia"},"loc":[[11,"RECRUITING",[[6,"pi"]]],[28,"RECRUITING",[[621,"pi"]]],[8,"UNKNOWN",[[64,"pi"]]],[45,"UNKNOWN",[[62,"pi"]]],[26,"UNKNOWN",[[20,"pi"]]],[63,"UNKNOWN",[[290,"pi"]]],[76,"UNKNOWN",[[126,"pi"]]],[9,"UNKNOWN",[[163,"pi"]]],[62,"UNKNOWN",[[138,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]]]},{"id":"NCT06265727","t":"A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors","sp":"Corbus Pharmaceuticals Inc.","c":["Solid Tumor, Adult"],"iv":["CRB-701","Anti-PD-1"],"ivro":["CRB-701"],"d":["onco"],"tu":["solide"],"bm":["nectin4"],"f":"1/2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"CRB-701, conjugat anticorp-medicament anti-nectină-4, singur sau cu imunoterapie anti-PD-1, în tumori solide avansate"},"loc":[[583,"RECRUITING",[[765,"c"]]],[584,"RECRUITING",[[765,"c"]]],[10,"RECRUITING",[[765,"c"]]],[63,"RECRUITING",[[765,"c"]]]]},{"id":"NCT06885502","t":"Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)","dn":"PHRASE","sp":"Eodyne Systems SL","c":["Stroke","Stroke Rehabilitation","Chronic Stroke Patients","Post Stroke Recovery"],"iv":["RGS"],"d":["cardio","neuro"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Recuperare la domiciliu după accident vascular cerebral cu aplicația de realitate virtuală RGSapp (PHRASE)"},"loc":[[79,"RECRUITING",[[71,"pi"]]]]},{"id":"NCT07138495","t":"Integrating AI in Stroke Neurorehabilitation","dn":"AISN","sp":"Eodyne Systems SL","c":["Stroke"],"iv":["AI-personalized virtual reality rehabilitation system for unsupervised home-based stroke therapy"],"d":["cardio","neuro"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Recuperare la domiciliu după accident vascular cerebral prin realitate virtuală, cu sau fără sprijin de inteligență artificială (AISN)"},"loc":[[77,"RECRUITING",[[66,"c"]]]]},{"id":"NCT06861686","t":"A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores","sp":"Wissenschaftliches Institut Bethanien e.V","c":["Obstructive Sleep Apnea (OSA)"],"iv":[],"d":["neuro","resp"],"f":"","tip":"O","vmin":40,"vmax":null,"content_status":"complete","ro":{"titlu":"Clasificarea Baveno modificată a apneei obstructive în somn, pe baza somnolenței și a riscului cardiovascular"},"loc":[[433,"RECRUITING",[[564,"pi"],[565,"si"],[566,"si"],[567,"si"],[568,"si"]]],[199,"RECRUITING",[[337,"c"]]]]},{"id":"NCT06551662","t":"DCB vs. DES in Bifurcation Coronary Lesions","dn":"PICCOLETO V","sp":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","c":["Coronary Artery Disease","DCB"],"iv":["Paclitaxel drug-coated balloons","Sirolimus drug-coated balloons","New generation drug-eluting stent"],"ivro":["paclitaxel","sirolimus"],"d":["cardio"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Baloane active (cu paclitaxel sau sirolimus) față de stenturi active în leziunile coronariene de bifurcație (PICCOLETO V)"},"loc":[[66,"RECRUITING",[[291,"c"]]],[69,"RECRUITING",[[292,"c"]]]]},{"id":"NCT03553420","t":"Registry for Patients With Lipodystrophy","dn":"ECLip Registry","sp":"University of Ulm","c":["Lipodystrophy Acquired","Lipodystrophy Congenital"],"iv":[],"d":["metab","derm"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul european al pacienților cu lipodistrofie (ECLip) (studiu observațional)"},"loc":[[178,"RECRUITING",[[280,"c"]]]]},{"id":"NCT07237451","t":"Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients","dn":"CARE FOR CKD HFpEF","sp":"Grigore T. Popa University of Medicine and Pharmacy","c":["CKD - Chronic Kidney Disease","Heart Failure Preserved Ejection Fraction","SGLT2 Inhibitors","Diabetes (DM)"],"iv":["Arterial stiffness","Echocardiography","Biomarkers determination","NMR metabolomics and uremic toxins mapping"],"d":["cardio","metab","nefro","gin"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Evenimente cardiovasculare și renale la pacienții cu boală cronică de rinichi și insuficiență cardiacă cu fracție de ejecție păstrată, cu și fără inhibitori SGLT2 (studiu observațional)"},"loc":[[116,"RECRUITING",[[399,"pi"],[365,"si"],[400,"si"],[401,"pi"]]]]},{"id":"NCT03817502","t":"Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia","sp":"Gedeon Richter Plc.","c":["Schizophrenia"],"iv":["Cariprazine"],"ivro":["cariprazină"],"d":["psih"],"f":"3","tip":"I","vmin":13,"vmax":17,"content_status":"complete","ro":{"titlu":"Cariprazină față de placebo la adolescenții de 13–17 ani cu schizofrenie"},"loc":[[20,"WITHDRAWN",[]],[267,"RECRUITING",[]]]},{"id":"NCT07113483","t":"Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery","dn":"REMIND-ORTHO","sp":"Romanian Society for Enteral and Parenteral Nutrition","c":["Postoperative Cognitive Dysfunction","Orthopedic Procedures","Postoperative Pain Management","Hip Fracture"],"iv":["Midazolam","REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]"],"ivro":["remimazolam","propofol","midazolam"],"d":["psih"],"f":"3","tip":"I","vmin":65,"vmax":null,"content_status":"complete","ro":{"titlu":"Remimazolam față de midazolam pentru sedare și recuperarea cognitivă precoce la vârstnicii operați ortopedic cu anestezie regională (REMIND-ORTHO)"},"loc":[[61,"RECRUITING",[[321,"c"]]]],"ofi":[[322,"pi"],[321,"director"]]},{"id":"NCT07201480","t":"Death Anxiety, Depression and Anxiety: An Experimental Study","sp":"Babes-Bolyai University","c":["Death Anxiety","Depression","Anxiety"],"iv":["Mortality Salience Prompts","Dental Pain Prompts"],"d":["psih"],"f":"","tip":"I","vmin":18,"vmax":65,"vs":1,"content_status":"complete","ro":{"titlu":"Anxietatea față de moarte, depresia și anxietatea: un studiu experimental la persoane din populația generală"},"loc":[[78,"RECRUITING",[[67,"c"]]]]},{"id":"NCT06479135","t":"Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib","dn":"POIESIS","sp":"Kartos Therapeutics, Inc.","c":["Myelofibrosis","Post-PV MF","Post-ET Myelofibrosis","Primary Myelofibrosis","MF"],"iv":["Navtemadlin","Navtemadlin placebo","Ruxolitinib"],"ivro":["ruxolitinib","navtemadlin"],"d":["onco"],"tu":["nmp"],"bm":["tp53"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Navtemadlin adăugat la ruxolitinib în mielofibroza cu răspuns insuficient la ruxolitinib"},"loc":[[32,"RECRUITING",[]],[29,"RECRUITING",[]],[8,"RECRUITING",[]],[105,"RECRUITING",[]],[505,"RECRUITING",[]]]},{"id":"NCT07141043","t":"Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients","sp":"Grigore T. Popa University of Medicine and Pharmacy","c":["Hemodyalysis","Kidney Tansplant","Osteoporosis","CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder"],"iv":[],"d":["metab","reum","nefro","gin"],"f":"","tip":"O","vmin":20,"vmax":70,"vs":1,"content_status":"complete","ro":{"titlu":"Evaluarea tulburărilor minerale și osoase la pacienții cu transplant renal"},"loc":[[353,"RECRUITING",[[411,"c"]]]]},{"id":"NCT05200715","t":"AutoInflammatory Disease Alliance Registry (AIDA)","dn":"AIDA","sp":"University of Siena","c":["Hereditary Autoinflammatory Diseases","Schnitzler Syndrome","Behcet Syndrome","PFAPA Syndrome","Still Disease","Autoinflammatory Syndrome, Unspecified","Uveitis","Scleritis"],"iv":["No intervention is foreseen by the protocol."],"d":["hem","cardio","reum","derm","oft"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul internațional AIDA pentru bolile autoinflamatorii (studiu observațional)"},"loc":[[67,"RECRUITING",[[369,"c"]]]]},{"id":"NCT04740424","t":"FS222 First in Human Study in Patients With Advanced Malignancies","sp":"invoX Pharma Limited","c":["Advanced Cancer","Metastatic Cancer"],"iv":["FS222"],"ivro":["FS222"],"d":["onco"],"tu":["solide"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"FS222, prima administrare la om, în tumorile solide avansate"},"loc":[[62,"RECRUITING",[[142,"c"]]],[8,"RECRUITING",[[64,"c"]]]]},{"id":"NCT06725888","t":"Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.","sp":"S.I.I.T. Srl","c":["Bacterial Vaginosis (BV)","Recurrent Bacterial Vaginosis"],"iv":["Vagitab -T vaginal tablets. Components: tyndallized probiotic L. plantarum HA-119, lactic acid, and xylo-oligosaccharides, lauryl glucoside, and macrogol 3350:"],"ivro":["Vagitab-T","metronidazol"],"d":["nefro","inf","gin"],"f":"","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Vagitab-T ca tratament adjuvant al vaginozei bacteriene recidivante, alături de metronidazol"},"loc":[[323,"RECRUITING",[[358,"pi"]]]],"ofi":[[358,"pi"]]},{"id":"NCT05982119","t":"Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study","dn":"ActiLiège Next","sp":"Centre Hospitalier Universitaire de Liege","c":["Duchenne Muscular Dystrophy","Fascioscapulohumeral Muscular Dystrophy","Myotonic Dystrophy 1","Charcot-Marie-Tooth","Centronuclear Myopathy","Congenital Muscular Dystrophy"],"iv":["ActiMyo/Syde"],"d":["neuro","reum"],"f":"","tip":"I","vmin":1,"vmax":80,"vs":1,"content_status":"complete","ro":{"titlu":"Măsurarea mersului, a urcatului scărilor și a mișcării brațelor cu un senzor purtabil în bolile neuromusculare și la voluntari sănătoși (ActiLiège Next)"},"loc":[[19,"RECRUITING",[]],[266,"ACTIVE_NOT_RECRUITING",[]]]},{"id":"NCT03964480","t":"Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.","dn":"T-Cell Project 2.0","sp":"Associazione Angela Serra per la ricerca sul cancro","c":["Peripheral T-Cell Lymphoma"],"iv":[],"d":["onco"],"tu":["lnh"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul internațional T-Cell Project 2.0 pentru limfoamele cu celule T periferice nou diagnosticate — studiu observațional"},"loc":[[8,"RECRUITING",[[25,"c"],[739,"c"]]]]},{"id":"NCT06955026","t":"Effect of the Hockey Slideboard Training Combined With Blood Flow Restriction (BFR) in the Rehabilitation Following Anterior Cruciate Ligament Surgical Reconstruction (ACL-R)","sp":"Spitalul Municipal Odorheiu Secuiesc","c":["Anterior Cruciate Ligament Rupture","Rehabilitation After ACL Reconstruction"],"iv":["Hockey slideboard combined with BFR training","Hockey slideboard"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":45,"content_status":"complete","ro":{"titlu":"Antrenament pe placa de alunecare combinat cu restricția fluxului de sânge, în recuperarea după reconstrucția ligamentului încrucișat anterior"},"loc":[[526,"RECRUITING",[[694,"pi"],[695,"pi"]]]]},{"id":"NCT06251869","t":"Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty (Electrocoagulation vs Scalpel)","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Compassion"],"iv":["total hip arthroplasty with electrocoagulation","total hip arthroplasty without electrocoagulation","total knee arthroplasty with electrocoagulation","total knee arthroplasty without electrocoagulation"],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":90,"content_status":"complete","ro":{"titlu":"Electrocoagulare comparată cu tehnica fără electrocoagulare (bisturiu) în protezarea totală de șold și de genunchi (studiu observațional)"},"loc":[[401,"RECRUITING",[[495,"pi"],[496,"si"],[497,"si"]]]],"ofi":[[495,"pi"]]},{"id":"NCT05201404","t":"Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis","dn":"LIVERATION","sp":"Can-Fite BioPharma","c":["Hepatocellular Carcinoma","Cirrhosis"],"iv":["Namodenoson"],"ivro":["namodenoson"],"d":["onco"],"tu":["hcc"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Namodenoson față de placebo în carcinomul hepatocelular avansat cu ciroză Child-Pugh B7, după cel puțin o linie de tratament"},"loc":[[155,"RECRUITING",[]],[8,"NOT_YET_RECRUITING",[]],[518,"NOT_YET_RECRUITING",[]],[10,"RECRUITING",[]],[11,"RECRUITING",[]],[63,"RECRUITING",[]],[25,"RECRUITING",[]],[151,"RECRUITING",[]],[9,"RECRUITING",[]],[135,"RECRUITING",[]]]},{"id":"NCT06262464","t":"An OCD Prevention Programme for at Risk Adults","dn":"ØCD","sp":"Babes-Bolyai University","c":["Obsessive-Compulsive Disorder"],"iv":["Prevention"],"d":["psih"],"f":"","tip":"I","vmin":18,"vmax":65,"vs":1,"content_status":"complete","ro":{"titlu":"Program online de prevenție a tulburării obsesiv-compulsive pentru adulții cu risc (ØCD)"},"loc":[[558,"RECRUITING",[[67,"c"]]]]},{"id":"NCT04366804","t":"International Validation of Two Non-motor Scales in PD (NFS and SPARK)","sp":"Insel Gruppe AG, University Hospital Bern","c":["Parkinson's Disease","Non-motor Symptoms"],"iv":[],"d":["neuro"],"f":"","tip":"O","vmin":30,"vmax":75,"content_status":"complete","ro":{"titlu":"Validarea internațională a două scale pentru simptomele non-motorii din boala Parkinson (NFS și SPARK)"},"loc":[[521,"RECRUITING",[]]]},{"id":"NCT06724666","t":"Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression","dn":"NEURO4C","sp":"Babes-Bolyai University","c":["Anxiety Disorders","Depressive Disorder","Social Anxiety Disorder","Major Depressive Disorder","Dysthymia","Generalized Anxiety Disorder"],"iv":["Transdiagnostic Internet-delivered intervention"],"d":["psih"],"f":"","tip":"I","vmin":13,"vmax":17,"content_status":"complete","ro":{"titlu":"Program psihologic online transdiagnostic pentru adolescenții cu anxietate și depresie (NEURO4C)"},"loc":[[78,"NOT_YET_RECRUITING",[[720,"si"]]],[78,"RECRUITING",[]]]},{"id":"NCT05942924","t":"The NEU-STIM Trial","dn":"NEU-STIM","sp":"Leiden University Medical Center","c":["Infant, Premature, Diseases","Birth, Preterm"],"iv":["Repeated tactile stimulation","Selective tactile stimulation"],"d":["nefro","gin"],"f":"","tip":"I","vmin":null,"vmax":0,"content_status":"complete","ro":{"titlu":"Stimulare tactilă repetată comparată cu stimularea selectivă la nașterea prematurilor (NEU-STIM)"},"loc":[[68,"RECRUITING",[[57,"c"]]],[69,"RECRUITING",[[58,"c"]]],[70,"RECRUITING",[[59,"c"]]]]},{"id":"NCT06867172","t":"Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma","dn":"SPACE","sp":"Carol Davila University of Medicine and Pharmacy","c":["Pancreatic Steatosis","Pancreatic Cyst","Pancreatic Adenocarcinoma"],"iv":["computerized tomography","Endosonography (EUS)"],"d":["onco"],"tu":["pancreas"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Steatoza pancreatică la pacienții cu chisturi pancreatice neoplazice și adenocarcinom pancreatic — studiu observațional"},"loc":[[47,"RECRUITING",[[56,"c"]]]],"ofi":[[56,"chair"]]},{"id":"NCT06858358","t":"Robotic Medial Congruent Vs. Conventional Medial Pivot TKA","sp":"George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures","c":["Knee Osteoarthristis"],"iv":["Robotic assisted total knee arthroplasty","Conventional total knee arthroplasty (cTKA)"],"d":["alte"],"f":"","tip":"I","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Proteză totală de genunchi implantată cu asistență robotică (Medial Congruent) comparată cu tehnica convențională (Medial Pivot) în artroza severă"},"loc":[[441,"RECRUITING",[[592,"c"]]],[442,"RECRUITING",[[495,"c"]]]]},{"id":"NCT06823466","t":"Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants","dn":"ASPERA","sp":"University of L'Aquila","c":["Ischemic Stroke","Oral Anticoagulation","Atrial Fibrillation (AF)","Outcome Assessment","Clinical Presentations"],"iv":[],"d":["cardio","neuro"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Accidentul vascular cerebral ischemic apărut în timpul tratamentului anticoagulant oral: registrul internațional ASPERA (studiu observațional)"},"loc":[[142,"RECRUITING",[[217,"c"]]]]},{"id":"NCT06758492","t":"A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn Infants","dn":"NEU-VODEtec","sp":"University College Dublin","c":["Respiratory Distress Syndrome (Neonatal)","Respiratory Distress Syndrome (RDS)","Video Laryngoscopy","Surfactant"],"iv":["Video laryngoscopy used to insert thin endotracheal catheter","Direct laryngoscopy used to insert thin endotracheal catheter"],"ivro":["surfactant"],"d":["resp"],"f":"","tip":"O","vmin":0,"vmax":0,"content_status":"complete","ro":{"titlu":"Videolaringoscopie față de laringoscopie directă pentru introducerea cateterului subțire de administrare a surfactantului la nou-născuți (NEU-VODEtec)"},"loc":[[69,"RECRUITING",[[58,"c"]]],[368,"RECRUITING",[[428,"c"]]]]},{"id":"NCT06835023","t":"Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis","sp":"Satu Mare County Emergency Hospital","c":["Acute Pancreatitis (AP)","Acute Pancreatic Fluid Collection","Fluid Resuscitation"],"iv":["Ringer lactate (RLS)","Dextran+Ringer Lactat(D+RLS)"],"ivro":["dextran 40","Ringer lactat"],"d":["gastro"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Dextran 40 asociat cu Ringer lactat față de Ringer lactat singur pentru reechilibrarea cu lichide în pancreatita acută ușoară sau moderată"},"loc":[[101,"RECRUITING",[[639,"c"]]]]},{"id":"NCT06815588","t":"Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring","dn":"RoGer Pedi","sp":"Research Center Borstel","c":["Tuberculosis"],"iv":[],"d":["inf"],"f":"","tip":"O","vmin":0,"vmax":14,"vs":1,"content_status":"complete","ro":{"titlu":"Metode noi de diagnostic și de monitorizare a tratamentului la copiii evaluați pentru tuberculoză respiratorie (studiu observațional)"},"loc":[[324,"RECRUITING",[[376,"pi"]]]]},{"id":"NCT06804434","t":"Impact of Intraoperative Non-invasive Analgesia Monitoring Using Nociception Level Index on Patient Management","sp":"Osoian Cristiana","c":["Pain","Anesthesia","Perioperative Care"],"iv":["Lidocaine Intravenous Infusion","NOL"],"ivro":["lidocaină"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Monitorizarea durerii în timpul anesteziei cu indicele NOL și lidocaina intravenoasă în chirurgia abdominală majoră"},"loc":[[155,"RECRUITING",[[689,"pi"]]]]},{"id":"NCT04174157","t":"Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)","sp":"Novartis Pharmaceuticals","c":["Spinal Muscular Atrophy (SMA)"],"iv":["Prospective observational registry","Zolgensma"],"ivro":["onasemnogen abeparvovec"],"d":["neuro"],"f":"","tip":"O","vmin":null,"vmax":null,"content_status":"complete","ro":{"titlu":"Registru prospectiv pe termen lung al pacienților cu atrofie musculară spinală (SMA) tratați cu onasemnogen abeparvovec"},"loc":[[266,"RECRUITING",[[281,"pi"]]],[436,"RECRUITING",[[577,"pi"]]]]},{"id":"NCT06775028","t":"Integrated Approach in Frail Older People with Atrial Fibrillation","dn":"AFFIRMO","sp":"Heart Care Foundation","c":["Atrial Fibrillation (AF)","Hypertension","Coronary Arterial Disease (CAD)","Heart Failure","COPD","Peripheral Arterial Disease","CKD","Diabetes Mellitus"],"iv":["iABC platform use"],"d":["cardio","metab","neuro","resp"],"f":"","tip":"I","vmin":65,"vmax":null,"content_status":"complete","ro":{"titlu":"AFFIRMO: îngrijire integrată (iABC) pentru vârstnicii cu fibrilație atrială și mai multe boli cronice"},"loc":[[29,"RECRUITING",[[554,"c"]]],[29,"RECRUITING",[[555,"c"]]],[27,"RECRUITING",[[556,"c"]]],[98,"RECRUITING",[[557,"c"]]],[429,"RECRUITING",[[273,"c"]]],[46,"RECRUITING",[[558,"c"]]],[142,"RECRUITING",[[559,"c"]]],[36,"RECRUITING",[[560,"c"]]]]},{"id":"NCT05729438","t":"Nutritional Assesment in Patients With Cirrhosis","sp":"SUUMC Central Military Hospital Dr Carol Davila","c":["Cirrhosis, Liver"],"iv":["BCAA"],"ivro":["aminoacizi cu lanț ramificat"],"d":["gastro"],"f":"","tip":"O","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Evaluarea stării de nutriție la pacienții cu ciroză hepatică"},"loc":[[0,"RECRUITING",[[0,"c"]]]]},{"id":"NCT06142032","t":"Support Groups in the Metaverse for Ukrainian Refugees","dn":"METASUPUKR","sp":"University of Bucharest","c":["Mental Health Wellness 1","Well-Being, Psychological"],"iv":["Metaverse support group","In-Person support group"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":85,"vs":1,"content_status":"complete","ro":{"titlu":"Grupuri de sprijin în Metavers pentru refugiații ucraineni"},"loc":[[284,"RECRUITING",[[299,"c"]]]],"ofi":[[299,"pi"]]},{"id":"NCT04754022","t":"Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery","dn":"TRICS-IV","sp":"Unity Health Toronto","c":["Disorder","Heart","Postoperative","Cardiac Surgery"],"iv":["Restrictive Transfusion Strategy","Liberal transfusion strategy"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Pragul de transfuzie la pacienții de cel mult 65 de ani operați pe inimă (TRICS-IV)"},"loc":[[289,"RECRUITING",[[304,"c"]]]]},{"id":"NCT06033976","t":"Endoscopic Submucosal Dissection Registry","dn":"ESDREG","sp":"Carol Davila University of Medicine and Pharmacy","c":["Neoplasm, Stomach","Neoplasm, Colorectal","Neoplasm, Esophagus","Neoplasm, Duodenal"],"iv":["Endoscopic submucosal dissection (ESD)"],"d":["onco"],"tu":["esofag","gastric","colorectal"],"f":"","tip":"O","vmin":18,"vmax":100,"content_status":"complete","ro":{"titlu":"Registrul pacienților tratați prin disecție submucosală endoscopică (ESD) la Spitalul „Agrippa Ionescu”"},"loc":[[47,"RECRUITING",[[56,"c"]]]],"ofi":[[56,"pi"]]},{"id":"NCT06510348","t":"Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction","dn":"ATTAINMENT","sp":"Romanian Society for Enteral and Parenteral Nutrition","c":["Parenteral Nutrition","Gastroparesis","Gastrointestinal Dysfunction","Protein Deficiency","Critical Illness"],"iv":["Supplemental Parenteral Nutrition (SPN)"],"d":["metab","gastro"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nutriție parenterală suplimentară comparată cu nutriția enterală la pacienții de terapie intensivă cu tulburări digestive (ATTAINMENT)"},"loc":[[61,"RECRUITING",[[322,"pi"],[716,"pi"],[717,"pi"],[321,"si"],[47,"si"],[718,"si"],[235,"si"],[719,"si"]]]],"ofi":[[716,"pi"],[322,"director"],[718,"chair"],[717,"chair"]]},{"id":"NCT02328131","t":"European Registry on the Management of Helicobacter Pylori Infection","dn":"Hp-EuReg","sp":"Javier P. Gisbert","c":["H. Pylori Infection"],"iv":[],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Registrul european al tratamentului infecției cu Helicobacter pylori"},"loc":[[226,"RECRUITING",[[152,"c"]]]]},{"id":"NCT05797831","t":"Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer","sp":"Kartos Therapeutics, Inc.","c":["Endometrial Cancer"],"iv":["Navtemadlin","Navtemadlin Placebo"],"ivro":["navtemadlin"],"d":["onco"],"tu":["endometru"],"bm":["tp53"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Navtemadlin ca tratament de întreținere în cancerul endometrial avansat sau recidivat TP53 normal, după răspuns la chimioterapie"},"loc":[[342,"RECRUITING",[]],[26,"RECRUITING",[]],[74,"RECRUITING",[]],[10,"RECRUITING",[]],[150,"RECRUITING",[]],[135,"RECRUITING",[]],[9,"RECRUITING",[]]]},{"id":"NCT05747404","t":"The FUnctional TricUspid REgurgitation by 3D EChocardiography Cooperative Study","dn":"FUTURE 3D","sp":"Istituto Auxologico Italiano","c":["Heart Valve Incompetence","Echocardiography, Transthoracic"],"iv":["Echocardiography"],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Insuficiența tricuspidiană funcțională evaluată prin ecocardiografie 3D: studiu observațional (FUTURE 3D)"},"loc":[[387,"RECRUITING",[[453,"c"]]],[388,"RECRUITING",[[454,"c"]]]]},{"id":"NCT06275204","t":"H. Pylori Screen-and-treat Study in a Population of Young Adults","sp":"University of Latvia","c":["Gastric Cancer","H Pylori Infection","H Pylori Eradication","H-pylori"],"iv":["Bismuth-based quadruple therapy","Levofloxacin-based quadruple therapy","Standard triple therapy","Levofloxacin-based triple"],"ivro":["tratament cvadruplu cu bismut","amoxicilină","claritromicină","metronidazol","esomeprazol","oxid de bismut"],"d":["gastro"],"f":"","tip":"O","vmin":30,"vmax":34,"vs":1,"content_status":"complete","ro":{"titlu":"Testarea și tratarea infecției cu H. pylori la tineri adulți (30–34 de ani), în șase țări europene"},"loc":[[316,"RECRUITING",[[344,"c"],[345,"si"]]]]},{"id":"NCT04920617","t":"DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma","dn":"VITALIZE","sp":"ImmunoVaccine Technologies, Inc. (IMV Inc.)","c":["Relapsed Diffuse Large B-cell Lymphoma","Refractory Diffuse Large B-cell Lymphoma"],"iv":["DPX-Survivac","Pembrolizumab","CPA"],"ivro":["DPX-Survivac","pembrolizumab","ciclofosfamidă"],"d":["onco"],"tu":["lnh"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"DPX-Survivac și pembrolizumab, cu sau fără ciclofosfamidă în doză mică, în limfomul difuz cu celule B mari recidivat sau refractar"},"loc":[[62,"RECRUITING",[[707,"c"],[708,"pi"]]],[8,"RECRUITING",[[709,"c"],[710,"c"],[35,"pi"]]]]},{"id":"NCT05207358","t":"Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis","dn":"GLUREDLUP","sp":"Institutul Clinic Fundeni","c":["Lupus Nephritis"],"iv":["Rituximab","Mycophenolate Mofetil","Cyclophosphamide","Corticosteroids"],"ivro":["rituximab","metilprednisolon","micofenolat mofetil","prednisolon","ciclofosfamidă","azatioprină"],"d":["reum","derm","nefro","gin"],"f":"4","tip":"I","vmin":18,"vmax":80,"content_status":"complete","ro":{"titlu":"Reducerea corticosteroizilor în nefrita lupică proliferativă: schema RITUXILUP față de schema standard EUROLUPUS"},"loc":[[30,"RECRUITING",[[752,"c"]]]],"ofi":[[75,"pi"]]},{"id":"NCT07686263","t":"Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia","sp":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","c":["Schizophrenia"],"iv":["Xanomeline/Trospium Chloride"],"ivro":["xanomelină–trospiu"],"d":["psih"],"f":"3","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"Xanomelină–trospiu (KarXT) pentru prevenirea recăderilor în schizofrenie: studiu de menținere cu retragere randomizată"},"loc":[[22,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]]]},{"id":"NCT06317805","t":"Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients","dn":"TripleTRE","sp":"AOP Orphan Pharmaceuticals AG","c":["Pulmonary Arterial Hypertension"],"iv":["Generic treprostinil sodium + Standard of Care (Double Oral)","Standard of Care - Double Oral"],"ivro":["treprostinil","tadalafil","sildenafil","ambrisentan","bosentan","macitentan"],"d":["resp"],"f":"4","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"Terapie triplă inițială cu treprostinil parenteral față de terapia dublă orală inițială în hipertensiunea arterială pulmonară (TripleTRE)"},"loc":[[138,"NOT_YET_RECRUITING",[[700,"pi"]]],[92,"NOT_YET_RECRUITING",[[701,"pi"]]]]},{"id":"NCT07476729","t":"International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)","dn":"IntReALL BCP 2020","sp":"Charite University, Berlin, Germany","c":["B-Cell Acute Lymphoblastic Leukaemia"],"iv":["Inotuzumab ozogamicin (INO)","Blinatumomab"],"ivro":["ALL-R3","mitoxantronă","inotuzumab ozogamicin","blinatumomab","vincristină","dexametazonă"],"d":["onco"],"tu":["lal"],"bm":["cd22","cd19"],"f":"3","tip":"I","vmin":1,"vmax":null,"content_status":"complete","ro":{"titlu":"IntReALL BCP 2020: tratamentul primei recidive a leucemiei acute limfoblastice cu precursori B la copii și tineri, cu inotuzumab ozogamicin și blinatumomab"},"loc":[[30,"NOT_YET_RECRUITING",[[65,"c"]]]]},{"id":"NCT07845487","t":"A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis","dn":"ASCENTRA-UC","sp":"Palisade Bio","c":["Ulcerative Colitis (UC)","Severe Ulcerative Colitis","Moderate Ulcerative Colitis"],"iv":["PALI-2108"],"ivro":["PALI-2108"],"d":["gastro"],"f":"2","tip":"I","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"PALI-2108 în două doze comparat cu placebo în colita ulcerativă moderat până la sever activă (ASCENTRA-UC)"},"loc":[[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[23,"NOT_YET_RECRUITING",[]],[186,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]]]},{"id":"NCT06968845","t":"A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis","sp":"Rein Therapeutics","c":["Idiopathic Pulmonary Fibrosis (IPF)"],"iv":["LTI-03","Dry Powder Inhaler"],"d":["resp"],"f":"2","tip":"I","vmin":40,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 2 — pneumologie","gen":1},"loc":[[208,"NOT_YET_RECRUITING",[]],[227,"NOT_YET_RECRUITING",[[228,"pi"]]],[147,"NOT_YET_RECRUITING",[]],[228,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07497087","t":"A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis","dn":"VERANDA-SSc","sp":"Boehringer Ingelheim","c":["Systemic Sclerosis"],"iv":["Nerandomilast formulation 1","Nerandomilast formulation 2"],"ivro":["nerandomilast"],"d":["reum","derm"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nerandomilast comparat cu placebo la adulții cu scleroză sistemică (VERANDA-SSc)"},"loc":[[13,"NOT_YET_RECRUITING",[[10,"pi"]]],[43,"NOT_YET_RECRUITING",[[40,"pi"]]],[59,"NOT_YET_RECRUITING",[[54,"pi"]]],[420,"NOT_YET_RECRUITING",[[537,"pi"]]]]},{"id":"NCT06757634","t":"Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)","dn":"VIKTORIA-2","sp":"Celcuity Inc","c":["Breast Cancer"],"iv":["Arm A: Gedatolisib + Palbociclib + Fulvestrant","Arm B: Ribociclib + Fulvestrant","Arm C: Gedatolisib + Palbociclib + Letrozole","Arm D: Ribociclib + Letrozole"],"ivro":["gedatolisib","palbociclib","fulvestrant","ribociclib","letrozol"],"d":["onco"],"tu":["san_hr","san"],"bm":["hr","her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Gedatolisib cu palbociclib și hormonoterapie față de ribociclib cu hormonoterapie, în prima linie a cancerului mamar avansat HR-pozitiv, HER2-negativ"},"loc":[[10,"NOT_YET_RECRUITING",[]],[73,"NOT_YET_RECRUITING",[]],[8,"NOT_YET_RECRUITING",[]],[62,"NOT_YET_RECRUITING",[]],[74,"NOT_YET_RECRUITING",[]],[45,"NOT_YET_RECRUITING",[]],[75,"NOT_YET_RECRUITING",[]],[25,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07100080","t":"Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)","dn":"IZABRIGHT-Lung01","sp":"Bristol-Myers Squibb","c":["Non-Small Cell Lung Cancer"],"iv":["Iza-bren","Carboplatin","Cisplatin","Pemetrexed"],"ivro":["izalontamab brengitecan","cisplatină","carboplatină","pemetrexed"],"d":["onco"],"tu":["nsclc"],"bm":["egfr"],"f":"2/3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Izalontamab brengitecan comparat cu chimioterapia cu platină și pemetrexed în cancerul pulmonar cu mutație EGFR, după progresie la osimertinib sau alt inhibitor EGFR de generația a 3-a"},"loc":[[5,"WITHDRAWN",[]],[5,"NOT_YET_RECRUITING",[]],[137,"WITHDRAWN",[]],[4,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[3,"NOT_YET_RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]]]},{"id":"NCT06568627","t":"A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)","dn":"VALUE","sp":"MediWound Ltd","c":["Venous Leg Ulcer (VLU)"],"iv":["EscharEx (EX-03)"],"ivro":["EscharEx"],"d":["cardio","derm"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"EscharEx (EX-03) comparat cu placebo pentru curățarea enzimatică a ulcerelor venoase de gambă"},"loc":[[437,"NOT_YET_RECRUITING",[[579,"c"],[580,"pi"]]],[98,"NOT_YET_RECRUITING",[[581,"c"],[582,"pi"]]],[107,"NOT_YET_RECRUITING",[[583,"c"],[584,"pi"],[585,"si"]]],[31,"NOT_YET_RECRUITING",[[586,"pi"]]],[49,"NOT_YET_RECRUITING",[[587,"pi"]]],[438,"NOT_YET_RECRUITING",[[588,"pi"]]]]},{"id":"NCT07768189","t":"A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma","dn":"TEMPO-1","sp":"Corbus Pharmaceuticals Inc.","c":["Oropharyngeal Carcinoma (OPC)"],"iv":["CRB-701","capcitabine","Cetuximab (EGFR inhibitor)","Docetaxel"],"ivro":["CRB-701","capecitabină","cetuximab","docetaxel"],"d":["onco"],"tu":["capgat"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"CRB-701 față de capecitabină, cetuximab sau docetaxel în cancerul orofaringian scuamos recidivat sau metastatic, după platină și imunoterapie"},"loc":[[16,"NOT_YET_RECRUITING",[[142,"pi"]]],[17,"NOT_YET_RECRUITING",[[64,"pi"]]],[10,"NOT_YET_RECRUITING",[[5,"pi"]]],[63,"NOT_YET_RECRUITING",[[290,"pi"]]],[64,"NOT_YET_RECRUITING",[[662,"pi"]]]]},{"id":"NCT07287670","t":"EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)","dn":"EncompaSSc","sp":"Mediar Therapeutics","c":["Diffuse Cutaneous Systemic Sclerosis"],"iv":["MTX-474"],"ivro":["MTX-474"],"d":["reum","derm"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"MTX-474 față de placebo în sclerodermia sistemică cutanată difuză (EncompaSSc)"},"loc":[[22,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07623161","t":"A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib","dn":"ELRiSE MF","sp":"Takeda","c":["Myelofibrosis","Anemia"],"iv":["Elritercept"],"ivro":["Elritercept","ruxolitinib","elritercept"],"d":["onco"],"tu":["nmp"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elritercept comparat cu placebo pentru anemia din mielofibroză la pacienții tratați cu ruxolitinib"},"loc":[[8,"NOT_YET_RECRUITING",[[25,"pi"]]],[37,"NOT_YET_RECRUITING",[[33,"pi"]]],[29,"NOT_YET_RECRUITING",[[313,"pi"]]],[28,"NOT_YET_RECRUITING",[[22,"pi"]]]]},{"id":"NCT07564414","t":"A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight","sp":"Novo Nordisk A/S","c":["Obesity","Type 2 Diabetes"],"iv":["Cagrisema","Semaglutide"],"ivro":["CagriSema","cagrilintidă","semaglutidă"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Două doze de CagriSema comparate cu semaglutidă pentru scăderea în greutate în obezitate, cu sau fără diabet de tip 2"},"loc":[[504,"ACTIVE_NOT_RECRUITING",[]],[222,"ACTIVE_NOT_RECRUITING",[]],[230,"ACTIVE_NOT_RECRUITING",[]],[234,"ACTIVE_NOT_RECRUITING",[]],[223,"NOT_YET_RECRUITING",[]],[240,"ACTIVE_NOT_RECRUITING",[]],[252,"ACTIVE_NOT_RECRUITING",[]],[105,"ACTIVE_NOT_RECRUITING",[]],[95,"ACTIVE_NOT_RECRUITING",[]],[247,"ACTIVE_NOT_RECRUITING",[]],[140,"ACTIVE_NOT_RECRUITING",[]]]},{"id":"NCT07761117","t":"A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF","dn":"Elevate-HF","sp":"AstraZeneca","c":["Heart Failure With Preserved Ejection Fraction (HFpEF)","Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)"],"iv":["Elecoglipron"],"ivro":["elecoglipron","dapagliflozină"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elecoglipron față de placebo, adăugat la dapagliflozină și la tratamentul standard, în insuficiența cardiacă cu fracție de ejecție păstrată sau ușor redusă (Elevate-HF)"},"loc":[[170,"NOT_YET_RECRUITING",[]],[22,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[87,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[205,"UNKNOWN",[[202,"pi"]]],[46,"UNKNOWN",[[258,"pi"]]],[100,"UNKNOWN",[[88,"pi"]]],[103,"UNKNOWN",[[93,"pi"]]],[104,"UNKNOWN",[[94,"pi"]]],[313,"UNKNOWN",[[451,"pi"]]],[212,"UNKNOWN",[[209,"pi"]]],[28,"UNKNOWN",[[253,"pi"]]],[208,"UNKNOWN",[[205,"pi"]]],[31,"UNKNOWN",[[89,"pi"]]]]},{"id":"NCT07476326","t":"Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma","sp":"Biocon Biologics UK PLC","c":["Melanoma"],"iv":["Bmab1700","Opdivo"],"ivro":["Bmab1700","Bmab1700","Opdivo","nivolumab"],"d":["onco"],"tu":["melanom"],"f":"1","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Bmab1700, biosimilar propus pentru nivolumab, comparat cu Opdivo ca tratament adjuvant după operația completă a melanomului"},"loc":[[5,"NOT_YET_RECRUITING",[]],[3,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[62,"UNKNOWN",[[142,"pi"]]],[8,"UNKNOWN",[[64,"pi"]]],[10,"UNKNOWN",[[5,"pi"]]]]},{"id":"NCT07624305","t":"A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)","dn":"BalanceD-CKD","sp":"AstraZeneca","c":["Renal Insufficiency, Chronic"],"iv":["Balcinrenone/dapagliflozin","Dapagliflozin"],"ivro":["balcinrenonă/dapagliflozin","dapagliflozin"],"d":["nefro","gin"],"f":"3","tip":"I","vmin":18,"vmax":99,"content_status":"complete","ro":{"titlu":"Balcinrenonă/dapagliflozin față de dapagliflozin în boala cronică de rinichi stadiul 3b și 4 (BalanceD-CKD)"},"loc":[[22,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[259,"NOT_YET_RECRUITING",[]],[85,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[30,"UNKNOWN",[[75,"pi"]]],[206,"UNKNOWN",[]],[209,"UNKNOWN",[[206,"pi"]]],[210,"UNKNOWN",[[207,"pi"]]],[208,"UNKNOWN",[[108,"pi"]]],[140,"UNKNOWN",[]],[105,"UNKNOWN",[[271,"pi"]]]]},{"id":"NCT07547540","t":"A Study of LY3971297 in Participants With Heart Failure","sp":"Eli Lilly and Company","c":["Heart Failure","Heart Failure, Diastolic","Heart Failure, Systolic"],"iv":["LY3971297"],"ivro":["LY3971297"],"d":["cardio"],"f":"1","tip":"I","vmin":18,"vmax":65,"content_status":"complete","ro":{"titlu":"LY3971297 în doză unică, cu doze crescătoare, la pacienții cu insuficiență cardiacă cu fracție de ejecție păstrată sau redusă (studiu de fază 1)"},"loc":[[17,"NOT_YET_RECRUITING",[[374,"pi"]]]]},{"id":"NCT06515821","t":"Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods","dn":"ONCOSCREEN-CS","sp":"Firalis SA","c":["Colorectal Cancer"],"iv":["ONCOSCREEN"],"d":["onco"],"tu":["colorectal"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Teste experimentale de depistare a cancerului colorectal din aerul expirat, sânge, scaun și probe bucale (ONCOSCREEN-CS)"},"loc":[[62,"NOT_YET_RECRUITING",[[604,"c"]]]]},{"id":"NCT07436299","t":"Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation","dn":"HFcAF","sp":"Oslo University Hospital","c":["Heart Failure (HF)","Atrial Fibrillation (AF)"],"iv":[],"d":["cardio"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Metode noi de ecografie cardiacă pentru estimarea presiunii de umplere în insuficiența cardiacă cu fibrilație atrială (HFcAF)"},"loc":[[387,"NOT_YET_RECRUITING",[[622,"pi"]]]]},{"id":"NCT07753993","t":"A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.","dn":"Elevate-CKD","sp":"AstraZeneca","c":["Chronic Kidney Disease"],"iv":["Elecoglipron"],"ivro":["elecoglipron","dapagliflozină"],"d":["nefro","gin"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Elecoglipron comparat cu placebo în boala cronică de rinichi, adăugat la tratamentul standard cu dapagliflozină"},"loc":[[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[5,"NOT_YET_RECRUITING",[]],[3,"NOT_YET_RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]],[85,"NOT_YET_RECRUITING",[]],[85,"NOT_YET_RECRUITING",[]],[85,"NOT_YET_RECRUITING",[]],[85,"NOT_YET_RECRUITING",[]],[186,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[6,"NOT_YET_RECRUITING",[]],[232,"UNKNOWN",[]],[30,"UNKNOWN",[[75,"pi"]]],[59,"UNKNOWN",[[658,"pi"],[419,"pi"]]],[206,"UNKNOWN",[]],[268,"UNKNOWN",[[294,"pi"]]],[403,"UNKNOWN",[[116,"pi"]]],[140,"UNKNOWN",[[659,"pi"],[418,"pi"]]],[509,"UNKNOWN",[[660,"pi"]]],[208,"UNKNOWN",[[108,"pi"]]],[105,"UNKNOWN",[[271,"pi"]]],[240,"UNKNOWN",[[242,"pi"]]],[504,"UNKNOWN",[[650,"pi"]]],[231,"UNKNOWN",[[255,"pi"]]]]},{"id":"NCT04232917","t":"Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.","dn":"PAPION","sp":"Labo'Life","c":["Human Papilloma Virus"],"iv":["2LPAPI®"],"ivro":["2LPAPI"],"d":["alte"],"f":"4","tip":"I","vmin":25,"vmax":45,"content_status":"complete","ro":{"titlu":"2LPAPI față de placebo pentru eliminarea infecției genitale cu HPV cu risc înalt la femeile între 25 și 45 de ani (PAPION)"},"loc":[[543,"NOT_YET_RECRUITING",[[702,"c"]]]]},{"id":"NCT06861361","t":"Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients","dn":"START YOUNG","sp":"Ceric Sàrl","c":["Symptomatic Severe Aortic Stenosis"],"iv":["Myval balloon-expandable THV Series","Surgical bioprosthetic valve"],"d":["alte"],"f":"","tip":"I","vmin":65,"vmax":75,"content_status":"complete","ro":{"titlu":"Înlocuirea valvei aortice prin cateter (valva Myval) comparată cu înlocuirea chirurgicală, la pacienți de 65–75 de ani cu stenoză aortică severă"},"loc":[[61,"NOT_YET_RECRUITING",[[347,"c"],[348,"c"]]],[36,"NOT_YET_RECRUITING",[[349,"c"],[350,"c"]]],[318,"NOT_YET_RECRUITING",[[351,"c"],[352,"c"]]]]},{"id":"NCT06051409","t":"A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)","dn":"POLARIS-1","sp":"Ascentage Pharma Group Inc.","c":["Ph+ ALL","Leukemia, Lymphoblastic, Acute, Philadelphia-Positive"],"iv":["Olverembatinib","Investigator's choice of TKI"],"ivro":["olverembatinib"],"d":["onco"],"tu":["lal"],"bm":["bcrabl"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Olverembatinib cu chimioterapie comparat cu un inhibitor de tirozin-kinază ales de medic, cu chimioterapie, în leucemia acută limfoblastică Ph+ nou diagnosticată"},"loc":[[5,"NOT_YET_RECRUITING",[]],[3,"NOT_YET_RECRUITING",[]],[4,"NOT_YET_RECRUITING",[]],[24,"NOT_YET_RECRUITING",[]]]},{"id":"NCT04895839","t":"Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program","dn":"PC-PEP","sp":"Gabriela Ilie","c":["Prostate Cancer"],"iv":["Patient Empowerment Program"],"d":["onco"],"tu":["prostata"],"f":"","tip":"I","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Program de responsabilizare a pacientului (PC-PEP) pentru sănătatea mintală și calitatea vieții în cancerul de prostată"},"loc":[[76,"NOT_YET_RECRUITING",[[126,"c"]]]]},{"id":"NCT05879757","t":"Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency","sp":"Takeda","c":["Multiple Myeloma","Secondary Immunodeficiency (SID)"],"iv":["No Intervention"],"ivro":["HyQvia"],"d":["onco"],"tu":["mielom"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Utilizarea HyQvia în practica obișnuită la adulții cu mielom multiplu și imunodeficiență secundară — studiu observațional"},"loc":[[29,"NOT_YET_RECRUITING",[[313,"pi"]]],[30,"NOT_YET_RECRUITING",[[26,"pi"]]],[8,"NOT_YET_RECRUITING",[[25,"pi"]]],[37,"NOT_YET_RECRUITING",[[33,"pi"]]]]},{"id":"NCT05421650","t":"Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr","sp":"CHA University","c":["Cervical Cancer"],"iv":["CCRT","Surgical debulking of lymph nodes + CCRT"],"d":["onco"],"tu":["col"],"f":"","tip":"I","vmin":20,"vmax":70,"content_status":"complete","ro":{"titlu":"Îndepărtarea chirurgicală a ganglionilor metastatici voluminoși înainte de radiochimioterapie în cancerul de col uterin stadiul IIICr"},"loc":[[175,"NOT_YET_RECRUITING",[[173,"pi"]]]]},{"id":"NCT05651724","t":"Global Research Initiative for Patients Screening on MASH","dn":"GRIPonMASH","sp":"Julius Clinical","c":["MASH","MASLD","MASH With Fibrosis","Fibrosis, Liver","Steatosis of Liver","Type 2 Diabetes","Obesity","Metabolic Syndrome"],"iv":[],"d":["cardio","metab","gastro"],"f":"","tip":"O","vmin":18,"vmax":75,"content_status":"complete","ro":{"titlu":"GRIPonMASH: depistarea bolii ficatului gras asociate tulburărilor metabolice la pacienții cu diabet de tip 2, obezitate, sindrom metabolic sau hipertensiune"},"loc":[[33,"NOT_YET_RECRUITING",[]]]},{"id":"NCT07789015","t":"A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies","dn":"VERANDA-IIM","sp":"Boehringer Ingelheim","c":["Idiopathic Inflammatory Myopathies"],"iv":["Nerandomilast"],"ivro":["nerandomilast"],"d":["neuro","reum"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nerandomilast adăugat la tratamentul de fond în miopatiile inflamatorii idiopatice active (VERANDA-IIM)"},"loc":[[176,"UNKNOWN",[]],[373,"UNKNOWN",[]],[59,"UNKNOWN",[]]]},{"id":"NCT07878858","t":"Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Blood Pressure Measurement"],"iv":["blood pressure measurement in the semi-recumbent position","Standard BP measurement"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"vs":1,"content_status":"preparing","ro":{"titlu":"Studiu clinic — medicină","gen":1},"loc":[[475,"UNKNOWN",[]],[59,"UNKNOWN",[]]],"ofi":[]},{"id":"NCT07900633","t":"A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk","sp":"Eli Lilly and Company","c":["Obesity","Overweight","Cardiovascular Diseases","Diabetes Mellitus, Type 2"],"iv":["Eloralintide"],"d":["cardio","metab"],"f":"3","tip":"I","vmin":45,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — cardiologie, diabet și endocrinologie","gen":1},"loc":[[204,"UNKNOWN",[]],[205,"UNKNOWN",[[202,"pi"]]],[206,"UNKNOWN",[]],[207,"UNKNOWN",[[204,"pi"]]],[208,"UNKNOWN",[[205,"pi"]]],[209,"UNKNOWN",[[206,"pi"]]],[210,"UNKNOWN",[[207,"pi"]]],[211,"UNKNOWN",[]],[212,"UNKNOWN",[[209,"pi"]]],[213,"UNKNOWN",[[210,"pi"]]],[214,"UNKNOWN",[[204,"pi"]]]]},{"id":"NCT06282575","t":"Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer","sp":"Jazz Pharmaceuticals","c":["Biliary Tract Cancer"],"iv":["Zanidatamab","Cisplatin","Gemcitabine","Pembrolizumab","Durvalumab"],"ivro":["zanidatamab","cisplatină","gemcitabină","durvalumab","pembrolizumab"],"d":["onco"],"tu":["biliar","urotelial"],"bm":["her2"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Zanidatamab adăugat la tratamentul standard în cancerul căilor biliare avansat HER2-pozitiv, prima linie"},"loc":[[105,"UNKNOWN",[[541,"pi"]]],[10,"WITHDRAWN",[[5,"pi"]]],[30,"WITHDRAWN",[[128,"pi"]]],[63,"WITHDRAWN",[[290,"pi"]]]]},{"id":"NCT07885891","t":"Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia","sp":"Wockhardt","c":["Hospital Acquired Bacterial Pneumonia (HABP)","Ventilator Associated Bacterial Pneumonia (VABP)"],"iv":["Cefepime-Zidebactam","Ceftazidime-avibactam with or without Colistin"],"d":["alte"],"f":"3","tip":"I","vmin":18,"vmax":90,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — medicină","gen":1},"loc":[[142,"UNKNOWN",[]],[166,"UNKNOWN",[]],[21,"UNKNOWN",[[167,"c"]]],[140,"UNKNOWN",[]]]},{"id":"NCT07881458","t":"A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes","sp":"Eli Lilly and Company","c":["Obesity","Overweight","Diabetes Mellitus, Type 2"],"iv":["eloralintide and tirzepatide","Tirzepatide"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 3 — diabet și endocrinologie","gen":1},"loc":[[205,"UNKNOWN",[]],[12,"UNKNOWN",[[241,"pi"]]],[207,"UNKNOWN",[[204,"pi"]]],[224,"UNKNOWN",[[243,"pi"]]],[208,"UNKNOWN",[[205,"pi"]]],[209,"UNKNOWN",[[206,"pi"]]],[210,"UNKNOWN",[[207,"pi"]]],[211,"UNKNOWN",[]],[233,"UNKNOWN",[[247,"pi"]]],[212,"UNKNOWN",[[209,"pi"]]]]},{"id":"NCT07871214","t":"A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)","sp":"Bristol-Myers Squibb","c":["Early-Stage Non-Small Cell Lung Cancer"],"iv":["Pumitamig","Carboplatin","Cisplatin","Paclitaxel","Pemetrexed"],"d":["onco"],"tu":["nsclc"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Studiu clinic de fază 2 — Cancer pulmonar non-microcelular","gen":1},"loc":[[5,"UNKNOWN",[]],[3,"UNKNOWN",[]],[5,"UNKNOWN",[]],[24,"UNKNOWN",[]]]},{"id":"NCT07128199","t":"A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection","sp":"Taiho Oncology, Inc.","c":["Lung Cancer","Adjuvant","Post-surgical","EGFR","Exon 20","Early Stage Lung Cancer","Uncommon EGFR Mutations","NSCLC, Early Stage"],"iv":["TAS6417","Zipalertinib Matching-placebo"],"ivro":["zipalertinib (TAS6417)","placebo corespunzător zipalertinib"],"d":["onco"],"tu":["nsclc"],"bm":["egfr"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"preparing","ro":{"titlu":"Zipalertinib comparativ cu placebo după rezecția completă a tumorii în cancerul pulmonar fără celule mici incipient cu mutații EGFR rare"},"loc":[[62,"UNKNOWN",[[138,"pi"]]],[58,"UNKNOWN",[]],[45,"UNKNOWN",[[62,"pi"]]],[26,"UNKNOWN",[[20,"pi"]]],[369,"UNKNOWN",[[179,"pi"]]],[101,"UNKNOWN",[[595,"pi"]]],[135,"UNKNOWN",[[164,"pi"]]],[71,"UNKNOWN",[[61,"pi"]]]]},{"id":"NCT07850453","t":"Vortosiran for VTE Prevention","sp":"Ribocure Pharmaceuticals AB","c":["Venous Thromboembolism (VTE)","Cancer","Pulmonary Embolism (Diagnosis)"],"iv":["Vortosiran"],"ivro":["vortosiran"],"d":["onco"],"tu":["suport"],"f":"2","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Vortosiran pentru prevenirea trombozelor venoase, inclusiv la pacienții cu cancer care încep chimioterapia"},"loc":[[150,"UNKNOWN",[[721,"pi"]]],[561,"UNKNOWN",[[91,"pi"]]],[2,"UNKNOWN",[[132,"pi"]]],[139,"UNKNOWN",[[127,"pi"]]],[492,"UNKNOWN",[[92,"pi"]]],[21,"UNKNOWN",[[722,"pi"]]],[97,"UNKNOWN",[[85,"pi"]]]]},{"id":"NCT07285798","t":"A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder","sp":"Bristol-Myers Squibb","c":["Irritability Associated With Autism Spectrum Disorder"],"iv":["KarXT","KarX-EC","KarXT + KarX-EC Matching Placebo"],"ivro":["KarXT","xanomelină/clorură de trospiu","KarX-EC","xanomelină"],"d":["psih"],"f":"3","tip":"I","vmin":5,"vmax":17,"content_status":"complete","ro":{"titlu":"Xanomelină/trospiu (KarXT) plus xanomelină cu eliberare enterică (KarX-EC) pentru iritabilitatea din tulburarea de spectru autist la copii și adolescenți"},"loc":[[5,"UNKNOWN",[]],[5,"UNKNOWN",[]],[5,"UNKNOWN",[]],[3,"UNKNOWN",[]],[24,"UNKNOWN",[]],[147,"UNKNOWN",[]],[6,"UNKNOWN",[]]]},{"id":"NCT07157774","t":"Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)","dn":"MOVE-Lp(a)","sp":"Eli Lilly and Company","c":["Elevated Lp(a)","Atherosclerotic Cardiovascular Disease (ASCVD)"],"iv":["Muvalaplin"],"ivro":["muvalaplin"],"d":["cardio"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Muvalaplin față de placebo pentru reducerea evenimentelor cardiovasculare majore la adulții cu lipoproteina(a) crescută (MOVE-Lp(a))"},"loc":[[229,"UNKNOWN",[[202,"pi"]]],[49,"UNKNOWN",[[240,"pi"]]],[251,"UNKNOWN",[[254,"pi"]]],[240,"UNKNOWN",[[242,"pi"]]],[231,"UNKNOWN",[[255,"pi"]]],[224,"UNKNOWN",[[243,"pi"]]],[13,"UNKNOWN",[[256,"pi"]]],[50,"UNKNOWN",[[257,"pi"]]],[31,"UNKNOWN",[[89,"pi"]]],[46,"UNKNOWN",[[258,"pi"]]],[242,"UNKNOWN",[[245,"pi"]]],[252,"UNKNOWN",[[259,"pi"]]],[225,"UNKNOWN",[[207,"pi"]]],[253,"UNKNOWN",[[260,"pi"]]],[85,"UNKNOWN",[[261,"pi"]]],[212,"UNKNOWN",[[209,"pi"]]],[245,"UNKNOWN",[[249,"pi"]]],[246,"UNKNOWN",[[250,"pi"]]],[234,"UNKNOWN",[[262,"pi"],[251,"pi"]]],[234,"UNKNOWN",[[251,"pi"]]],[88,"UNKNOWN",[[72,"pi"]]],[254,"UNKNOWN",[[77,"pi"]]],[247,"UNKNOWN",[[252,"pi"]]],[97,"UNKNOWN",[[85,"pi"]]],[255,"UNKNOWN",[[263,"pi"]]],[256,"UNKNOWN",[[72,"pi"]]],[250,"UNKNOWN",[[250,"pi"]]],[92,"UNKNOWN",[[77,"pi"]]]]},{"id":"NCT07821554","t":"Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma","dn":"NutriCa65-PDAC","sp":"Inna Chen, MD","c":["Pancreatic Cancer"],"iv":["Experimental: Personalised nutritional care delivered by a trained dietitian"],"d":["onco"],"tu":["pancreas"],"f":"","tip":"I","vmin":65,"vmax":null,"content_status":"complete","ro":{"titlu":"Îngrijire nutrițională personalizată comparată cu îngrijirea nutrițională obișnuită la pacienții de 65 de ani și peste cu cancer pancreatic"},"loc":[[472,"UNKNOWN",[[146,"c"]]]]},{"id":"NCT07551830","t":"Process-Based Psychological Processes in Alcohol Use Disorder: A Case-Control Study Using PBAT, PHQ-9, and GAD-7","sp":"George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures","c":["Alcohol Use Disorder (AUD)"],"iv":[],"d":["psih"],"f":"","tip":"O","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Procesele psihologice în tulburarea de consum de alcool: studiu caz–control cu chestionarele PBAT, PHQ-9 și GAD-7"},"loc":[[220,"UNKNOWN",[[218,"c"]]]]},{"id":"NCT07687784","t":"A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia","sp":"AFT Pharmaceuticals, Ltd.","c":["Iron Deficiency Anemia (IDA)"],"iv":["Ferric Bepectate IV Injection","Ferric Carboxymaltose Injection [Ferinject]","Ferric Carboxymaltose Injection [Injectafer®]"],"ivro":["bepectat feric","carboximaltoză ferică","Injectafer","Ferinject"],"d":["hem","metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Bepectat feric intravenos comparat cu carboximaltoza ferică în anemia prin deficit de fier"},"loc":[[179,"UNKNOWN",[[484,"pi"]]],[29,"UNKNOWN",[[23,"pi"]]],[55,"UNKNOWN",[[485,"pi"]]],[396,"UNKNOWN",[[25,"pi"]]]]},{"id":"NCT07762027","t":"A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection","sp":"Assembly Biosciences","c":["Chronic Hepatitis D Infection"],"iv":["ABI-6250"],"ivro":["ABI-6250"],"d":["alte"],"f":"2","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"ABI-6250 la adulții cu infecție cronică cu virusul hepatitei D"},"loc":[[16,"UNKNOWN",[]],[218,"UNKNOWN",[]],[30,"UNKNOWN",[]],[162,"UNKNOWN",[]]]},{"id":"NCT07734922","t":"High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized Trial","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Osteoporosis, Postmenopausal","Osteopenia"],"iv":["High-Intensity Laser Therapy","Sham Laser","Standardised Physiotherapy Programme"],"d":["metab","reum"],"f":"","tip":"I","vmin":50,"vmax":70,"content_status":"complete","ro":{"titlu":"Terapia cu laser de intensitate mare adăugată la fizioterapie pentru sănătatea oaselor la femei după menopauză, cu osteopenie sau osteoporoză"},"loc":[[525,"UNKNOWN",[[690,"si"],[691,"pi"]]]]},{"id":"NCT07719673","t":"Enteral Nutrition and Colonization Resistance Through Microbiota Modulation in Critically Ill Patients","dn":"MICRON","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Bacterial Colonization","Multidrug Resistant Organisms","Critical Illness","Gut Microbiota Dysbiosis"],"iv":["Fibre-Enriched Enteral Nutrition","Standard Enteral Nutrition"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Nutriție enterală îmbogățită cu fibre pentru protecția față de bacteriile multirezistente la pacienții de terapie intensivă (MICRON)"},"loc":[[235,"UNKNOWN",[[359,"c"]]]],"ofi":[[360,"chair"]]},{"id":"NCT07697469","t":"Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization","dn":"ATRIO-CKM","sp":"Grigore T. Popa University of Medicine and Pharmacy","c":["Cardiovascular-Kidney-Metabolic Syndrome","Atrial Cardiomyopathy","Atrial Fibrillation","Chronic Kidney Disease","Metabolic Syndrome"],"iv":[],"d":["cardio","metab","nefro","gin"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"ATRIO-CKM: caracterizarea neinvazivă a cardiomiopatiei atriale la pacienții cu sindrom cardiovascular-renal-metabolic"},"loc":[[327,"UNKNOWN",[]]],"ofi":[[363,"director"],[364,"chair"],[365,"chair"],[366,"chair"],[367,"chair"]]},{"id":"NCT07676786","t":"Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients","dn":"EU-PHASE-HD","sp":"Stefan Lujinschi","c":["Pulmonary Hypertension (PH)","End Stage Kidney Disease (ESRD)","Hemodialysis Patients","Volume Overload","Volume Assessment","Hemodialysis"],"iv":["Observational Assessment"],"d":["cardio","resp","nefro","gin"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Hipertensiunea pulmonară la pacienții hemodializați evaluați în stare de euvolemie (EU-PHASE-HD)"},"loc":[[138,"UNKNOWN",[[123,"pi"],[124,"si"]]],[30,"UNKNOWN",[[125,"pi"]]]],"ofi":[[75,"chair"]]},{"id":"NCT07669285","t":"Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women","dn":"PRP-EpiHeal","sp":"Saint Andrew Hospital Constanta","c":["Episiotomy","Platelet Rich Plasma (PRP)","Wound Healing","Obstetric"],"iv":["Autologous Platelet-Rich Plasma (PRP)","Standard Wound Care"],"ivro":["plasmă bogată în trombocite"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"vs":1,"content_status":"complete","ro":{"titlu":"Plasmă bogată în trombocite autologă pentru vindecarea plăgii de epiziotomie și reducerea durerii perineale după naștere (PRP-EpiHeal)"},"loc":[[450,"UNKNOWN",[[598,"c"],[599,"c"]]]]},{"id":"NCT07652502","t":"Physical Exercise During the Cancer Care Pathway","dn":"ECOLE","sp":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","c":["Cancer, Treatment-Related","Cancer","Oncology","Oncologic Disorders"],"iv":[],"d":["onco"],"tu":["suport"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"ECOLE: chestionar despre cunoștințele, atitudinile și obiceiurile legate de exercițiul fizic la pacienții cu cancer"},"loc":[[464,"UNKNOWN",[[614,"pi"]]]]},{"id":"NCT07397091","t":"Using Routine Inflammatory and Metabolic Blood Tests (Bedside Included) to Predict Brain Injury in Children After Minor Head Trauma","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Brain Injury Traumatic Mild"],"iv":[],"d":["neuro"],"f":"","tip":"O","vmin":null,"vmax":18,"content_status":"complete","ro":{"titlu":"Analizele de sânge de rutină pentru a prezice leziunile creierului la copiii cu traumatism cranian ușor (studiu observațional)"},"loc":[[190,"UNKNOWN",[[182,"pi"]]],[191,"UNKNOWN",[[183,"c"],[184,"pi"]]],[156,"UNKNOWN",[[185,"pi"]]],[192,"UNKNOWN",[[186,"pi"]]],[193,"UNKNOWN",[[187,"pi"]]],[136,"UNKNOWN",[[188,"pi"]]],[14,"UNKNOWN",[[189,"pi"]]]],"ofi":[[190,"pi"],[188,"pi"]]},{"id":"NCT07472283","t":"Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma","dn":"ALEX","sp":"University Children's Hospital Basel","c":["Paediatric Asthma"],"iv":["Phase I (months 1-3): DHA core functionality","Phase II (months 3-6): platform augmentation","Embedded qualitative study"],"d":["resp"],"f":"","tip":"O","vmin":10,"vmax":19,"content_status":"complete","ro":{"titlu":"Asistentul digital de sănătate „Alex” pentru copiii și adolescenții cu astm bronșic"},"loc":[[269,"UNKNOWN",[[283,"c"]]],[270,"UNKNOWN",[[284,"c"]]],[271,"UNKNOWN",[[285,"c"]]],[199,"UNKNOWN",[[286,"c"]]],[199,"UNKNOWN",[[287,"c"]]]]},{"id":"NCT07475299","t":"Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome","sp":"Iuliu Hatieganu University of Medicine and Pharmacy","c":["Irritable Bowel Syndrome (IBS)"],"iv":["Synbiotic supplement containing probiotic strains, botanical extracts, magnesium, vitamin B1, and L-theanine designed to support gut microbiota balance."],"ivro":["TERRANOVA Microbiome Challenge"],"d":["gastro"],"f":"","tip":"I","vmin":18,"vmax":70,"content_status":"complete","ro":{"titlu":"Supliment simbiotic cu extracte din plante pentru echilibrul florei intestinale în sindromul de intestin iritabil: studiu-pilot"},"loc":[[424,"UNKNOWN",[[540,"c"]]]]},{"id":"NCT07400107","t":"AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight","dn":"AMAZE 8","sp":"Novo Nordisk A/S","c":["Obesity","Overweight","Diabetes Mellitus, Type 2"],"iv":["NNC0487-0111","Semaglutide"],"ivro":["NNC0487-0111","semaglutidă"],"d":["metab"],"f":"3","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"NNC0487-0111 săptămânal față de semaglutidă săptămânal pentru scăderea în greutate la persoanele cu supraponderalitate sau obezitate și diabet de tip 2"},"loc":[[50,"UNKNOWN",[]],[298,"UNKNOWN",[]],[204,"UNKNOWN",[]],[224,"UNKNOWN",[]],[242,"UNKNOWN",[]],[85,"UNKNOWN",[]],[101,"UNKNOWN",[]],[247,"UNKNOWN",[]]]},{"id":"NCT07391098","t":"Peripheral Perfusion and Outcomes in ICU Patients With Sepsis","dn":"PERFUSE-ICU","sp":"Alexandra Elena Lazăr","c":["SEPSIS","Septic Patients"],"iv":["PERIPHERAL PERFUSION EVALUATION"],"d":["inf"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Perfuzia periferică și evoluția pacienților cu sepsis internați în terapie intensivă (studiu observațional PERFUSE-ICU)"},"loc":[[510,"UNKNOWN",[[661,"c"]]]],"ofi":[[661,"pi"]]},{"id":"NCT07379749","t":"Impact of Positive Bile Cultures on Plastic Biliary Stent Exchange","dn":"TEMPEST 2","sp":"Clinical Hospital Colentina","c":["Acute Cholangitis"],"iv":["stent exchange","Scheduled biliary stent exchange at one month"],"d":["alte"],"f":"","tip":"I","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Schimbarea stentului biliar de plastic la 1 lună față de 3 luni la pacienții cu cultură biliară pozitivă (TEMPEST 2)"},"loc":[[29,"UNKNOWN",[]]]},{"id":"NCT07357363","t":"REThink for Mental Health of Youths in Romania","dn":"REThink","sp":"Babes-Bolyai University","c":["Bullying Victimisation","Bullying of Child","Bullying Behavior"],"iv":["REThink Intervention"],"d":["alte"],"f":"","tip":"I","vmin":10,"vmax":24,"vs":1,"content_status":"complete","ro":{"titlu":"REThink: joc terapeutic online pentru sănătatea mintală a elevilor și studenților din România și pentru reducerea bullyingului"},"loc":[[78,"UNKNOWN",[]]]},{"id":"NCT07307001","t":"Vojta Therapy Versus Conservative Therapy for Patients With Stroke","sp":"Lucaci Doru Nicolae","c":["Stroke, Ischemic"],"iv":["Vojta therapy","Conservative therapy"],"d":["cardio","neuro"],"f":"","tip":"I","vmin":45,"vmax":65,"content_status":"complete","ro":{"titlu":"Terapia Vojta față de terapia de recuperare convențională pentru recâștigarea independenței după accidentul vascular cerebral ischemic"},"loc":[[345,"UNKNOWN",[[405,"c"],[406,"pi"]]]]},{"id":"NCT07304830","t":"The Effects of the PsyPills App on Emotion Regulation and Risk Behaviors in Emerging Adults: A Randomized Clinical Trial","sp":"Babes-Bolyai University","c":["Emotion Regulation Difficulties; Risky Behaviors (Substance Use, Risky Sexual Behavior, Self-harm, Aggression, Disordered Eating)"],"iv":["PsyPills","MoodWheel"],"d":["psih"],"f":"","tip":"I","vmin":18,"vmax":29,"vs":1,"content_status":"complete","ro":{"titlu":"Aplicația PsyPills pentru reglarea emoțiilor și comportamentele de risc la tinerii adulți"},"loc":[[78,"UNKNOWN",[]]]},{"id":"NCT07258238","t":"Romanian Validation and Cross-cultural Adaptation of the QoR-15Ro","sp":"SUUMC Central Military Hospital Dr Carol Davila","c":["Humans","Anesthesia","Recovery","Postoperative Care","Postoperative Period"],"iv":[],"d":["alte"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Validarea versiunii în limba română a chestionarului QoR-15 privind calitatea recuperării după anestezie (QoR-15Ro)"},"loc":[[366,"UNKNOWN",[[425,"c"]]]]},{"id":"NCT07148219","t":"EMBRACE YOUR POWER","dn":"EMBRACE YOUR POWER","sp":"University of Bucharest","c":["Bullying","Distress","Bullying Victimisation"],"iv":["Embrace Your Power: A VR Journey to Overcome Negative Emotions"],"d":["alte"],"f":"","tip":"I","vmin":10,"vmax":14,"vs":1,"content_status":"complete","ro":{"titlu":"Program de realitate virtuală împotriva bullyingului pentru elevii de clasele a V-a și a VI-a (Embrace Your Power)"},"loc":[[284,"UNKNOWN",[]]]},{"id":"NCT06931847","t":"SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New","dn":"SUNRISE 2","sp":"Biobizkaia Health Research Institute","c":["Cancer"],"iv":["SUNRISE program"],"d":["alte"],"f":"","tip":"O","vmin":10,"vmax":19,"vs":1,"content_status":"complete","ro":{"titlu":"Program digital în școli pentru obiceiuri sănătoase și prevenirea cancerului la adolescenți (SUNRISE, studiul 2)"},"loc":[[8,"UNKNOWN",[[278,"pi"],[279,"si"]]]]},{"id":"NCT06903663","t":"The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting","dn":"MANIFEST-HCC","sp":"Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor","c":["Hepatocellular Carcinoma (HCC)"],"iv":[],"ivro":["atezolizumab","bevacizumab"],"d":["onco"],"tu":["hcc"],"f":"","tip":"O","vmin":18,"vmax":null,"content_status":"complete","ro":{"titlu":"Pacienții cu carcinom hepatocelular tratați cu atezolizumab și bevacizumab în practica din România — studiu retrospectiv"},"loc":[[30,"UNKNOWN",[[745,"c"]]],[155,"UNKNOWN",[[746,"c"]]],[25,"UNKNOWN",[]],[64,"UNKNOWN",[[4,"c"]]]],"ofi":[[746,"pi"]]},{"id":"NCT06922201","t":"The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program","dn":"SUNRISE 1","sp":"Biobizkaia Health Research Institute","c":["Cancer"],"iv":["SmartCoach"],"d":["alte"],"f":"","tip":"I","vmin":14,"vmax":18,"vs":1,"content_status":"complete","ro":{"titlu":"SUNRISE / SmartCoach: program pe telefonul mobil pentru prevenirea fumatului și a consumului de alcool la adolescenți"},"loc":[[8,"UNKNOWN",[[278,"pi"],[279,"si"]]]]},{"id":"NCT06885775","t":"Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds","sp":"DEXLEVO","c":["Dermal Fillers","Nasolabial Folds, Wrinkles"],"iv":["DXP01","Juvederm ULTRA 3"],"ivro":["DXP01","Juvéderm ULTRA 3"],"d":["alte"],"f":"2","tip":"I","vmin":19,"vmax":70,"vs":1,"content_status":"complete","ro":{"titlu":"Materialul de umplere DXP01 (policaprolactonă) față de Juvéderm ULTRA 3 pentru corectarea temporară a șanțurilor nazolabiale moderate până la severe"},"loc":[[365,"UNKNOWN",[]]]},{"id":"NCT06883773","t":"Digital Rewards and Retention in a M-health App","dn":"DIGITALRCT","sp":"University of Bucharest","c":["Transdiagnostic Psychopathology","Attrition","Engagement","Depression, Anxiety","Stress"],"iv":["Multipurpose Online Tool","No intervention"],"d":["psih","inf"],"f":"","tip":"I","vmin":18,"vmax":60,"vs":1,"content_status":"complete","ro":{"titlu":"Recompense digitale (criptomonedă sau tombolă cu vouchere) și participarea la o intervenție online pentru sănătatea mintală"},"loc":[[284,"UNKNOWN",[[299,"c"]]]]},{"id":"NCT06833749","t":"Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis","sp":"KeyBioscience AG","c":["Osteoarthritis in the Knee","Obesity"],"iv":["KBP-336"],"ivro":["KBP-336"],"d":["metab","reum"],"f":"2","tip":"I","vmin":45,"vmax":null,"content_status":"complete","ro":{"titlu":"KBP-336 adăugat la dietă și exerciții fizice, comparat cu placebo, la persoane cu obezitate și artroză de genunchi"},"loc":[[43,"UNKNOWN",[[40,"pi"]]],[522,"UNKNOWN",[]],[40,"UNKNOWN",[[38,"pi"]]]]},{"id":"NCT06646159","t":"REThink for Mental Health of the Youths in Romania","dn":"REThink","sp":"Babes-Bolyai University","c":["Bullying of Child","Bullying Victimisation","Bullying"],"iv":["REThink Intervention"],"d":["alte"],"f":"","tip":"I","vmin":10,"vmax":24,"vs":1,"content_status":"complete","ro":{"titlu":"Jocul REThink pentru prevenirea bullyingului și pentru sănătatea mintală a tinerilor din România"},"loc":[[78,"UNKNOWN",[[288,"c"]]]]}],"centre":{"0":{"n":"Suumc","o":"București"},"1":{"n":"Sanador Hospital","o":"București"},"2":{"n":"Clinica Polisano","o":"Sibiu"},"3":{"n":"Centru nenumit de sponsor","o":"Cluj-Napoca","g":1},"4":{"n":"Centru nenumit de sponsor","o":"Craiova","g":1},"5":{"n":"Centru nenumit de sponsor","o":"București","g":1},"6":{"n":"Centru nenumit de sponsor","o":"Timișoara","g":1},"7":{"n":"Spitalul Clinic Filantropia","o":"București"},"8":{"n":"Institutul Oncologic „Prof. Dr. Ion Chiricuță”","o":"Cluj-Napoca"},"9":{"n":"Centrul de Oncologie OncoMed","o":"Timișoara"},"10":{"n":"Centrul de Oncologie „Sf. Nectarie”","o":"Craiova"},"11":{"n":"Oncolab","o":"Craiova"},"12":{"n":"Centrul Medical Neomed","o":"Brașov"},"13":{"n":"Delta Health Care","o":"București"},"14":{"n":"Spitalul Clinic Județean de Urgență","o":"Craiova"},"15":{"n":"Medaudio-Optica","o":"Râmnicu Vâlcea"},"16":{"n":"Arensia Exploratory Medicine","o":"București"},"17":{"n":"Arensia Exploratory Medicine","o":"Cluj-Napoca"},"18":{"n":"Centru nenumit de sponsor","o":"Târgu Mureș","g":1},"19":{"n":"Spitalul Clinic de Psihiatrie „Prof. Dr. Alexandru Obregia”","o":"București"},"20":{"n":"Institutul de Psihiatrie „Socola” Iași","o":"Iași"},"21":{"n":"Spitalul Clinic Județean Mureș","o":"Târgu Mureș"},"22":{"n":"Centru nenumit de sponsor","o":"Brașov","g":1},"23":{"n":"Centru nenumit de sponsor","o":"Constanța","g":1},"24":{"n":"Centru nenumit de sponsor","o":"Iași","g":1},"25":{"n":"Institutul Regional de Oncologie Iași","o":"Iași"},"26":{"n":"Ovidius Clinical Hospital","o":"Ovidiu"},"27":{"n":"Spitalul Clinic Colțea","o":"București"},"28":{"n":"Spitalul Clinic Municipal de Urgență Timișoara","o":"Timișoara"},"29":{"n":"Spitalul Clinic Colentina","o":"București"},"30":{"n":"Institutul Clinic Fundeni","o":"București"},"31":{"n":"Spitalul Universitar de Urgență București","o":"București"},"32":{"n":"Onco Card","o":"Brașov"},"33":{"n":"Sacele Municipal Hospital","o":"Săcele"},"34":{"n":"Dr. Tîrziu Dermato-Chirurgie","o":"Timișoara"},"35":{"n":"Centrul Medical Euromed","o":"București"},"36":{"n":"Spitalul Universitar de Urgență Militar Central „Dr. Carol Davila”","o":"București"},"37":{"n":"Spitalul Clinic Municipal Filantropia","o":"Craiova"},"38":{"n":"Institutului Regional de Oncologie IASI","o":"Iași"},"39":{"n":"Sl0046 40382","o":"Galați"},"40":{"n":"Quantum Medical Center","o":"București"},"41":{"n":"Hiperdia","o":"București"},"42":{"n":"Centrul Medical Unirea","o":"Iași"},"43":{"n":"CCBR Clinical Research","o":"București"},"44":{"n":"Cardiomed","o":"Cluj-Napoca"},"45":{"n":"Centrul de Radioterapie Amethyst Cluj","o":"Florești"},"46":{"n":"Spitalul Clinic „Prof. Dr. Theodor Burghele”","o":"București"},"47":{"n":"Spitalul Clinic de Urgență „Prof. Dr. Agrippa Ionescu”","o":"București"},"48":{"n":"Spitalul Clinic Municipal Cluj-Napoca","o":"Cluj-Napoca"},"49":{"n":"Spitalul Clinic de Urgență „Prof. Dr. Agrippa Ionescu”","o":"Balotești"},"50":{"n":"Institutul Național de Diabet „N.C. Paulescu”","o":"București"},"51":{"n":"Clinic of Diabetes Cluj","o":"Cluj-Napoca"},"52":{"n":"Centru Medical Dr. Negrisanu","o":"Timișoara"},"53":{"n":"3rd Clinic for Nutrition-Spitalulul Județean de Urgenta","o":"Timișoara"},"54":{"n":"\"Carol Davila\" Military Emergency Hospital","o":"București"},"55":{"n":"Centrul Medical Sana","o":"București"},"56":{"n":"Clinica Diabnutrimed","o":"București"},"57":{"n":"Centrul Medical Medicum SRL, Specialitatea Gastroenterologie","o":"București"},"58":{"n":"Spitalul de Oncologie Monza","o":"București"},"59":{"n":"Spitalul Clinic Județean de Urgență","o":"Cluj-Napoca"},"60":{"n":"Centrul Medical Renasterea Craiova","o":"Craiova"},"61":{"n":"Emergency Clinical Hospital Bucharest","o":"București"},"62":{"n":"Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu”","o":"București"},"63":{"n":"Centrul de Oncologie Euroclinic","o":"Iași"},"64":{"n":"Centrul de Oncologie OncoHelp","o":"Timișoara"},"65":{"n":"Victoria Hospital","o":"Iași"},"66":{"n":"Institutul Inimii „Niculae Stăncioiu”","o":"Cluj-Napoca"},"67":{"n":"Spitalul Clinic „Sf. Maria”","o":"București"},"68":{"n":"University Ovidius of Constanta","o":"Constanța"},"69":{"n":"Spitalul Clinic Județean de Urgență","o":"Sibiu"},"70":{"n":"George Emil Palade University of Medicine","o":"Târgu Mureș"},"71":{"n":"Memorial Healthcare International","o":"București"},"72":{"n":"Centru nenumit de sponsor","o":"Otopeni","g":1},"73":{"n":"OncoPremium Team","o":"Baia Mare"},"74":{"n":"Onco Clinic Consult","o":"Craiova"},"75":{"n":"Victoria Hospital - Oncology","o":"Iași"},"76":{"n":"Medisprof Cancer Center","o":"Cluj-Napoca"},"77":{"n":"UMF","o":"Cluj-Napoca"},"78":{"n":"Babeș-Bolyai University","o":"Cluj-Napoca"},"79":{"n":"RoNeuro Institute for Neurological Research and Diagnostics","o":"Cluj-Napoca"},"80":{"n":"Gastromond","o":"Constanța"},"81":{"n":"Spitalul Clinic Județean de Urgențe \"Sfântul Spiridon\"","o":"Iași"},"82":{"n":"Policlinica Algomed","o":"Timișoara"},"83":{"n":"Centru nenumit de sponsor","o":"Balotești","g":1},"84":{"n":"Centru nenumit de sponsor","o":"Brăila","g":1},"85":{"n":"Centru nenumit de sponsor","o":"Oradea","g":1},"86":{"n":"Centru nenumit de sponsor","o":"Pitești","g":1},"87":{"n":"Centru nenumit de sponsor","o":"Satu Mare","g":1},"88":{"n":"Cabinet Medical Dr. Cristian Podoleanu","o":"Târgu Mureș"},"89":{"n":"Ecocard","o":"București"},"90":{"n":"Emergency Institute For Cardiovascular Diseases And Transplant","o":"Târgu Mureș"},"91":{"n":"Clinica New Aid","o":"Pitești"},"92":{"n":"Spitalul Clinic Județean de Urgență","o":"Târgu Mureș"},"93":{"n":"Spitalul Clinic De Urgenta Bucuresti","o":"București"},"94":{"n":"Cabinet Medical Dr Tudoran","o":"Timișoara"},"95":{"n":"Sal Med","o":"Pitești"},"96":{"n":"Spitalul Județean de Urgență","o":"Brăila"},"97":{"n":"Institutul de Boli Cardiovasculare Timișoara","o":"Timișoara"},"98":{"n":"Spitalul Clinic de Urgență „Bagdasar-Arseni”","o":"București"},"99":{"n":"Lotus Med","o":"București"},"100":{"n":"Cardio Med","o":"Craiova"},"101":{"n":"Spitalul Județean de Urgență","o":"Satu Mare"},"102":{"n":"Cardio Med","o":"Targu"},"103":{"n":"Thera Card","o":"Brașov"},"104":{"n":"Medicali's","o":"Timișoara"},"105":{"n":"Spitalul Clinic Județean de Urgență Bihor","o":"Oradea"},"106":{"n":"Centrul de Dializa Fresenius NephroCare Brasov","o":"Brașov"},"107":{"n":"Spitalul Clinic de Urgență „Sf. Ioan”","o":"București"},"108":{"n":"Centrul De Nefrologie si Dializa DIAVERUM SPLAI","o":"București"},"109":{"n":"Centrul de Dializa Fresenius NephroCare Bucaresti","o":"București"},"110":{"n":"Centrul de Nefrologie si Dializa DIAVERUM Sema Parc","o":"București"},"111":{"n":"Centrul de Dializa Fresenius NephroCare Cluj","o":"Cluj-Napoca"},"112":{"n":"Centrul de Dializa Fresenius NephroCare Constanta","o":"Constanța"},"113":{"n":"Spitalul Clinic Județean de Urgență „Sf. Apostol Andrei”","o":"Constanța"},"114":{"n":"Centrul de Nefrologie si Dializa Diaverum Craiova","o":"Craiova"},"115":{"n":"Spitalul Județean de Urgență","o":"Deva"},"116":{"n":"Institutul Național de Endocrinologie „C.I. Parhon”","o":"Iași"},"117":{"n":"Spitalul Clinic Municipal Dr. Gavril Curteanu Oradea","o":"Oradea"},"118":{"n":"Centrul de Dializa Fresenius NephroCare Ploiesti","o":"Ploiești"},"119":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Targu Mures","o":"Târgu Mureș"},"120":{"n":"Spitalul Clinic Judetean De Urgenta Sfantul Apostol Andrei Constanta","o":"Constanța"},"121":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Brasov","o":"Brașov"},"122":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Craiova","o":"Craiova"},"123":{"n":"Nefromed Dialysis Centers","o":"Cluj-Napoca"},"124":{"n":"Fresenius Nephrocare Romania","o":"Ploiești"},"125":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Oradea","o":"Oradea"},"126":{"n":"Fresenius Nephrocare Romania","o":"București"},"127":{"n":"Fresenius Nephrocare Romania","o":"Constanța"},"128":{"n":"Fresenius Nephrocare Romania","o":"Brașov"},"129":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Splai","o":"București"},"130":{"n":"Centrul de Dializa Avitum","o":"Târgu Jiu"},"131":{"n":"Centrul Medical de Nefrologie si Dializa Diaverum Sema Parc","o":"București"},"132":{"n":"Clinica Gastro Med","o":"Cluj-Napoca"},"133":{"n":"Monza Ares","o":"București"},"134":{"n":"Dermastyle","o":"București"},"135":{"n":"OncoCenter Oncologie Clinică","o":"Timișoara"},"136":{"n":"Spitalul Clinic de Urgență pentru Copii Cluj-Napoca","o":"Cluj-Napoca"},"137":{"n":"Centru nenumit de sponsor","o":"Florești","g":1},"138":{"n":"Institutul de Urgență pentru Boli Cardiovasculare „Prof. Dr. C.C. Iliescu”","o":"București"},"139":{"n":"Sigmedical Services","o":"Suceava"},"140":{"n":"Spitalul Clinic Județean de Urgență „Pius Brânzeu”","o":"Timișoara"},"141":{"n":"Spitalul Clinic Județean de Urgență","o":"Brașov"},"142":{"n":"Spitalul Universitar de Urgență Elias","o":"București"},"143":{"n":"Bucharest University Emergency Hospital","o":"București"},"144":{"n":"County Clinical Emergency Hospital of Constanta","o":"Constanța"},"145":{"n":"Timiş County Emergency Clinical Hospital- Neurology","o":"Timișoara"},"146":{"n":"Spitalul Clinic Județean de Urgență","o":"Timișoara"},"147":{"n":"Centru nenumit de sponsor","o":"Sibiu","g":1},"148":{"n":"Radiology Therapeutic Center (RTC)","o":"Otopeni"},"149":{"n":"Centrul Medical Medicover Victoria","o":"București"},"150":{"n":"Gral Medical","o":"Pitești"},"151":{"n":"Spitalul Pelican","o":"Oradea"},"152":{"n":"Oculens Med","o":"Cluj-Napoca"},"153":{"n":"Euroclinic Hospital","o":"București"},"154":{"n":"Spitalul Clinic de Pneumoftiziologie „Leon Daniello”","o":"Cluj-Napoca"},"155":{"n":"Institutul Regional de Gastroenterologie și Hepatologie „Prof. Dr. Octavian Fodor”","o":"Cluj-Napoca"},"156":{"n":"Spitalul Clinic Județean de Urgență","o":"Bistrița"},"157":{"n":"Memormed","o":"București"},"158":{"n":"Explora Group","o":"Suceava"},"159":{"n":"Centrul Medical Tuculanu","o":"Timișoara"},"160":{"n":"National Institute Of Infectious Diseases","o":"București"},"161":{"n":"Spitalul Clinic de Boli Infecțioase și Tropicale „Dr. Victor Babeș”","o":"București"},"162":{"n":"Institutul Național de Boli Infecțioase „Prof. Dr. Matei Balș”","o":"București"},"163":{"n":"Spitalul Clinic de Boli Infecțioase Constanța","o":"Constanța"},"164":{"n":"Centrul Medical Sanador","o":"București"},"165":{"n":"Clinical Emergency Hospital","o":"Constanța"},"166":{"n":"Spitalul Clinic de Urgență „Sf. Pantelimon”","o":"București"},"167":{"n":"Centru nenumit de sponsor","o":"Suceava","g":1},"168":{"n":"CMI Dr. Buhas Ramocea Elena Daniela - Cabinet Medical de Psihiarie","o":"Oradea"},"169":{"n":"Carpe Diem","o":"Sibiu"},"170":{"n":"Centru nenumit de sponsor","o":"Baia Mare","g":1},"171":{"n":"Centru nenumit de sponsor","o":"Ovidiu","g":1},"172":{"n":"Spitalul clinic de urgenta pentru copii Sf. Maria","o":"Iași"},"173":{"n":"Gral Medical","o":"București"},"174":{"n":"Maria Sklodowska Curie Childrens Clinical Emergency Hospital","o":"București"},"175":{"n":"First Obstetrics and Gynecology Clinic, \"G. E. Palade\" University of Medicine, Pharmacy, Science and Technology","o":"Târgu Mureș"},"176":{"n":"Spitalul Clinic „Dr. I. Cantacuzino”","o":"București"},"177":{"n":"Spitalul Clinic Județean de Urgență","o":"Baia Mare"},"178":{"n":"Institutul Național de Endocrinologie „C.I. Parhon”","o":"București"},"179":{"n":"Centru nenumit de sponsor","o":"Bragadiru","g":1},"180":{"n":"Centrul Medical Sana","o":"Brașov"},"181":{"n":"Centru nenumit de sponsor","o":"Călărași","g":1},"182":{"n":"Clintrial Medical Centre","o":"Dobrosloveni"},"183":{"n":"Spitalul de Pneumologie „Dr. Lavinia Davidescu”","o":"Oradea"},"184":{"n":"Spitalul Municipal Ploiești","o":"Ploiești"},"185":{"n":"Focus Lab Plus","o":"București"},"186":{"n":"Centru nenumit de sponsor","o":"Ploiești","g":1},"187":{"n":"Department of Dermatology, Carol Davila University of Medicine and Pharmacy","o":"București"},"188":{"n":"Centrul de Evaluare și Tratament al Toxicodependențelor pentru Tineri „Sf. Stelian”","o":"București"},"189":{"n":"Spitalul de Psihiatrie și Neurologie Brașov","o":"Sânpetru"},"190":{"n":"Spitalul Clinic Județean de Urgență","o":"Arad"},"191":{"n":"Spitalul Județean de Urgență","o":"Baia Mare"},"192":{"n":"Spitalul Judetean de Urgenta MAVROMATI","o":"Botoșani"},"193":{"n":"Spitalul Clinic de Urgenta penru Copii","o":"Brașov"},"194":{"n":"Onco Medint","o":"București"},"195":{"n":"Rou004","o":"Cluj-Napoca"},"196":{"n":"Rou002","o":"Târgu Mureș"},"197":{"n":"Rou001","o":"Timișoara"},"198":{"n":"Rou003","o":"București"},"199":{"n":"Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie „Dr. Victor Babeș” Timișoara","o":"Timișoara"},"200":{"n":"Institutul Privat de Cercetări Melchisedec","o":"Craiova"},"201":{"n":"CMI Dr. Sarpe Marcel-Claudiu","o":"Focșani"},"202":{"n":"Spitalul Clinic de Psihiatrie „Dr. Gheorghe Preda” Sibiu","o":"Sibiu"},"203":{"n":"Spitalul Clinic De Psihiatrie Si Neurologie Brasov","o":"Sânpetru"},"204":{"n":"CMI Dr.Pletea Noemi","o":"Bacău"},"205":{"n":"Cabinet Medical Individual Cardiologie Dr. Mercea Corina Delia","o":"Baia Mare"},"206":{"n":"FutureMeds","o":"Brașov"},"207":{"n":"Geea Medical Easy Diet","o":"București"},"208":{"n":"FutureMeds","o":"București"},"209":{"n":"FutureMeds","o":"Craiova"},"210":{"n":"FutureMeds","o":"Galați"},"211":{"n":"Gama Diamed","o":"Mangalia"},"212":{"n":"Clinica Korall","o":"Satu Mare"},"213":{"n":"Rinart Diab","o":"Târgoviște"},"214":{"n":"Easydiet","o":"București"},"215":{"n":"Spitalul Județean de Urgență","o":"Piatra Neamț"},"216":{"n":"Spitalul Județean de Urgență „Sf. Ioan cel Nou”","o":"Suceava"},"217":{"n":"Spitalului Judetean De Urgenta Piatra Neamt","o":"Piatra Neamț"},"218":{"n":"Fundația „Dr. Victor Babeș”","o":"București"},"219":{"n":"Gastromedica","o":"Iași"},"220":{"n":"George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures","o":"Târgu Mureș"},"221":{"n":"\"Sfanta Vineri\" Medical Center","o":"București"},"222":{"n":"Top Diabet","o":"Craiova"},"223":{"n":"Mariodiab Clinic","o":"Brașov"},"224":{"n":"Centrul Medical Nutrilife","o":"București"},"225":{"n":"Milena Sante","o":"Galați"},"226":{"n":"Timisoara","o":"Timișoara"},"227":{"n":"Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie „Victor Babeș” Craiova","o":"Craiova"},"228":{"n":"Spitalul Clinic Județean de Urgență","o":"Suceava"},"229":{"n":"Cardioplus Center","o":"Baia Mare"},"230":{"n":"cmi Pop Lavinia","o":"Baia Mare"},"231":{"n":"Hightech Medical Services","o":"București"},"232":{"n":"Centrul Medical Consultmed","o":"Iași"},"233":{"n":"Diabdana","o":"Oradea"},"234":{"n":"Centrul Medical Mediab","o":"Târgu Mureș"},"235":{"n":"Spitalul Clinic Militar de Urgență „Dr. Constantin Papilian”","o":"Cluj-Napoca"},"236":{"n":"Policlinica Providența","o":"Iași"},"237":{"n":"Centrul de Medicina de Familie","o":"Iași"},"238":{"n":"Institutul de Urgenta pentru Boli Cardiovasculare","o":"București"},"239":{"n":"CMI DNBM Dr. Pop Lavinia","o":"Baia Mare"},"240":{"n":"Nicodiab","o":"București"},"241":{"n":"CRN Clinical Research Network","o":"București"},"242":{"n":"Diabet Med","o":"București"},"243":{"n":"Cardiomed","o":"Iași"},"244":{"n":"Centrul Medical Nutrilife","o":"Ploiești"},"245":{"n":"Gensan Policlinica Astra","o":"Sibiu"},"246":{"n":"Dentosim Queen SRL - Centrul Medical Diamed","o":"Târgu Mureș"},"247":{"n":"Cabinet Medical Dr.Geru","o":"Timișoara"},"248":{"n":"Centrul Medical Medicalis","o":"Timișoara"},"249":{"n":"Cabinet Medical Individual Diabet, Nutritie, Boli Metabolice Dr. Pop Lavinia","o":"Maramureș"},"250":{"n":"Dentosim-Queen","o":"Târgu Mureș"},"251":{"n":"Centrul Medical Unirea","o":"Brașov"},"252":{"n":"Mat-Cord Biomedica","o":"Buzău"},"253":{"n":"Diamed Obesity","o":"Galați"},"254":{"n":"Spital Clinic Judetean de Urgenta Tg.Mures","o":"Târgu Mureș"},"255":{"n":"Sanamed Hospital","o":"București"},"256":{"n":"Cabinet Medical Dr. Cristian Podoleanu","o":"—"},"257":{"n":"Neurocity","o":"București"},"258":{"n":"Clinic Hospital Targu Mures & S.C. Cardio Med","o":"Târgu Mureș"},"259":{"n":"Centru nenumit de sponsor","o":"Galați","g":1},"260":{"n":"Timisoara Emergency County Clinical Hospital","o":"Timișoara"},"261":{"n":"Centru nenumit de sponsor","o":"Buzău","g":1},"262":{"n":"Cabinet Medical Individual Cardiologie Dr. Pop Călin","o":"Baia Mare"},"263":{"n":"Davius Clinicmed","o":"București"},"264":{"n":"Institutul de Boli Cardiovasculare Prof. Dr. George I.M. Georgescu","o":"Iași"},"265":{"n":"C.M.I. Dr. Busegeanu Mihaela Magdalena","o":"Ploiești"},"266":{"n":"Centrul Național Clinic de Recuperare Neuropsihomotorie Copii „Dr. Nicolae Robănescu”","o":"București"},"267":{"n":"Spitalul Clinic de Urgență pentru Copii „Louis Țurcanu”","o":"Timișoara"},"268":{"n":"Diabmed Dr Popescu Alexandrina","o":"Ploiești"},"269":{"n":"Theramed Healthcare and Transylvania University","o":"Brașov"},"270":{"n":"University Carol Davila and Componenta de Pediatrie - Institutul Național pentru Sănătatea Mamei și Copilului \"Alessandrescu-Rusescu\" București (INSMC)","o":"București"},"271":{"n":"Spitalul Județean de Urgență","o":"Suceava"},"272":{"n":"Centrul Medical Medicum","o":"București"},"273":{"n":"Gastromed","o":"Constanța"},"274":{"n":"Centrul de Gastroenterologie Dr. Goldiș","o":"Timișoara"},"275":{"n":"University of Oradea","o":"Oradea"},"276":{"n":"Centru nenumit de sponsor","o":"Câmpulung","g":1},"277":{"n":"County Clinical emergency hospital of Brasov - Department of Interventional Cardiology","o":"Brașov"},"278":{"n":"Spital Clinic CF Constanta","o":"Constanța"},"279":{"n":"Centru nenumit de sponsor","o":"Bacău","g":1},"280":{"n":"Eco-Diagnosis","o":"București"},"281":{"n":"Cabinet Medical Individual Diabet, Nutritie, Boli Metabolice Dr. Pop Lavinia","o":"Baia Mare"},"282":{"n":"Minimed","o":"Bacău"},"283":{"n":"Spitalul Municipal Schuller","o":"Ploiești"},"284":{"n":"University of Bucharest","o":"București"},"285":{"n":"Centru nenumit de sponsor","o":"Codlea","g":1},"286":{"n":"Centru nenumit de sponsor","o":"Deva","g":1},"287":{"n":"Targu-Mures Emergency Clinical County Hospital - Str. Gh. Marinescu nr.50","o":"Târgu Mureș"},"288":{"n":"Spitalul Clinic de Copii „Dr. Victor Gomoiu”","o":"București"},"289":{"n":"Emergency Institute of Cardiovascular Diseases","o":"București"},"290":{"n":"Spitalul PDR Medlife","o":"Brașov"},"291":{"n":"Policlinica De Diagnostic Rapid","o":"Brașov"},"292":{"n":"Centrul de Excelență în Rinologie","o":"Craiova"},"293":{"n":"MNT Healthcare Europe","o":"București"},"294":{"n":"Spitalul Clinic de Obstetrica-Ginecologie \"Cuza-Voda\" Iasi","o":"Iași"},"295":{"n":"Centrul Medical Sanconfind","o":"Câmpina"},"296":{"n":"Ianuli Med Consult","o":"București"},"297":{"n":"Babeş-Bolyai University, Department of Clinical Psychology and Psychotherapy","o":"Cluj-Napoca"},"298":{"n":"Poli Cardinal Med","o":"Reghin"},"299":{"n":"Cmi Dr. Cojocaru Cristina","o":"Constanța"},"300":{"n":"A&C Medical Prime","o":"Craiova"},"301":{"n":"Anima Specialty Medical Services","o":"București"},"302":{"n":"Institutul Dermato - Estetic","o":"București"},"303":{"n":"Centru nenumit de sponsor","o":"Sângeorgiu de Mureș","g":1},"304":{"n":"Clinica Aide Sante","o":"București"},"305":{"n":"Medical Link","o":"Constanța"},"306":{"n":"Spitalul de Pneumoftiziologie Bacău","o":"Bacău"},"307":{"n":"Angisan Grup","o":"Bragadiru"},"308":{"n":"Pneumo Bronho Med","o":"Brașov"},"309":{"n":"Theramed Healthcare","o":"Brașov"},"310":{"n":"Spitalul Clinic Nr.1 Cai Ferate Witing","o":"București"},"311":{"n":"Medical Center","o":"Deva"},"312":{"n":"M-Profilaxis","o":"Timișoara"},"313":{"n":"Neoclinic Concept","o":"Timișoara"},"314":{"n":"Pneumo Bronho Med","o":"Timișoara"},"315":{"n":"Spitalul Clinic Nr.1 Cf Witting Bucuresti","o":"București"},"316":{"n":"Iuliu Hatieganu University of Medicine and Pharmacy","o":"Cluj-Napoca"},"317":{"n":"Spitalul Clinic Jude?ean de Urgen?? Sfântul Apostol Andrei Galati;oncology","o":"Galați"},"318":{"n":"IBCV Iasi","o":"Iași"},"319":{"n":"Spiatlul Clinic De Urgenta, \"Profesor Doctor Nicolae Oblu\"","o":"Iași"},"320":{"n":"Centru nenumit de sponsor","o":"Suceagu","g":1},"321":{"n":"Spitalul Clinic Județean de Urgență","o":"Constanța"},"322":{"n":"Centru nenumit de sponsor","o":"Focșani","g":1},"323":{"n":"Gyniclinique - Strada Johann Wolfgang von Goethe nr","o":"Timișoara"},"324":{"n":"Institutul de Pneumoftiziologie „Marius Nasta”","o":"București"},"325":{"n":"Centrul Medical Neolife- Baneasa","o":"București"},"326":{"n":"Clinical Hospital of Obstetrics and Gynecology \"Prof. Dr. Panait Sârbu\"","o":"București"},"327":{"n":"Spitalul Clinic Județean de Urgență","o":"Iași"},"328":{"n":"Spitalul Clinic de Recuperare","o":"Iași"},"329":{"n":"Ecomed","o":"Oradea"},"330":{"n":"Spitalul Clinic de Urgență pentru Copii „Grigore Alexandrescu”","o":"București"},"331":{"n":"Institutul National de Gerontologie si Geriatrie \"Ana Aslan\" - Clinica Bucuresti","o":"București"},"332":{"n":"Cabinet Medical Individual Dr Gheorghita Karina Lidia","o":"București"},"333":{"n":"Cluj Napoca Emergency Hospital for Children, Department of Pediatric Psychiatry","o":"Cluj-Napoca"},"334":{"n":"Clinica Animedica","o":"București"},"335":{"n":"Retina Clinic","o":"București"},"336":{"n":"Clinica Bine","o":"București"},"337":{"n":"Vista Vision","o":"București"},"338":{"n":"Centrul Oftalmologic Dr. Munteanu","o":"Timișoara"},"339":{"n":"Spitalul Clinic de Urgenta pentru Copii- Pediatrie II-Nefrologie Pediatrica","o":"Cluj-Napoca"},"340":{"n":"Diana Kamal","o":"Craiova"},"341":{"n":"Carol Davila University of Medicine and Pharmacy Bucharest","o":"București"},"342":{"n":"Spitalul Clinic CF 2 București","o":"București"},"343":{"n":"Centru nenumit de sponsor","o":"Sânpetru","g":1},"344":{"n":"Spitalul Clinic Nr.1 Cai Ferate Witting","o":"București"},"345":{"n":"Auxologico President Recovery Hospital","o":"Cordău"},"346":{"n":"Centrul Medical Endocrinologie si Diabet Dr. Paveliu","o":"București"},"347":{"n":"Bucuresti","o":"București"},"348":{"n":"Craiova","o":"Craiova"},"349":{"n":"Targu Mures","o":"Târgu Mureș"},"350":{"n":"University of Medicine and Pharmacy of Targu Mures","o":"Târgu Mureș"},"351":{"n":"Centrul de Diagnostic si Tratament Oncologic Brasov","o":"Brașov"},"352":{"n":"Spital Judetean Sibiu","o":"Sibiu"},"353":{"n":"University of Medicine and Pharmacy \"Grigore T. Popa\"","o":"Iași"},"354":{"n":"Brainaxy Clinic","o":"Constanța"},"355":{"n":"Medisof Diagnostic","o":"Craiova"},"356":{"n":"Medbanat","o":"Timișoara"},"357":{"n":"Banat Carina Med","o":"Timișoara"},"358":{"n":"Spitalul Clinic De Nefrologie Dr. Carol Davila","o":"București"},"359":{"n":"Aligos Investigational Sites","o":"București"},"360":{"n":"Spitalul Clinic CF Constanța","o":"Constanța"},"361":{"n":"Medlife","o":"Cluj-Napoca"},"362":{"n":"Med Life","o":"Cluj-Napoca"},"363":{"n":"San Medica","o":"Caracal"},"364":{"n":"Tvm Med Serv","o":"Cluj-Napoca"},"365":{"n":"Societatea Civila Medicala Dr. Rosu","o":"—"},"366":{"n":"The Central Military University Emergency Hospital \"Dr. Carol Davila\" in Bucharest","o":"București"},"367":{"n":"Polaris Medical","o":"Suceagu"},"368":{"n":"George Emil Palade University","o":"Târgu Mureș"},"369":{"n":"Gral Medical","o":"Ploiești"},"370":{"n":"Spitalul Clinic Judetean de Urgenta Sibiu - Oncologie","o":"Sibiu"},"371":{"n":"Neolife Medical Center","o":"Bucharest (district 1)"},"372":{"n":"West University of Timișoara","o":"Timișoara"},"373":{"n":"Centrul Clinic De Boli Reumatismale Dr. Ion Stoia","o":"București"},"374":{"n":"Spitalul Memorial Baneasa","o":"București"},"375":{"n":"Ponderas Academic Hospital","o":"București"},"376":{"n":"Neolife Medical Center Bucharest","o":"București"},"377":{"n":"Institutul Oncologic-Day Hospital Unit","o":"Cluj-Napoca"},"378":{"n":"Spitalul Clinic Judetean Sibiu","o":"Sibiu"},"379":{"n":"Baneasa Tumor Center Hospital","o":"București"},"380":{"n":"Spitalul Județean de Urgență „Dr. Constantin Opriș”","o":"Baia Mare"},"381":{"n":"Clinica Medicala Data Plus","o":"București"},"382":{"n":"Spitalul Angiocare","o":"Cluj-Napoca"},"383":{"n":"Angiocare","o":"Cluj-Napoca"},"384":{"n":"Diana Barbonta","o":"Alba Iulia"},"385":{"n":"Societatea Civila Medicala Dr. Paveliu","o":"București"},"386":{"n":"Fundatia Cardioprevent","o":"Timișoara"},"387":{"n":"University of Medicine and Pharmacy Carol Davila","o":"București"},"388":{"n":"University of Medicine and Pharmacy of Craiova","o":"Craiova"},"389":{"n":"Centrul Medical Focus","o":"București"},"390":{"n":"Association of Recovering Alcoholics Don Orione","o":"Iași"},"391":{"n":"Spitalul Judetean de Urgenta Constanta","o":"Constanța"},"392":{"n":"Iasi - St Spiridon Emergency Conty Hospital","o":"Iași"},"393":{"n":"Institutul de Boli Cardio-Vasculare Timisoara","o":"Timișoara"},"394":{"n":"Centrul Medical Sfanta Vineri","o":"București"},"395":{"n":"Sf. Maria Children Emergency Clinical Hospital Iasi","o":"Iași"},"396":{"n":"The Oncology Institute","o":"Cluj-Napoca"},"397":{"n":"Medical Center TOPMED","o":"Târgu Mureș"},"398":{"n":"Fundatia Tanner","o":"București"},"399":{"n":"Genesys Fertility Center","o":"București"},"400":{"n":"Centrul Medical Unirea","o":"Târgu Mureș"},"401":{"n":"Clinica Ortopedie-Traumatologie, Secția","o":"Cluj-Napoca"},"402":{"n":"Centru nenumit de sponsor","o":"Piatra Neamț","g":1},"403":{"n":"Diaverum Romania","o":"București"},"404":{"n":"Diaverum Romania","o":"Craiova"},"405":{"n":"Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi","o":"Iași"},"406":{"n":"Centru nenumit de sponsor","o":"Caracal","g":1},"407":{"n":"Clinica Nutrimed Cercetare Sr","o":"București"},"408":{"n":"Centrul Pentru Studiul Metabolismului","o":"București"},"409":{"n":"Cluj County Clinical Emergency Hospital","o":"Cluj-Napoca"},"410":{"n":"Policlinica SelfMed Clinique","o":"Timișoara"},"411":{"n":"Medart Cliniq","o":"Râmnicu Vâlcea"},"412":{"n":"Spitalul Clinic De Psihiatrie Si Neurologie Brasov","o":"Brașov"},"413":{"n":"Centrul de Diagnostic și Tratament Provita","o":"București"},"414":{"n":"Clubul Sanatatii","o":"Câmpulung"},"415":{"n":"Explora Group","o":"Scheia"},"416":{"n":"Centrul Medical Perseide","o":"Afumați"},"417":{"n":"Spitalul Clinic de Boli Infecțioase Cluj-Napoca","o":"Cluj-Napoca"},"418":{"n":"Spitalul Clinic de Boli Infectioase Sfanta Parascheva Iasi - Infectious diseases I","o":"Iași"},"419":{"n":"Sibiu Emergency County Clinical Hospital","o":"Sibiu"},"420":{"n":"Aqua-Med Consulting","o":"Constanța"},"421":{"n":"County Hospital Timis Othopedy and Trauma Clinic II","o":"Timișoara"},"422":{"n":"Spitalul Clinic Judetean de Urgenta Sibiu Sectia Oncologie Medicala","o":"Sibiu"},"423":{"n":"Regina Maria","o":"Cluj-Napoca"},"424":{"n":"Department of Pharmaceutical Botany, Univeristy of Medicine and Pharmacy \"Iuliu Hațieganu\", 23 Gheorghe Marinescu Street, 3rd Floor, Cluj-Napoca, Romania","o":"Cluj-Napoca"},"425":{"n":"Institutul Național de Neurologie și Boli Neurovasculare","o":"București"},"426":{"n":"Spitalul De Psihiatrie Elisabeta Doamna Galaţi","o":"Galați"},"427":{"n":"Private Practice - Dr. Orasan Remus","o":"Cluj-Napoca"},"428":{"n":"Centru nenumit de sponsor","o":"Râmnicu Vâlcea","g":1},"429":{"n":"Spitalul Clinic de Urgenta Bucuresti-Cardiology","o":"București"},"430":{"n":"Institul Regional de Oncologie lasi;","o":"Iași"},"431":{"n":"Bucharest","o":"București"},"432":{"n":"Spitalul Clinic Județean de Urgență","o":"Alba Iulia"},"433":{"n":"Clinica Somnolog","o":"București"},"434":{"n":"Spitalul Județean de Urgență","o":"Bacău"},"435":{"n":"Diabs&Nutricare","o":"București"},"436":{"n":"Spitalul Clinic de Psihiatrie","o":"București"},"437":{"n":"Bio Terra Med","o":"București"},"438":{"n":"Timisoara Hospital","o":"Timișoara"},"439":{"n":"Saint Luke Hospital for Chronic Disease-Geriatrics and Gerontology II","o":"București"},"440":{"n":"Fundatia Ana Aslan International","o":"București"},"441":{"n":"MedLife Humanitas Hospital","o":"Cluj-Napoca"},"442":{"n":"Medicover Cluj Hospital","o":"Cluj-Napoca"},"443":{"n":"Spitalul de Psihiatrie și Neurologie Brașov","o":"Brașov"},"444":{"n":"Cabinet Medical Dermato-Venerologie","o":"Cluj-Napoca"},"445":{"n":"Centrul Medical Vitaplus","o":"Craiova"},"446":{"n":"Iasiprest","o":"Iași"},"447":{"n":"New Derm Clinic","o":"Timișoara"},"448":{"n":"CABINET MEDICAL DE DERMATO VENEROLOGIE Prof.Dr. ORASAN R. REMUS IOAN","o":"Cluj-Napoca"},"449":{"n":"Newderm Clinic","o":"Timișoara"},"450":{"n":"Saint Andrew Hospital","o":"Constanța"},"451":{"n":"Kilostop Junior","o":"București"},"452":{"n":"Spitalul Clinic de Urgenta pentru Copii \"M.S.Curie\"","o":"București"},"453":{"n":"Craiova Emergency Clinical County","o":"Craiova"},"454":{"n":"Institutul Național de Gerontologie și Geriatrie \"Ana Aslan\"","o":"București"},"455":{"n":"Centrul de Sanatate Mintala","o":"București"},"456":{"n":"Spitalul Clinic Judetean de Urgenta Sibiu (SCJS) (Clinical County Hospital Sibiu)","o":"Sibiu"},"457":{"n":"Cabinet Dermatologie Lauderma","o":"Iași"},"458":{"n":"Fundatia Medicala Providenta","o":"Iași"},"459":{"n":"Derma Luxury Style","o":"Reghin"},"460":{"n":"County Clinical Emergency Hospital Targu Mures","o":"Târgu Mureș"},"461":{"n":"Institutul de Urgenta pentru Boli Cardiovasculare si Transplant Targu Mures","o":"Târgu Mureș"},"462":{"n":"Institute of Cardiovascular Diseases Timisoara","o":"Timișoara"},"463":{"n":"Emergency County Clinical Hospital Ploiesti","o":"Ploiești"},"464":{"n":"Universitatea Alexandru Ioa Cuza din Iasi","o":"Iași"},"465":{"n":"Centru nenumit de sponsor","o":"Afumați","g":1},"466":{"n":"Centru nenumit de sponsor","o":"Arad","g":1},"467":{"n":"Fizio Center","o":"București"},"468":{"n":"Elytis Hospital Hope","o":"Iași"},"469":{"n":"Spitalul Clinic Municipal \"Dr. Gavril Curteanu\" Oradea - Centrul Oncologie Medicala","o":"Oradea"},"470":{"n":"Universitatea Transilvania Brasov School of Medicine","o":"Brașov"},"471":{"n":"Cabinet Medical Dr Triff Carina","o":"Timișoara"},"472":{"n":"Department of Medical Oncology","o":"București"},"473":{"n":"MedEuropa Bucuresti - Centru de Radioterapie-Oncology","o":"București"},"474":{"n":"Medeuropa","o":"București"},"475":{"n":"Centrul Medical Transilvania","o":"Cluj-Napoca"},"476":{"n":"Univ Emergency Hosp Bucharest","o":"București"},"477":{"n":"\"Dr. Carol Davila\" Nephrology Clinical Hospital Bucharest","o":"București"},"478":{"n":"Medsana CM Cotroceni Pulmonology","o":"București"},"479":{"n":"Rimmed Centru Medical Pulmonology","o":"București"},"480":{"n":"Cabinet Medical de Pneumologie Dr. Mincu Bogdan","o":"Cluj-Napoca"},"481":{"n":"Sp.Clinic Pneumo Constanta Pulmon","o":"Palazu Mare"},"482":{"n":"Clintrial Medical Center","o":"Dobrosloveni"},"483":{"n":"Clintrial Medical Center","o":"Resca"},"484":{"n":"Rimmed Centru Medical","o":"București"},"485":{"n":"Spitalul Clinic De Pneumoftiziologie Constanta","o":"Palazu Mare"},"486":{"n":"Medsana Bucharest Medical Center","o":"București"},"487":{"n":"Centru nenumit de sponsor","o":"Târgoviște","g":1},"488":{"n":"Centrul Medical Valahia","o":"Ploiești"},"489":{"n":"Spitalul Clinic CF Cluj Napoca","o":"Cluj-Napoca"},"490":{"n":"Institutul Gastroenterologie-Hepatologie Cluj-Napoca","o":"Cluj-Napoca"},"491":{"n":"Gastroenterologie Spitalul Judetean Constanta","o":"Constanța"},"492":{"n":"Cardiomed","o":"Târgu Mureș"},"493":{"n":"Arcadia Spitale Si Centre Medicale","o":"Iași"},"494":{"n":"Neurotim Med","o":"Timișoara"},"495":{"n":"Ep0224 40769","o":"București"},"496":{"n":"Ep0224 40770","o":"Timișoara"},"497":{"n":"Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi","o":"Iași"},"498":{"n":"Spitalul Euroclinic","o":"București"},"499":{"n":"Clinica Medicum","o":"București"},"500":{"n":"U 2 Serv Com","o":"Suceava"},"501":{"n":"Spitalul Sf. Constantin","o":"Brașov"},"502":{"n":"Euroclinic Hospital Bucharest","o":"București"},"503":{"n":"Dr.Carol Davila Emergency University Central Military Hospital","o":"București"},"504":{"n":"Centrul Medical Grandmed","o":"Oradea"},"505":{"n":"Targu Mures County Emergency Clinical Hospital, Internal Medicine Department I, Hematology Unit","o":"Târgu Mureș"},"506":{"n":"Spitalul Clinic Judetean de Urgenta Targu Mures - Sectia Clinica Neurologie I","o":"Târgu Mureș"},"507":{"n":"Aria Clinic","o":"Sibiu"},"508":{"n":"Clinica Neolife Băneasa București","o":"București"},"509":{"n":"Diaverum Romania","o":"Oradea"},"510":{"n":"Emergebcy Clinical County Hospital - Intensive Care Clinic","o":"Târgu Mureș"},"511":{"n":"Institute of Gastroenterology and Hepatology","o":"Iași"},"512":{"n":"Netconsult","o":"Iași"},"513":{"n":"Cluj Napoca Infectious Disease Clinical Hospital","o":"Cluj-Napoca"},"514":{"n":"Medeuropa","o":"Oradea"},"515":{"n":"Regina Maria Brasov Hospital","o":"Brașov"},"516":{"n":"Nicolae Malaxa Clinical Hospital","o":"București"},"517":{"n":"AMCA Medical Clinic","o":"București"},"518":{"n":"809 Spitalul Clinic Judetean de Urgenta Constanta Oncology Dept","o":"Constanța"},"519":{"n":"Institul Oncologic Cluj-Napoca","o":"Cluj-Napoca"},"520":{"n":"Med Fam Apolo","o":"Călărași"},"521":{"n":"Transilvania University","o":"Brașov"},"522":{"n":"Quantum Medical Bucharest","o":"București"},"523":{"n":"Institute of Cardiovascular Diseases \"Prof. George I.M. Georgescu\" Iasi","o":"Iași"},"524":{"n":"Institute for Cardiovascular Diseases Timisoara","o":"Timișoara"},"525":{"n":"Clinical Rehabilitation Hospital","o":"Cluj-Napoca"},"526":{"n":"Spital Municipal Odorheiu Secuiesc","o":"Odorheiu Secuiesc"},"527":{"n":"City Hospital Onesti","o":"Onești"},"528":{"n":"Spitalul Municipal Onesti Sf. Ierarh Luca","o":"Onești"},"529":{"n":"Ambulatoriul de Stomatologie al SCJU Cluj-Napoca, România","o":"Cluj-Napoca"},"530":{"n":"Centrul medical DiabNutriMed","o":"București"},"531":{"n":"Mihaila G. Georgiana - Cabinet Medical Individual Dermatovenerologie","o":"Bârlad"},"532":{"n":"Qualimed","o":"Brașov"},"533":{"n":"Alin Nicolescu Medic Primar Dermato Venerologie","o":"București"},"534":{"n":"OptiDerm Estet","o":"București"},"535":{"n":"Innovative Derm","o":"Constanța"},"536":{"n":"MC Medica","o":"Craiova"},"537":{"n":"Policlinica Dr.Corbeanu","o":"Craiova"},"538":{"n":"Policlinica Top Med Buna Vestire","o":"Craiova"},"539":{"n":"Derma Lux","o":"Iași"},"540":{"n":"Derma Lux","o":"Reghin"},"541":{"n":"Evaderm Health","o":"Slatina"},"542":{"n":"Clinica Cabimed","o":"Târgu Mureș"},"543":{"n":"Spitalul Nicolae Malaxa","o":"București"},"544":{"n":"Clinical Hospital of Emergency Sibiu Ambulatory if Endocrinology","o":"Sibiu"},"545":{"n":"Centru nenumit de sponsor","o":"Giroc","g":1},"546":{"n":"Centrul de Kinetoterapie si Masaj Banat","o":"Timișoara"},"547":{"n":"Spitalul Clinic De Boli Infectioase Sf. Parascheva Iasi","o":"Iași"},"548":{"n":"Institute of Oncology Prof. Dr Ion Chirircuta","o":"Cluj-Napoca"},"549":{"n":"Spital Digenio - Centrul de Excelen?? în Afec?iuni Digestive","o":"Cluj-Napoca"},"550":{"n":"Centru nenumit de sponsor","o":"Bistrița","g":1},"551":{"n":"Spitalul Clinic de Urgenta pentru Copii Marie Sklodowska Curie","o":"București"},"552":{"n":"Cluj Napoca Clinical County Hospital","o":"Cluj-Napoca"},"553":{"n":"Artiva Investigational Site Bucuresti","o":"București"},"554":{"n":"Artiva Investigational Site Bucharest","o":"București"},"555":{"n":"Spitalul Clinic Judetean De Urgenta Brasov- Sectia Cardiologie","o":"Brașov"},"556":{"n":"Spitalul Clinic Judetean De Urgenta Craiova- Sectia de Cardiologie","o":"Craiova"},"557":{"n":"Spitalul Universitar de Urgență București","o":"Târgu Mureș"},"558":{"n":"Babes-Bolyai University, Faculty of Psychology and Educational Sciences, Department of Clinical Psychology and Psychotherapy","o":"Cluj-Napoca"},"559":{"n":"Digenio - Centrul Medical de Gastroenterologie, Hepatologie si Endoscopie Digestiva","o":"Cluj-Napoca"},"560":{"n":"Centrul de Oncologie Sfantu Necta","o":"Craiova"},"561":{"n":"Spitalul Clinic Județean de Urgență","o":"Satu Mare"},"562":{"n":"Cardiomed","o":"Craiova"},"563":{"n":"University Hospital of Bucharest","o":"București"},"564":{"n":"County Clinical Hospital Tirgu Mures","o":"Târgu Mureș"},"565":{"n":"Clinical County Hospital Timisoara","o":"Timișoara"},"566":{"n":"Spitalul de Urgență „Prof. Dr. Dimitrie Gerota”","o":"București"},"567":{"n":"Spitalul Clinic Județean de Urgență Ilfov","o":"București"},"568":{"n":"Gnosis Evomed","o":"București"},"569":{"n":"Materna Care","o":"Timișoara"},"570":{"n":"Infectious and Tropical Diseases Hospital Dr. Victor Babes","o":"Bucarest"},"571":{"n":"Sj de Urgenta Bacau","o":"Bacău"},"572":{"n":"Global Medical Ultra","o":"București"},"573":{"n":"Spitalul Judetean de Urgenta Alba Iulia","o":"Alba Iulia"},"574":{"n":"Centru nenumit de sponsor","o":"Leamna de Sus","g":1},"575":{"n":"Centru nenumit de sponsor","o":"Negrești-Oaș","g":1},"576":{"n":"Sb Clinique Diagnostic","o":"Timișoara"},"577":{"n":"Clinica Pajura","o":"București"},"578":{"n":"Spitalul De Pneumoftiziologie Leamna","o":"Regiunea Oltenia"},"579":{"n":"Ruscovan I. Alina - Cabinet Individual DE Pneumologie","o":"Negrești-Oaș"},"580":{"n":"Romanian sites are managed by the European Clinical Research Alliance on Infectious Diseases","o":"București"},"581":{"n":"Instiute of Oncology - Medical Oncology","o":"Cluj-Napoca"},"582":{"n":"Spital Municipal Ploiesti","o":"Ploiești"},"583":{"n":"Aresnsia Research Clinic Bucharest","o":"București"},"584":{"n":"Aresnsia Research Clinic Cluj-Napoca","o":"Cluj-Napoca"},"585":{"n":"Spitalul Clinic Judetean de Urgenta Cluj Napoca-Gastroenterology","o":"Cluj-Napoca"},"586":{"n":"Centrul Medical de Diagnostic si Tratament Ambulatoriu si Medicina Preventiva","o":"București"},"587":{"n":"Institutul de Boli Cardiovasculare Iasi","o":"Iași"},"588":{"n":"Cabinet Medical Cardiologie Cojocariu Titel Razvan","o":"Suceava"},"589":{"n":"Clinica Medicaliss","o":"Timișoara"}},"persoane":{"0":{"n":"Sandica Bucurica","nr":"Săndica Bucurică","sp":["Gastroenterologie"],"su":"https://umfcd.ro/wp-content/uploads/2019/CONC_DID_NEDET_SEM_2_2018_2019/CV%26FV/MEDICINA/CV-Bucurica_Sandica-NicoletaSL4.pdf"},"2":{"n":"Dragos Mircea Median"},"4":{"n":"Cristina M Oprean","sp":["Oncologie medicală"],"su":"https://oncohelp.ro/centrul-de-oncologie/oncologie/"},"5":{"n":"Michael Schenker","sp":["Oncologie medicală"],"su":"https://centruldeoncologie.ro/oncologie/","aliases":["Michael Schenker","Michel Schenker"]},"6":{"n":"Dan Stelian Stefan Lungulescu","nr":"Dan Stelian Ștefan Lungulescu","sp":["Oncologie medicală"],"su":"https://oncolab.ro/despre-noi/"},"9":{"n":"Liliana Duca"},"10":{"n":"Bogdan-Horia Chicos"},"11":{"n":"Anca Streinu Cercel","sp":["Boli infecțioase","Medicină de familie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"12":{"n":"Coralia-Alexandra Caluian"},"13":{"n":"Vlad-Andrei Ichim","sp":["Gastroenterologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"14":{"n":"Emanuela Beni"},"15":{"n":"Valentin Petre Matei","sp":["Psihiatrie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"16":{"n":"Cristinel Ștefănescu","sp":["Psihiatrie"],"su":"https://e-psihiatrie.ro/wp-content/uploads/2019/05/Aplicatie-CNP-2020-Iasi.pdf"},"17":{"n":"Adriana Mihai","sp":["Psihiatrie"],"su":"https://ralcom.eventsair.com/v-cnp-2021/adriana-mihai"},"18":{"n":"Simona Trifu","sp":["Psihiatrie"],"su":"https://medwayevents.ro/team-members/conf-univ-dr-simona-trifu/"},"19":{"n":"Catalin Doru Danaila"},"20":{"n":"Laura Mazilu","sp":["Oncologie medicală"],"su":"https://www.univ-ovidius.ro/images/2019/doctorat/dosare_abilitare/Dosar_Mazilu/CV_Laura%20Mazilu.pdf"},"21":{"n":"Gabriela Borsaru","nr":"Gabriela Borșaru","sp":["Hematologie","Medicină internă"],"su":"https://www.vascularte.ro/medici/gabriela-borsaru_35"},"22":{"n":"Ioana Ionita","sp":["Hematologie"],"su":"https://app.srh.org.ro/membri"},"23":{"n":"Georgeta-Daniela Georgescu"},"24":{"n":"Aurelia Tatic","sp":["Hematologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/","ss":["https://icfundeni.ro/echipa-medicala-a-spitalului/","https://www.srh.org.ro/membri-srh"]},"25":{"n":"Ionut-Ciprian Tomuleasa","nr":"Ionuț-Ciprian Tomuleasa","sp":["Hematologie"],"su":"https://iocn.ro/sectia-hematologie/","aliases":["Ionut-Ciprian Tomuleasa","Cirpian Ionut Tomuleasa"]},"26":{"n":"Sorina-Nicoleta Badelita"},"27":{"n":"Horia Bumbea","sp":["Hematologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"28":{"n":"Mihaela Cornelia Lazaroiu","sp":["Hematologie"],"su":"https://app.srh.org.ro/membri"},"31":{"n":"Maria Magdalena Constantin","sp":["Dermatovenerologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"33":{"n":"Luminita Ocroteala","nr":"Luminița Ocroteală","sp":["Hematologie"],"su":"https://app.srh.org.ro/membri"},"34":{"n":"Daniel Coriu","sp":["Hematologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"35":{"n":"Delia Monica Dima","sp":["Hematologie"],"su":"https://iocn.ro/sectia-hematologie/"},"36":{"n":"Ana-Maria Moldovianu","sp":["Hematologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"37":{"n":"Mihnea Tudor Zdrenghea","sp":["Hematologie"],"su":"https://iocn.ro/sectia-hematologie/"},"38":{"n":"Catalina Irina Florea","nr":"Cătălina Irina Florea","sp":["Medicină internă","Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"39":{"n":"Camelia Maricica Nita","sp":["Reumatologie"],"su":"https://www.medicover.ro/medici/camelia-maricica-nita%2C4194%2Cd%2C256"},"40":{"n":"Sorica Mustatea","nr":"Sorica Mustățea","sp":["Reumatologie"],"su":"https://apaa.ro/Docs/program-conferinta-apaa-2024.pdf"},"41":{"n":"Georgeta Camelia Badea","sp":["Medicină internă","Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"42":{"n":"Andrea Craciunescu","nr":"Andrea Crăciunescu","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"43":{"n":"Viorel Jinga","sp":["Urologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"44":{"n":"Ramona Doina Matei","sp":["Oncologie medicală","Hematologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"45":{"n":"Michel Schenker","nr":"Michael Schenker","sp":["Oncologie medicală"],"su":"https://centruldeoncologie.ro/oncologie/","aliases":["Michael Schenker","Michel Schenker"]},"46":{"n":"Cornelia Nițipir","sp":["Oncologie medicală"],"su":"https://spitalulagrippaionescu.ro/personal/cornelia-nitipir/"},"47":{"n":"Mihaela Buiuc","sp":["Anestezie și terapie intensivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"48":{"n":"Andrei Colita","nr":"Andrei Coliță","sp":["Hematologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"49":{"n":"Ioana Codruta Rus"},"51":{"n":"Ovidiu Anchidin","sp":["Cardiologie"],"su":"https://www.institutulinimii.ro/clinica-de-cardiologie/sectia-cardiologie-2"},"52":{"n":"Ionut Anghel","nr":"Ionuț Anghel"},"53":{"n":"Andra-Rodica Balanescu"},"54":{"n":"Simona Rednic"},"56":{"n":"Mihai L Ciocirlan","nr":"Mihai L Ciocîrlan","sp":["Gastroenterologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"57":{"n":"Irina Franciuc","sp":["Neonatologie"],"su":"https://www.univ-ovidius.ro/images/-docs/posturi-universitare/2012-pe-facultati/CV/medicina/FRANCIUC%20IRINA-%20MEDICINA%20-%20LECT.%20POZ.%2052/CV%20Franciuc%20Irina.pdf"},"58":{"n":"Maria Livia Ognean","sp":["Neonatologie"],"su":"https://www.cmsibiu.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT.pdf"},"59":{"n":"Manuela Cucerea","sp":["Pediatrie","Neonatologie"],"su":"https://amaltea.ro/medicina/manuela-cucerea","aliases":["Manuela Cucerea","Manuela Curcerea"]},"61":{"n":"Ingrid Adriana Iordan","sp":["Oncologie medicală"],"su":"https://www.memorial.ro/medici/dr-ingrid-iordan"},"62":{"n":"Andrei Ungureanu","sp":["Oncologie medicală"],"su":"https://amethyst-radiotherapy.ro/en/medical-team/"},"63":{"n":"Calin Ioan Cainap","nr":"Călin Ioan Căinap","sp":["Oncologie medicală"],"su":"https://colmedcj.ro/wp-content/uploads/2023/09/Cainap-Calin-Ioan.pdf"},"64":{"n":"Tudor Eliade Ciuleanu"},"65":{"n":"Anca Colita","nr":"Anca Coliță","sp":["Pediatrie","Oncologie și hematologie pediatrică"],"su":"https://icfundeni.ro/wp-content/uploads/2024/04/CV-PROF.DR_.COLITA-ANCA_-martie-2024.pdf"},"66":{"n":"Adina Dora Stan","sp":["Neurologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"67":{"n":"Roxana Ai Cardos","nr":"Roxana Ai Cardoș"},"68":{"n":"Larisa C.I. Tînc"},"69":{"n":"Andrei Popescu","sp":["Oncologie medicală"],"su":"https://nou.spitalulcolentina.ro/medici/andrei-popescu/"},"70":{"n":"Ileana-Raluca Patru","nr":"Ileana-Raluca Pătru","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"71":{"n":"Fior-Dafin Mureşanu","nr":"Fior-Dafin Mureșanu","sp":["Neurologie"],"su":"https://www.scjucluj.ro/index.php/sectii-si-compartimente/personal-medical"},"72":{"n":"Cristian Gheorghe Calin Podoleanu"},"73":{"n":"Maria Dorobantu","nr":"Maria Dorobanțu","sp":["Medicină internă","Cardiologie"],"su":"https://umfcd.ro/wp-content/uploads/2020/ALEGERI/ALEGERI_2020-2024/SENAT/CV_DOROBANTU_MARIA.pdf"},"74":{"n":"Dan Dobreanu","sp":["Cardiologie","Medicină internă"],"su":"https://www.umfst.ro/fileadmin/doctorate/sustineri_pub/2022/Sus_Ioana/12.2-Sus_CV_prof.dr._Dobreanu_cond.pdf"},"75":{"n":"Gener Ismail","sp":["Nefrologie"],"su":"https://www.sanador.ro/prof-dr-gener-ismail"},"76":{"n":"Elvis Gabriel Botu","sp":["Cardiologie"],"su":"https://e-medicii.ro/echipa-medicala/"},"77":{"n":"Theodora Mariana Nicoleta Benedek"},"78":{"n":"Camelia Diaconu","sp":["Medicină internă","Cardiologie"],"su":"https://www.editurauniversitara.ro/medicina-33/pneumologie-clinica-pentru-studenti-si-medicii-rezidenti-camelia-c-diaconu.html"},"79":{"n":"Daniel-Florin Lighezan","sp":["Cardiologie","Medicină internă"],"su":"https://umfcd.ro/wp-content/uploads/2017/01/CV_Lighezan.pdf"},"80":{"n":"Mariana Tudoran","sp":["Medicină internă","Cardiologie"],"su":"https://www.umft.ro/wp-content/uploads/2022/02/Carte-curs-cardiologie.pdf"},"81":{"n":"Alin Ionut Grosu","nr":"Alin Ionuț Grosu","sp":["Cardiologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"82":{"n":"Gabriela-Elena Stanciulescu","nr":"Gabriela-Elena Stănciulescu","sp":["Cardiologie"],"su":"https://www.cmarges.ro/LISTA%20ELECTORALA%20PERMANENTA%20Arges%20actualizata.pdf"},"83":{"n":"Doina-Luminita Serban","nr":"Doina-Luminița Serban"},"84":{"n":"Andrei Mihnea Rosu","nr":"Andrei Mihnea Roșu","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"85":{"n":"Dan Ion Gaita","nr":"Dan Ion Gaiță","sp":["Cardiologie","Medicină internă"],"su":"https://cardioprevent.org/prof-dr-dan-gaita/"},"86":{"n":"Catalina Liliana Andrei","nr":"Cătălina Liliana Andrei","sp":["Cardiologie"],"su":"https://www.bagdasar-arseni.ro/sectia-clinica-cardiologie","ss":["https://www.bagdasar-arseni.ro/sectia-clinica-cardiologie","https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"],"aliases":["Catalina Liliana Andrei","Catalina L Andrei"]},"87":{"n":"Iulia Teodorescu","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"88":{"n":"Constantin Militaru","sp":["Cardiologie"],"su":"https://www.umfcv.ro/ro/despre-noi/personalul-didactic-al-umf-craiova/constantin-militaru"},"89":{"n":"Dragos Vinereanu","nr":"Dragoș Vinereanu","sp":["Cardiologie"],"su":"https://www.suub.ro/media/28-01-2020-domnul-profesor-dragos-vinereanu-a-fost-ales-presedinte-al-senatului-umf-carol-davila/"},"90":{"n":"Cristian Mornos","nr":"Cristian Mornoș","sp":["Cardiologie"],"su":"https://cdn.umfcluj.ro/uploads/2026/02/CV-Prof.dr_.-Mornos.pdf"},"91":{"n":"Maria-Melinda Kurtinecz","sp":["Cardiologie"],"su":"https://sjusm.ro/sectia-cardiologie/"},"92":{"n":"Imre Benedek","sp":["Cardiologie","Medicină internă"],"su":"https://www.benedekimre.ro/"},"93":{"n":"Cornelia-Ancuta Zara","nr":"Cornelia-Ancuța Zara","sp":["Medicină de urgență","Cardiologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/docs/lista_alegatori_2020_cmbv_site.pdf"},"94":{"n":"Valentina-Gabriela Ciobotaru","sp":["Cardiologie","Medicină internă"],"su":"https://www.umft.ro/wp-content/uploads/2026/03/09_CV_CIOBOTARU_VALENTINA_SL_2026.pdf"},"95":{"n":"Octavian Istratoaie","nr":"Octavian Istrătoaie","sp":["Cardiologie","Medicină internă"],"su":"https://www.umfcv.ro/ro/despre-noi/personalul-didactic-al-umf-craiova/octavian-istratoaie"},"96":{"n":"Ioana Adriana Ardelean","sp":["Cardiologie"],"su":"https://www.reginamaria.ro/medici/dr-ardelean-ioana-adriana"},"97":{"n":"Ionut Nistor","nr":"Ionuț Nistor","sp":["Nefrologie"],"su":"https://emc.formaremedicala.ro/autor/ionut-nistor/"},"98":{"n":"Bogdan Cimpineanu","nr":"Bogdan Cîmpineanu","sp":["Medicină internă","Nefrologie"],"su":"https://doctorat.univ-ovidius.ro/wp-content/uploads/2026/10/4web-.Curriculum-vitae_Bogdan-Cimpineanu.pdf"},"99":{"n":"Raluca-Maria Lie-Ungurean","sp":["Nefrologie"],"su":"https://clinicco.ro/medici/"},"100":{"n":"Cristina-Mariana Vaduva","nr":"Cristina-Mariana Văduva","sp":["Medicină internă","Nefrologie"],"su":"https://www.scjuc.ro/storage/2025/04/EchipaMedicala.pdf"},"101":{"n":"Adriana-Roxana Jurubita","nr":"Adriana-Roxana Jurubiță","sp":["Nefrologie"],"su":"https://icfundeni.ro/department/nefrologie/"},"102":{"n":"Remus Ioan Orasan","nr":"Remus Ioan Orăsan","sp":["Dermatovenerologie"],"su":"https://www.scjucluj.ro/index.php/sectii-si-compartimente/personal-medical"},"103":{"n":"Marcel Palamar","sp":["Nefrologie"],"su":"https://spital-deva.ro/spj/policlinica/"},"104":{"n":"Mirela-Liana Gliga","sp":["Nefrologie"],"su":"https://abbvietransparenta.ro/wp-content/uploads/2016/07/FORMULARUL-DE-DECLARARE-ABBVIE-SRL-Publicat-pe-abbvietransparenta-v2.pdf"},"105":{"n":"Sabina Grigorescu","sp":["Nefrologie"],"su":"https://nephrocare.com/ro-ro/clinic/ploiesti/"},"106":{"n":"Catalin Tacu","nr":"Cătălin Tacu","sp":["Nefrologie"],"su":"https://ralcom.eventsair.com/webinar-srmv-accesul-vascular-pentru-hemodializa/catalin-tacu"},"107":{"n":"Gabriel-Cristian Bako","nr":"Gabriel-Cristian Bakó","sp":["Medicină internă","Nefrologie"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"108":{"n":"Cristian Serafinceanu","sp":["Diabet zaharat, nutriție și boli metabolice","Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"109":{"n":"Andrea-Maria Cucui","sp":["Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"110":{"n":"Ileana Adela Vacaroiu","nr":"Ileana Adela Văcăroiu","sp":["Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"111":{"n":"Emilia Gilice"},"112":{"n":"Adina Vlasceanu","sp":["Nefrologie"],"su":"https://www.medlife.ro/medic-vlasceanu-adina"},"113":{"n":"Monica Nitu","nr":"Monica Nițu","sp":["Medicină internă","Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"114":{"n":"Suzana-Anca Berca","sp":["Nefrologie","Medicină internă"],"su":"https://www.bbraun.ro/ro/centre-de-dializ-avitum-romania.html"},"115":{"n":"Viorica-Adela Chindris","nr":"Viorica-Adela Chindriș","sp":["Nefrologie"],"su":"https://www.cmr.ro/wp-content/uploads/2026/02/2026.02.23_lista-experti-malpraxis.pdf"},"116":{"n":"Emanuela-Marta Gemene","sp":["Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"117":{"n":"Liliana Simona Gheorghe","sp":["Gastroenterologie"],"su":"https://cemt.ro/personal/liliana-simona-gheorghe/"},"118":{"n":"Razvan Gheorghe Diaconescu","nr":"Răzvan Gheorghe Diaconescu","sp":["Gastroenterologie"],"su":"https://oncohelp.ro/echipa-oncohelp/"},"119":{"n":"Eugeniu Ion Craciun","nr":"Eugeniu Ion Crăciun","sp":["Gastroenterologie"],"su":"https://baneasahospital.com/medici/dr-eugen-ion-craciun/"},"120":{"n":"Olga Brusnic","sp":["Gastroenterologie"],"su":"https://www.medlife.ro/centrul-de-boli-inflamatorii-intestinale-targu-mures"},"121":{"n":"Andrada Seicean","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.clinica-gastromed.ro/cv-andrada-seicean/"},"122":{"n":"Theodor Alexandru Voiosu"},"123":{"n":"Georgiana Olaru","sp":["Cardiologie"],"su":"https://www.neuroaxis.ro/doctors/dr-georgiana-olaru/"},"124":{"n":"Lucian M Predescu","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"125":{"n":"Stefan N Lujinschi","nr":"Ștefan N Lujinschi"},"126":{"n":"Anghel Adrian Udrea","sp":["Oncologie medicală"],"su":"https://medisprof.ro/echipa/adrian-a-udrea/"},"127":{"n":"Doina Elena Ganea","sp":["Oncologie medicală"],"su":"https://www.sigmed.ro/echipa"},"128":{"n":"Adina Emilia Croitoru"},"131":{"n":"Simona Macovei"},"132":{"n":"Victor Marian Nimirceag","sp":["Oncologie medicală"],"su":"https://www.medlife.ro/articole-medicale/interviu-dr-victor-nimirceag-medlife-oncologia-moderna-si-relatia-cu-pacientul"},"133":{"n":"Elena Ciubotaru","sp":["Oncologie medicală"],"su":"https://amethyst-radiotherapy.ro/doctor/dr-elena-ciubotaru/"},"134":{"n":"Serban Mircea Negru","nr":"Șerban Mircea Negru","sp":["Oncologie medicală"],"su":"https://oncohelp.ro/centrul-de-oncologie/oncologie/"},"135":{"n":"Cristian-Virgil Lungulescu"},"136":{"n":"Radu Emanuel Berceanu-Ion"},"137":{"n":"Adela-Luiza Chirila","nr":"Adela-Luiza Chirilă","sp":["Oncologie medicală"],"su":"https://www.gralmedical.ro/medici/adela-luiza-chirila","aliases":["Adela-Luiza Chirila","Adela Lucia Chirila"]},"138":{"n":"Aurelia Alexandru","sp":["Oncologie medicală"],"su":"https://iob.ro/echipa-medicala/"},"139":{"n":"Camelia Chioncel","sp":["Gastroenterologie"],"su":"https://www.reginamaria.ro/medici/dr-chioncel-camelia"},"140":{"n":"Nicoleta-Zenovia Antone","sp":["Oncologie medicală"],"su":"https://ctm.iocn.ro/2022/11/26/doctor-cutarescu/"},"141":{"n":"Bogdan Gafton","sp":["Oncologie medicală"],"su":"https://www.iroiasi.ro/userfiles/files/program-ambulatoriu/program-consultatii-ambulatoriul-integrat-2024-2025-v3.pdf"},"142":{"n":"Laurenția Nicoleta Galeș","sp":["Oncologie medicală"],"su":"https://iob.ro/oncologie-medicala-2/"},"143":{"n":"Patricia Visan","nr":"Patricia Vișan","sp":["Oncologie medicală"],"su":"https://oncoclinic.ro/medic/dr-patricia-visan/"},"145":{"n":"Corina-Ionela Radu","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.medlife.ro/medici/medicina-interna/cluj"},"146":{"n":"Ruxandra-Maria Irimia","sp":["Hematologie"],"su":"https://spitalulagrippaionescu.ro/personal/ruxandra-maria-irimia/"},"152":{"n":"Adrian-Eugen Goldis","nr":"Adrian-Eugen Goldiș","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.umft.ro/wp-content/uploads/2022/03/Goldis-Adrian-CV.pdf"},"153":{"n":"Elena Laura Iliescu"},"154":{"n":"Corneliu Petru Popescu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"155":{"n":"Liliana Lucia Preotescu","nr":"Liliana Lucia Preoțescu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"156":{"n":"Irina Magdalena Dumitru","sp":["Boli infecțioase","Epidemiologie"],"su":"https://www.aosr.ro/membrii-sectiei-stiinte-medicale/"},"157":{"n":"Oana Săndulescu","sp":["Boli infecțioase","Epidemiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"158":{"n":"Catalina Mihaela Luca","nr":"Cătălina Mihaela Luca","sp":["Boli infecțioase"],"su":"https://www.reginamaria.ro/medici/prof-univ-dr-luca-catalina"},"159":{"n":"Ioan Macarie","sp":["Medicină internă"],"su":"https://www.umfst.ro/fileadmin/materiale/concurs_posturi/2019-2020/dosare/nedeterminat/medicina-limba-engleza/Macarie%20Ioan/2_CV_europass_macarie_ioan.pdf"},"161":{"n":"Cristina Ligia Cebotaru","sp":["Oncologie medicală"],"su":"https://iocn.ro/sectia-oncologie-medicala/"},"162":{"n":"Teodora Alexa Stratulat","sp":["Oncologie medicală"],"su":"https://www.iroiasi.ro/userfiles/files/program-ambulatoriu/program-consultatii-ambulatoriul-integrat-2024-2025-v3.pdf"},"163":{"n":"Elvira Daniela Sirbu"},"164":{"n":"Roxana Ioana Scheusan","nr":"Roxana Ioana Scheușan","sp":["Oncologie medicală"],"su":"https://www.oncocenter.ro/informatii-utile/program"},"167":{"n":"Mircea Stoian","sp":["Anestezie și terapie intensivă"],"su":"https://sraticongres.ro/2024/index.php/speaker/stoian-mircea/"},"170":{"n":"Cristina Tiut","sp":["Oncologie medicală"],"su":"https://www.oncofort.ro/storage/files/studii-clinice/Dr_Tiut-Cristina-Studii-Clinice-Oncologice.pdf"},"171":{"n":"Robert Stoica","sp":["Urologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"172":{"n":"Beatrice Bunea","sp":["Chirurgie pediatrică"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"173":{"n":"Mihai Capilna","nr":"Mihai Căpîlna","sp":["Obstetrică-ginecologie"],"su":"https://www.umfst.ro/fileadmin/doctorate/abilitare/Capilna_Mihai/CV_Capilna-Mihai.pdf"},"174":{"n":"Sergiu Sargarovschi","nr":"Sergiu Șargarovschi","sp":["Anestezie și terapie intensivă"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"175":{"n":"Ana-Maria Gheorghiu"},"176":{"n":"Corin Virgil Badiu","sp":["Diabet zaharat, nutriție și boli metabolice","Endocrinologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"178":{"n":"Carmen Emanuela Georgescu","sp":["Endocrinologie","Diabet zaharat, nutriție și boli metabolice"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"179":{"n":"Turcu Alina Cristina","sp":["Oncologie medicală"],"su":"https://spitalulmunicipalploiesti.ro/documente/diverse-documente/rcf.pdf"},"180":{"n":"Amedeia-Lavinia Nita","nr":"Amedeia-Lavinia Niță","sp":["Oncologie medicală"],"su":"https://www.gralmedical.ro/medici/nita-amedeia"},"181":{"n":"Sarah Duggan"},"182":{"n":"Monica I Puticiu","sp":["Medicină de urgență","Cardiologie"],"su":"https://www.colmedarad.ro/public/data_files/media/alegeri/2024/202501101158-lista-electorala-permanenta-tur-11-12oct-2024.pdf"},"183":{"n":"Dacian Juca","sp":["Medicină de urgență"],"su":"https://legislatie.just.ro/public/DetaliiDocument/278481"},"184":{"n":"Lavinia D Ciurdas","nr":"Lavinia D Ciurdaș","sp":["Pediatrie"],"su":"https://www.spitaljbm.ro/images/personal-septembrie2025.pdf"},"185":{"n":"Julia Magyar","sp":["Medicină de urgență"],"su":"https://sjub.ro/structura/upu-smurd/"},"186":{"n":"Ramona I Ciornea"},"187":{"n":"Octavian Dumitras","nr":"Octavian Dumitraș","sp":["Medicină de urgență"],"su":"https://brasov-colmed.ro/cmbvweb/2024-candidati/dumitras_octavian.pdf"},"188":{"n":"Daniela M Mitrofan","sp":["Medicină de urgență"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"189":{"n":"Luciana Rotaru","sp":["Medicină de urgență"],"su":"https://www.umfcv.ro/ro/despre-noi/personalul-didactic-al-umf-craiova/luciana-teodora-rotaru"},"190":{"n":"Eugenia M Lupan-Muresan","nr":"Eugenia M Lupan-Mureșan","sp":["Medicină de urgență"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"191":{"n":"Ovidiu Fira-Mladinescu","nr":"Ovidiu Firă-Mlădinescu","sp":["Pneumologie"],"su":"https://www.umft.ro/ro/conf-univ-dr-ovidiu-fira-mladinescu-la-drumul-spre-sanatate/"},"192":{"n":"Dragoş Bumbăcea","nr":"Dragoș Bumbăcea","sp":["Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"193":{"n":"Milena-Adina Man","sp":["Alergologie și imunologie clinică","Pneumologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"194":{"n":"George Stefan Badescu","nr":"George Ștefan Bădescu"},"195":{"n":"Petru-Iulian Ifteni","sp":["Psihiatrie"],"su":"https://medicina.unitbv.ro/images/documente/echipa-conducere/CV%20Ifteni%20Petru.pdf"},"196":{"n":"Adrian Bumbu","sp":["Urologie","Psihiatrie"],"su":"https://evenimente-arpp.ro/speaker/prof-univ-dr-adrian-bumbu-3/"},"197":{"n":"Sebastian I Isac","sp":["Anestezie și terapie intensivă"],"su":"https://icfundeni.ro/department/ati-1/"},"198":{"n":"Gabriela Droc","sp":["Anestezie și terapie intensivă"],"su":"https://icfundeni.ro/department/ati-1/"},"199":{"n":"Bogdan Pavel","sp":["Anestezie și terapie intensivă"],"su":"https://umfcd.ro/wp-content/uploads/2024/CONC_DID_2024_2025/INFORMATII_CANDIDATI/PER_NEDETERMINATA/FACULTATEA_DE_MEDICINA/%5BCV%5DPavel_Bogdan%28C3%29.pdf"},"200":{"n":"Rares Luca","nr":"Rareș Luca"},"202":{"n":"Corina-Delia Mercea","sp":["Cardiologie"],"su":"https://colmedmm.ro/wp-content/uploads/2024/10/Dosar-candidatura-pentru-functia-de-presedinte-Dr.-Mercea-Corina-Delia.pdf"},"204":{"n":"Georgeta Vacaru","nr":"Georgeta Văcaru","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"205":{"n":"Oana-Andreea Parliteanu","nr":"Oana-Andreea Parlițeanu","sp":["Diabet zaharat, nutriție și boli metabolice","Geriatrie și gerontologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"206":{"n":"Ionela Mihaela Vladu","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://umfcd.ro/wp-content/uploads/2025/SCOALA_DOCTORALA/TEZE_DOCTORAT/SPINEAN_I_IULIANA_ALINA/CV%20Prof.%20univ.%20Dr.%20VLADU%20IONELA%20MIHAELA.pdf"},"207":{"n":"Cristina-Victoria Mistodie"},"209":{"n":"Adriana Filimon","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.clinicakorall.ro/"},"210":{"n":"Anca Nicoara","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://sponsorizari.anm.ro/afisare-2016/sponsori?page=927","ss":["https://sponsorizari.anm.ro/afisare-2016/sponsori?page=927","https://sponsorizari-dm.anm.ro/afisare-2024/sponsori?page=38"]},"211":{"n":"Rodica Gurau","nr":"Rodica Gurău","sp":["Neurologie"],"su":"https://www.sjuneamt.ro/wp-content/uploads/2025/03/Medici-AmBulatoriu-Instegrat-Spital-Acreditare-1-1.pdf"},"212":{"n":"Cristian Falup-Pecurariu","sp":["Neurologie"],"su":"https://www.unitbv.ro/documente/cercetare/doctorat-postdoctorat/abilitare/teze-de-abilitare/falup-pecurariu-cristian/05-Falup-Pecurariu-Cristian-Teza_abilitare_RO.pdf"},"213":{"n":"Catalin Hreniuc","nr":"Cătălin Hreniuc","sp":["Neurologie"],"su":"https://www.uvvg.ro/docs/Facultati/cv_profesori/facultate_medicina/CV_MEDICINA/CV_HRENIUC_CATALIN.pdf"},"215":{"n":"Daniela Beatrice Neagu","sp":["Neurologie"],"su":"https://fiziomedsv.ro/doctor/dr-neagu-daniela-beatrice"},"216":{"n":"Cristina Buzatu"},"217":{"n":"Tiu Vlad","sp":["Neurologie"],"su":"https://www.medicover.ro/medici/vlad-tiu%2C2108%2Cd%2C256"},"218":{"n":"Octavian C. Popa"},"219":{"n":"Alina Simona Muntean"},"220":{"n":"Razvan Radu","nr":"Răzvan Radu"},"221":{"n":"Christina Tiu"},"222":{"n":"Raluca Mihaila","nr":"Raluca Mihăilă","sp":["Oncologie medicală"],"su":"https://www.cmr.ro/wp-content/uploads/2026/02/Decizie-CN-nr.-11-din-11.03.2022.pdf"},"223":{"n":"Marieta-Madalina Florescu","nr":"Marieta-Mădălina Florescu","sp":["Gastroenterologie"],"su":"https://umfcd.ro/wp-content/uploads/2024/SCOALA_DOCTORALA/TEZA_DOCTORAT/GREERE_c%C4%83s_FLORESCU_V_MARIETA_M%C4%82D%C4%82LINA/cv%20Florescu.pdf"},"224":{"n":"Radu Bogdan Mateescu","sp":["Gastroenterologie","Medicină internă"],"su":"https://nou.spitalulcolentina.ro/medici/bogdan-radu-mateescu/"},"228":{"n":"Dragos Nicolosu","nr":"Dragoș Nicolosu","sp":["Pneumologie"],"su":"https://sponsorizari.anm.ro/afisare-2025/beneficiari?page=83"},"233":{"n":"Georgeta Crisan"},"234":{"n":"Mihai-Vasile Marinca"},"235":{"n":"Emanuel Moisa","nr":"Emanuel Moisă","sp":["Anestezie și terapie intensivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"238":{"n":"Mariana Vasilica","nr":"Mariana Vasilică","sp":["Hematologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"239":{"n":"Lavinia Pop","sp":["Diabet zaharat, nutriție și boli metabolice","Endocrinologie"],"su":"https://www.spitaljbm.ro/index.php/sm/cabinet-diabet-zaharat-nutritie-si-boli-metabolice"},"240":{"n":"Ileana Silvia Craciunescu","nr":"Ileana Silvia Crăciunescu","sp":["Cardiologie"],"su":"https://spitalulagrippaionescu.ro/personal/dr-ileana-silvia-craciunescu/"},"241":{"n":"Liliana Marin","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://spitalulsfconstantin.ro/868-2/"},"242":{"n":"Nicoleta Mihaela Mindrescu","nr":"Nicoleta Mihaela Mîndrescu","sp":["Diabet zaharat, nutriție și boli metabolice","Endocrinologie"],"su":"https://nicodiab.ro/echipa"},"243":{"n":"Marlena Pascu","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"244":{"n":"Ion-Vlad Vinereanu","sp":["Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"245":{"n":"Daniela Strajer","nr":"Daniela Străjer","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"246":{"n":"Sirona Lupu","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://cardiomediasi.ro/diabet-boli-de-nutritie-si-metabolism/"},"247":{"n":"Dana Cosma","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.spitalpelican.ro/articole-medicale/am-testat-gratuit-glicemia-si-tensiunea"},"248":{"n":"Bogdan Popa"},"249":{"n":"Georgiana Nicolescu","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmsibiu.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT.pdf"},"250":{"n":"Daniela Elena Ciomos","nr":"Daniela Elena Ciomoș","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://medicpuls.ro/dr-ciomos-daniela/"},"251":{"n":"Adriana Cif"},"252":{"n":"Polina Geru","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://sponsorizari.anm.ro/afisare-2025/beneficiari?page=19"},"253":{"n":"Minodora Andor","sp":["Cardiologie","Medicină internă"],"su":"https://www.umft.ro/wp-content/uploads/2024/03/CV-Andor-Minodora_RO-2024.pdf"},"254":{"n":"Codrut Ioan Ciurea","nr":"Codruț Ioan Ciurea","sp":["Medicină internă"],"su":"https://www.brasov-colmed.ro/cmbvweb/docs/alegeri_disciplina_NEvotanti_2011_lit_A_Z.pdf"},"255":{"n":"Ciprian Constantin","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"256":{"n":"Andreea Rachieru","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"257":{"n":"Viviana-Iulia Elian","sp":["Diabet zaharat, nutriție și boli metabolice","Endocrinologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"258":{"n":"Turkes Ablachim","sp":["Cardiologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"259":{"n":"Florin Lucian Matei"},"260":{"n":"Magdalena Morosanu","nr":"Magdalena Moroșanu","sp":["Diabet zaharat, nutriție și boli metabolice","Medicină internă"],"su":"https://diamedobesity.ro/conf-dr-magdalena-morosanu/"},"261":{"n":"Mihaela Popoviciu"},"262":{"n":"Carmen Crisan"},"263":{"n":"Mihai Ovidiu Comsa","nr":"Mihai Ovidiu Comșa","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.sanamed.ro/medici/mihai-comsa/"},"264":{"n":"Vasilia-Cristina Iorgoveanu-Stoian","sp":["Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"265":{"n":"Amelia-Doina Ghicu","sp":["Cardiologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"266":{"n":"Raluca-Irinel Parepa","sp":["Cardiologie","Medicină internă"],"su":"https://umfcd.ro/wp-content/uploads/2024/SCOALA_DOCTORALA/TEZA_DOCTORAT/ADAM_C_ROBERT_DANIEL/CV%20PROF.%20UNIV.%20DR.%20PAREPA%20IRINEL%20RALUCA.pdf"},"267":{"n":"Calin-Florin Pop","nr":"Călin-Florin Pop","sp":["Cardiologie"],"su":"https://www.spitaljbm.ro/index.php/sm/cardiologie"},"269":{"n":"Sanziana Barbulescu","nr":"Sânziana Bărbulescu","sp":["Cardiologie"],"su":"https://www.rmn-diagnostica.ro/echipa-medicala/dr-sanziana-barbulescu/"},"270":{"n":"Alina-Laura Dumitrascu","nr":"Alina-Laura Dumitrașcu","sp":["Cardiologie","Medicină internă","Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"271":{"n":"Cristian Gavril Toma","sp":["Nefrologie","Medicină internă"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"272":{"n":"Elena-Mirela Suciu"},"273":{"n":"Alexandru Scafa-Udriste","nr":"Alexandru Scafa-Udriște","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"274":{"n":"Monica Popescu"},"275":{"n":"Cristian Statescu","nr":"Cristian Stătescu","sp":["Cardiologie"],"su":"https://emeraldmed.ro/medici/prof-dr-cristian-statescu/"},"276":{"n":"Mihaela Magdalena Busegeanu","nr":"Mihaela Magdalena Bușegeanu","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://sponsorizari.anm.ro/afisare-2018/sponsori?page=1874"},"277":{"n":"Elena Emilia Babes","nr":"Elena Emilia Babeș","sp":["Cardiologie"],"su":"https://www.uoradea.ro/wp-content/uploads/2024/documente/display12395.pdf"},"278":{"n":"Delia Nicoara","nr":"Delia Nicoară","sp":["Sănătate publică și management"],"su":"https://wp8.eunetccc.eu/lead-team-eunetccc-work-package-8/dr-delia-nicoara"},"279":{"n":"Nina Nicoara"},"280":{"n":"Iuliana Gherlan","sp":["Endocrinologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"281":{"n":"Madalina Cristina Leanca","nr":"Mădălina Cristina Leanca","sp":["Neurologie pediatrică"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"282":{"n":"Otilia Marginean","nr":"Otilia Mărginean","sp":["Pediatrie","Endocrinologie"],"su":"https://www.umfiasi.ro/ro/academic/programe-de-studii/doctorat/Documents/Finalizare%20studii/2019-2020/Medicina/CIUBOTARIU%20%28GHIGA%29%20GABRIELA/CV%20Prof.Dr.%20Marginean%20Otilia.pdf"},"283":{"n":"Ioana Octavia Agache","sp":["Alergologie și imunologie clinică"],"su":"https://www.cnatdcu.ro/wp-content/uploads/2020/08/04_Agache-Ioana-Octavia.pdf"},"284":{"n":"Mihai Craiu","sp":["Pediatrie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"285":{"n":"Elena Tataranu","nr":"Elena Tătăranu","sp":["Pediatrie"],"su":"https://roamedical.ro/despre-noi"},"286":{"n":"Ioana Ciuca","nr":"Ioana Ciucă","sp":["Pneumologie pediatrică"],"su":"https://pneumopedia.ro/echipa.html"},"287":{"n":"Carmen Bunu","sp":["Alergologie și imunologie clinică"],"su":"https://www.oncogen.ro/specialisti"},"288":{"n":"Cristina Tomoiaga"},"289":{"n":"Felicia Manole","sp":["Otorinolaringologie"],"su":"https://www.cureus.com/users/223780-felicia-manole"},"290":{"n":"Constantin Volovat","nr":"Constantin Volovăț","sp":["Oncologie medicală"],"su":"https://www.umfiasi.ro/ro/universitate/alegeri-academice/Documents/2024/01/Candidati/Senat/MEDICINA/Departament%205%20Medicale%20III/VOLOVAT%20CONSTANTIN/Curriculum%20vitae.pdf"},"291":{"n":"Alexandru Achim","sp":["Cardiologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"292":{"n":"Leontin Lazar","nr":"Leontin Lazăr","sp":["Cardiologie"],"su":"https://clinica-omnis.ro/medici/lazar-leontin-florin"},"293":{"n":"Elena Caceaune","sp":["Diabet zaharat, nutriție și boli metabolice","Medicină de familie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"294":{"n":"Alexandrina Popescu","sp":["Diabet zaharat, nutriție și boli metabolice","Medicină internă"],"su":"https://diabmed.ro/"},"295":{"n":"Cristian Guja","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"296":{"n":"Silviu Ionel Dumitrescu","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"297":{"n":"Valerica Nafornita"},"298":{"n":"Pompilia Motatu","sp":["Oncologie medicală"],"su":"https://www.gralmedical.ro/medici/motatu-pompilia-elena"},"299":{"n":"Cezar Giosan"},"301":{"n":"Ioana Raluca Mindruta","nr":"Ioana Raluca Mîndruță","sp":["Neurologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"304":{"n":"Daniela Filipescu","sp":["Anestezie și terapie intensivă"],"su":"https://umfcd.ro/wp-content/uploads/2019/ALEGERI/alegeri_2020-2024/consiliu_cv/CV_Filipescu_Daniela.pdf"},"306":{"n":"Catalin Stefan","nr":"Cătălin Ștefan","sp":["Otorinolaringologie","Chirurgie plastică, estetică și microchirurgie reconstructivă"],"su":"https://www.reginamaria.ro/medici/dr-stefan-catalin"},"307":{"n":"Anemone Sorana Lupescu","sp":["Otorinolaringologie"],"su":"https://www.medlife.ro/medic-lupescu-anemone-sorana"},"308":{"n":"Valeriu Bronescu","sp":["Otorinolaringologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/LISTA_cu_%20membri_cu_drept_de_vot_TURUL_1_gata.pdf"},"309":{"n":"Corina-Camelia Mella","sp":["Otorinolaringologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"310":{"n":"Jana-Sorina Dindere","sp":["Otorinolaringologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"311":{"n":"Gheorghe Doinel Radeanu","nr":"Gheorghe Doinel Rădeanu","sp":["Otorinolaringologie"],"su":"https://www.scjucluj.ro/index.php/sectii-si-compartimente/personal-medical"},"312":{"n":"Mihaela-Roxana Mitroi","sp":["Otorinolaringologie"],"su":"https://old.umfcv.ro/mitroi-mihaela-roxana"},"313":{"n":"Mihaela Andreescu","sp":["Hematologie"],"su":"https://nou.spitalulcolentina.ro/medici/mihaela-andreescu/"},"315":{"n":"Bogdan Georgescu","sp":["Oncologie medicală"],"su":"https://ginecologieoncologica.ro/echipa-medicala/"},"316":{"n":"Georgiana Florenta","nr":"Georgiana Florența","sp":["Oncologie medicală"],"su":"https://www.iroiasi.ro/specialitati/oncologie-medicala","ss":["https://www.iroiasi.ro/specialitati/oncologie-medicala","https://www.iroiasi.ro/uploads/cv/popescu-georgiana.pdf"]},"320":{"n":"Ramona Moldovan"},"321":{"n":"Ana Maria Dumitriu","sp":["Anestezie și terapie intensivă"],"su":"https://umfcd.ro/wp-content/uploads/2024/SCOALA_DOCTORALA/TEZA_DOCTORAT/COTAE_cas_DUMITRIU_I_L_ANA_MARIA/cv%20Cotae.pdf"},"322":{"n":"Liliana Mirea","sp":["Anestezie și terapie intensivă"],"su":"https://ralcom.eventsair.com/svm-2023/liliana-mirea"},"323":{"n":"Veronica Florentina Surlea","nr":"Veronica Florentina Șurlea","sp":["Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"324":{"n":"Adela Magdalena Ciobanu","sp":["Psihiatrie"],"su":"https://www.asociatiapsihiatrilor.ro/despre-aplr/prof-univ-dr-adela-magdalena-ciobanu/"},"325":{"n":"Andrei Lesan","nr":"Andrei Leșan","sp":["Pneumologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"326":{"n":"Manuela Cosmina Magdau","nr":"Manuela Cosmina Magdău","sp":["Pneumologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"327":{"n":"Lavinia Davidescu-Butar","sp":["Pneumologie"],"su":"https://www.uoradea.ro/wp-content/uploads/2024/documente/display25876.pdf"},"328":{"n":"Monica Marc","sp":["Pneumologie"],"su":"https://www.umft.ro/ro/dr-monica-marc-la-drumul-spre-sanatate/"},"329":{"n":"Dragos Gabriel Ungureanu","nr":"Dragoș Gabriel Ungureanu"},"330":{"n":"Angelica Savu"},"331":{"n":"Ionela Iovan","sp":["Pneumologie"],"su":"https://www.vbabestm.ro/pagini/clinici/pneumologie1.html"},"332":{"n":"Poliana Leru","nr":"Polliana Mihaela Leru","sp":["Alergologie și imunologie clinică","Medicină de familie","Medicină internă"],"su":"https://sraic.eu/assoc-prof-dr-polliana-leru/","ss":["https://sraic.eu/assoc-prof-dr-polliana-leru/","https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf","https://sraic.eu/harta-cabinetelor/"],"aliases":["Poliana Leru","Polliana Mihaela Leru"]},"333":{"n":"Ana Maria Trailescu","nr":"Ana Maria Trăilescu","sp":["Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"334":{"n":"Ioan Dorin Petrui","sp":["Pneumologie"],"su":"https://spital-deva.ro/spj/declaratii-avere/"},"335":{"n":"Cristian Stefan Mago","nr":"Cristian Ștefan Mago"},"336":{"n":"Carmen Panaitescu","sp":["Alergologie și imunologie clinică"],"su":"https://sraic.eu/prof-dr-carmen-panaitescu-2/"},"337":{"n":"Stefan Mihaicuta","nr":"Ștefan Mihăicuță","sp":["Pneumologie"],"su":"https://www.neoclinic.ro/medici/dr-stefan-mihaicuta/"},"338":{"n":"Cristian Iulian Oancea","sp":["Pneumologie"],"su":"https://www.umft.ro/wp-content/uploads/2026/03/Prof.-univ.-Dr.-Oancea-Cristian_CV-RO_2026.pdf"},"339":{"n":"Polliana Mihaela Leru","sp":["Alergologie și imunologie clinică","Medicină de familie","Medicină internă"],"su":"https://sraic.eu/assoc-prof-dr-polliana-leru/","ss":["https://sraic.eu/assoc-prof-dr-polliana-leru/","https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf","https://sraic.eu/harta-cabinetelor/"],"aliases":["Poliana Leru","Polliana Mihaela Leru"]},"340":{"n":"Bianca Gergely-Domokos Hancu","sp":["Pneumologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"341":{"n":"Filomon Raluca"},"342":{"n":"Dan Corneci Pr","sp":["Anestezie și terapie intensivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"343":{"n":"Oanamaria Tudorache"},"344":{"n":"Dan Lucian Dumitrascu","nr":"Dan Lucian Dumitrașcu","sp":["Medicină internă","Gastroenterologie"],"su":"https://www.scjucluj.ro/index.php/sectii-si-compartimente/sectii/61-medicina-interna-iii"},"345":{"n":"Radu Farcas","nr":"Radu Fărcaș"},"347":{"n":"Lucian Calmac","nr":"Lucian Câlmâc","sp":["Cardiologie"],"su":"https://www.cardioclinic.ro/medici/dr-lucian-calmac/"},"348":{"n":"Horațiu Moldovan","sp":["Chirurgie cardiovasculară"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"349":{"n":"Mohamed Khattab","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"350":{"n":"Liviu Stan"},"351":{"n":"Igor Nedelciuc","sp":["Cardiologie"],"su":"https://www.cardioiasi.ro/medic/dr-nedelciuc-igor/"},"352":{"n":"Grigore Tinica","nr":"Grigore Tinică","sp":["Chirurgie cardiovasculară"],"su":"https://www.umfiasi.ro/ro/universitate/alegeri-academice/ianuarie-2020/Documents/senat/medicina/DEP.%20CHIRURGIE%20I/Tinic%C4%83%20Grigore/CV%20Grigore%20Tinica%20Ro%202019.pdf"},"353":{"n":"Eugen Cezar Popescu","sp":["Ortopedie și traumatologie"],"su":"https://neuroiasi.ro/declaratii-avere-sefi-sectii/"},"354":{"n":"Augustin Georghe","nr":"Augustin Gheorghe","aliases":["Augustin Gheorghe","Augustin Georghe"]},"355":{"n":"Nicoleta Dalbea"},"356":{"n":"Georgeta Negret"},"358":{"n":"Attila Fogarassy","sp":["Obstetrică-ginecologie"],"su":"https://azeena.ro/membru/dr-attila-fogarassy/"},"359":{"n":"Andra Elena Goicea","sp":["Anestezie și terapie intensivă"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"360":{"n":"Constantin Bodolea","sp":["Anestezie și terapie intensivă"],"su":"https://spitalclujana.ro/sectii-clinice/sectia-clinica-anestezie-si-terapie-intensiva/"},"361":{"n":"Roxana Maria Nemeș","sp":["Pediatrie","Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"362":{"n":"Dan-Corneliu Jinga","sp":["Medicină internă","Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"363":{"n":"Marius T Marcu"},"364":{"n":"Mugurel C Apetrii","sp":["Nefrologie"],"su":"https://www.arcadiamedical.ro/echipa-medicala/apetrii-mugurel"},"365":{"n":"Anca E Stefan"},"366":{"n":"Laura Huiban","sp":["Gastroenterologie"],"su":"https://asociatiadeplin.ro/"},"367":{"n":"Alexandru F Oancea"},"368":{"n":"Florin Alexandru Caruntu","nr":"Florin Alexandru Căruntu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"369":{"n":"Daniela Opriș-Belinski","sp":["Medicină internă","Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"370":{"n":"Daniela Fodor","sp":["Medicină internă","Reumatologie"],"su":"https://scjucluj.ro/index.php/sectii-si-compartimente/sectii/12-medicina-interna-ii"},"371":{"n":"Mihai Abobului","sp":["Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"372":{"n":"Natalia E. Cojocaru"},"373":{"n":"Adriana Badau"},"374":{"n":"Mihaela Mocan","sp":["Medicină internă","Cardiologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"375":{"n":"Răzvan Ene","sp":["Ortopedie și traumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"376":{"n":"Dragos Baiceanu","nr":"Dragoș Băiceanu","sp":["Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"377":{"n":"Florina Rad","sp":["Psihiatrie pediatrică"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"378":{"n":"Karina Gheorghita","nr":"Karina Gheorghiță","sp":["Neurologie pediatrică"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"379":{"n":"Carmen Lupusoru","nr":"Carmen Lupușoru","sp":["Neuropsihiatrie pediatrică"],"su":"https://socola.eu/wp-content/uploads/2020/06/Dr.-Lupusoru-Carmen-Gabriela.pdf"},"380":{"n":"Laura Nussbaum","sp":["Psihiatrie pediatrică"],"su":"https://www.spital-copii-timisoara.info/sectii/sectii/data_files/content-static/raport-activitate-psihiatrie-pediatrica-2018.pdf"},"381":{"n":"Monica Safer","sp":["Neurologie pediatrică","Psihiatrie pediatrică"],"su":"https://www.animedica.ro/echipa/monica-safer/"},"382":{"n":"Elena Predescu","sp":["Psihiatrie pediatrică"],"su":"https://cdn.umfcluj.ro/uploads/2023/09/CV-Elena-Predescu-25.06.2023.pdf"},"383":{"n":"Alin Ovidiu Petris","nr":"Alin Ovidiu Petriș","sp":["Psihiatrie"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"384":{"n":"Mihnea Costin Manea","sp":["Psihiatrie"],"su":"https://evenimente-arpp.ro/speaker/conf-univ-dr-mihnea-manea-2/"},"385":{"n":"Traian Barbu","sp":["Psihiatrie"],"su":"https://cetttsfantulstelian.ro/program-pacienti-din-cadrul-csm/"},"386":{"n":"Dana Iancu","sp":["Oncologie medicală"],"su":"https://iocn.ro/sectia-oncologie-medicala/"},"387":{"n":"Augustin Gheorghe","aliases":["Augustin Gheorghe","Augustin Georghe"]},"390":{"n":"Alexandru Crișan"},"393":{"n":"Carmen Crihana","nr":"Carmen Crihană","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"394":{"n":"Cristina Pruteanu","sp":["Oncologie medicală"],"su":"https://revial.ro/"},"396":{"n":"Matild Keresztes","sp":["Anestezie și terapie intensivă"],"su":"https://www.spitalmures.ro/servicii-medicale/sectii-si-compartimente-cu-paturi/compartiment-ati-obstetrica-ginecologie-ati-si-terapia-durerii/personal/"},"397":{"n":"Janos Szederjesi","nr":"János Szederjesi","sp":["Anestezie și terapie intensivă"],"su":"https://www.umfst.ro/fileadmin/doctorate/abilitare/2025/Szederjesi_Janos/Szederjesi_CV.pdf"},"398":{"n":"Serban Turliuc","nr":"Șerban Turliuc","sp":["Psihiatrie"],"su":"https://ralcom.eventsair.com/cnp-2022/serban-turliuc"},"399":{"n":"Adrian Covic","sp":["Medicină internă","Nefrologie"],"su":"https://www.parhoniasi.ro/structura-spital/compartiment-transplant-renal/prof-dr-covic-adrian-constantin"},"400":{"n":"Alexandra Covic"},"401":{"n":"Gianina Dodi"},"402":{"n":"Ramona Florina Stroescu","sp":["Pediatrie","Nefrologie pediatrică"],"su":"https://www.umft.ro/wp-content/uploads/2026/03/CV_Stroescu-Ramona_2026_Romana.pdf"},"403":{"n":"Anca Florina Zgura"},"404":{"n":"Mihaela Maria Pasca Fenesan"},"405":{"n":"Laszlo Ritli","nr":"László Ritli"},"406":{"n":"Doru Nicolae Lucaci"},"407":{"n":"Alina Camelia Catana","sp":["Hematologie"],"su":"https://www.scjus.ro/wp-content/uploads/2022/04/Lista-medicilor-acreditati-ambulatoriu-04_2022.pdf"},"408":{"n":"Andreea Craciunescu"},"409":{"n":"Bogdan-Daniel Carlan","nr":"Bogdan-Daniel Cârlan","sp":["Oncologie medicală"],"su":"https://www.brasov-colmed.ro/cmbvweb/LISTA_cu_%20membri_cu_drept_de_vot_TURUL_1_gata.pdf"},"410":{"n":"Paul Milan Kubelac"},"411":{"n":"Nada Akad"},"415":{"n":"Anca Emanuela Musetescu","nr":"Anca Emanuela Mușetescu","sp":["Reumatologie"],"su":"https://old.umfcv.ro/files/c/v/CV%20Anca%20Emanuela%20Musetescu.pdf"},"416":{"n":"Carina Anna Triff","sp":["Medicină internă","Reumatologie"],"su":"https://www.colegmed-tm.ro/public/data_files/media/alegeri/2024/Birou%20si%20reprezentant%2014-10-2024/Vicepresedinti/Secretar/202410141324-Triff%20Carina-Anna.pdf"},"418":{"n":"Flaviu-Raul Bob","sp":["Nefrologie"],"su":"https://www.umft.ro/wp-content/uploads/2026/03/CV-Bob-Flaviu-2026-rom.pdf"},"419":{"n":"Ina Maria Kacso","sp":["Nefrologie","Medicină internă"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"423":{"n":"Silvia-Maria Nicolae","sp":["Neurologie"],"su":"https://smcaracal.ro/spitalul-caracal/structuri-medicale/situatia-medicilor-pe-specialitati-si-competente/situatia-medicilor-pe-specialitati-si-competente"},"424":{"n":"Alina Tantau","nr":"Alina Tanțău","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.doctortantau.ro/?q=alina_tantau"},"425":{"n":"Florin Cristian Blajut","sp":["Chirurgie generală"],"su":"https://www.gralmedical.ro/medici/blajut-florin-cristian"},"427":{"n":"Iona Luca"},"428":{"n":"Manuela Curcerea","nr":"Manuela Cucerea","sp":["Pediatrie","Neonatologie"],"su":"https://amaltea.ro/medicina/manuela-cucerea","aliases":["Manuela Cucerea","Manuela Curcerea"]},"429":{"n":"Iulia Florentina Tincu","nr":"Iulia Florentina Țincu","sp":["Gastroenterologie pediatrică","Pediatrie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"430":{"n":"Oana Belei","sp":["Pediatrie","Gastroenterologie"],"su":"https://www.reginamaria.ro/medici/dr-belei-oana"},"434":{"n":"Karoly Adrian Hajdu","sp":["Oncologie medicală"],"su":"https://www.brasov-colmed.ro/cmbvweb/docs/lista_alegatori_2020_cmbv_site.pdf"},"435":{"n":"Ioana Adriana Ciurescu"},"436":{"n":"Amalia Mara Rosu","nr":"Amalia Mara Roșu","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"438":{"n":"Alina Amalia Herzal","sp":["Oncologie medicală"],"su":"https://www.spitaljbm.ro/images/personal-septembrie2025.pdf"},"439":{"n":"Adrian Gheorghe Boicean","sp":["Gastroenterologie","Medicină internă"],"su":"https://medicina.ulbsibiu.ro/wp-content/uploads/BOICEAN-ADRIAN_DOCUMENTE_DIRECTOR-DEP-REZIDENTIAT_copie-2.pdf"},"440":{"n":"Florin-George Musat","sp":["Gastroenterologie"],"su":"https://www.clinica360.ro/asistenta-medicala-ambulatorie-in-gastroenterologie/"},"441":{"n":"Cristian George Tieranu","nr":"Cristian George Țieranu","sp":["Gastroenterologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"442":{"n":"Dan Ionut Gheonea","nr":"Dan Ionuț Gheonea","sp":["Gastroenterologie","Medicină internă"],"su":"https://umfcd.ro/wp-content/uploads/2024/SCOALA_DOCTORALA/TEZA_DOCTORAT/IONI%C8%9A%C4%82_c%C4%83s_STATE%20_I_ROXANA_MONICA/CV%20Prof.univ.Dr.%20GHEONEA%20DAN-IONU%C8%9A.pdf"},"443":{"n":"Cristina Pojoga","sp":["Gastroenterologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"444":{"n":"Iulian Copaci","sp":["Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2020/02/MediciVot_2020.pdf"},"445":{"n":"Stefan Dan Cezar Mot","nr":"Ștefan Dan Cezar Moț","sp":["Cardiologie"],"su":"https://cdn.umfcluj.ro/uploads/2023/07/CV-Stefan-Mot.pdf"},"446":{"n":"Viviana Onofrei","sp":["Cardiologie","Medicină internă"],"su":"https://elytis-hospital.ro/doctori-elytis/conf-univ-dr-viviana-onofrei-medic-primar-cardiologie/"},"447":{"n":"Daniela Bartos","nr":"Daniela Bartoș","sp":["Cardiologie","Medicină internă","Sănătate publică și management"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"448":{"n":"Virgil Popa","sp":["Sănătate publică și management","Cardiologie"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"449":{"n":"Silvia Paveliu","sp":["Endocrinologie"],"su":"https://endocrinologie.centre-medicale.ro/"},"450":{"n":"Diana-Hortensia Barbonta","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmralba.ro/registrul-medicilor-alba/"},"451":{"n":"Bogdan Mut-Vitcu","sp":["Cardiologie"],"su":"https://cardioprevent.org/dr-bogdan-mut/"},"452":{"n":"Cornelia Zetu","sp":["Diabet zaharat, nutriție și boli metabolice","Endocrinologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"453":{"n":"Noela Radu"},"454":{"n":"Diana Florescu"},"455":{"n":"Simona Ruxandra Volovat","nr":"Simona Ruxandra Volovăț","sp":["Oncologie medicală"],"su":"https://www.umfiasi.ro/ro/academic/programe-de-studii/doctorat/Curriculum%20vitae/CD%20-%20Medicina/Volovat%20Simona.pdf"},"456":{"n":"Valeriu Gheorghiță","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"457":{"n":"Ana Dobrin"},"458":{"n":"Violeta Melinte","sp":["Boli infecțioase"],"su":"https://spitalulagrippaionescu.ro/personal/dr-melinte-violeta/"},"459":{"n":"Maria Adelina Radu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"460":{"n":"Maria Cristina Văcăroiu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"461":{"n":"Irina Florentina Talpoși"},"462":{"n":"Silvia Chiran","sp":["Medicină de laborator"],"su":"https://spitalulagrippaionescu.ro/personal/dr-silvia-gabriela-chiran/"},"463":{"n":"Tiberiu Sebastian Holban","sp":["Medicină de laborator"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"464":{"n":"Amalia Loredana Călinoiu","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"465":{"n":"Indira Rădoi","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"466":{"n":"Maria Cristina Orlov-Slavu","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"467":{"n":"Simona Crintea","sp":["Hematologie"],"su":"https://spitalulagrippaionescu.ro/personal/dr-simona-consuela-crintea/"},"468":{"n":"Alin Baciu","sp":["Anestezie și terapie intensivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"469":{"n":"Robert Ciupan","sp":["Anestezie și terapie intensivă"],"su":"https://spitalulagrippaionescu.ro/wp-content/uploads/2023/06/Robert-Catalin-Ciupan.pdf"},"470":{"n":"Adrian Tulin","sp":["Chirurgie generală"],"su":"https://spitalulagrippaionescu.ro/specialitati/sectia-clinica-chirurgie-generala/"},"471":{"n":"Ana Dobrotă"},"472":{"n":"Andrei Alexandru Muntean","sp":["Microbiologie medicală","Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"474":{"n":"Marcel Vasile Tantau"},"476":{"n":"Ioana Grigore","sp":["Neurologie pediatrică","Pediatrie"],"su":"https://www.sfmaria-iasi.ro/sectia-clinica-neurologie-pediatrica/"},"477":{"n":"Anca Victorita Trifan","nr":"Anca Victorița Trifan","sp":["Gastroenterologie","Medicină internă"],"su":"https://ancatrifan.ro/anca-trifan/CV_Europass_2025_Profesor_Trifan_Anca%20Victorita.pdf"},"478":{"n":"Bogdan Busuioc","sp":["Gastroenterologie"],"su":"https://www.clinicamedicum.ro/doctor/dr-busuioc-bogdan/"},"479":{"n":"Bogdan-Calin Pintea","nr":"Bogdan-Călin Pintea","sp":["Gastroenterologie"],"su":"https://sjusm.ro/wp-content/uploads/2013/05/Prezentare-Dr.-Pintea-Bogdan.pdf"},"482":{"n":"Gabriel Kacso","nr":"Gabriel Kacsó","sp":["Radioterapie","Oncologie medicală"],"su":"https://amethyst-radiotherapy.ro/doctor/prof-dr-gabriel-kacso/"},"484":{"n":"Carastoian Nicoleta","sp":["Nefrologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"485":{"n":"Adrian Sarbu"},"486":{"n":"Stefania Diana St Nilca","nr":"Ștefania Diana St Nilca"},"495":{"n":"Benea R Horea","sp":["Ortopedie și traumatologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"496":{"n":"Cicio Dennis"},"497":{"n":"Ciornei Vladimir","sp":["Ortopedie și traumatologie (rezidențiat în 2024)"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"498":{"n":"Simona Mihutiu","nr":"Simona Mihuțiu","sp":["Oncologie medicală"],"su":"https://cj.vesmart.ro/files-dispozitii/394-29.03.2022--Dispozi%C5%A3ia%20nr.%20394%20din%2029.03.2022.pdf"},"499":{"n":"Mariana Sporis","nr":"Mariana Sporiș","sp":["Oncologie medicală"],"su":"https://www.rmn-diagnostica.ro/dr-mariana-sporis-medic-oncologie-medicala/"},"500":{"n":"Daniela Radulescu","nr":"Daniela Rădulescu","sp":["Nefrologie","Medicină internă"],"su":"https://clinica.gmh.ro/public/medic/daniela-radulescu"},"501":{"n":"Daniela-Teodora Maria"},"502":{"n":"Dimitrie Siriopol","sp":["Nefrologie"],"su":"https://aspeninstitute.ro/people/dimitrie-siriopol/"},"503":{"n":"Dana Clement","sp":["Oncologie medicală"],"su":"https://www.iroiasi.ro/userfiles/files/program-ambulatoriu/program-consultatii-ambulatoriul-integrat-2024-2025-v3.pdf"},"504":{"n":"Dan Delean","sp":["Pediatrie","Nefrologie pediatrică"],"su":"https://centruldepediatrie.ro/dr-dan-delean/"},"506":{"n":"Catalina Mihai","nr":"Cătălina Mihai","sp":["Gastroenterologie"],"su":"https://cdn.umfcluj.ro/uploads/2024/08/CV-Prof.dr_.-Catalina-Mihai.pdf"},"507":{"n":"Carmen Monica Preda","sp":["Gastroenterologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"508":{"n":"Catalin Codreanu","nr":"Cătălin Codreanu","sp":["Reumatologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"509":{"n":"Ruxandra Simionescu","sp":["Oftalmologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"510":{"n":"Simona Nicoara","nr":"Simona Nicoară","sp":["Oftalmologie"],"su":"https://www.scjucluj.ro/index.php/sectii-si-compartimente/personal-medical"},"511":{"n":"Polixenia Iorga","sp":["Oncologie medicală"],"su":"https://www.conferintele-suub.ro/comitet-stiintific-si-lectori/"},"512":{"n":"Claudia Cimpoeru","sp":["Gastroenterologie"],"su":"https://sponsorizari.anm.ro/afisare-2016/beneficiari?page=207"},"513":{"n":"Simona Bataga","nr":"Simona Bățaga","sp":["Gastroenterologie","Medicină internă"],"su":"https://snvgh.ro/team/simona-bataga/"},"515":{"n":"Ana Anca Chendea","sp":["Psihiatrie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"516":{"n":"Ana Aliana Miron","sp":["Psihiatrie"],"su":"https://ralcom.eventsair.com/cnp-2022/ana-aliana-miron"},"517":{"n":"Andrei O Mitre","sp":["Anestezie și terapie intensivă (rezidențiat în 2024)"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"521":{"n":"Octaviana-Adriana Dulămea","sp":["Neurologie"],"su":"https://icfundeni.ro/sectia-clinica-neorologie/"},"524":{"n":"Emilian Silviu Manescu","nr":"Emilian Silviu Mănescu","sp":["Neurologie"],"su":"https://www.cmarges.ro/LISTA%20ELECTORALA%20PERMANENTA%20Arges%20actualizata.pdf"},"526":{"n":"Any Docu Axelerad","sp":["Neurologie"],"su":"https://www.spitalulconstanta.ro/sectia-neurologie-prezentare/"},"528":{"n":"Petra Curescu","sp":["Oncologie medicală"],"su":"https://www.spitalul-municipal-timisoara.ro/sectii/sectii-clinice/clinica-de-oncologie-medicala"},"529":{"n":"Daniela Manolache"},"530":{"n":"Nicoleta Baloseanu","nr":"Nicoleta Baloșeanu","sp":["Boli infecțioase"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"531":{"n":"Andrei Vata","nr":"Andrei Vâță","sp":["Boli infecțioase"],"su":"https://news.umfiasi.ro/trateaza-antibioticele-cu-grija-pentru-un-viitor-fara-grija/"},"533":{"n":"Maria-Camelia Stancioaica"},"535":{"n":"Claudiu Ionele","sp":["Gastroenterologie"],"su":"https://centrulmedicalrimedis.ro/medici/"},"536":{"n":"Dorin Gheorghe"},"537":{"n":"Ana Maria Mihaela Ramazan"},"538":{"n":"Marius Neculoiu","sp":["Urologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/2024-candidati/neculoiu_marius.pdf"},"540":{"n":"Rares Candrea","nr":"Rareș Candrea"},"541":{"n":"Amalia Hora","sp":["Oncologie medicală"],"su":"https://dafmed.ro/services-post/oncologie/"},"542":{"n":"Corina Pienar","sp":["Gastroenterologie pediatrică","Pediatrie"],"su":"https://gastrotm.ro/profile/dr-corina-pienar/"},"543":{"n":"Cristina Adriana Becheanu","sp":["Gastroenterologie pediatrică","Pediatrie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"544":{"n":"Florian Antonescu","sp":["Neurologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"545":{"n":"Anca-Ioana Motataianu","nr":"Anca-Ioana Moțățăianu","sp":["Neurologie"],"su":"https://www.umfst.ro/fileadmin/materiale/concurs_posturi/2019-2020/dosare/nedeterminat/Medicina/Motataianu%20Anca%20Ioana/2_CV_Motataianu.pdf"},"546":{"n":"Mircea Marta","sp":["Pneumologie"],"su":"https://www.medlife.ro/medic-marta-mircea-florin"},"547":{"n":"Bogdan Mihai Mincu","sp":["Pneumologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"548":{"n":"Ghiulten Apti","sp":["Pneumologie","Cardiologie"],"su":"https://old.pneumoconstanta.ro/sectii/pneumologie-2/"},"550":{"n":"Aurelian-Emil Ranetti"},"552":{"n":"Brindusa Adriana Cofaru","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.brasov-colmed.ro/cmbvweb/docs/lista_alegatori_2020_cmbv_site.pdf"},"553":{"n":"Bogdan Ionescu"},"554":{"n":"Anca Rodica Dan","sp":["Cardiologie","Medicină de familie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"555":{"n":"Cristian Rasvan Baicus","nr":"Cristian Răsvan Băicuș","sp":["Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"556":{"n":"Ilinca Mihaela Savulescu-Fiedler","nr":"Ilinca Mihaela Săvulescu-Fiedler","sp":["Cardiologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"557":{"n":"Crina Sinescu","sp":["Cardiologie"],"su":"https://www.bagdasar-arseni.ro/activitate-de-cercetare"},"558":{"n":"Ana Maria Balahura","sp":["Cardiologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"559":{"n":"Serban Balanescu","nr":"Șerban Bălănescu","sp":["Cardiologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"560":{"n":"Silviu Stanciu","sp":["Cardiologie"],"su":"https://emc.formaremedicala.ro/autor/silviu-stanciu/"},"564":{"n":"Oana Claudia Deleanu","sp":["Pneumologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"565":{"n":"Corina Borcea","sp":["Pneumologie"],"su":"https://somnologie.konektor.ro/media/2023/10/dr.-Corina-Borcea-CV-site.pdf"},"566":{"n":"Andreea Petcu"},"567":{"n":"Razvan Lungu","nr":"Răzvan Lungu","sp":["Pneumologie"],"su":"https://doctorescu.eu/doctor/dr-razvan-lungu/"},"568":{"n":"Valentin Cosei","nr":"Valentin Coșei","sp":["Pneumologie"],"su":"https://doctorescu.eu/doctor/dr-valentin-cosei/"},"569":{"n":"Bahtiar Ismail"},"571":{"n":"Rodica Maricela Anghel","sp":["Oncologie medicală","Radiologie - imagistică medicală","Radioterapie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"572":{"n":"Elena Popovici","sp":["Gastroenterologie"],"su":"https://www.spitaluljudeteanbacau.ro/compartiment-gastroenterologie/"},"573":{"n":"Lucian Negreanu","sp":["Gastroenterologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"574":{"n":"Eugen Dumitru","sp":["Gastroenterologie"],"su":"https://www.reginamaria.ro/medici/prof-univ-dr-dumitru-eugen"},"575":{"n":"Paula Iuliana Toma","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"577":{"n":"Loana Minciu"},"578":{"n":"Ruxandra-Oana Jurcut","nr":"Ruxandra-Oana Jurcuț","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"579":{"n":"Adriana Cojocaru"},"580":{"n":"Horia Beti","nr":"Horia Beți","sp":["Dermatovenerologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"581":{"n":"Oana Leulescu"},"582":{"n":"Silviu Adrian Marinescu","sp":["Chirurgie plastică și microchirurgie reconstructivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"583":{"n":"Daniela Teodorescu","sp":["Medicină de familie","Medicină sportivă","Medicină fizică și de reabilitare"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"584":{"n":"Carmen Giuglea","sp":["Chirurgie plastică și microchirurgie reconstructivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"585":{"n":"Serban Dumitrache","nr":"Șerban Dumitrache","sp":["Chirurgie plastică, estetică și microchirurgie reconstructivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"586":{"n":"Ana Maria Oproiu","sp":["Chirurgie plastică și microchirurgie reconstructivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"587":{"n":"Laura Raducu","nr":"Laura Răducu","sp":["Chirurgie plastică și microchirurgie reconstructivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"588":{"n":"Andreea Luciana Rata"},"589":{"n":"Luiza Spiru","sp":["Geriatrie și gerontologie","Medicină internă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"590":{"n":"Mihaela Jian","sp":["Dermatovenerologie"],"su":"https://premiumderma.ro/echipa/dr-jian-mihaela-anca-2/"},"591":{"n":"Diana Radaschin","sp":["Dermatovenerologie"],"su":"https://www.medlife.ro/medic-radaschin-diana-sabina"},"592":{"n":"Razvan M Melinte","nr":"Răzvan M Melinte","sp":["Ortopedie și traumatologie"],"su":"https://medicpuls.ro/servicii-medicale/ambulatoriu-de-specialitate/ortopedie/"},"595":{"n":"Luchian Stefan Dan","nr":"Luchian Ștefan Dan","sp":["Oncologie medicală"],"su":"https://starmedica.ro/staff/dr-luchian-stefan-dan"},"598":{"n":"Vlad Tica","sp":["Obstetrică-ginecologie"],"su":"https://armoniahospital.ro/echipa/"},"599":{"n":"Viorel Cristurean","sp":["Obstetrică-ginecologie"],"su":"https://www.univ-ovidius.ro/images/-docs/posturi-universitare/2013-pe-facultati-ianuarie/CANDIDATI/MEDICINA/CRISTUREAN%20VIOREL%20-%20POZ%2033/CV.pdf"},"600":{"n":"Viola Maria Popov"},"601":{"n":"Ioana Streata","nr":"Ioana Streață","sp":["Genetică medicală"],"su":"https://mzhg.org.mk/speakers/streata-ioana/"},"602":{"n":"Claudia Ilincuta"},"603":{"n":"Cristina Aura Panea","sp":["Neurologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"604":{"n":"Geanina Papuc"},"614":{"n":"Beatrice Abalasei","nr":"Beatrice Abalașei"},"615":{"n":"Elena Gavrilescu"},"616":{"n":"Dan Alexandru Darabantiu","nr":"Dan Alexandru Dărăbanțiu","sp":["Medicină internă","Cardiologie"],"su":"https://www.colmedarad.ro/public/data_files/media/alegeri/2024/202501101158-lista-electorala-permanenta-tur-11-12oct-2024.pdf"},"617":{"n":"Emil Mihail Ursu","sp":["Cardiologie"],"su":"https://sponsorizari.anm.ro/afisare-2016/beneficiari?page=38"},"618":{"n":"Dragomir Chioncel","sp":["Cardiologie"],"su":"https://umfcd.ro/wp-content/uploads/2020/CONC_DID_NEDET_SEM1_2020_2021/INFORMATII_CANDIDATI/MEDICINA/CV-Chioncel_Dragomir-OvidiuP2-.pdf"},"621":{"n":"Razvan Daniel Bobora","nr":"Răzvan Daniel Bobora","sp":["Oncologie medicală"],"su":"https://www.reginamaria.ro/medici/dr-bobora-razvan-daniel"},"622":{"n":"Bogdan Alexandru Popescu","sp":["Cardiologie"],"su":"https://umfcd.ro/wp-content/uploads/2020/TEZA_DOCTORAT/PREDESCU-G-LUCIAN-MARIUS/CV-Prof.-Bogdan-Alexandru-Popescu.pdf"},"624":{"n":"Marius Tudor Radu","sp":["Urologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"625":{"n":"Ana Ologeanu"},"626":{"n":"Dragos Razvan Multescu","nr":"Dragoș Răzvan Mulțescu","sp":["Urologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"627":{"n":"Elena Timofte","sp":["Farmacologie clinică","Medicină de familie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"628":{"n":"Vlad Barbos","sp":["Urologie"],"su":"https://www.medlife.ro/medic-barbos-vlad-ilie"},"629":{"n":"Mihail Claudius Berechet","sp":["Urologie"],"su":"https://www.uoradea.ro/wp-content/uploads/2024/documente/display23207.pdf"},"630":{"n":"Mattar lasmina","nr":"Mattar Iasmina","sp":["Urologie"],"su":"https://affidea.ro/ro-RO/centre-de-diagnostic/affidea-timisoara-2/"},"631":{"n":"Razvan Tiberiu Bardan","nr":"Răzvan Tiberiu Bardan","sp":["Urologie"],"su":"https://www.umft.ro/wp-content/uploads/2026/03/CV-BARDAN-RAZVAN-RO-2026.pdf"},"632":{"n":"Ioan Scarneciu","nr":"Ioan Scârneciu","sp":["Urologie"],"su":"https://umfcd.ro/wp-content/uploads/2025/SCOALA_DOCTORALA/TEZE_DOCTORAT/IANIOTESCU_I_IOAN_STELIAN/cv%20Prof%20Scarneciu.pdf"},"637":{"n":"Ştefan Marian Frenţ","nr":"Ștefan Marian Frenț","sp":["Pneumologie"],"su":"https://www.praxistm.ro/dr_Stefan_Frent.html"},"639":{"n":"Costea Nicolae Cristian","sp":["Gastroenterologie"],"su":"https://drcosteacristian.ro/termeni-si-conditii/"},"640":{"n":"Alin-Horea Suta","nr":"Alin-Horea Șuta","sp":["Gastroenterologie"],"su":"https://afbh.ro/user_files/prezentare_membri/Brosura_Pelican.pdf"},"641":{"n":"George Stancu","sp":["Medicină internă","Gastroenterologie"],"su":"https://umfcd.ro/wp-content/uploads/2024/SCOALA_DOCTORALA/TEZA_DOCTORAT/STANCU_N_GEORGE/CV%20-%20George%20Stancu.pdf"},"642":{"n":"Maximilian Vlad Muntean","sp":["Chirurgie plastică, estetică și microchirurgie reconstructivă","Chirurgie generală"],"su":"https://umfcluj.ro/medicina/facultate/departamente/departamentul-10/chirurgie-oncologica-ginecologie-oncologica/"},"643":{"n":"Cirpian Ionut Tomuleasa","nr":"Ionuț-Ciprian Tomuleasa","sp":["Hematologie"],"su":"https://iocn.ro/sectia-hematologie/","aliases":["Ionut-Ciprian Tomuleasa","Cirpian Ionut Tomuleasa"]},"644":{"n":"Ciprian Bacila","nr":"Ciprian Băcilă","sp":["Psihiatrie"],"su":"https://www.tratament-dependenta.ro/echipa/"},"647":{"n":"Ovidiu Florin Ortan","nr":"Ovidiu Florin Orțan","sp":["Cardiologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/LISTA_cu_%20membri_cu_drept_de_vot_TURUL_1_gata.pdf"},"648":{"n":"Titel Razvan Cojocariu","nr":"Titel Răzvan Cojocariu","sp":["Cardiologie"],"su":"https://legislatie.just.ro/Public/FormaPrintabila/00000G0FHCXFQIU286N1L8D8WCRSZ9HD"},"650":{"n":"Adriana Gabriela Onaca","sp":["Medicină internă","Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"654":{"n":"Dan-Andrei Mitrea","sp":["Neurologie"],"su":"https://www.romedic.ro/neuroaxis/medici/mitrea-dan-andrei"},"656":{"n":"Cosmin Mutu","sp":["Neurologie"],"su":"https://scjus.ro/wp-content/uploads/2024/08/Medici-acreditati-ambulatoriu-08_2024.pdf"},"657":{"n":"Crisanda Vilciu","nr":"Crisanda Vîlciu","sp":["Neurologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"658":{"n":"Cornelia Bala","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.reginamaria.ro/medici/prof-univ-dr-bala-cornelia"},"659":{"n":"Adelina Mihaescu","nr":"Adelina Mihăescu","sp":["Nefrologie"],"su":"https://umft.ro/wp-content/uploads/2025/03/CV-Europass_Adelina-Mihaescu_RO_2025.pdf"},"660":{"n":"Nicoleta Havasi","sp":["Medicină internă","Nefrologie"],"su":"https://www.cmbihor.ro/fisiere/LISTA_%20ALEGATORI.pdf"},"661":{"n":"Alexandra Elena Lazăr","sp":["Anestezie și terapie intensivă"],"su":"https://arhiva.umfst.ro/fileadmin/declaratii_de_avere/2023/lazar.alexandra-elena.pdf"},"662":{"n":"Alexandra Kovacs","sp":["Oncologie medicală"],"su":"https://oncohelp.ro/echipa-oncohelp/"},"663":{"n":"Cristina Muzica","nr":"Cristina Muzică","sp":["Gastroenterologie"],"su":"https://www.velvet.clinic/gastroenterologie"},"664":{"n":"Irina Girleanu","nr":"Irina Gîrleanu","sp":["Gastroenterologie"],"su":"https://promedicaiasi.ro/gastroenterologie/"},"665":{"n":"Sebastian Zenovia","sp":["Gastroenterologie"],"su":"https://www.arcadiamedical.ro/echipa-medicala/zenovia-ioan-sebastian"},"666":{"n":"Iulian Buzincu","sp":["Anestezie și terapie intensivă"],"su":"https://sraticongres.ro/2024/index.php/speaker/buzincu-iulian/"},"667":{"n":"Raluca Avram"},"670":{"n":"Ioana Cosmina Radus","nr":"Ioana Cosmina Răduș","sp":["Reumatologie"],"su":"https://abbvietransparenta.ro/wp-content/uploads/2025/06/FORMULAR-DECLARARE_ABBVIE-SRL_PHARMA_2024.pdf"},"671":{"n":"Violeta Tincuta Briciu","nr":"Violeta Tincuța Briciu","sp":["Boli infecțioase"],"su":"https://umfcluj.ro/medicina/facultate/departamente/departamentul-5/boli-infectioase/"},"672":{"n":"Simona Tetradov","sp":["Boli infecțioase"],"su":"https://spitalulbabes.ro/sec%C8%9Bii-clinice/sec%C5%A3ia-a-v-a-clinic%C4%83-boli-infec%C5%A3ioase-%C5%9Fi-tropicale-adul%C5%A3i-pavilion-a-et1/"},"673":{"n":"Catalina L Andrei","nr":"Cătălina Liliana Andrei","sp":["Cardiologie"],"su":"https://www.bagdasar-arseni.ro/sectia-clinica-cardiologie","ss":["https://www.bagdasar-arseni.ro/sectia-clinica-cardiologie","https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"],"aliases":["Catalina Liliana Andrei","Catalina L Andrei"]},"674":{"n":"Maria-Alexandra Ciuca-Pana","nr":"Maria-Alexandra Ciucă-Pană"},"678":{"n":"Mircea Dediu","sp":["Oncologie medicală"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"679":{"n":"Letitia Zecheru-Lapusneanu","nr":"Letiția Zecheru-Lăpușneanu","sp":["Neurologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/LISTA_cu_%20membri_cu_drept_de_vot_TURUL_1_gata.pdf"},"680":{"n":"Cecilia Laura Albu"},"681":{"n":"Bogdan-Dumitru Procopet","nr":"Bogdan-Dumitru Procopeț","sp":["Medicină internă","Gastroenterologie"],"su":"https://cdn.umfcluj.ro/uploads/2024/04/CV_Procopet-Bogdan_Conf.dr_._CSD.pdf"},"682":{"n":"Andrei Voiosu","sp":["Gastroenterologie"],"su":"https://spitalulmonza.ro/medic/dr-andrei-voiosu/"},"683":{"n":"Dana Baraghin","sp":["Pediatrie"],"su":"https://www.brasov-colmed.ro/cmbvweb/docs/lista_alegatori_2020_cmbv_site.pdf"},"684":{"n":"Alexandra Carmen Cara"},"686":{"n":"Angela Dascalescu","nr":"Angela Dăscălescu","sp":["Hematologie"],"su":"https://www.iroiasi.ro/userfiles/files/program-ambulatoriu/program-consultatii-ambulatoriul-integrat-2024-2025-v3.pdf"},"689":{"n":"Cristiana Osoian","sp":["Anestezie și terapie intensivă (rezidențiat în 2024)"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"690":{"n":"Viorela Mihaela Ciortea","sp":["Medicină fizică și de reabilitare"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"691":{"n":"Titus Vari","sp":["Medicină fizică și de reabilitare (rezidențiat în 2024)"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"694":{"n":"Claudia I Nedelcu"},"695":{"n":"Toma Vasilescu"},"696":{"n":"Iuliu Ion Ionas","sp":["Oncologie medicală"],"su":"https://www.gralmedical.ro/medici/ionas-iuliu-ion"},"697":{"n":"Adrian Lungu","sp":["Pediatrie","Nefrologie pediatrică"],"su":"https://www.erknet.org/our-experts/the-european-reference-centers/adrian-catalin-lungu"},"698":{"n":"Carmen Viorica Duicu","sp":["Pediatrie"],"su":"https://arhiva.umfst.ro/fileadmin/f_medicina_engleza/cadre_didactice/ME2/Duicu_Carmen_Viorica_CV_RO.pdf"},"700":{"n":"Ioan Mircea Coman","sp":["Cardiologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"701":{"n":"Ioan Tilea","nr":"Ioan Țilea","sp":["Cardiologie","Medicină internă"],"su":"https://cdn.umfcluj.ro/uploads/2023/10/CV-Prof.dr_.-Tilea-Ioan.pdf"},"702":{"n":"Antoine Edu","sp":["Obstetrică-ginecologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"703":{"n":"Mihaela Stancia","nr":"Mihaela Stanciu","sp":["Endocrinologie"],"su":"https://scjus.ro/wp-content/uploads/2024/08/Medici-acreditati-ambulatoriu-08_2024.pdf","aliases":["Mihaela Stanciu","Mihaela Stancia"]},"704":{"n":"Mihaela-Maria Vlad","sp":["Endocrinologie"],"su":"https://ulctimisoara.ro/wp-content/uploads/2024/02/Mihaela-Vlad-brief-CV.pdf"},"705":{"n":"Mihaela Stanciu","sp":["Endocrinologie"],"su":"https://scjus.ro/wp-content/uploads/2024/08/Medici-acreditati-ambulatoriu-08_2024.pdf","aliases":["Mihaela Stanciu","Mihaela Stancia"]},"706":{"n":"Cristina Preda","sp":["Endocrinologie"],"su":"https://roderma.ro/endocrinologie/"},"707":{"n":"Monica Rosoiu"},"708":{"n":"Laura-Aifer Calustian","sp":["Hematologie"],"su":"https://iob.ro/oncologie-medicala-2/"},"709":{"n":"Nataliia Moskalenko"},"710":{"n":"Hanna Varytska"},"714":{"n":"Daniela Sandulescu","nr":"Daniela Sândulescu","sp":["Medicină internă"],"su":"https://www.roald.ro/public/data_files/cv/40/20210406092012_1_q7i5hp6nsZe2ubGXnZKtzp24qYWmzKqYrs6mmK2nqYadzL2XnMyymLK7rouylb6Gsqy9rJ3PubKtvsLC.pdf"},"715":{"n":"Iulia Simionov","sp":["Gastroenterologie"],"su":"https://icfundeni.ro/echipa-medicala-a-spitalului/"},"716":{"n":"Cristian Cobilinschi","sp":["Anestezie și terapie intensivă"],"su":"https://umfcd.ro/wp-content/uploads/2019/CONC_DID_NEDET_SEM1_2019_2020/INFORMATII_CANDIDATI/MEDICINA/CVCristian_CobilinschiA8.pdf"},"717":{"n":"Ioana Grințescu Profesor","nr":"Ioana Grințescu","sp":["Anestezie și terapie intensivă"],"su":"https://www.rospen.ro/revista/byautor.aspx?kAutor=17"},"718":{"n":"Radu Tincu","nr":"Radu Țincu","sp":["Anestezie și terapie intensivă"],"su":"https://www.topderm.ro/prof-univ-dr-radu-ciprian-tincu-medic-primar/"},"719":{"n":"Bruno Velescu"},"720":{"n":"Costina R Poetar"},"721":{"n":"Adela Lucia Chirila","nr":"Adela-Luiza Chirilă","sp":["Oncologie medicală"],"su":"https://www.gralmedical.ro/medici/adela-luiza-chirila","aliases":["Adela-Luiza Chirila","Adela Lucia Chirila"]},"722":{"n":"Attila Frigy","sp":["Medicină internă","Cardiologie"],"su":"https://www.umfst.ro/fileadmin/doctorate/abilitare/2024/Frigy_Attila/Frigy_CV.pdf"},"725":{"n":"Andreea Monica Birjaru","sp":["Anestezie și terapie intensivă"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"726":{"n":"Mihai Dumitrache","sp":["Urologie"],"su":"https://www.spcaroldavila.ro/compartiment-urologie/"},"727":{"n":"Dragos Georgescu","nr":"Dragoș Georgescu"},"728":{"n":"Mihail Dragutescu","nr":"Mihail Drăguțescu","sp":["Urologie"],"su":"https://www.medicover.ro/medici/mihail-daniel-dragutescu%2C357%2Cd%2C256"},"729":{"n":"Catalin Belinski","nr":"Cătălin Belinski","sp":["Urologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"730":{"n":"Alexandru Mihalache","sp":["Urologie"],"su":"https://drmihalache.ro/"},"731":{"n":"Andrei Manu Marin","sp":["Urologie"],"su":"https://www.evo-med.ro/en/team/andrei-manu-marin-md/"},"732":{"n":"Petru Octavian Dragoescu","nr":"Petru Octavian Drăgoescu","sp":["Urologie"],"su":"https://www.scjuc.ro/storage/2025/04/EchipaMedicala.pdf"},"733":{"n":"Valentin Pirvut","nr":"Valentin Pîrvuț","sp":["Urologie"],"su":"https://sb.prefectura.mai.gov.ro/wp-content/uploads/sites/28/2020/05/op-197.pdf"},"734":{"n":"Nicolae Crisan","nr":"Nicolae Crișan","sp":["Urologie"],"su":"https://colmedcj.ro/wp-content/uploads/2024/10/liste-actualizate-alegeri-2024-tur-2.pdf"},"735":{"n":"Cristian Condoiu","sp":["Urologie"],"su":"https://www.reginamaria.ro/medici/dr-condoiu-cristian"},"736":{"n":"Victor Madan","nr":"Victor Mădan","sp":["Urologie"],"su":"https://www.cmb.ro/wp-content/uploads/2024/09/LISTA-MEMBRILOR-CU-DREPT-DE-VOT-TUR-II.pdf"},"739":{"n":"Catalin Vlad","nr":"Cătălin Vlad","sp":["Chirurgie generală"],"su":"https://iocn.ro/sectia-chirurgie-oncologica-ii/"},"745":{"n":"Vlad Croitoru","sp":["Oncologie medicală"],"su":"https://www.clinica.gmh.ro/medic/vlad-croitoru"},"746":{"n":"Adrian Radu Vidra","sp":["Oncologie medicală"],"su":"https://www.spitalpelican.ro/blog/articole-medicale/campania-de-preventie-continua"},"747":{"n":"Cosmin O. Popa"},"748":{"n":"Oana Capraru","nr":"Oana Căpraru","sp":["Endocrinologie"],"su":"https://www.rmn-diagnostica.ro/echipa-medicala/dr-oana-capraru/"},"749":{"n":"Adina Braha","sp":["Diabet zaharat, nutriție și boli metabolice"],"su":"https://www.umft.ro/wp-content/uploads/2025/12/CV_Braha-Adina-RO_2025.pdf"},"750":{"n":"Ioana Luca"},"751":{"n":"Marilena Cioropariu","sp":["Neurologie"],"su":"https://www.brasov-colmed.ro/cmbvweb/LISTA_cu_%20membri_cu_drept_de_vot_TURUL_1_gata.pdf"},"752":{"n":"Bogdan Obrisca","nr":"Bogdan Obrișcă","sp":["Nefrologie"],"su":"https://umfcd.ro/wp-content/uploads/2022/CONC_DID_NEDET_SEM1_2022_2023/INFORMATII_CANDIDATI/FACULTATEA_DE_MEDICINA/%5BCV%5DObrisca_Bogdan%28SL7%29.pdf"},"753":{"n":"Ruxandra-Mioara Râjnoveanu","sp":["Pneumologie"],"su":"https://umfcluj.ro/medicina/facultate/departamente/departamentul-10/medicina-paliativa/"},"754":{"n":"Corina Marginean","nr":"Corina Mărginean","sp":["Pneumologie"],"su":"https://zonamed.ro/servicii/pneumologie/"},"755":{"n":"Marius Balint-Gib","sp":["Pneumologie"],"su":"https://azeena.ro/echipa/"},"756":{"n":"Mihnea Dumitrescu"},"757":{"n":"Daniela Matei"},"758":{"n":"Alina Ruscovan","sp":["Pneumologie"],"su":"https://colmedsm.ro/registru.php"},"759":{"n":"Eugenia Budin","sp":["Pneumologie"],"su":"https://www.galenus.ro/medic/budin-eugenia-corina/"},"760":{"n":"Renata Gheorghiu"},"761":{"n":"Andra Saulea"},"762":{"n":"Roxana Grigorovici"},"763":{"n":"Marc Bonaca"},"765":{"n":"Rodney Carter"}},"tumori":[["nsclc","Pulmonar non-microcelular (NSCLC)","Torace","Cancer pulmonar non-microcelular","plaman plamani pulmonar bronhopulmonar bronsic adenocarcinom scuamos nsclc","Non-small Cell Lung Cancer"],["sclc","Pulmonar microcelular (SCLC)","Torace","Cancer pulmonar microcelular","plaman plamani pulmonar bronhopulmonar microcelular sclc","Small Cell Lung Cancer"],["plaman","Pulmonar, fără precizare","Torace","Cancer pulmonar","plaman plamani pulmonar bronhopulmonar","Lung Cancer"],["mezoteliom","Mezoteliom","Torace","Mezoteliom","mezoteliom pleura pleural azbest","Mesothelioma"],["timus","Timom, carcinom timic","Torace","Timom","timom timus timic","Thymoma"],["san_hr","Sân HR+/HER2−","Sân","Cancer de sân hormonodependent (HR+/HER2−)","san mamar mamara hormonal hormonodependent luminal","HR-positive HER2-negative Breast Cancer"],["san_her2","Sân HER2+","Sân","Cancer de sân HER2 pozitiv","san mamar mamara her2","HER2-positive Breast Cancer"],["san_her2low","Sân HER2-low / ultralow","Sân","Cancer de sân HER2-low","san mamar mamara her2 low","HER2-low Breast Cancer"],["san_tn","Sân triplu negativ","Sân","Cancer de sân triplu negativ","san mamar mamara triplu negativ","Triple Negative Breast Cancer"],["san","Sân, toate subtipurile","Sân","Cancer de sân","san sani mamar mamara glanda mamara","Breast Cancer"],["esofag","Esofag","Digestiv","Cancer esofagian","esofag esofagian","Esophageal Cancer"],["gastric","Stomac și joncțiune esogastrică","Digestiv","Cancer gastric (stomac)","stomac gastric gastrica jonctiune esogastrica cardia","Gastric Cancer"],["colorectal","Colon și rect","Digestiv","Cancer colorectal (colon, rect)","colon rect rectal colorectal intestin gros sigmoid","Colorectal Cancer"],["anal","Canal anal","Digestiv","Cancer anal","anal anus","Anal Cancer"],["pancreas","Pancreas","Digestiv","Cancer pancreatic","pancreas pancreatic","Pancreatic Cancer"],["hcc","Hepatocarcinom","Digestiv","Cancer hepatic (hepatocarcinom)","ficat hepatic hepatocarcinom hepatocelular","Hepatocellular Carcinoma"],["biliar","Căi biliare, colangiocarcinom","Digestiv","Cancer de căi biliare","biliar biliare colangiocarcinom vezica biliara colecist","Biliary Tract Cancer"],["net","Tumori neuroendocrine","Digestiv","Tumori neuroendocrine","neuroendocrin neuroendocrine carcinoid","Neuroendocrine Tumors"],["prostata","Prostată","Urologic","Cancer de prostată","prostata prostatic","Prostate Cancer"],["rinichi","Rinichi (carcinom renal)","Urologic","Cancer renal","rinichi renal","Renal Cell Carcinoma"],["urotelial","Vezică urinară și uroteliu","Urologic","Cancer de vezică urinară","vezica urinara vezical urotelial uretere","Urothelial Carcinoma"],["testicul","Testicul, tumori germinale","Urologic","Cancer testicular","testicul testicular germinal","Testicular Cancer"],["ovar","Ovar, trompă, peritoneu","Ginecologic","Cancer ovarian","ovar ovarian ovare trompa peritoneu","Ovarian Cancer"],["endometru","Endometru (corp uterin)","Ginecologic","Cancer endometrial (uterin)","endometru endometrial uter uterin corp uterin","Endometrial Cancer"],["col","Col uterin","Ginecologic","Cancer de col uterin","col uterin cervical cervix","Cervical Cancer"],["vulva","Vulvă","Ginecologic","Cancer vulvar","vulva vulvar","Vulvar Cancer"],["capgat","Cap și gât (ORL)","Cap și gât","Cancer ORL (cap și gât)","orl cap gat laringe faringe limba cavitate bucala amigdala","Head and Neck Cancer"],["tiroida","Tiroidă","Cap și gât","Cancer tiroidian","tiroida tiroidian","Thyroid Cancer"],["melanom","Melanom","Piele","Melanom","melanom alunita","Melanoma"],["piele","Alte cancere de piele","Piele","Alte cancere de piele","piele cutanat bazocelular spinocelular merkel","Skin Cancer"],["snc","Tumori cerebrale primare","Sistem nervos","Tumori cerebrale","creier cerebral glioblastom gliom glioame meningiom","Brain Tumor"],["metcerebral","Metastaze cerebrale","Sistem nervos","Metastaze cerebrale","metastaze cerebrale creier","Brain Metastases"],["sarcom","Sarcoame","Sarcoame","Sarcom","sarcom sarcoame os osos tesut moale","Sarcoma"],["gist","GIST","Sarcoame","GIST","gist stromal","Gastrointestinal Stromal Tumor"],["lam","Leucemie acută mieloidă","Hematologie malignă","Leucemie acută mieloidă","leucemie acuta mieloida lam aml","Acute Myeloid Leukemia"],["lal","Leucemie acută limfoblastică","Hematologie malignă","Leucemie acută limfoblastică","leucemie acuta limfoblastica lal","Acute Lymphoblastic Leukemia"],["llc","Leucemie limfocitară cronică","Hematologie malignă","Leucemie limfocitară cronică","leucemie limfocitara cronica llc","Chronic Lymphocytic Leukemia"],["lmc","Leucemie mieloidă cronică","Hematologie malignă","Leucemie mieloidă cronică","leucemie mieloida cronica lmc","Chronic Myeloid Leukemia"],["smd","Sindroame mielodisplazice","Hematologie malignă","Sindrom mielodisplazic","mielodisplazic smd mielodisplazie","Myelodysplastic Syndromes"],["nmp","Neoplazii mieloproliferative","Hematologie malignă","Neoplazii mieloproliferative","mieloproliferativ mielofibroza policitemie trombocitemie","Myeloproliferative Neoplasms"],["hodgkin","Limfom Hodgkin","Hematologie malignă","Limfom Hodgkin","limfom hodgkin","Hodgkin Lymphoma"],["lnh","Limfoame non-Hodgkin","Hematologie malignă","Limfom non-Hodgkin","limfom limfoame non hodgkin folicular manta","Non-Hodgkin Lymphoma"],["mielom","Mielom multiplu","Hematologie malignă","Mielom multiplu","mielom multiplu","Multiple Myeloma"],["amiloidoza","Amiloidoză AL","Hematologie malignă","Amiloidoză","amiloidoza","Amyloidosis"],["alte_hem","Alte hemopatii maligne","Hematologie malignă","Alte boli maligne ale sângelui","hemopatie","Hematologic Malignancies"],["suport","Îngrijire de suport și prevenție","Altele","Îngrijire de suport","greata varsaturi casexie tromboza suport paliativ","Cancer Supportive Care"],["continuare","Continuarea tratamentului din studii anterioare","Altele","Continuarea tratamentului din studii","continuare extensie","Cancer"],["solide","Mai multe tipuri de tumori solide","Altele","Mai multe tipuri de cancer","tumori solide avansat metastatic","Solid Tumor"]],"biomarkeri":[["egfr","EGFR"],["alk","ALK"],["ros1","ROS1"],["kras","KRAS"],["braf","BRAF"],["her2","HER2 (ERBB2)"],["met","MET"],["ret","RET"],["ntrk","NTRK"],["pik3ca","PIK3CA"],["esr1","ESR1"],["brca","BRCA / HRD"],["msi","MSI / MMR"],["pdl1","PD-L1 (după nivelul de expresie)"],["fgfr","FGFR"],["cldn","Claudin 18.2"],["flt3","FLT3"],["idh","IDH1 / IDH2"],["hla","HLA"],["mtap","MTAP"],["npm1","NPM1"],["tp53","TP53"],["nectin4","Nectin-4"],["cd19","CD19"],["cd22","CD22"],["bcrabl","BCR::ABL1 / Philadelphia"],["pmlrara","PML::RARA / t(15;17)"],["del5q","Deleție 5q"],["dll3","DLL3"],["hr","Receptori hormonali (ER / PR)"],["hpv","HPV"],["p16","p16"],["nras","NRAS"],["del17p","Deleție 17p"],["cyclind1","Cyclin D1"],["t1114","t(11;14)"],["trop2","TROP2"],["aga","Alterări genomice acționabile"],["genomic_risk","Risc genomic tumoral"],["kit","KIT"],["pdgfra","PDGFRA"],["rb1","RB1"],["akt","AKT"],["pten","PTEN"],["ki67","Ki-67"],["tils","Limfocite infiltrante tumorale (TILs)"]]}